03.02.2015 Views

08-3187 Volume Appendix15.pdf - Medical Supply Chain

08-3187 Volume Appendix15.pdf - Medical Supply Chain

08-3187 Volume Appendix15.pdf - Medical Supply Chain

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

IN THE UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

SAMUEL K. LIPARI, )<br />

)<br />

Plaintiff, )<br />

)<br />

v. ) Case No. 07-CV-02146-CM-DJW<br />

)<br />

U.S. BANCORP, and )<br />

)<br />

U.S. BANK NATIONAL ASSOCIATION, )<br />

)<br />

Defendants. )<br />

DEFENDANTS’ RESPONSE TO PLAINTIFF’S<br />

OBJECTION TO MAGISTRATE ORDER<br />

COMPELLING DISCOVERY AND SANCTIONING THE PLAINTIFF<br />

Defendants U.S. Bancorp and U.S. Bank National Association, by and through counsel,<br />

file this Response to the Plaintiff’s Objection to the Magistrate’s Order Compelling Discovery<br />

and Sanctioning the Plaintiff. The Magistrate’s Order was correct on all accounts and should be<br />

upheld in its entirety.<br />

As noted in the Magistrate’s Order, the plaintiff failed to serve any response to plaintiff’s<br />

Motion to Compel. This alone is sufficient justification for the Magistrate’s ruling. See, D. Kan.<br />

R. 7.4. Nonetheless, the plaintiff contends that despite not serving any responses to defendants’<br />

Requests for Production, he as provided all responsive documents in a voluminous settlement<br />

package. Plaintiff’s arguments fail for two reasons.<br />

First, plaintiff did not assert this argument before the Magistrate’s ruling. If the plaintiff<br />

believes he has sufficiently responded to defendants’ discovery requests, he should have filed a<br />

response to the Motion to Compel asserting these arguments. But he did not do so and may not<br />

assert them here for the first time.<br />

2342450.01<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5576


Next, even if plaintiff had asserted this argument, service of his argumentative settlement<br />

brief (which exceeds 500 pages) does not relieve plaintiff of his responsibility to respond to<br />

defendants’ properly served discovery requests. In the context of discovery responses, courts in<br />

this District recognize that a party must specifically identify which documents are responsive to a<br />

particular request. See¸ e.g., Johnson v. Kraft Foods North America, Inc., 236 F. R. D. 535, 541<br />

(D. Kan. 2006).<br />

Therefore, even if plaintiff’s settlement brief contains some relevant<br />

information, mere service of it is still non-responsive because it does not delineate which<br />

documents are supposedly responsive to which requests.<br />

The plaintiff makes further accusations that the defendants have failed to comply with his<br />

discovery requests. These are false. While the plaintiff has submitted Requests for Production<br />

to the defendants, the defendants timely filed a Motion for Protective Order which is currently<br />

pending before this Court.<br />

Likewise, defendants also made formal objections to each of<br />

plaintiff’s discovery requests. The plaintiff failed to challenge these objections within the time<br />

frame set forth in D. Kan. Rule 37.1, and has therefore waived his ability to do so.<br />

But despite the objections and Motion for a Protective Order, the defendants still made a<br />

good faith effort to search for responsive information and have produced responsive<br />

non-privileged documentation where they could reasonably do so. Therefore, the defendants<br />

have fully complied with their obligations under the rules of this Court and the Federal Rules of<br />

Civil Procedure.<br />

The plaintiff has failed to show any justification for the District Court to overrule the<br />

Magistrate’s Order. For the above-stated reasons, the defendants request the District Court fully<br />

uphold the Magistrate’s Order compelling production of documents and sanctioning the plaintiff,<br />

and further grant defendants what other relief to which they are justly entitled.<br />

2342450.01<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5577


Respectfully submitted,<br />

/s/ Jay E. Heidrick<br />

ANDREW M. DeMAREA KS #16141<br />

JAY E. HEIDRICK KS #20770<br />

SHUGHART THOMSON & KILROY, P.C.<br />

32 Corporate Woods, Suite 1100<br />

9225 Indian Creek Parkway<br />

Overland Park, Kansas 66210<br />

(913) 451-3355<br />

(913) 451-3361 (FAX)<br />

MARK A. OLTHOFF KS # 70339<br />

SHUGHART THOMSON & KILROY, P.C.<br />

1700 Twelve Wyandotte Plaza<br />

120 W 12th Street<br />

Kansas City, Missouri 64105-1929<br />

(816) 421-3355<br />

(816) 374-0509 (FAX)<br />

ATTORNEYS FOR DEFENDANTS<br />

U.S. BANCORP and U.S. BANK NATIONAL<br />

ASSOCIATION<br />

CERTIFICATE OF SERVICE<br />

I hereby certify that a copy of the above and foregoing document was filed electronically<br />

with the above-captioned court, with notice of case activity to be generated and sent<br />

electronically by the Clerk of said court (with a copy to be e-mailed to any individuals who do<br />

not receive electronic notice from the Clerk) this 18th day of July, 20<strong>08</strong>, to:<br />

Mr. Samuel K. Lipari<br />

297 NE Bayview<br />

Lee’s Summit, MO 64064<br />

/s/ Jay E. Heidrick<br />

Attorney for Defendants<br />

2342450.01<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5578


DJW/bh<br />

SAMUEL K. LIPARI,<br />

IN THE UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

v.<br />

U.S. BANCORP, N.A., et al.,<br />

Plaintiff,<br />

Defendants.<br />

CIVIL ACTION<br />

No. 07-2146-CM-DJW<br />

MEMORANDUM AND ORDER<br />

This matter is before the Court on Defendants’ Motion to Compel Compliance with Rule<br />

26(a)(1) (doc. 68). For the reasons set forth below, the Motion is granted in part and denied in part.<br />

I. Background Information<br />

On April 20, 2007, Plaintiff served his initial disclosures pursuant to Federal Rule of Civil<br />

Procedure 26(a)(1). His disclosure statement listed 67 individuals and provided a generic<br />

identification for each person, such as “Antitrust,” “Technology,” “Contracting,” “Funding,” and<br />

“FBI.” Other individuals were identified only as “Witness.” No addresses or telephone numbers<br />

were provided for any of the 67 listed individuals.<br />

Plaintiff’s disclosure statement also listed thousands of documents, 1 many of which were<br />

only briefly described. 2 Some of the documents were also identified by Bates Stamp Numbers.<br />

Accompanying the disclosure statement was a CD containing the documents listed in the disclosure<br />

statement. The disc contains more than 11,000 pages of documents.<br />

1 The listing of documents is approximately 39 pages in length.<br />

2<br />

For example, documents were identified as “Neil Marsh Invoice,” “Article When Private<br />

Goes Public,” “Vendor Rating a GPO Model.”<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5579


After the instant Motion to Compel was filed, Plaintiff served a supplemental disclosure<br />

statement that lists the names of 34 individuals. All but one of the 34 individuals listed in the<br />

supplemental statement were also listed in the initial statement. Unlike the initial statement, the<br />

supplemental statement provides addresses for 14 of the listed individuals.<br />

Defendants seek an order directing Plaintiff to amend his disclosures. Defendants contend<br />

that Plaintiff’s witness disclosures are deficient because Plaintiff fails to provide the telephone<br />

numbers and addresses for the individuals disclosed, and the subjects of those individuals’<br />

knowledge. Defendants assert that Plaintiff’s document disclosures are deficient because Plaintiff<br />

has disclosed thousands of pages of documents that are not only irrelevant to his claims but do not<br />

even pertain to this lawsuit. Defendants also contend that Plaintiff’s document disclosures are<br />

deficient because the written listing of documents is “not organized by category.” 3<br />

In his brief opposing the Motion to Compel, Plaintiff explains that he “has now supplemented<br />

his disclosures to include the addresses he knows,” 4 but states that “[t]he majority of<br />

witnesses . . . come from the defendants.” 5 He also states that in his initial disclosures he “included<br />

the relevant documents to the plaintiff’s claims and factual averments in his complaint.” 6<br />

In<br />

addition, he explains that he “has served the documents to the defendants in indexed form on a<br />

conveniently searchable disc, with an informative description of each.” 7<br />

3 Defs.’ Mem. in Supp. of Defs.’ Mot. to Compel (doc. 70) at p. 4.<br />

4<br />

Pl.’s Mem. In Opp. to Defs.’ Mot. to Compel (doc. 75) at p. 1.<br />

5 Id. at p. 7.<br />

6 Id. at p.1.<br />

7<br />

Id. at p. 7.<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5580


In their reply, Defendants state that it is unclear whether Plaintiff’s supplemental list of 34<br />

individuals is intended to replace the list of 67 individuals disclosed in Plaintiff’s initial disclosure<br />

statement or whether it is simply another list that further identifies some of the initially disclosed<br />

67 individuals. In addition, Defendants point out that Plaintiff has failed to provide the subject<br />

matter of the discoverable information known by any of the 34 individuals listed in the supplemental<br />

disclosure statement. Defendants further state that the disc provided by Plaintiff is not searchable<br />

and is, in fact, password protected, which prevents the documents from being searched or re-created<br />

in .pdf format. Defendants concede, however, that they have been able “to view” each of the 11,000<br />

pages of documents that are on the disc. 8<br />

II.<br />

Discussion<br />

A. Disclosure of Witnesses<br />

Rule 26(a)(1)(A)(i) provides for the disclosure of certain individuals who are likely to have<br />

discoverable information about the case. It provides that a party must provide to the other parties:<br />

the name and, if known, the address and telephone number of each<br />

individual likely to have discoverable information –– along with the<br />

subjects of that information –– that the disclosing party may use to<br />

support its claims or defenses, unless the use would be solely for<br />

impeachment[.] 9 <strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5581<br />

8 Defs.’ Reply (doc. 79) at p. 1<br />

9<br />

Fed. R. Civ. P. 26(a)(1)(A)(i).<br />

3


Thus, under Rule 26(a)(1)(A)(i), Plaintiff was required to provide the following information<br />

about any individuals likely to have discoverable information that he may use to support his claims<br />

or defenses:<br />

! person’s name;<br />

! person’s telephone number and address, if known by Plaintiff; and<br />

! the subject of the discoverable information known by that person.<br />

As noted above, Defendants fault Plaintiff’s witness disclosures for three main reasons.<br />

First, Defendants contend that Plaintiff has failed to adequately identify the subject of the<br />

discoverable information known by each individual. This Court has found only a handful of cases<br />

that address the degree of specificity required under Rule 26(a)(1)(A)(i) regarding the subject of the<br />

discoverable information known by the potential witness. 10 Some guidance, however, can be<br />

gleaned from Federal Rule of Civil Procedure 26(g)(1), which provides that initial disclosures must<br />

10 See, e.g., Lobato v. Ford, No. 05-cv-01437-LTB-CBS, 2007 WL 2593485, at *5 (D. Colo.<br />

Sept. 5, 2007) (“While a party is not necessarily required to provide a minute recitation of the<br />

putative witness’ knowledge, the Rule 26(a)(1)(A) disclosure should indicate briefly the general<br />

topics on which such persons have knowledge.”); Hertz v. Luzenac Am., Inc., No. 04-cv-1961-LTB-<br />

CBS, 2006 WL 994431, at *7 (D. Colo. Apr. 13, 2006) (“[D]isclosures should provide the opposing<br />

party with enough useful information to make informed decisions regarding discovery and trial<br />

preparation”); Sender v. Mann, 225 F.R.D. 645, 650-51 (D. Colo. 2004) (holding that disclosures<br />

should be complete and detailed and should give opposing party more than “a laundry list of<br />

undifferentiated witnesses” and finding disclosures deficient where plaintiff identified brokers and<br />

investors as “having knowledge regarding the sale of promissory notes and the amounts owed to<br />

them pursuant to such notes” or “in some instances, having knowledge of other schemes attempted<br />

or contemplated by [Defendants]”); Crouse Cartage Co. v. Nat’l Warehouse Inv. Co., No. IP02-<br />

071CTK, 2003 WL 23142182, at *1 (S.D. Ind. 2003) (holding that “initial disclosures should be<br />

complete and detailed, and should give the opposing party information as to the identification and<br />

location of persons with knowledge so that they can be contacted in connection with the litigation.”);<br />

see also generally City and County of San Francisco v. Tutor-Saliba Corp., 218 F.R.D. 219, 221<br />

(N.D. Cal. 2003) (disclosures function “to assist the parties in focusing and prioritizing their<br />

organization of discovery.”).<br />

4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5582


e based upon a “reasonable inquiry” by counsel or the disclosing party, and must be “complete and<br />

correct as of the time [they] are made.” 11 Guidance is also provided by the Advisory Committee’s<br />

Note to the 1993 amendments, which states that a “major purpose of the [Rule] is to accelerate the<br />

exchange of basic information about the case and to eliminate the paper work involved in requesting<br />

such information, and the rule should be applied in a manner to achieve those objectives.” 12<br />

Furthermore, the Advisory Committee explains:<br />

[The parties] are expected to disclose the identity of those persons who may be used<br />

by them as witnesses or who, if their potential testimony were known, might<br />

reasonably be expected to be deposed or called as a witness by any of the other<br />

parties. Indicating briefly the general topics on which such persons have information<br />

should not be burdensome, and will assist other parties in deciding which depositions<br />

will actually be needed. 13<br />

Thus, while a party is not required to provide a detailed narrative of the potential witness’<br />

knowledge, the Rule 26(a)(1)(A) disclosure should provide enough information that would allow<br />

the opposing party to help focus the discovery that is needed and to determine whether a deposition<br />

of a particular person identified as a potential witness might be necessary. Clearly, Plaintiff’s<br />

witness disclosures do not meet this standard. It is difficult to understand how Plaintiff’s generic<br />

descriptions of “Technology, “Communications,”“FBI,” etc., for these potential witnesses could<br />

11<br />

Fed. R. Civ. P. 26(g)(1).<br />

12 Fed. R. Civ. P. 26(a) advisory committee’s note (1993 amendment); see also Biltrite Corp.<br />

v. World Road Markings, Inc., 202 F.R.D. 359, 362 (D. Mass. 2001) (“The obvious purpose of the<br />

disclosure requirement of Rule 26(a)(1)(A) is to give the opposing party information as to the<br />

identification and location of persons with knowledge so that they can be contacted in connection<br />

with the litigation. . . .”).<br />

13<br />

Fed. R. Civ. P. 26(a) advisory committee’s note (1993 amendment).<br />

5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5583


help focus the discovery efforts of Defendants or assist Defendants in determining whether a<br />

deposition of a particular listed individual might be necessary.<br />

Plaintiff may not excuse his compliance with this requirement merely because, as Plaintiff<br />

puts it, most of the identified individuals “come from the defendants.” 14<br />

The Rule requires the<br />

disclosing party to identify those individuals who may have discoverable information that the<br />

disclosing party may use to support its own claims and defenses. 15<br />

In other words, Plaintiff need<br />

only disclose those individuals that may have discoverable information that Plaintiff himself may<br />

use to support his claims or defenses. Once he makes that determination and identifies certain<br />

persons, he must provide a sufficient description of the discoverable knowledge that he believes they<br />

possess.<br />

Defendants also find fault with Plaintiff’s witness disclosures because Plaintiff fails to list<br />

addresses for many of the individuals and fails to list telephone numbers for all of them. Also, it is<br />

unclear whether the supplemental disclosure statement is intended to merely supplement the initial<br />

disclosure statement or to take its place.<br />

Rule 26(a)(1)(A)(i) requires the disclosing party to provide the name and telephone numbers<br />

of the individuals only “if known” by the disclosing party Thus, Plaintiff can be compelled to<br />

provide addresses and telephone numbers only if that information is known to him. Assuming that<br />

information is known to him, he is not excused from providing it merely because he believes<br />

Defendants already have knowledge of these individuals and their contact information.<br />

14 Pl.’s Mem. In Opp. to Defs.’ Mot. to Compel (doc. 75) at p. 7.<br />

15<br />

See Rule 26(a)(1)(A)(i) (party must disclose each individual “likely to have discoverable<br />

information . . . that the disclosing party may use to support its claims or defenses, unless the use<br />

would be solely for impeachment.” (Emphasis added.)<br />

6<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5584


In light of the foregoing, the Court directs Plaintiff to serve amended Rule 26(a)(1)(A)(i)<br />

disclosures that take the place of his initial and supplemental disclosures 16 and which provide<br />

sufficiently detailed information regarding the subject of each potential witness’ knowledge. In<br />

addition, the amended disclosures shall provide each individual’s address and telephone number,<br />

if known to Plaintiff. Finally, Plaintiff shall insure that any individuals listed are those who he<br />

believes are likely to have discoverable information that he may use to support his claims or<br />

defenses in this particular lawsuit. These amended disclosures shall be served on Defendants by<br />

July 30, 20<strong>08</strong>.<br />

B. Disclosure of Documents<br />

Rule 26(a)(1)(A)(ii) requires a party to provide to the other parties in the lawsuit “a copy ––<br />

or a description by category and location –– of all documents, electronically stored information, and<br />

tangible things that the disclosing party has in its possession, custody, or control and may use to<br />

support its claims or defenses, unless the use would be solely for impeachment.” 17 To comply with<br />

the Rule, then, Plaintiff was required to provide Defendants with the following:<br />

! either a copy or a description by category and location, of all documents, electronically<br />

stored information, and tangible things;<br />

! that are in Plaintiff’s possession, custody or control; and<br />

! that Plaintiff may use to support his claims or defenses in this lawsuit.<br />

Defendants essentially argue that the first and third of these requirements have not meet satisfied.<br />

16<br />

This should end any confusion as to whether the supplemental disclosures were intended<br />

to replace the initial disclosures.<br />

17<br />

Fed. R. Civ. P. 26(a)(1)(A)(ii).<br />

7<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5585


With respect to the first requirement, Defendants assert that Plaintiff’s written descriptions<br />

of the indexed documents are “far from informative” 18 and that the disc of documents provided by<br />

Plaintiff is password protected so that Defendants cannot search it and cannot re-create the<br />

documents in .pdf format. Defendants do not dispute, however, that they have been able to review<br />

all of the documents that are found on the disc. 19<br />

The Court finds that Plaintiff has complied with the first requirement by providing the disc<br />

to Defendants. By doing so, Plaintiff, in effect, provided a “copy” (albeit in electronic form) of each<br />

of the disclosed documents. The Rule is written in the disjunctive; Plaintiff may provide either a<br />

copy or a description of the documents by category and location. As Plaintiff provided a copy, he<br />

was not required to provide a description. It is thus immaterial that he may have provided<br />

insufficient descriptions of his documents on his written index of documents. Furthermore, there<br />

is no requirement that Plaintiff provide Defendant with a disc of the documents that is “searchable”<br />

or that allows the documents contained on it to be converted to .pdf format. Defendants concede<br />

that they have been able to review each of the documents contained on the disc; thus, whether the<br />

disc is searchable or allows the documents to be recreated in .pdf format is immaterial.<br />

With respect to the third requirement, Defendants argue that none of the thousands of pages<br />

of documents that Plaintiff has disclosed is relevant to this case. More specifically, Defendants<br />

argue that Plaintiff’s disclosures are a duplicate of what he served in another case, Lipari, et al. v.<br />

General Electric, et al., Case No. 0616-CV7421, filed in the Circuit Court of Jackson County,<br />

18 Defs.’ Reply (doc. 79) at p. 2.<br />

19 Id.<br />

8<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5586


Missouri (“General Electric case”). 20 According to Defendants, those documents are unrelated to<br />

this case because the General Electric case involves different defendants and different facts.<br />

Plaintiff argues that Defendants are incorrect when they argue that his document disclosures<br />

must be deficient because they are the same document disclosures made in the General Electric<br />

case. Plaintiff argues that both this case and General Electric stem from the same underlying facts.<br />

He states that “both cases cover the same events and rely on the same determination of <strong>Medical</strong><br />

<strong>Supply</strong> <strong>Chain</strong>, Inc.’s income if [Defendants] had not breached their contracts with <strong>Medical</strong> <strong>Supply</strong><br />

<strong>Chain</strong>, Inc.” and engaged in the other wrongful acts alleged in Plaintiff’s Complaint. 21 Plaintiff<br />

further states that he has disclosed “the documents related to the launch of his business and his<br />

claims against the defendants that the plaintiff will likely be using in court before a jury.” 22<br />

Not having reviewed the documents at issue and not being intimately familiar with the facts<br />

and allegations of this case, or for that matter, the General Electric case, the Court is not in a<br />

position to determine whether each and every document disclosed by Plaintiff is one that he might<br />

use to support his claims and defenses. The Court declines to enter an order, based upon nothing<br />

more than doubt and speculation, that would require Plaintiff to remove certain documents from his<br />

disclosures. The Court will, however, direct Plaintiff to file a supplemental Rule 26(a)(1)(A)(ii)<br />

disclosure statement in which he makes an affirmative statement that the documents listed on his<br />

initial Rule 26(a)(1)(A)(ii) written disclosure statement, and contained on the disc provided to<br />

20 Plaintiff states that the General Electric case is now filed in the Western District of<br />

Missouri, Case No. 07-<strong>08</strong>49-CV-W-FJG. Pl.’s Mem. in Opp. to Defs.’ Mot. to Compel (doc. 75)<br />

at p. 1.<br />

21 Id. at p.3.<br />

22<br />

Id. at p. 5.<br />

9<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5587


Defendants, are documents that he (1) has in his possession, custody, or control, and (2) may use<br />

to support his claims or defenses in this case. To the extent Plaintiff has disclosed documents that<br />

fall outside of this definition, he shall serve amended document disclosures that comply with Rule<br />

26(a)(1)(a)(ii) and this Memorandum and Order. The supplemental disclosure statement or amended<br />

disclosures shall be served on Defendants by July 30, 20<strong>08</strong>.<br />

III.<br />

Attorney’s Fees and Expenses<br />

Defendants do not expressly request an award of expenses or fees in connection with their<br />

Motion to Compel; they merely “request all . . . relief to which they are justly entitled.” 23 The Court<br />

must look to Federal Rule of Civil Procedure 37(a)(5), which deals with the payment of expenses<br />

incurred in connection with motions to compel. Subsection (C) provides for the payment of the<br />

moving party’s expenses if the motion to compel discovery is granted in part. It provides that the<br />

Court “may, after giving an opportunity to be heard, apportion the reasonable expenses for the<br />

motion.” 24<br />

To satisfy the requirement that the parties be given the opportunity to be heard, the Court<br />

directs Plaintiff to show cause, in a pleading filed on or before August 13, 20<strong>08</strong>, why he should not<br />

be required to pay a portion of the reasonable expenses and attorney’s fees Defendants incurred in<br />

making their Motion to Compel. Defendants shall have until August 24, 20<strong>08</strong> to file a response<br />

thereto, if they so choose. In the event the Court determines that expenses and fees should be<br />

awarded and apportioned, the Court will issue an order setting forth a schedule for the filing of an<br />

23 Defs.’ Mem. in Supp. of Mot. to Compel (doc. 70) at p. 5.<br />

24<br />

Fed. R. Civ. P. 37(a)(5)(C).<br />

10<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5588


affidavit reflecting the amount of expenses and fees that Defendants have incurred, and for the filing<br />

of any related briefs.<br />

IV.<br />

Other Relief<br />

Defendants ask that the Court caution Plaintiff that any further discovery abuses may result<br />

in severe sanctions, including the possible dismissal of his claims. The Court declines to enter such<br />

an order, finding that Defendants have not shown that Plaintiff has engaged in discovery abuses in<br />

connection with his Rule 26(a)(1) disclosures.<br />

IT IS THEREFORE ORDERED that Defendants’ Motion to Compel Compliance with<br />

Rule 26(a)(1) (doc. 68) is granted in part and denied in part, as set forth herein..<br />

IT IS FURTHER ORDERED that, on or before July 30, 20<strong>08</strong>, Plaintiff shall serve an<br />

amended Rule 26(a)(1)(A)(i) witness disclosure statement in compliance with this Memorandum<br />

and Order.<br />

IT IS FURTHER ORDERED that, on or before July 30, 20<strong>08</strong>, Plaintiff shall serve a<br />

supplemental Rule 26(a)(1)(A)(ii) document disclosure statement or amended Rule 26(a)(1)(A)(ii)<br />

document disclosures in compliance with this Memorandum and Order.<br />

IT IS FURTHER ORDERED that, on or before August 13, 20<strong>08</strong>, Plaintiff shall show<br />

cause in a pleading filed with the Court, why he should not be required to pay a portion of the<br />

reasonable fees and expenses that Defendants incurred in making their Motion to Compel.<br />

Defendants shall have until August 24, 20<strong>08</strong> to file a response thereto.<br />

11<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5589


IT IS SO ORDERED.<br />

Dated in Kansas City, Kansas on this 22nd day of July 20<strong>08</strong>.<br />

s/ David J. Waxse<br />

David J. Waxse<br />

U.S. Magistrate Judge<br />

cc:<br />

All counsel and pro se parties<br />

12<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5590


DJW/bh<br />

SAMUEL K. LIPARI,<br />

IN THE UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

v.<br />

U.S. BANCORP, N.A., et al.,<br />

Plaintiff,<br />

Defendants.<br />

CIVIL ACTION<br />

No. 07-2146-CM-DJW<br />

MEMORANDUM AND ORDER<br />

This matter is before the Court on Plaintiff’s Motion for Leave to Amend Petition (doc.<br />

101). For the reasons set forth below, the Court denies the motion.<br />

I. Background Information<br />

Plaintiff filed this action on November 28, 2006 in the Circuit Court of Jackson County,<br />

Missouri. On December 13, 2006, Defendants removed the case to the United States District Court<br />

for the Western District of Missouri, based on diversity jurisdiction. The District Court for the<br />

Western District of Missouri transferred the case to this District. Plaintiff’s Petition asserts claims<br />

for breach of contract, fraud, misappropriation of trade secrets under R.S.Mo. § 417.450, breach of<br />

fiduciary duty, and prima facie tort.<br />

This Court held a scheduling conference on January 11, 20<strong>08</strong>, at which time the Court set<br />

a March 1, 20<strong>08</strong> deadline for filing motions to join additional parties or otherwise amend the<br />

pleadings. 1 In addition, the Court set a July 1, 20<strong>08</strong> deadline for completing discovery, a July 30,<br />

1 Scheduling Order (doc. 5), 3.a.<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5591


20<strong>08</strong> pretrial conference, and an August 15, 20<strong>08</strong> dispositive motion deadline. 2 Trial was set for<br />

March 2, 2009. On July 23, 20<strong>08</strong>, the Court converted the pretrial conference to a telephone status<br />

conference to take up Plaintiff’s motion to stay proceedings. 3<br />

Plaintiff filed the instant Motion to Amend on July 18, 20<strong>08</strong>, more than three and one-half<br />

months after the March 1, 20<strong>08</strong> deadline for filing motions to amend, and more than two weeks after<br />

the close of discovery. Plaintiff is proceeding in this action pro se.<br />

Two motions to dismiss have been filed in this case. The first motion was granted in part<br />

on November 16, 2007 (see doc. 39). Defendants filed a second motion to dismiss (doc. 43) on<br />

December 19, 2007, and that motion is pending before the District Court Judge.<br />

II.<br />

Plaintiff’s Proposed Amendments<br />

In support of his motion, Plaintiff asserts that his initial petition “was written for a Missouri<br />

state court forum,” 4 and that his amendments are intended “to correct any deficiencies found in the<br />

second dismissal.” 5<br />

Plaintiff’s motion does not include “a concise statement” of the proposed<br />

amendments, as required by D. Kan. Rule 15.1. He merely states that “[t]he amended text is<br />

between paragraphs 257 and 258 on pages 70 to 73.” 6<br />

Plaintiff attaches a copy of the proposed Amended Petition, in which he adds a new cause<br />

of action under Count VI. It is entitled:<br />

2 Id., 2.b., 3.c., and 4.b.<br />

3<br />

See Order (doc. 104).<br />

4<br />

Pl.’s Mot. for Leave to Amend Pet. (doc. 101) at p.1.<br />

5 Id.<br />

6<br />

Id.<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5592


Cause of Action for Declaratory and Injunctive Relief Against US Bank NA and US<br />

Bancorp That Subtitle B, Section 351 of the Uniting and Strengthening America by<br />

Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA<br />

Patriot) Act of 2001 Amendment of 31 U.S.C. §5318(g) Violates the First and Fifth<br />

Amendments of the United States Constitution. 7<br />

Proposed Count VI consists of nine paragraphs, in which Plaintiff alleges, inter alia, that<br />

Defendants have deprived him of property and prevented him “from seeking redress in their role as<br />

the enforcement officers or agents of the government under 31 U.S.C. § 5318(g).” 8<br />

Under Count<br />

VI, Plaintiff requests that the Court declare 31 U.S.C. §5318(g)(2)(A)(i) unconstitutional and enjoin<br />

Defendants “from withholding documents related to their enforcement of the USA PATRIOT Act.” 9<br />

Plaintiff argues that Defendants will not be prejudiced by the amendments. He contends<br />

there is no potential for prejudice because “the audio recording and email shows the parties knew<br />

they were in contract and then later used the USA PATRIOT ACT to default on the contract.” 10<br />

III.<br />

Standard for Ruling on a Motion to Amend<br />

Pursuant to Federal Rule of Civil Procedure 15(a)(2), once a responsive pleading has been<br />

filed, “a party may amend its pleading only with the opposing party’s written consent or the court’s<br />

leave.” 11 Rule 15(a)(2) specifies that the court “freely give leave when justice so requires.” 12<br />

Nonetheless, a court may refuse to grant leave to amend based on “undue delay, bad faith or dilatory<br />

7 Proposed Am. Pet., attached as Ex. 2 to Pl.’s Mot. for Leave to Amend Pet. (doc. 101).<br />

8<br />

Id., 257.2.<br />

9 Id., 257.9.<br />

10 Pl.’s Mot. for Leave to Amend Pet. (doc. 101) at p. 2.<br />

11 Fed. R. Civ. P. 15(a)(2).<br />

12<br />

Id.<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5593


motive on the part of the movant, repeated failure to cure deficiencies by amendments previously<br />

allowed, undue prejudice to the opposing party by virtue of allowance of the amendment, [or] futility<br />

of amendment.” 13<br />

When a motion is filed beyond the deadline for filing motions to amend, as in this case, the<br />

court must also take into account the good cause standard found in Rule 16(b)(4), 14 which provides<br />

that a scheduling order deadline “may be modified only for good cause and with the judge’s<br />

consent.” 15 Thus, when a motion to amend is filed beyond the Scheduling Order deadline, the court<br />

must first determine whether the moving party has established “good cause” within the meaning of<br />

Rule 16(b)(4) so as to justify allowing the untimely motion, and, only after determining that good<br />

cause has been established, will the Court proceed to determine if the Rule 15(a) standard for<br />

amendment has been satisfied. 16<br />

To establish good cause under Rule 16, the moving party must show that the deadline “could<br />

not have been met with diligence.” 17 “Carelessness is not compatible with a finding of diligence and<br />

13<br />

Minter v. Prime Equip. Co., 451 F.3d 1196, 1204 (10th Cir. 2006) (quoting Foman v.<br />

Davis, 371 U.S. 178, 182 (1962)).<br />

14 Boatright v. Larned State Hosp., No. 05-3183-JAR-KGS, 2007 WL 2693674, at *6 (D.<br />

Kan. Sept. 20, 2007); McCormick v. <strong>Medical</strong>odges, Inc., No. 05-2429-KHV-JPO, 2007 WL 471127<br />

at *2 (D. Kan. Feb. 8, 2007).<br />

15 Fed. R. Civ. P. 16(b)(4).<br />

16 See, e.g., Boatright, 2007 WL 2693674, at *5 (applying two-part test); McCormick, 2007<br />

WL 471127, at *2 (same); Deghand v. Wal-Mart Stores, Inc., 904 F.Supp. 1218, 1221 (D. Kan.<br />

1995) (“Because the plaintiff sought leave to amend her complaint after the deadline established in<br />

the pretrial scheduling order, Rule 16 of the Federal Rules of Civil Procedure is the plaintiff's first<br />

hurdle. . . . Rule 15 is the next hurdle for the plaintiff.”).<br />

17 Simpson v. Home Depot, Inc., 203 F.R.D. 643, 644 (D. Kan. 2001) (quoting Denmon v.<br />

Runyon, 151 F.R.D. 404, 407 (D. Kan. 1993)); accord Deghand, 904 F.Supp. at 1221 (the moving<br />

(continued...)<br />

4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5594


offers no reason for a grant of relief.” 18 Furthermore, the lack of prejudice to the nonmovant does<br />

not show “good cause.” 19<br />

IV.<br />

Analysis<br />

Plaintiff offers no explanation as to why he did not timely file his motion to add this new<br />

cause of action. In addition, Plaintiff has not made any attempt to demonstrate why he could not<br />

have met the March 1, 20<strong>08</strong> deadline through diligence. He merely argues that Defendants will not<br />

be prejudiced by the amendments, that his amendments are intended “to correct any deficiencies<br />

found in the second dismissal,” 20 and that his Petition needs to be modified because it was initially<br />

drafted as a state court pleading.<br />

Plaintiff’s arguments are not persuasive. As noted above, whether Defendants may or may<br />

not be prejudiced by the amendment is not a consideration in determining whether Plaintiff has<br />

established good cause for filing his motion to amend out of time. Secondly, Plaintiff’s assertion<br />

that the proposed amendments are intended to correct the deficiencies raised by Defendant’s second<br />

motion to dismiss does not establish good cause for why he did not move to amend by the March<br />

1, 20<strong>08</strong> deadline. Defendants filed their second motion to dismiss on December 19, 2007; yet<br />

Plaintiff waited seven months to file the instant motion to amend. The same is true with respect to<br />

17<br />

(...continued)<br />

party “must show that despite due diligence it could not have reasonably met the scheduled<br />

deadlines.”).<br />

18<br />

Deghand, 904 F.Supp. at 1221 (quoting Johnson v. Mammoth Recreations, Inc., 975 F.2d<br />

604, 609 (9th Cir. 1992)).<br />

19 Id. (citations omitted).<br />

20<br />

Pl.’s Mot. for Leave to Amend Pet. (doc. 101) at p. 1.<br />

5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5595


Plaintiff’s contention that he needs to amend his Petition because it was drafted to be filed in state<br />

court, and not federal court. This case was removed to federal court in December 2006; yet Plaintiff<br />

did not move to amend until one and one-half years later.<br />

In light of the above, the Court holds that Plaintiff has failed to demonstrate why he could<br />

not have met the March 1, 20<strong>08</strong> amendment deadline with diligence, and, thus, has failed to<br />

establish “good cause” within the meaning of Rule 16(b)(4) so as to justify allowing his untimely<br />

motion. The Court is mindful that Plaintiff is proceeding pro se and that his filings must be liberally<br />

construed and held to a less stringent standard than pleadings filed by an attorney. 21 This requires<br />

that the Court look past any confusion of legal theories or failure to cite proper legal authority. 22<br />

Despite this liberal standard, the Tenth Circuit has made it clear that a court is not allowed to craft<br />

arguments or theories for a pro se plaintiff in the absence of any discussion of those issues. 23 Thus,<br />

the Court will not attempt to speculate or formulate explanations as to why Plaintiff may have been<br />

unable to file his motion to amend by the March 1, 20<strong>08</strong> deadline.<br />

As Plaintiff has failed to satisfy Rule 16’s good cause standard, the Court is not required to<br />

consider whether Plaintiff has satisfied the standard for amendment under Rule 15(a). 24 In light of<br />

21 See Hall v. Bellmon, 935 F.2d 1106, 1110 (10th Cir. 1991) (“A pro se litigant’s pleadings<br />

are to be construed liberally and held to a less stringent standard than formal pleadings drafted by<br />

lawyers.”).<br />

22 Id.<br />

23 Drake v. City of Fort Collins, 927 F.2d 1156, 1159 (10th Cir. 1991).<br />

24 If the Court were to consider Plaintiff’s motion under Rule 15(a), one factor the Court<br />

would consider is the potential for prejudice to Defendants. The Court finds that Defendants would<br />

be prejudiced by the introduction of a new cause of action at this late stage of the lawsuit –– after<br />

discovery has been completed and with the dispositive motion deadline only a few weeks away.<br />

Such prejudice would be sufficient for the Court to deny Plaintiff leave to amend under Rule 15.<br />

6<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5596


Plaintiff’s failure to demonstrate good cause for filing his motion to amend out of time, the Court<br />

must deny the motion.<br />

101) is denied.<br />

IT IS THEREFORE ORDERED that Plaintiff’s Motion for Leave to Amend Petition (doc.<br />

IT IS SO ORDERED.<br />

Dated in Kansas City, Kansas on this 28th day of July 20<strong>08</strong>.<br />

s/ David J. Waxse<br />

David J. Waxse<br />

U.S. Magistrate Judge<br />

cc:<br />

All counsel and pro se parties<br />

7<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5597


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5598


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5599


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5600


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5601


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5602


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5603


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5604


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5605


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5606


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5607


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 56<strong>08</strong>


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5609


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5610


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5611


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5612


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5613


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5614


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5615


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5616


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5617


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5618


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5619


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5620


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5621


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5622


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5623


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5624


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5625


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5626


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5627


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5628


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5629


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5630


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5631


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5632


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5633


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5634


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5635


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5636


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5637


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5638


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5639


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5640


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5641


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5642


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5643


IN THE UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

SAMUEL K. LIPARI, )<br />

)<br />

Plaintiff, )<br />

)<br />

v. ) Case No. 07-CV-02146-CM-DJW<br />

)<br />

U.S. BANCORP, and )<br />

)<br />

U.S. BANK NATIONAL ASSOCIATION, )<br />

)<br />

Defendants. )<br />

DEFENDANTS’ RESPONSE TO PLAINTIFF’S<br />

MOTION TO ALTER OR AMEND JUDGMENT<br />

AND TO STAY FURTHER PRE-TRIAL PROCEEDINGS<br />

Defendants U.S. Bancorp and U.S. Bank National Association, through counsel Shughart<br />

Thomson & Kilroy, P.C., file this response to plaintiff’s Motion to Alter Or Amend Judgment<br />

pursuant to Rule 59(e) and to stay further proceedings. Plaintiff’s request to stay the proceedings<br />

has already been denied by this Court and his Motion is moot. On July 18, 20<strong>08</strong>, plaintiff filed a<br />

Motion to Alter or Amend Judgment and Motion to Stay Further Pre-Trial Proceedings<br />

concerning the Court’s denial of his motion for time to extend discovery. In that motion,<br />

plaintiff also sought to stay all further pre-trial proceedings. See, Doc. #100. Defendants<br />

responded to this motion on July 28, 20<strong>08</strong>. See, Doc. #106. On July 30, 20<strong>08</strong>, the Court denied<br />

plaintiff’s Motion to Stay Further Pre-Trial Proceedings. See, Doc. #1<strong>08</strong>. Therefore, plaintiff’s<br />

request to stay further proceedings is moot.<br />

As to plaintiff’s request to Alter or Amend Judgment pursuant to Rule 59(e), defendants<br />

incorporate by reference all arguments made in their Memorandum In Opposition to Plaintiff’s<br />

Motion to Alter or Amendment Judgment and to Stay Further Pre-Trial Proceedings contained in<br />

Doc. #106, and request the Court deny plaintiff’s Motion.<br />

2356512.01<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5644


WHEREFORE, for the above stated reasons, defendants request this Court deny<br />

plaintiff’s Motion to Alter or Amend Judgment and to Stay Further Pre-Trial Proceedings (Doc.<br />

#107) and grant defendants all other relief to which they are justly entitled.<br />

Respectfully submitted,<br />

/s/ Jay E. Heidrick<br />

ANDREW M. DeMAREA KS #16141<br />

JAY E. HEIDRICK KS #20770<br />

SHUGHART THOMSON & KILROY, P.C.<br />

32 Corporate Woods, Suite 1100<br />

9225 Indian Creek Parkway<br />

Overland Park, Kansas 66210<br />

(913) 451-3355<br />

(913) 451-3361 (FAX)<br />

MARK A. OLTHOFF KS # 70339<br />

SHUGHART THOMSON & KILROY, P.C.<br />

1700 Twelve Wyandotte Plaza<br />

120 W 12th Street<br />

Kansas City, Missouri 64105-1929<br />

(816) 421-3355<br />

(816) 374-0509 (FAX)<br />

ATTORNEYS FOR DEFENDANTS<br />

U.S. BANCORP and U.S. BANK NATIONAL<br />

ASSOCIATION<br />

CERTIFICATE OF SERVICE<br />

I hereby certify that a copy of the above and foregoing document was filed electronically<br />

with the above-captioned court, with notice of case activity to be generated and sent<br />

electronically by the Clerk of said court (with a copy to be e-mailed to any individuals who do<br />

not receive electronic notice from the Clerk) this 11th day of August, 20<strong>08</strong>, to:<br />

Mr. Samuel K. Lipari<br />

297 NE Bayview<br />

Lee’s Summit, MO 64064<br />

/s/ Jay E. Heidrick<br />

Attorney for Defendants<br />

2356512.01<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5645


IN THE UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

SAMUEL K. LIPARI, )<br />

)<br />

Plaintiff, )<br />

)<br />

v. ) Case No. 07-CV-02146-CM-DJW<br />

)<br />

U.S. BANCORP, and )<br />

)<br />

U.S. BANK NATIONAL ASSOCIATION, )<br />

)<br />

Defendants. )<br />

DEFENDANTS’ RESPONSE TO THE COURT’S SHOW CAUSE ORDER TO<br />

PLAINITFF REGARDING PLAINTIFF’S RULE 26 DISCLOSURES<br />

Defendants, by and though counsel, file this Response to the Court’s Show Cause Order<br />

to Plaintiff Regarding his insufficient Rule 26(a)(1)(A) disclosures. On July 22, 20<strong>08</strong>, the Court<br />

granted defendants’ Motion to Compel Plaintiff’s Compliance with Rule 26 and ordered the<br />

plaintiff to supplement his Rule 26(a)(1)(A) disclosures by July 30, 20<strong>08</strong>. See, Doc. No. 103.<br />

The Court also ordered the plaintiff to file a pleading on or before August 13, 20<strong>08</strong> to show<br />

cause as to why he should not be required to pay for a portion of the defendants’ reasonable fees<br />

and expenses incurred with filing the motion to compel. Id. The Order stated that defendants<br />

would then have until August 24, 20<strong>08</strong> to file a response.<br />

The plaintiff has not supplemented his Rule 26 disclosures in accordance with the Court’s<br />

Order and failed to file any response to the Court’s show cause order. Any decision to award<br />

costs and fees related to this motion lies within the sound discretion of the Court. Despite the<br />

plaintiff’s refusal to comply with the Court’s mandate, the defendants take no position on the<br />

issue and leave the matter to the Court’s discretion.<br />

2360310.01<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5646


Respectfully submitted,<br />

/s/ Jay E. Heidrick<br />

ANDREW M. DeMAREA KS #16141<br />

JAY E. HEIDRICK KS #20770<br />

SHUGHART THOMSON & KILROY, P.C.<br />

32 Corporate Woods, Suite 1100<br />

9225 Indian Creek Parkway<br />

Overland Park, Kansas 66210<br />

(913) 451-3355<br />

(913) 451-3361 (FAX)<br />

MARK A. OLTHOFF KS # 70339<br />

SHUGHART THOMSON & KILROY, P.C.<br />

1700 Twelve Wyandotte Plaza<br />

120 W 12th Street<br />

Kansas City, Missouri 64105-1929<br />

(816) 421-3355<br />

(816) 374-0509 (FAX)<br />

ATTORNEYS FOR DEFENDANTS<br />

U.S. BANCORP and U.S. BANK NATIONAL<br />

ASSOCIATION<br />

CERTIFICATE OF SERVICE<br />

I hereby certify that a copy of the above and foregoing document was filed electronically<br />

with the above-captioned court, with notice of case activity to be generated and sent<br />

electronically by the Clerk of said court (with a copy to be e-mailed to any individuals who do<br />

not receive electronic notice from the Clerk) this 18th day of August, 20<strong>08</strong>, to:<br />

Mr. Samuel K. Lipari<br />

297 NE Bayview<br />

Lee’s Summit, MO 64064<br />

/s/ Jay E. Heidrick<br />

Attorney for Defendants<br />

2360310.01<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5647


IN THE UNITED STATES COURT<br />

DISTRICT OF KANSAS<br />

SAMUEL K. LIPARI, )<br />

)<br />

Plaintiff, )<br />

)<br />

v. ) Case No. 2:07-cv-02146-CM<br />

)<br />

U.S. BANCORP and )<br />

U.S. BANK NATIONAL ASSOCIATION, )<br />

)<br />

Defendants. )<br />

PLAINTIFF’S ANSWER TO DEFENDANTS’ RULE 59 RESPONSE<br />

Comes now the plaintiff Samuel K. Lipari appearing pro se and makes the following answer to the<br />

defendants’ reply to plaintiff’s motion to alter or amend judgment.<br />

1. The plaintiff sought to stay proceedings in this action pending appeal.<br />

2. The defendants were unsuccessful in getting the appeal dismissed. See exb. 1 August 11 Order of<br />

the Tenth Circuit Court of Appeals.<br />

3. This action is the same matter in controversy before the appellate court by virtue of being the<br />

concurrent Missouri state court proceeding improperly removed to federal court during federal jurisdiction<br />

over all pendant state claims in the US Court of Appeals for the Tenth Circuit which now has reacquired<br />

appellate jurisdiction over the matter.<br />

In Little Rock School District v. Armstrong, No. 02-3867EA (8th Cir., 2004) the Eighth Circuit<br />

was required to determine if a “mandamus proceeding in 1987 involved the same ‘matter in controversy’ as<br />

the present questions before the court for purposes of 28 U.S.C. § 455(b)(2). The court’s analysis would<br />

find that because the state law claims are consistent and unchanged (and as yet never ruled on), the present<br />

action is the same “matter in controversy” as MSCI v. Neoforma et al now on appeal. See exb 1.<br />

Respectfully Submitted,<br />

S/ Samuel K. Lipari<br />

____________________<br />

Samuel K. Lipari<br />

297 NE Bayview<br />

Lee's Summit, MO 64064<br />

816-365-1306<br />

saml@medicalsupplychain.com<br />

Pro se<br />

1<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5648


CERTIFICATE OF SERVICE<br />

I certify I have sent a copy to the undersigned opposing counsel via electronic filing on 8/18/<strong>08</strong>.<br />

Mark A. Olthoff, Esq.,<br />

Jay E. Heidrick, Esq.<br />

Shughart Thomson & Kilroy, P.C.<br />

Twelve Wyandotte Plaza<br />

120 W. 12th Street<br />

Kansas City, MO 64105<br />

via email<br />

jheidrick@stklaw.com<br />

molthoff@stklaw.com<br />

ademarea@stklaw.com<br />

S/ Samuel K. Lipari<br />

____________________<br />

Samuel K. Lipari<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5649


FILED<br />

United States Court of Appeals<br />

Tenth Circuit<br />

August 11, 20<strong>08</strong><br />

UNITED STATES COURT OF APPEALS<br />

Elisabeth A. Shumaker<br />

FOR THE TENTH CIRCUIT Clerk of Court<br />

MEDICAL SUPPLY CHAIN, INC.,<br />

Plaintiff,<br />

v.<br />

No. <strong>08</strong>-<strong>3187</strong><br />

NEOFORMA, INC, et al.,<br />

Defendants - Appellees,<br />

------------------------------<br />

SAMUEL K. LIPARI,<br />

Interested Party- Appellant.<br />

ORDER<br />

The court reserves judgment on the motion to dismiss filed by the appellees.<br />

The matter will be referred to the panel assigned to hear this appeal on the merits.<br />

Briefing on the merits shall proceed. The appellant shall file his opening brief<br />

within 40 days of the date of this order. Subsequent briefing shall proceed in<br />

Exb. 1<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5650


accordance with the schedule set forth in the Tenth Circuit Rules.<br />

Entered for the Court<br />

ELISABETH A. SHUMAKER, Clerk<br />

Ellen Rich Reiter<br />

Deputy Clerk/Jurisdictional Attorney<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5651


IN THE UNITED STATES COURT<br />

DISTRICT OF KANSAS<br />

SAMUEL K. LIPARI, )<br />

)<br />

Plaintiff, )<br />

)<br />

v. ) Case No. 2:07-cv-02146-CM<br />

)<br />

U.S. BANCORP and )<br />

U.S. BANK NATIONAL ASSOCIATION, )<br />

)<br />

Defendants. )<br />

PLAINTIFF’S RESPONSE TO DEFENDANTS ASSERTION SHOW CAUSE<br />

ORDER OVER DISCOVERY PRODUCTION HAS NOT BEEN COMPLIED WITH<br />

Comes now the plaintiff Samuel K. Lipari appearing pro se and makes the following response to<br />

defendants’ assertion the plaintiff has failed to comply with this court’s show cause order.<br />

1. The plaintiff sought to obtain instruction from the defendants regarding what additional<br />

disclosures were required:<br />

From: Samuel Lipari [mailto:Saml@<strong>Medical</strong><strong>Supply</strong>Line.com]<br />

Sent: Monday, July 14, 20<strong>08</strong> 8:25 AM<br />

To: Jay Heidrick<br />

Subject: First set of Interrogatories<br />

Jay, I am under the impression I have already complied with your<br />

requests Will you send me the original request so I can comply with the<br />

Magistrate order. Thanks, S~<br />

Subject: Re: First set of Interrogatories<br />

Date: Tuesday, July 15, 20<strong>08</strong> 9:09 AM<br />

From: Samuel Lipari <br />

To: Jay Heidrick <br />

Hi Jay, any request you feel I have not complied with and that the Magistrate<br />

ordered. I already have the paragraph numbers from the order but need to know<br />

what specific request you feel I have not complied with. The settlement brief and<br />

exhibits I submitted to the magistrate are conclusive but if you need me to extract<br />

the information I will. Best regards, S~<br />

See exb. 1 email to defendants.<br />

2. The defendants only responded:<br />

“On 7/14/<strong>08</strong> 9:56 PM, "Jay Heidrick" wrote:<br />

Sam-<br />

Are you wanting the original interrogatories I sent you”<br />

See exb. 1 email to defendants.<br />

1<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5652


And in response to the plaintiff’s further clarification:<br />

“Subject: FW: Lipari v. US Bank...<br />

Date: Wednesday, July 16, 20<strong>08</strong> 8:40 AM<br />

From: Jay Heidrick <br />

To: Samuel Lipari Saml@<strong>Medical</strong><strong>Supply</strong><strong>Chain</strong>.com<br />

Cc: Jay Heidrick jheidrick@stklaw.com<br />

Conversation: Lipari v. US Bank...<br />

Sam-<br />

Per your request, attached are the Interrogatories and Requests for Production we served. The<br />

deficiencies in your responses were outlined in the Memorandum that accompanied our Motion to<br />

Compel. You should have a copy of that document, but I'll resend if necessary. Let me know.<br />

Thanks.<br />

Jay “<br />

See exb. 2 email to defendants.<br />

3. The plaintiff’s responses to the interrogatories are the plaintiff’s responses in full. A<br />

misunderstanding that persists despite the plaintiff’s repeated briefing and the clearly stated<br />

averments of his complaint is that the emails are the written and signed contract between the parties<br />

for US Bank and US Bancorp to provide escrow accounts. That is why everyone receiving the email<br />

from Kabbes has a signed copy of the agreement. The emails were required to be preserved by the<br />

defendants after receiving notice in the original case management conference from 2003. Instead<br />

they committed spoliation and now have only the documents produced by the plaintiffs.<br />

4. The defendants have not produced any of their Rule 26 required disclosure documents or witness<br />

information and have also failed to produce documents specifically requested by the plaintiff (see<br />

exb. 3) using frivolous assertions of protective orders this court refuses to rule on in order to<br />

covertly grant the defendants the immunity from Rule 26 this court cannot lawfully give.<br />

4. The signed document the defendants are demanding is actually one of the ten escrow deposit<br />

agreements the complaint expressly states were sent out to the candidates on the approval of Kabbes<br />

but then US Bancorp subsequently repudiated their agreement to provide escrows, as the complaint<br />

avers no deposits were ever made. This is the blank document furnished the defendants in the<br />

plaintiff’s Rule 26 production as proof of the plaintiff’s complaint. See exb 4.<br />

5. The defendants having destroyed their email in deliberate spoliation then sought and fraudulently<br />

procured sanctions against the plaintiff for producing Rule 26 discovery and now seek to have the<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5653


plaintiff sanctioned for not producing a signed deposit agreement when the complaint alleges the<br />

deposits were never made.<br />

6. The plaintiff had originally sought an injunction in 2002 requiring the defendants to accept the<br />

deposits and to receive the $6000 fee from the plaintiff but the defendants prevailed and have used<br />

the denial of the injunction to fraudulently procure subsequent rulings sanctioning and denigrating<br />

the plaintiff.<br />

7. This court does not have jurisdiction over concurrent action state claims that were erroneously<br />

removed from Independence, Missouri and currently the court has lost jurisdiction over the federal<br />

action where these state claims are pendant due to the appeal in <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. v. US<br />

Bancorp et al.<br />

Respectfully Submitted,<br />

S/ Samuel K. Lipari<br />

____________________<br />

Samuel K. Lipari<br />

297 NE Bayview<br />

Lee's Summit, MO 64064<br />

816-365-1306<br />

saml@medicalsupplychain.com<br />

Pro se<br />

CERTIFICATE OF SERVICE<br />

I certify I have sent a copy to the undersigned opposing counsel via electronic filing on 8/18/<strong>08</strong>.<br />

Mark A. Olthoff, Esq.,<br />

Jay E. Heidrick, Esq.<br />

Shughart Thomson & Kilroy, P.C.<br />

Twelve Wyandotte Plaza<br />

120 W. 12th Street<br />

Kansas City, MO 64105<br />

via email<br />

jheidrick@stklaw.com<br />

molthoff@stklaw.com<br />

ademarea@stklaw.com<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5654


S/ Samuel K. Lipari<br />

____________________<br />

Samuel K. Lipari<br />

4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5655


Monday, August 18, 20<strong>08</strong> 9:06 AM<br />

Subject: Re: First set of Interrogatories<br />

Date: Tuesday, July 15, 20<strong>08</strong> 9:09 AM<br />

From: Samuel Lipari <br />

To: Jay Heidrick <br />

Hi Jay, any request you feel I have not complied with and that the Magistrate<br />

ordered. I already have the paragraph numbers from the order but need to know<br />

what specific request you feel I have not complied with. The settlement brief and<br />

exhibits I submitted to the magistrate are conclusive but if you need me to extract<br />

the information I will. Best regards, S~<br />

On 7/14/<strong>08</strong> 9:56 PM, "Jay Heidrick" wrote:<br />

Sam-<br />

Are you wanting the original interrogatories I sent you<br />

!Jay Heidrick<br />

Attorney At Law<br />

Shughart Thomson & Kilroy<br />

32 Corporate Woods, Suite 1100<br />

9225 Indian Creek Parkway<br />

Overland Park, KS 66210<br />

http://www.stklaw.com tel: 816-691-3743<br />

fax: 816-222-0519<br />

jheidrick@stklaw.com<br />

<br />

Page 1 of 3<br />

T Exb. 1<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma e <strong>Volume</strong> XV 5656


!<br />

From: Samuel Lipari [mailto:Saml@<strong>Medical</strong><strong>Supply</strong>Line.com]<br />

Sent: Monday, July 14, 20<strong>08</strong> 8:25 AM<br />

To: Jay Heidrick<br />

Subject: First set of Interrogatories<br />

Jay, I am under the impression I have already complied with your<br />

requests Will you send me the original request so I can comply with the<br />

Magistrate order. Thanks, S~<br />

********************PRIVATE AND<br />

CONFIDENTIAL********************<br />

This electronic message transmission and any files transmitted with it, are<br />

a communication from the law firm of Shughart Thomson Kilroy, P.C.<br />

This message contains information protected by the attorney/client<br />

privilege and is confidential or otherwise the exclusive property of the<br />

intended recipient or Shughart Thomson Kilroy. This information is<br />

solely for the use of the individual or entity that is the intended recipient.<br />

If you are not the designated recipient, or the person responsible for<br />

delivering the communication to its intended recipient, please be aware<br />

that any dissemination, distribution or copying of this communication is<br />

strictly prohibited. If you have received this electronic transmission in<br />

error, please notify by telephone (816-421-3355), collect or by electronic<br />

mail (solutions@stklaw.com ) and promptly destroy the original<br />

transmission. Thank you for your assistance.<br />

NOTICE: The Missouri Bar and Missouri Supreme Court require all<br />

Missouri attorneys to notify e-mail recipients that e-mail is not a secure<br />

Page 2 of 3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5657


method of communication, that it may be copied and held by any<br />

computer through which it passes, and persons not participating in the<br />

communication may intercept the communication. Should you wish to<br />

discontinue this method of communication, please advise, and no further<br />

e-mail communication will be sent.<br />

Page 3 of 3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5658


Monday, August 18, 20<strong>08</strong> 9:23 AM<br />

Subject: FW: Lipari v. US Bank...<br />

Date: Wednesday, July 16, 20<strong>08</strong> 8:40 AM<br />

From: Jay Heidrick <br />

To: Samuel Lipari Saml@<strong>Medical</strong><strong>Supply</strong><strong>Chain</strong>.com<br />

Cc: Jay Heidrick jheidrick@stklaw.com<br />

Conversation: Lipari v. US Bank...<br />

Per your request, attached are the Interrogatories and Requests for Production we served. The deficiencies in<br />

your responses were outlined in the Memorandum that accompanied our Motion to Compel. You should have<br />

a copy of that document, but I'll resend if necessary. Let me know.<br />

Thanks.<br />

Jay<br />

http://www.stklaw.com<br />

Jay Heidrick<br />

Attorney At Law<br />

Shughart Thomson & Kilroy<br />

32 Corporate Woods, Suite 1100<br />

9225 Indian Creek Parkway<br />

Overland Park, KS 66210<br />

tel: 816-691-3743<br />

fax: 816-222-0519<br />

jheidrick@stklaw.com<br />

From: Jay Heidrick<br />

Sent: Thursday, March 06, 20<strong>08</strong> 3:03 PM<br />

To: 'Samuel Lipari'<br />

Cc: Mark Olthoff; Jay Heidrick<br />

Subject: Lipari v. US Bank...<br />

Sam-<br />

Sam-<br />

I attach Defendants' First Requests for Production and First Interrogatories to Plaintiff. Please let me know if<br />

you have any questions.<br />

Thanks.<br />

Jay Heidrick<br />

Page 1 of 2<br />

Exb. 2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5659


********************PRIVATE AND CONFIDENTIAL********************<br />

This electronic message transmission and any files transmitted with it, are a communication from the law firm of Shughart<br />

Thomson & Kilroy, P.C. This message contains information protected by the attorney/client privilege and is confidential or<br />

otherwise the exclusive property of the intended recipient or Shughart Thomson & Kilroy. This information is solely for the<br />

use of the individual or entity that is the intended recipient. If you are not the designated recipient, or the person responsible<br />

for delivering the communication to its intended recipient, please be aware that any dissemination, distribution or copying of<br />

this communication is strictly prohibited. If you have received this electronic transmission in error, please notify by telephone<br />

(816-421-3355), collect or by electronic mail (solutions@stklaw.com ) and promptly destroy the original transmission.<br />

Thank you for your assistance.<br />

NOTICE: The Missouri Bar and Missouri Supreme Court require all Missouri attorneys to notify e-mail recipients that e-<br />

mail is not a secure method of communication, that it may be copied and held by any computer through which it passes, and<br />

persons not participating in the communication may intercept the communication. Should you wish to discontinue this<br />

method of communication, please advise, and no further e-mail communication will be sent.<br />

Page 2 of 2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5660


<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong><br />

Empowering Health Systems,<br />

Optimizing <strong>Supply</strong> <strong>Chain</strong> Results!<br />

March 10, 20<strong>08</strong><br />

Dear Jay,<br />

I will be happy to confer with you about complying with my discovery production request at your earliest<br />

opportunity. I am available every weekday between 8am and 4pm except that the noon hour is usually spent away<br />

from my office. With prior notice I could take your call instead of lunch.<br />

I think the issue you raised with Aikens v. Deluxe Financial Services, Inc., 217 F.R.D. 533 (D.Kan., 2003) is a<br />

misperception over the reasonable particularity requirement of Rule 34. This overly generalized request form was<br />

avoided by my request, which uses “all documents related”, and “all records related” as a modifier to a sufficiently<br />

particularized event or occurrence and the persons and time frame involved where known. See footnote 11 of<br />

Clearone Communications, Inc. v. Chiang et al Utah Dist. Court Case No: 2:07cv00037TC<br />

https://ecf.utd.uscourts.gov/cgi-bin/show_public_doc2007cv0037-628 which also discusses Aikens.<br />

I still seek the documents and records I requested and in electronic form. I would be more receptive to modifying<br />

my requests if you produced the two documents your professional responsibility and diligence required before<br />

signing motions in this action - the written contract for escrow accounts and the written contract for a financial line<br />

of credit secured with part of each escrow account.<br />

My proposed order addressed provisions for you to redact privileged information and a line-by-line privilege log<br />

for later in camera review. Since this is the same in Missouri and Kansas, I think it is a good procedure.<br />

I knew, as did you that these issues would arise and attempted to address them in our case management order where<br />

we had Magistrate Waxse available. After your sole lost weekend in this case, you, Mark and Andrew decided not<br />

to further brief our dispute over this issue prior to the case management conference. I cannot help but be reminded<br />

of Andrew telling Magistrate Waxse that the previous case management report did not have to be in the correct<br />

form specified under local rule by Judge Waxse because the case would be dismissed.<br />

I fear more people are without healthcare each day because you have recently made a similar assurance to your<br />

client US Bancorp and that assurance is not based on law.<br />

Sincerely,<br />

Samuel Lipari<br />

<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong><br />

297 NE Bayview<br />

Lee's Summit, MO 64064<br />

Phone: 816.365.1306<br />

Saml@<strong>Medical</strong><strong>Supply</strong><strong>Chain</strong>.com<br />

www.<strong>Medical</strong><strong>Supply</strong><strong>Chain</strong>.com<br />

Exb. 3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5661


Monday, August 18, 20<strong>08</strong> 9:55 AM<br />

Subject: Re: Documents on CD for Rule 26 disclosures...<br />

Date: Wednesday, May 7, 20<strong>08</strong> 11:19 AM<br />

From: Samuel Lipari <br />

Reply-To: Samuel Lipari <br />

To: Jay Heidrick jheidrick@stklaw.com<br />

Conversation: Documents on CD for Rule 26 disclosures...<br />

Jay,<br />

Sorry for the misunderstanding. I have not password protected any of the files. I think we are using two<br />

different meanings of searchable, the table of contents leads you to documents by keywords. Some are<br />

scanned images where keyword searching, cutting and pasting is not possible. Some were made into pdfs<br />

with the software I could afford, not Adobe and you have to go into the properties section to alter or save.<br />

You are no doubt inconvenienced but that is the software I have and the form I have created and store the<br />

pdfs in the normal course of business. You on the other hand give me only the paper versions of MS Word<br />

documents for the few docs you have produced in discovery even though I have requested only electronic<br />

documents. I hope this helps. Best regards, S~<br />

Samuel Lipari<br />

<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong><br />

297 NE Bayview<br />

Lee's Summit, MO 64064<br />

Phone: 816.365.1306<br />

Saml@<strong>Medical</strong><strong>Supply</strong><strong>Chain</strong>.com<br />

www.<strong>Medical</strong><strong>Supply</strong><strong>Chain</strong>.com<br />

This message is intended solely for the designated recipient, which may contain privileged or confidential<br />

information and may be subject to confidentiality agreement. Access to this email by any other recipient is<br />

unauthorized. If you are not the intended recipient, any disclosure, copying, distribution or action taken to<br />

be in reliance on its content is prohibited and may be unlawful. In no event shall this material be read,<br />

used, copied, reproduced, stored or retained by anyone other than the named recipient, except with the<br />

express consent of the sender or the named recipient. If you have received this message in error, please<br />

notify the sender immediately by reply and destroy this communication.<br />

----- Original Message -----<br />

From: Jay Heidrick<br />

To: Samuel Lipari<br />

Cc: Jay Heidrick<br />

Sent: Wednesday, May 07, 20<strong>08</strong> 9:54 AM<br />

Subject: Documents on CD for Rule 26 disclosures...<br />

Sam-<br />

In your response to our Motion to Compel, you indicated that the CD of documents you provided were<br />

searchable. That is not the case. The files are password protected that prevent any type of OCR, re-printing<br />

as a .pdf and searching. Please provide the password that will allow us to change the security setting for<br />

these files and make them searchable. Or please provide us with a new CD that allows OCR and searchable<br />

functions. Thanks.<br />

Jay<br />

Page 1 of 2<br />

Exb. 4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5662


http://www.stklaw.com<br />

Jay Heidrick<br />

Attorney At Law<br />

Shughart Thomson & Kilroy<br />

32 Corporate Woods, Suite 1100<br />

9225 Indian Creek Parkway<br />

Overland Park, KS 66210<br />

tel: 816-691-3743<br />

fax: 816-222-0519<br />

jheidrick@stklaw.com<br />

********************PRIVATE AND CONFIDENTIAL********************<br />

This electronic message transmission and any files transmitted with it, are a communication from the law firm of Shughart<br />

Thomson & Kilroy, P.C. This message contains information protected by the attorney/client privilege and is confidential<br />

or otherwise the exclusive property of the intended recipient or Shughart Thomson & Kilroy. This information is solely for<br />

the use of the individual or entity that is the intended recipient. If you are not the designated recipient, or the person<br />

responsible for delivering the communication to its intended recipient, please be aware that any dissemination, distribution<br />

or copying of this communication is strictly prohibited. If you have received this electronic transmission in error, please<br />

notify by telephone (816-421-3355), collect or by electronic mail (solutions@stklaw.com ) and promptly destroy the<br />

original transmission. Thank you for your assistance.<br />

NOTICE: The Missouri Bar and Missouri Supreme Court require all Missouri attorneys to notify e-mail recipients that e-<br />

mail is not a secure method of communication, that it may be copied and held by any computer through which it passes,<br />

and persons not participating in the communication may intercept the communication. Should you wish to discontinue this<br />

method of communication, please advise, and no further e-mail communication will be sent.<br />

Page 2 of 2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5663


DJW/bh<br />

IN THE UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

SAMUEL K. LIPARI,<br />

v.<br />

U.S. BANCORP, N.A., et al.,<br />

Plaintiff,<br />

Defendants.<br />

CIVIL ACTION<br />

No. 07-2146-CM-DJW<br />

NOTICE AND ORDER TO SHOW CAUSE<br />

TO THE PLAINTIFF SAMUEL K. LIPARI:<br />

On July 22, 20<strong>08</strong>, the Court issued a Memorandum and Order (doc. 103) granting in part<br />

Defendants’ Motion to Compel Compliance with Rule 26(a)(1) (doc. 68). In that Order, the Court<br />

directed Plaintiff to serve on Defendants an amended Rule 26(a)(1)(A)(i) witness disclosure<br />

statement on or before July 30, 20<strong>08</strong>. In addition, the Court directed Plaintiff to serve a<br />

supplemental Rule 26(a)(1)(A)(ii) document disclosure statement or amended Rule 26(a)(1)(A)(ii)<br />

document disclosures by that same date. Defendants have informed the Court through a pleading<br />

filed on August 18, 20<strong>08</strong> (doc. 111) that Plaintiff has not served any such disclosures or disclosure<br />

statements on Defendants.<br />

IT IS HEREBY ORDERED that Plaintiff Samuel K. Lipari is required to show cause to<br />

United States District Judge Carlos Murguia in a pleading filed by August 27, 20<strong>08</strong>, why this case<br />

should not be dismissed with prejudice pursuant to Federal Rule of Civile Procedure 37(b)(2)(A)<br />

for failing to comply with the Court’s July 22, 20<strong>08</strong> Order (doc. 103).<br />

IT IS SO ORDERED.<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5664


A copy of this Order shall be sent to Plaintiff Samuel K. Lipari by regular mail and<br />

certified mail, return receipt requested.<br />

Dated in Kansas City, Kansas on this 18th day of August 20<strong>08</strong>.<br />

s/ David J. Waxse<br />

David J. Waxse<br />

U.S. Magistrate Judge<br />

cc:<br />

All counsel and pro se parties<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5665


DJW/bh<br />

IN THE UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

SAMUEL K. LIPARI,<br />

v.<br />

U.S. BANCORP, N.A., et al.,<br />

Plaintiff,<br />

Defendants.<br />

ORDER<br />

CIVIL ACTION<br />

No. 07-2146-CM-DJW<br />

On July 22, 20<strong>08</strong>, the Court issued a Memorandum and Order (doc. 103) granting in part and<br />

denying in part Defendants’ Motion to Compel Compliance with Rule 26(a)(1) (doc. 68). In that<br />

Order, the Court directed Plaintiff, inter alia, to show cause, on or before August 13, 20<strong>08</strong>, why he<br />

should not be required to pay a portion of the reasonable attorney’s fees and expenses that<br />

Defendants incurred in making their Motion to Compel. 1 Plaintiff has filed no response to the<br />

Court’s Show Cause Order.<br />

In light of the above, the Court finds that Plaintiff should be required to pay a portion of the<br />

reasonable attorney’s fees and expenses that Defendants incurred in connection with their Motion<br />

to Compel. To aid the Court is determining the proper amount of the award, Defendants’ counsel<br />

shall file, by August 27, 20<strong>08</strong>, an affidavit itemizing the attorney’s fees and expenses that<br />

Defendants incurred in bringing their Motion to Compel, along with a pleading setting forth any<br />

argument counsel desires to make regarding the proper amount to be apportioned. Plaintiff shall<br />

1 The Court’s Order was made pursuant to Fed. R. Civ. P 37(a)(5)(C), which provides that<br />

a when a motion to compel is granted in part and denied in the party, a court may “apportion the<br />

reasonable expenses for the motion.”<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5666


have until September 10, 20<strong>08</strong> to file a response thereto. Thereafter, the Court will issue an order<br />

specifying the amount of the award and the time for payment.<br />

IT IS SO ORDERED.<br />

Dated in Kansas City, Kansas on this 18th day of August 20<strong>08</strong>.<br />

s/ David J. Waxse<br />

David J. Waxse<br />

U.S. Magistrate Judge<br />

cc:<br />

All counsel and pro se parties<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5667


IN THE UNITED STATES COURT<br />

DISTRICT OF KANSAS<br />

SAMUEL K. LIPARI, )<br />

)<br />

Plaintiff, )<br />

)<br />

v. ) Case No. 2:07-cv-02146-CM<br />

)<br />

U.S. BANCORP and )<br />

U.S. BANK NATIONAL ASSOCIATION, )<br />

)<br />

Defendants. )<br />

28 U.S.C. § 144_AFFIDAVIT OF PREJUDICE<br />

Comes now the plaintiff Samuel K. Lipari appearing pro se and makes the following affidavit of<br />

prejudice under 28 U.S.C. § 144.<br />

The plaintiff timely calls the court’s attention to its own prejudice when the court disregarded<br />

notice filed on August 18, 20<strong>08</strong> that the appeal in this same matter or controversy has not been dismissed.<br />

The magistrate Hon. Judge Waxse has issued orders at the instruction of the trial court Hon. Judge<br />

Murguia that disregard the loss of jurisdiction by the appeal.<br />

The orders corruptly continue what was revealed by the defendants motion served at<br />

approximately 6:30 am this morning to be the court’s scheme to not rule on the defendants frivolous<br />

protective orders and to dismiss the plaintiff’s cause for interrogatories and documents that the plaintiff<br />

submitted to the defendants in discovery.<br />

The court has meanwhile demonstrated its manifest prejudice and bias against the plaintiff by Hon.<br />

Judge Waxse and Hon. Judge Murguia jointly participating in this plan with disregard to their oaths of<br />

office and duty to their own court to be fair and unbiased revealed in an order filed by the magistrate on this<br />

day sanctioning the plaintiff in participation with the defendant counsel’s extrinsic fraud over the response<br />

of the plaintiff regarding the signed agreement to provide escrow accounts in the form of emails as<br />

recognized under Missouri and Federal statute and the lie regarding the failure to provide the documents in<br />

the plaintiff’s Rule 26 disclosure.<br />

This court does not have jurisdiction over the concurrent state claims filed in the State of Missouri<br />

that were in error removed and transferred to this court.<br />

The court was given notice it had irrefutably lost jurisdiction when the plaintiff timely appealed<br />

the striking of the plaintiff’s Rule 59 Motion in MSCI v. Neoforma et al.<br />

1<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5668


The plaintiff has been or will be irreparably harmed by the bias and prejudice of Hon. Judge<br />

Waxse and Hon. Judge Murguia.<br />

Signature _____________________________<br />

Date_____________<br />

_________________________<br />

Notary<br />

Subscribed and sworn before me on<br />

Date_______________________<br />

My commission expires:<br />

Date_______________________<br />

Respectfully Submitted,<br />

S/ Samuel K. Lipari<br />

____________________<br />

Samuel K. Lipari<br />

297 NE Bayview<br />

Lee's Summit, MO 64064<br />

816-365-1306<br />

saml@medicalsupplychain.com<br />

Pro se<br />

CERTIFICATE OF SERVICE<br />

I certify I have sent a copy to the undersigned opposing counsel via electronic filing on 8/18/<strong>08</strong>.<br />

Mark A. Olthoff, Esq.,<br />

Jay E. Heidrick, Esq.<br />

Shughart Thomson & Kilroy, P.C.<br />

Twelve Wyandotte Plaza<br />

120 W. 12th Street<br />

Kansas City, MO 64105<br />

via email<br />

jheidrick@stklaw.com<br />

molthoff@stklaw.com<br />

ademarea@stklaw.com<br />

S/ Samuel K. Lipari<br />

____________________<br />

Samuel K. Lipari<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5669


IN THE UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

SAMUEL K. LIPARI, )<br />

)<br />

Plaintiff, )<br />

)<br />

v. ) Case No. 07-CV-02146-CM-DJW<br />

)<br />

U.S. BANCORP, and )<br />

)<br />

U.S. BANK NATIONAL ASSOCIATION, )<br />

)<br />

Defendants. )<br />

MOTION FOR ORDER TO SHOW CAUSE<br />

Defendants, by and through counsel Shughart Thomson & Kilroy, P.C., move this Court<br />

for an Order requiring the plaintiff to show cause why this action should not be dismissed (or<br />

other sanctions levied) under Rule 37(b)(2)(A) for his failure to comply with the Court’s July 8,<br />

20<strong>08</strong> discovery Order. In support of this Motion, defendants state as follows:<br />

1. On July 8, 20<strong>08</strong>, the Court ordered plaintiff, within 14 days of the Order, to serve<br />

supplemental responses to defendants’ First Interrogatories Nos. 1, 3, 5-14, 16, 17 and 21; and to<br />

produce all documents responsive to defendants’ First Request for Production. The Court also<br />

ordered the plaintiff, within 21 days of the Order, to show cause why he should not be required<br />

to pay the reasonable fees and expenses the defendants incurred for their Motion to Compel.<br />

See, Memorandum and Order, Doc. # 96.<br />

2. On July 10, 20<strong>08</strong>, plaintiff filed an Objection to Magistrate’s Order, asking for<br />

District Court review of the July 8, 20<strong>08</strong> Order. See, Doc. # 97. But the plaintiff did not seek to<br />

stay the Order under D. Kan. Rule 72.1.4(d).<br />

3. Simply filing an Objection to Magistrate’s Order does not relieve a party’s<br />

obligation to comply with the order, absent an Order to Stay under D. Kan. Rule 72. See, Kelly<br />

236<strong>08</strong>76.01<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5670


v. Market USA, 2003 WL 21<strong>08</strong>9075, *2 (D. Kan. 2003) (holding that pro se plaintiff’s refusal to<br />

comply with the magistrate’s order to produce discovery was unexcused even though the<br />

plaintiff had filed an objection to the order). A copy of the Kelly decision is attached as Exhibit<br />

A.<br />

4. The plaintiff has not produced any documents or supplemental responses in<br />

accordance with the Court’s Order, and has also failed to respond to the Court’s Show Cause<br />

Order.<br />

5. Rule 37(b)(2)(A) states that if a party fails to comply with a court’s discovery<br />

order, the court may levy sanctions on the party, including dismissal of the action. Because the<br />

plaintiff has failed to comply with the July 8, 20<strong>08</strong> Order, the defendants request the Court order<br />

the plaintiff to show cause why this matter should not be dismissed or other sanctions issued<br />

pursuant to Rule 37(b)(2)(A).<br />

WHEREFORE, the above stated reasons, the defendants request the Court issue an Order<br />

requiring the plaintiff to show cause as to why this matter should not be dismissed or other<br />

sanctions issued against the plaintiff for his failure to comply with the Court’s July 8, 20<strong>08</strong><br />

Order. Defendants also request all other relief to which they are justly entitled.<br />

Respectfully submitted,<br />

/s/ Jay E. Heidrick<br />

ANDREW M. DeMAREA KS #16141<br />

JAY E. HEIDRICK KS #20770<br />

SHUGHART THOMSON & KILROY, P.C.<br />

32 Corporate Woods, Suite 1100<br />

9225 Indian Creek Parkway<br />

Overland Park, Kansas 66210<br />

(913) 451-3355<br />

(913) 451-3361 (FAX)<br />

236<strong>08</strong>76.01<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5671


MARK A. OLTHOFF KS # 70339<br />

SHUGHART THOMSON & KILROY, P.C.<br />

1700 Twelve Wyandotte Plaza<br />

120 W 12th Street<br />

Kansas City, Missouri 64105-1929<br />

(816) 421-3355<br />

(816) 374-0509 (FAX)<br />

ATTORNEYS FOR DEFENDANTS<br />

U.S. BANCORP and U.S. BANK NATIONAL<br />

ASSOCIATION<br />

CERTIFICATE OF SERVICE<br />

I hereby certify that a copy of the above and foregoing document was filed electronically<br />

with the above-captioned court, with notice of case activity to be generated and sent<br />

electronically by the Clerk of said court (with a copy to be e-mailed to any individuals who do<br />

not receive electronic notice from the Clerk) this 20th day of August, 20<strong>08</strong>, to:<br />

Mr. Samuel K. Lipari<br />

297 NE Bayview<br />

Lee’s Summit, MO 64064<br />

/s/ Jay E. Heidrick<br />

Attorney for Defendants<br />

236<strong>08</strong>76.01<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5672


Exhibit A<br />

Not Reported in F.Supp.2d Page 1<br />

Not Reported in F.Supp.2d, 2003 WL 21<strong>08</strong>9075 (D.Kan.)<br />

Kelly v. Market USA<br />

D.Kan.,2003.<br />

Only the Westlaw citation is currently available.<br />

United States District Court,D. Kansas.<br />

Lawrence L. KELLY, Plaintiff,<br />

v.<br />

MARKET USA, Defendant.<br />

No. 01-4169-SAC.<br />

April 11, 2003.<br />

Laurie E. Leader, Chicago-Kent Law Offices,<br />

Chicago, IL, Benoit M.J. Swinnen, Topeka, KS,<br />

James L. Wisler, James L. Wisler Law Offices,<br />

Lawrence, KS, for Defendant.<br />

MEMORANDUM AND ORDER<br />

SAM A. CROW, District Senior Judge.<br />

*1 This case comes before the court on plaintiff's<br />

objections to a magistrate judge's order regarding<br />

discovery (Dk.59), a magistrate judge's subsequent<br />

report and recommendation (Dk.67) and plaintiff's<br />

objection to that report and recommendation.<br />

(Dk.70).<br />

The factual background of this case is accurately set<br />

forth in the magistrate judge's subsequent report and<br />

recommendation (Dk.67), and will not be repeated<br />

herein. Suffice it to say that plaintiff, having been<br />

ordered to comply with outstanding discovery<br />

requests by defendant, refused to do so. Defendant<br />

then moved to dismiss the case as a sanction for<br />

plaintiff's discovery abuse. In his report and<br />

recommendation, the magistrate judge found the<br />

extreme sanction of dismissal warranted, in the event<br />

this court finds no error in the original order requiring<br />

plaintiff to comply with the outstanding discovery<br />

requests.<br />

Standard of Review<br />

“De novo review is statutorily and constitutionally<br />

required when written objections to a magistrate's<br />

report are timely filed with the district<br />

court.”Summers v. State of Utah, 927 F.2d 1165,<br />

1167 (10th Cir.1991) (citations omitted).Rule 72(b)<br />

of the Federal Rules of Civil Procedure requires a<br />

district judge to “make a de novo determination upon<br />

the record, ..., of any portion of the magistrate judge's<br />

disposition to which specific written objection has<br />

been made in accordance with this rule.”Those parts<br />

of the report and recommendation to which there has<br />

been no objection are taken as true and judged on the<br />

applicable law. See Campbell v. United States<br />

District Court for the Northern Dist. of California,<br />

501 F.2d 196, 206 (9th Cir.), cert. denied,419 U.S.<br />

879 (1974); see also Summers v. Utah, 927 F.2d at<br />

1167 (holding that “[i]n the absence of timely<br />

objection, the district court may review a magistrate's<br />

report under any standard it deems appropriate”). The<br />

district court has considerable judicial discretion in<br />

choosing what reliance to place on the magistrate<br />

judge's findings and recommendations. See Andrews<br />

v. Deland, 943 F.2d 1162, 1170 (10th Cir.1991)<br />

(citing United States v. Raddatz, 447 U.S. 667<br />

(1980)), cert. denied,502 U.S. 1110 (1992). When<br />

review is de novo, the district court is “ ‘free to<br />

follow ... or wholly ... ignore’ “ the magistrate judge's<br />

recommendation, but it “ ‘should make an<br />

independent determination of the issues' “ without<br />

giving “ ‘any special weight to the prior’ “<br />

recommendation.Andrews v. Deland, 943 F.2d at<br />

1170 (quoting Ocelot Oil Corp. v. Sparrow<br />

Industries, 847 F.2d 1458, 1464 (10th Cir.1988)). In<br />

short, the district court may accept, reject, or modify<br />

the magistrate judge's findings, or recommit the<br />

matter to the magistrate with instructions. See28<br />

U.S.C. § 636(b)(1)(C) (1994).<br />

Analysis<br />

Plaintiff's objections to the magistrate judge's report<br />

and recommendation are far from specific. See Dk.<br />

70 (alleging that the court has been operating<br />

“fraudulently,” that “defendant has no defense,”<br />

citing the Tenth Amendment and the Civil Rights Act<br />

of 1964.) In fact, they fail to reference the magistrate<br />

judge's report and recommendation, or any portion of,<br />

whatsoever. Had plaintiff's pleading not been<br />

captioned “plaintiff's response to report and<br />

recommendation,” the court would not have known<br />

that plaintiff's statements were in response to that<br />

document.<br />

© 20<strong>08</strong> Thomson Reuters/West. No Claim to Orig. US Gov. Works.<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5673


Not Reported in F.Supp.2d Page 2<br />

Not Reported in F.Supp.2d, 2003 WL 21<strong>08</strong>9075 (D.Kan.)<br />

*2 The court has reviewed the facts regarding the<br />

October 17, 2002 order, granting in large part<br />

defendant's motion to compel, and finds no error in<br />

that ruling. The court has reviewed plaintiff's<br />

objections to that order (Dk.59), and finds them<br />

lacking in specificity. Plaintiff's complaints that the<br />

course of discovery is “fraud,” that his “private<br />

matters are [his] private matters,” and that defendant<br />

has no right to the discovery sought are meritless.<br />

Plaintiff is a frequent litigant in this court, see Kelly<br />

v. Rogers, et. al, NO. 00-4175-RDR, Order of Dec.<br />

11, 2001, at 1, n. 1, and is bound to abide by the same<br />

procedural rules as are litigants represented by<br />

counsel. As this court recently stated in another case,<br />

a pro se litigant is required to follow the same rules<br />

of procedure as any other litigant.<br />

“A pro se litigant's pleadings are to be construed<br />

liberally and held to a less stringent standard than<br />

formal pleadings drafted by lawyers.”Hall v.<br />

Bellmon, 935 F.2d 1106, 1110 (10th Cir.1991). A pro<br />

se litigant, however, is not relieved from following<br />

the same rules of procedure as any other<br />

litigant.Ogden v. San Juan County, 32 F.3d 452, 455<br />

(10th Cir.1994), cert. denied,513 U.S. 1090<br />

(1995).“At the same time, we do not believe it is the<br />

proper function of the district court to assume the role<br />

of advocate for the pro se litigant.”Hall v. Bellmon,<br />

935 F.2d at 1110;see Drake v. City of Fort Collins,<br />

927 F.2d 1156, 1159 (10th Cir.1991) (“Despite<br />

liberal construction afforded pro se pleadings, the<br />

court will not construct arguments or theories for the<br />

plaintiff in the absence of any discussion of those<br />

issues”). Nor is the court to “supply additional factual<br />

allegations to round out a plaintiff's<br />

complaint.”Whitney v. State of New Mexico, 113 F.3d<br />

1170, 1173-74 (10th Cir.1997).<br />

McCormick v. Farrar, 2002 WL 31314681, *2<br />

(D.Kan.2002).<br />

Plaintiff was ordered to produce and respond to<br />

discovery, yet failed to do so. Plaintiff was not<br />

relieved from complying with the disputed order<br />

merely because he had filed an objection to it,<br />

seeFed.R.Civ.P. 72; D. Kan. R. 72.1.4, and made no<br />

application for a stay of the magistrate's nondispositive<br />

order regarding discovery. Plaintiff's<br />

failure to comply with the terms of the order is<br />

unexcused. Accordingly, plaintiff's objections to the<br />

magistrate judge's order of October 17, 2002 (Dk.59)<br />

are overruled. Plaintiff was properly ordered to<br />

respond to defendant's discovery requests, and has<br />

failed without good cause to do so.<br />

The court thus addresses the issue whether the<br />

sanction of dismissal with prejudice is warranted, as<br />

addressed in the magistrate judge's report and<br />

recommendation (Dk.67), and plaintiff's objection to<br />

that document (Dk.70).<br />

In all respects, the magistrate judge's report and<br />

recommendation fully, fairly and accurately sets forth<br />

the law, findings and facts relevant to this appeal.<br />

Plaintiff has intentionally chosen to ignore discovery<br />

requests and orders related to them, prejudicing the<br />

defendant and preventing the orderly administration<br />

of justice. For all the reasons set forth in detail in the<br />

report and recommendation, this court finds it<br />

appropriate to levy the most severe sanction of<br />

dismissal with prejudice, unless plaintiff provides to<br />

defendant within 15 days of this order all discovery<br />

which was the subject of the October 17, 2002 order.<br />

Accordingly, the court accepts and adopts the report<br />

and recommendation of the magistrate judge dated<br />

February 19, 2003.<br />

*3 IT IS THEREFORE ORDERED that plaintiff's<br />

objections to a magistrate judge's order regarding<br />

discovery (Dk.59) are overruled, that plaintiff's<br />

objection (Dk.70) to the report and recommendation<br />

of Magistrate Judge Bostwick is overruled, that the<br />

report and recommendation (Dk.67) is accepted and<br />

adopted.<br />

IT IS FURTHER ORDERED that plaintiff shall<br />

provide to defendant and to Magistrate Judge<br />

Sebelius, to whom this case has been transferred,<br />

within 15 days of this order all discovery which was<br />

the subject of the October 17, 2002 order. In the<br />

event plaintiff fails to do so in the determination of<br />

Magistrate Judge Sebelius, this case shall be<br />

dismissed, with prejudice, instanter, and without<br />

further notice or hearing.<br />

D.Kan.,2003.<br />

Kelly v. Market USA<br />

Not Reported in F.Supp.2d, 2003 WL 21<strong>08</strong>9075<br />

(D.Kan.)<br />

END OF DOCUMENT<br />

© 20<strong>08</strong> Thomson Reuters/West. No Claim to Orig. US Gov. Works.<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5674


Not Reported in F.Supp.2d Page 3<br />

Not Reported in F.Supp.2d, 2003 WL 21<strong>08</strong>9075 (D.Kan.)<br />

© 20<strong>08</strong> Thomson Reuters/West. No Claim to Orig. US Gov. Works.<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5675


DJW/bh<br />

IN THE UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

SAMUEL K. LIPARI,<br />

v.<br />

U.S. BANCORP, N.A., et al.,<br />

Plaintiff,<br />

Defendants.<br />

CIVIL ACTION<br />

No. 07-2146-CM-DJW<br />

SECOND NOTICE AND ORDER TO SHOW CAUSE<br />

TO THE PLAINTIFF SAMUEL K. LIPARI:<br />

This case is before the Court on Defendants’ Motion for Order to Show cause (doc. 118)<br />

relating to Plaintiff’s failure to comply with the Court’s July 8, 20<strong>08</strong> discovery order (doc. 96). The<br />

case is also before the Court based on information the parties have provided the Court via e-mail<br />

regarding preparation of the parties’ proposed pretrial order.<br />

I. Defendants’ Motion for Order to Show Cause Based on Plaintiff’s Failure to Comply<br />

with the Court’s July 8, 20<strong>08</strong> Order<br />

Defendants move the Court for an order directing Plaintiff to show cause why this action<br />

should not be dismissed, or other sanctions imposed, based on Plaintiff’s asserted failure to comply<br />

with a discovery order issued by the Court on July 8, 20<strong>08</strong> (doc. 96). In that Order, the Court<br />

granted Defendants’ Motion to Compel and directed Plaintiff to (1) serve supplemental responses<br />

to certain of Defendants’ First Interrogatories, and (2) produce all documents responsive to<br />

Defendants’ First Request for Production. On July 10, 20<strong>08</strong>, Plaintiff filed an Objection to the Order<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5676


(doc. 97), asking the District Judge to review the July 8, 20<strong>08</strong> Order. Plaintiff, however, filed no<br />

motion to stay the Order pursuant to D. Kan. Rule 72.1.4(d). 1<br />

As Defendants point out, the mere filing of an objection to a Magistrate Judge’s order,<br />

without applying for a stay, does not relieve a party of the obligation to comply with the order. 2<br />

Thus, in this case, Plaintiff was not relieved of the obligation to comply with the Court’s July 8,<br />

20<strong>08</strong> Order. Pursuant to Federal Rule of Civil Procedure 37(b)(2)(A), a court may impose a variety<br />

of sanctions against a party for failing to obey a discovery order, including dismissing the action in<br />

whole or in part. 3<br />

The Court finds that Defendants’ Motion for Order to Show Cause is well taken. The Court<br />

therefore grants Defendants’ Motion and directs Plaintiff to show cause to the District Judge, in a<br />

pleading filed by September 8, 20<strong>08</strong>, why this case should not be dismissed with prejudice, or other<br />

sanctions imposed, pursuant to Federal Rule of Civil Procedure 37(b)(2)(A), for failure to comply<br />

with the Court’s July 8, 20<strong>08</strong> Order regarding discovery.<br />

II.<br />

Failure to Participate in the Preparation of a Joint Proposed Pretrial Order<br />

The pretrial conference is presently scheduled for August 28, 20<strong>08</strong>. The parties were<br />

directed to prepare a joint proposed pretrial order for submission to the Magistrate Judge by August<br />

1 D. Kan. Rule 72.1.4(d) provides that “[a]pplication for stay of a magistrate judge’s order<br />

pending review of objections made thereto shall first be made to the magistrate judge.”<br />

2 See Kelly v. Market USA, No. 01-4169-SAC, 2003 WL 21<strong>08</strong>9075, at *2 (D. Kan. Apr. 11,<br />

2003) (“Plaintiff was ordered to produce and respond to discovery, yet failed to do so. Plaintiff was<br />

not relieved from complying with the disputed order merely because he had filed an objection to it<br />

. . ., and made no application for a stay of the magistrate’s non-dispositive order regarding discovery.<br />

Plaintiff’s failure to comply with the terms of the order is unexcused.”) (citations omitted).<br />

3<br />

See Fed. R. Civ. P. 37(b)(2)(A)(v).<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5677


21, 20<strong>08</strong>. 4 On August 21, 20<strong>08</strong>, Defendants’ counsel informed the Court via e-mail that Plaintiff<br />

had failed to participate in the preparation of a joint proposed pretrial order. Defendants’ counsel<br />

stated that they had repeatedly submitted a draft pretrial order to Plaintiff and sought his input as<br />

required by local rule. Counsel reported that despite their efforts, they had not received any<br />

comments or input from Plaintiff as to the proposed order. As a result, Defendants could only<br />

submit their version of a proposed pretrial order with the following sections left blank: Plaintiff’s<br />

factual contentions, Plaintiff’s theories of recovery, essential elements of Plaintiff’s theories of<br />

recovery, and Plaintiff’s damages.<br />

Plaintiff subsequently e-mailed the Court with his own version of the proposed pretrial order,<br />

which he admitted is incomplete. Plaintiff explained in his e-mail as follows:<br />

Attached is my version of the pretrial order. It is incomplete because this court lost<br />

jurisdiction at the filing of the notice of appeal on July 11. Every subsequent order<br />

has been void. The plaintiff's notice of the lack of jurisdiction and controlling law<br />

is in the first section of the attached proposed plan.<br />

Plaintiff’s proposed pretrial order fails to include any factual contentions. It also fails to<br />

provide an itemized list of his damages, including the dollar amounts sought.<br />

Based on the above, it appears to the Court that Plaintiff has failed to satisfy his obligation<br />

to participate in the preparation of a joint proposed pretrial order. Pursuant to the Court’s July 31,<br />

20<strong>08</strong> Order, which amended the initial Scheduling Order, the parties were to prepare a “proposed<br />

joint pretrial order” 5 for submission to the Court prior to the pretrial conference. The Scheduling<br />

Order required that the proposed pretrial order be “in the form available on the court’s website<br />

4<br />

See Orders Amending Scheduling Order (doc. 1<strong>08</strong> & 109).<br />

5<br />

Order Amending Scheduling Order (doc. 1<strong>08</strong>) (emphasis added).<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5678


(www.ksd.uscourts.gov).” 6 D. Kan. Rule 16.2(a) also requires that the parties submit “a proposed<br />

final pretrial order in the prescribed form.” 7<br />

Rule 16.2(a) explains that the parties have an obligation to confer and jointly prepare the<br />

proposed pretrial order. The Rule states:<br />

The parties have joint responsibility to attempt in good faith to formulate an agreed<br />

order which the judge can sign at the conference. If the parties disagree on any<br />

particulars, they are each to submit proposed language on the points in controversy,<br />

for the judge to rule on at the conference. To attempt in good faith to formulate an<br />

agreed order means more than mailing or faxing a form or letter to the opposing<br />

party. It requires that the parties in good faith converse, confer, compare views,<br />

consult and deliberate, or in good faith attempt to do so. 8<br />

The Court’s “prescribed form” for the proposed pretrial provides detailed instructions to the<br />

parties as to the preparation of a joint proposed pretrial order and requires that the parties make a<br />

“joint effort” to submit a single proposed order. 9 The instructions are as follows:<br />

Before the pretrial conference, the parties must confer, draft, and timely submit to<br />

the court a proposed pretrial order in accordance with the scheduling order and D.<br />

Kan. Rule 16. The proposed pretrial order is to be a joint effort of all parties. The<br />

parties have an equal obligation to cooperate fully in drafting the pretrial order and<br />

to submit an agreed order that the judge can sign at the pretrial conference. It is<br />

essential that each party’s factual contentions and legal theories be included. If the<br />

parties disagree on any particulars, they shall submit a single proposed order with<br />

bracketed notations revealing the nature of the disagreement in sufficient detail to<br />

enable the court to resolve the dispute at the conference. Submission of separate<br />

orders is not acceptable. 10 <strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5679<br />

6 Scheduling Order (doc. 50), 4.b.<br />

7 D. Kan. Rule 16.2(a).<br />

8<br />

Id.<br />

9 The form for the proposed pretrial order is found on the Court’s website at<br />

www.ksd.uscourts.gov.<br />

10<br />

See Pretrial Order Form at www.ksd.uscourts.gov (emphasis in original).<br />

4


Here, the parties have submitted separate orders, and, based on the information provided in<br />

the parties’ August 21, 20<strong>08</strong> e-mails, it appears that Plaintiff has failed to cooperate in the process<br />

of preparing a joint proposed order. If that is indeed the case, Plaintiff is subject to sanctions.<br />

Pursuant to Federal Rule of Civil Procedure 16(f), a court “may issue any just orders, including<br />

those authorized by Rule 37(b)(2)(A)(ii)-(vii)” when a party “is substantially unprepared to<br />

participate –– or does not participate in good faith –– in the [pretrial] conference” or when the party<br />

“fails to obey a scheduling order or other pretrial order.” 11 As noted above, dismissal of the case in<br />

whole or part is one of the sanctions authorized under Rule 37(b)(2)(A).<br />

In light of the foregoing, the Court directs Plaintiff to show cause, in a pleading filed by<br />

September 8, 20<strong>08</strong>, why this case should not be dismissed with prejudice, or other sanctions<br />

imposed, pursuant to Rules 16(f) and 37(b)(2)(A), based on Plaintiff’s failure to participate in the<br />

preparation of a joint proposed pretrial order.<br />

IT IS THEREFORE ORDERED that Defendants’ Motion for Order to Show Cause (doc.<br />

118) is granted.<br />

IT IS FURTHER ORDERED that Plaintiff Samuel K. Lipari is required to show cause to<br />

United States District Judge Carlos Murguia, in a pleading filed by September 8, 20<strong>08</strong>, why this<br />

case should not be dismissed with prejudice, or other sanctions imposed, pursuant to Federal Rule<br />

of Civil Procedure 37(b)(2)(A) for failure to comply with the Court’s July 8, 20<strong>08</strong> Order (doc. 96),<br />

and/or pursuant to Federal Rules of Civil Procedure 16(f) and 37(b)(2)(A) for failure to participate<br />

in the preparation of a joint proposed pretrial order.<br />

11<br />

Fed. R. Civ. P. 16(f)(1)(B) & (C).<br />

5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5680


IT IS SO ORDERED.<br />

A copy of this Order shall be sent to Plaintiff Samuel K. Lipari by regular mail and<br />

certified mail, return receipt requested.<br />

Dated in Kansas City, Kansas on this 25th day of August 20<strong>08</strong>.<br />

s/ David J. Waxse<br />

David J. Waxse<br />

U.S. Magistrate Judge<br />

cc:<br />

All counsel and pro se parties<br />

6<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5681


IN THE UNITED STATES COURT<br />

DISTRICT OF KANSAS<br />

SAMUEL K. LIPARI, )<br />

)<br />

Plaintiff, )<br />

)<br />

v. ) Case No. 2:07-cv-02146-CM<br />

)<br />

U.S. BANCORP and )<br />

U.S. BANK NATIONAL ASSOCIATION, )<br />

)<br />

Defendants. )<br />

OBJECTION TO MAGISTRATE’S ORDERS OF 8/18/<strong>08</strong><br />

Comes now the plaintiff appearing pro se and while objecting to the jurisdiction of this court after<br />

the notice of appeal, makes the following objection to the orders dated <strong>08</strong>/18/20<strong>08</strong> requiring the plaintiff to<br />

show cause and pay fees by Magistrate Judge David J. Waxse.<br />

STATEMENT OF FACTS<br />

1. The plaintiff made a pretrial affidavit of bias on August 18, 20<strong>08</strong>.<br />

2. The Hon. Judge Carlos Murguia has not yet responded to the affidavit of bias.<br />

3. The order of <strong>08</strong>/20/20<strong>08</strong> is by Magistrate Hon. Judge David J. Waxse not the trial judge:<br />

“<strong>08</strong>/20/20<strong>08</strong><br />

117<br />

ORDER regarding 114 Notice and Order to Show Cause. The Court has reviewed Plaintiff's reply<br />

(doc. 113) to Defendants' response (doc. 111) regarding Plaintiff's asserted noncompliance with the<br />

Court's 7/22/<strong>08</strong> Order (doc. 103). Plaintiff's filing of the reply does not relieve Plaintiff of the<br />

obligation to respond to the Order to Show Cause. Plaintiff shall file his response to the Order to<br />

Show Cause on or before 8/27/<strong>08</strong>. Entered by Magistrate Judge David J. Waxse on 8/20/<strong>08</strong>. (This is<br />

a TEXT ENTRY ONLY. There is no.pdf document associated with this entry.)<br />

(mh) (Entered: <strong>08</strong>/20/20<strong>08</strong>)<br />

4. The orders were made after the plaintiff filed a Notice of Appeal in this same matter or controversy,<br />

divesting this court of jurisdiction.<br />

MEMORANDUM OF LAW<br />

The plaintiff has filed an affidavit under 28 USC § 144 over the court’s proceeding to exert<br />

jurisdiction in a biased and prejudiced manner against the plaintiff despite being given conclusive notice<br />

that the plaintiff’s appeal has not been dismissed as sought by the defendants (the plaintiff supplied the<br />

court a copy of the August 11, 20<strong>08</strong> Order of the Tenth Circuit) and this court was under the controlling<br />

1<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5682


law of this circuit deprived of jurisdiction on July 11, 20<strong>08</strong>. See Plaintiff’s Objection to Magistrate’s Order<br />

of <strong>08</strong>/20/<strong>08</strong>.<br />

The plaintiff has consistently argued that the federal court lacks jurisdiction over his concurrent<br />

state court action which was erroneously removed from the State of Missouri 16 th Circuit court on the<br />

grounds of diversity and has only the jurisdiction over these claims as pendant state law claims dismissed<br />

without prejudice in MSC v. Neoforma, Inc. Case No. 05-2299. However, this court lost jurisdiction over<br />

this matter in controversy on July 11, 20<strong>08</strong> under controlling precedent of the Tenth Circuit in United<br />

States v. Prows, 448 F.3d 1223, 1228 (10th Cir. 2006) (recognizing the general rule that a notice of appeal<br />

divests the district court of jurisdiction over substantive claims).”<br />

This court erroneously continued to exert jurisdiction but on August 11, 20<strong>08</strong> the Tenth Circuit<br />

issued an order in MSCI v Neoforma, Inc. Case No. <strong>08</strong>-<strong>3187</strong> denying dismissal of the appeal. This court’s<br />

jurisdiction under Case No. 07-CV-02146-CM-DJW as a removed state court action over 05-2299’s<br />

pendant state law claims is impacted by the special rule applicable to exclusive jurisdiction over federal<br />

antitrust claims Holmes Financial Associates, Inc. v. Resolution Trust Corp., 33 F.3d 561 (C.A.6 (Tenn.),<br />

1994) and this court will permanently lose jurisdiction 1) under the exclusive federal jurisdiction rule, 2)<br />

the reversal of the dismissal of the plaintiff’s federal and pendant claims in 05-2299, and 3) the recognition<br />

that the removal never had the required complete diversity of citizenship for 28 U.S.C. § 1332 and must be<br />

remanded under 28 U.S.C. § 1447 (c)’s requirement that “If at any time before final judgment it appears<br />

that the district court lacks subject matter jurisdiction, the case shall be remanded”.<br />

The appeal concerns whether this is the same matter in controversy as MSCI v. Neoforma et al<br />

Case No. 05-2299 and whether substantive claims related to substantive claims still included in this case<br />

over the same conduct (aspects of the issues involved in the appeal halting this court under U.S. v. Salzano,<br />

994 F.Supp. 1321 (D. Kan., 1998) ) were lawfully dismissed in light of the US Supreme Court’s<br />

overturning of the Tenth Circuit Rule 12(b)(6) standard or practice used by this court in Erickson v. Pardus,<br />

No. 06-7317 (U.S. 6/4/2007) (2007). This court’s orders subsequent to the July 11, 20<strong>08</strong> Notice of Appeal<br />

are “null and void” under Garcia v. Burlington Northern R.R. Co., 818 F.2d 713, 721 (10th Cir.1987).<br />

CONCLUSION<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5683


Whereas the trial judge has not reviewed the plaintiff’s affidavit of prejudice or has not made an<br />

order regarding that review, under 28 USC § 144 there are no further proceedings in this court and because<br />

this court lost jurisdiction due to the notice of appeal filed on July 11, 20<strong>08</strong>, the magistrate’s orders are void<br />

for want of jurisdiction.<br />

Respectfully Submitted,<br />

S/ Samuel K. Lipari<br />

____________________<br />

Samuel K. Lipari<br />

297 NE Bayview<br />

Lee's Summit, MO 64064<br />

816-365-1306<br />

saml@medicalsupplychain.com<br />

Pro se<br />

CERTIFICATE OF SERVICE<br />

I certify I have sent a copy to the undersigned opposing counsel via electronic filing on 8/22/<strong>08</strong>.<br />

Mark A. Olthoff, Esq.,<br />

Jay E. Heidrick, Esq.<br />

Shughart Thomson & Kilroy, P.C.<br />

Twelve Wyandotte Plaza<br />

120 W. 12th Street<br />

Kansas City, MO 64105<br />

via email<br />

jheidrick@stklaw.com<br />

molthoff@stklaw.com<br />

ademarea@stklaw.com<br />

S/ Samuel K. Lipari<br />

____________________<br />

Samuel K. Lipari<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5684


IN THE UNITED STATES COURT<br />

DISTRICT OF KANSAS<br />

SAMUEL K. LIPARI, )<br />

)<br />

Plaintiff, )<br />

)<br />

v. ) Case No. 2:07-cv-02146-CM<br />

)<br />

U.S. BANCORP and )<br />

U.S. BANK NATIONAL ASSOCIATION, )<br />

)<br />

Defendants. )<br />

OBJECTION TO MAGISTRATE’S ORDER OF 8/20/<strong>08</strong><br />

Comes now the plaintiff appearing pro se and while objecting to the jurisdiction of this court after<br />

the notice of appeal, makes the following objection to the order dated <strong>08</strong>/20/20<strong>08</strong> (Doc. 117) by Magistrate<br />

Judge David J. Waxse.<br />

STATEMENT OF FACTS<br />

1. The plaintiff made a pretrial affidavit of bias on August 18, 20<strong>08</strong>.<br />

2. The Hon. Judge Carlos Murguia has not yet responded to the affidavit of bias.<br />

3. The Chief Judge of this District Kansas District Court Judge Kathryn H. Vratil recused herself in<br />

this same matter or controversy 05-cv-02299-CM-GLR (under the matter or controversy standard in Little<br />

Rock School District v. Armstrong, No. 02-3867EA (8th Cir., 2004) ) on October 20, 2005:<br />

61 ORDER REASSIGNING CASE. Case reassigned to Judge Carlos Murguia for<br />

all further proceedings. Judge Kathryn H. Vratil no longer assigned to case.<br />

(This is a TEXT ENTRY ONLY. There is no.pdf document associated with this<br />

entry)(ls) (Entered: 10/20/2005)<br />

5. All Kansas District court judges including the Hon. Judge Carlos Murguia recused themselves in<br />

the injunctive relief action styled Landrith v. Stanton Hazlet, KS Dist. Case No. 04-2215-DVB to prevent<br />

the defendants’ disbarment of the plaintiff’s counsel that covered the same conduct as described by the<br />

petition in 05-cv-02299-CM-GLR.<br />

6. The order of <strong>08</strong>/20/20<strong>08</strong> is by Magistrate Hon. Judge David J. Waxse and states:<br />

“<strong>08</strong>/20/20<strong>08</strong><br />

117<br />

ORDER regarding 114 Notice and Order to Show Cause. The Court has reviewed Plaintiff's reply<br />

(doc. 113) to Defendants' response (doc. 111) regarding Plaintiff's asserted noncompliance with the<br />

Court's 7/22/<strong>08</strong> Order (doc. 103). Plaintiff's filing of the reply does not relieve Plaintiff of the<br />

obligation to respond to the Order to Show Cause. Plaintiff shall file his response to the Order to<br />

Show Cause on or before 8/27/<strong>08</strong>. Entered by Magistrate Judge David J. Waxse on 8/20/<strong>08</strong>. (This is<br />

a TEXT ENTRY ONLY. There is no.pdf document associated with this entry.)<br />

1<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5685


(mh) (Entered: <strong>08</strong>/20/20<strong>08</strong>)<br />

7. The defendants’ law firm Shughart Thomson & Kilroy, P.C. had notice of the petition in Judicial<br />

Council The Tenth Circuit Case No. 20<strong>08</strong>-10-372-<strong>08</strong> describing the extrinsic fraud scheme to procure the<br />

dismissal of the plaintiff’s contract based claims through a fraudulent Motion to Compel production of<br />

documents already produced and to answer interrogatories more fully to include addresses of witnesses<br />

known to the defendants and which the plaintiff was himself seeking in discovery. See letter of disclosure<br />

to Jay E. Heidrick atch. 1 and atch 1 Part B Petition with exhibits Case No. 20<strong>08</strong>-10-372-<strong>08</strong> including exb<br />

36.<br />

“64. The defendants’ law firm is aware of the changes made in the judicial council’s treatment of<br />

judicial misconduct complaints yet they still file pleadings that contain extrinsic fraud believing the<br />

respondent will grant them.<br />

See Exb 36.<br />

65. The US Bank and US Bancorp defendants are currently arguing before the respondent in the<br />

state contract based claims case for a protective order to evade having to turn over the email contract<br />

for the escrow accounts and the written loan application that are the writings of the subject contract<br />

dispute because the documents are not “relevant.”<br />

66. While this will no doubt lead to new sanctions against the petitioner for “frivolously” arguing<br />

the writings to a written contract are relevant and discoverable the danger to justice is that the<br />

respondent will severely restrict discovery of the records related to the extrinsic fraud in the<br />

preceding litigation used by the defendants to evade their liability under contract and which is<br />

inherent in a Missouri state law breach of contract claim as a breach in the UCC duty of good faith<br />

and fair dealing.<br />

67. Because the respondent and US Bancorp defense counsel failed to research the applicable law,<br />

they thought their plan of having the federal racketeering claims over misconduct in the litigation<br />

including extrinsic fraud and depriving the petitioner of counsel dismissed would prevent the<br />

petitioner from proving their unlawful behavior.”<br />

Atch 1 Part B Petition 64-66 at pg. 19-20<br />

8. The Magistrate Hon. Judge David J. Waxse and Jay E. Heidrick were given notice that the law firm<br />

Shughart Thomson & Kilroy, P.C. was proceeding in a crime against the court and that the order to<br />

compel had been obtained through extrinsic fraud on the court. Atch, 2.<br />

9. Despite the exposure of their plan to procure dismissal of the plaintiff’s claims through extrinsic<br />

fraud, the defendants’ law firm Shughart Thomson & Kilroy, P.C. proceeded with the scheme by filing the<br />

motion at 6:30 am on 8/18/<strong>08</strong> that on its face reveals the deception and the expectation that Hon. Judge<br />

David J. Waxse will participate in the extrinsic fraud on the court, the motion faults the plaintiff for not<br />

producing the documents already served on both the magistrate and the defendants in the settlement brief<br />

and information not required in response to interrogatories including addresses unknown to the plaintiff<br />

and the pro se plaintiff’s legal theories but expressly not seeking the sanction of dismissal Shughart<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5686


Thomson & Kilroy, P.C. had previously arranged for outside of court. See atch. 3<br />

10. Despite conclusive notice that the matter or controversy was in appeal and that this court was<br />

thereby deprived of jurisdiction, Magistrate Hon. Judge David J. Waxse participated in the extrinsic or<br />

extrajudicial fraud by ruling on the motion filed earlier that morning by the defendants. See atch. 4 Order<br />

of Magistrate Hon. Judge David J. Waxse.<br />

11. Fearing the extrinsic fraud on the court scheme had been derailed by the plaintiff’s notice that the<br />

appeal had not been dismissed and other filings of the plaintiff on 8/18/<strong>08</strong>; Shughart Thomson & Kilroy,<br />

P.C.’s attorney Jay E. Heidrick filed a redundant motion to require the plaintiff to show cause in which<br />

Heidrick unconsciously has revealed the fraud on the court used to obtain the order to compel and the<br />

order of Hon. Judge Carlos Murguia to deny the objection to Hon. Judge David J. Waxse’s order to<br />

compel production by omitting the demand for the documents Shughart Thomson & Kilroy, P.C. had<br />

already been served and which the defendants US Bank NA and US Bancorp had corruptly destroyed<br />

committing spoliation even after being noticed to preserve the electronic discovery by the plaintiff. See<br />

atch. 5. Jay E. Heidrick Motion to Require Show Cause<br />

12. The Jay E. Heidrick Motion to Require Show Cause also reveals the fraud scheme to dismiss the<br />

contract claims that depended on Magistrate Hon. Judge David J. Waxse’s participation even after<br />

receiving notice that the scheme was extrinsic fraud on the court because Shughart Thomson & Kilroy,<br />

P.C.’s motion now states the true goal of the scheme -the dismissal of the plaintiff’s contract claims as a<br />

sanction for complying with discovery, even though US Bank and US Bancorp have breached even the<br />

case management order contract and have not produced any discovery or even the documents they specify<br />

they will use in their Rule 26(a)(1) disclosure; just as the defendants have had this court repeatedly<br />

sanctioned for being correct on the law. See exb. 5. Jay E. Heidrick Motion to Require Show Cause<br />

13. Facts outside of the affidavit of prejudice are known to Magistrate Hon. Judge David J. Waxse and<br />

Hon. Judge Carlos Murguia including why the plaintiff’s concurrent state antitrust claims were dismissed<br />

without findings of law or fact by the state court Hon. Judge Manners and that like the plaintiff’s federal<br />

antitrust and racketeering claims were dismissed for not having pled elements clearly on the face of the<br />

complaint where the table of contents specified, the plaintiff’s federal racketeering claims were dismissed<br />

by the W. D. of Missouri Chief Judge Hon. Judge Feranado J. Gaitan in a temporal relationship exceeding<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5687


that rejected in Glass v. Pfeffer, 849 F.2d 1261 at 1268 (C.A.10 (Kan.), 1988) and giving rise to the<br />

appearance of a lack of independence or extra judicial bias and prejudice by this court. See atch. 6. Notice<br />

of Appeal in Lipari v. Novation LLC and atch. 7,8 and 9 Rule 59(e) Motion and Answer Suggestions.<br />

MEMORANDUM OF LAW<br />

The plaintiff has filed an affidavit under 28 USC § 144 over the court’s proceeding to exert<br />

jurisdiction in a biased and prejudiced manner against the plaintiff despite being given conclusive notice<br />

that the plaintiff’s appeal has not been dismissed as sought by the defendants (the plaintiff supplied the<br />

court a copy of the August 11, 20<strong>08</strong> Order of the Tenth Circuit) and this court was under the controlling<br />

law of this circuit deprived of jurisdiction on July 11, 20<strong>08</strong>. See Plaintiff’s Objection to Magistrate’s Order<br />

of <strong>08</strong>/18/<strong>08</strong>.<br />

The affidavit was irrefutably timely being before the term in which the case is to be heard and on<br />

the same day that the plaintiff acquired conclusive evidence requiring recusal of the District Court judge<br />

court.<br />

The District Court Judge Hon. Judge Carlos Murguia,( not Magistrate Hon. Judge David J.<br />

Waxse) is required to determine whether the affidavit is sufficient. The judge against whom an affidavit<br />

under § 144 is filed must pass upon the legal sufficiency of the facts alleged. Green v. Murphy, 259 F.2d<br />

591, 593 (3 Cir. 1958). Because Hon. Judge Carlos Murguia is required to examine the circumstances and<br />

information beyond the affidavit and that information which is known to Hon. Judge Carlos Murguia alone,<br />

the affidavit has not yet been ruled on:<br />

“1 The Ninth Circuit in United States v. Sibla, 624 F.2d 864, 868 (9th Cir. 1980), outlined the<br />

procedures for recusal of a federal judge. The court explained that a motion brought under Sec.<br />

144 will raise a question concerning recusal under Sec. 455(b)(1) as well; the test for personal<br />

bias or prejudice is the same in both. Sec. 455 modifies Sec. 144 in requiring the judge to go<br />

beyond the Sec. 144 affidavit and consider the merits of the motion pursuant to Sec. 455(a)<br />

and (b)(1). [Emphasis added]”<br />

Gerald v. Duckworth, 46 F.3d 1133 at fn 1 (C.A.7 (Ind.), 1994).<br />

Section 144 requires that where an affidavit of personal bias or prejudice is filed, the judge must<br />

cease to act in the case and proceed to determine the legal sufficiency of the affidavit. Bell v. Chandler, 569<br />

F.2d 556 at 559 (C.A.10, 1978).<br />

4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5688


The plaintiff’s complaint, unchanged since its initial filing in Independence, Missouri gives notice<br />

to Hon. Judge Carlos Murguia of the existence 28 U.S.C. Section 455 bias.<br />

“31. No further court action occurred in the <strong>Medical</strong> <strong>Supply</strong> action until the petitioner’s<br />

counsel had been disbarred, then Kansas District Court Judge Carlos Murguia began in earnest<br />

making rulings with the visible purpose of dismissing the action for the lack of counsel and<br />

completing the removal of representation participated in by the Kansas District court and to further<br />

its adversarial interest in the petitioner’s proceeding.<br />

32. The Kansas District Court Judge Carlos Murguia dismissed the federal claims in their<br />

entirety for failure to state a claim despite the fact that the compliant was identical in elements of<br />

pleading for its claims to the complaint filed in Craftsman Limousine, Inc. vs. Ford Motor Company<br />

and American Custom Coachworks, et al, 8th Cir. 03- 1441 and 03-1554 and Judge Murguia<br />

expressly declined to exert jurisdiction over the state law based claims.<br />

33. The Kansas District court retained jurisdiction over the federal action to sanction<br />

<strong>Medical</strong> <strong>Supply</strong>’s former counsel and SAMUEL K. LIPARI for among other reasons, witnessing his<br />

counsel’s disbarment but then because of a timely motion for reconsideration ruled <strong>Medical</strong> <strong>Supply</strong><br />

<strong>Chain</strong>, Inc. would be sanctioned.”<br />

Plaintiff’s Petition at pg. 8 31-33.<br />

The significance of Hon. Judge Carlos Murguia not making rulings in the prior litigation was to<br />

facilitate the defendants’ scheme to deprive the plaintiff of counsel by preventing the discovery related to<br />

the racketeering claims over the defense counsel Shughart, Thomson & Kilroy, P.C.’s conduct to cause the<br />

plaintiff’s counsel’s disbarment as descried in detail in the later dismissed for not having required pleading<br />

elements clearly on the face of the 05-cv-02299-CM-GLR complaint.<br />

Hon. Judge Carlos Murguia has been discovered by the plaintiff on August 18, 20<strong>08</strong> to be giving<br />

the appearance of using the same tactic of not ruling on the plaintiff’s objections to the defendants’<br />

frivolous discovery protective orders as part of an extrajudicial scheme to cause the plaintiff’s contract<br />

claims to be dismissed through the extrinsic fraud of failing to produce documents already produced to the<br />

defendants and the magistrate.<br />

The extra-judicial nature of Hon. Judge Carlos Murguia’s appearance of bias and prejudice against<br />

the plaintiff and of presiding over this action without independence is the temporally related dismissal of<br />

racketeering claims by W. D. of Missouri Chief Judge Hon. Judge Feranado J. Gaitan, the judge that<br />

refused to remand the plaintiff’s state law claims despite their concurrent jurisdiction before the US Court<br />

of Appeals of the Tenth Circuit and instead transferred them to the District of Kansas. Hon. Judge Feranado<br />

J. Gaitan dismissal as detailed in atch 9 also dismisses the plaintiff’s racketeering claims for not containing<br />

elements clearly present on the face of the complaint.<br />

5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5689


Prior Extrajudicial Source Bias<br />

The court has participated in an extrajudicial source of prejudice and bias through extrinsic fraud<br />

by the defendants to procure an order to compel production of documents already produced and addresses<br />

or legal theories in response to interrogatories. The defendants procured these orders through extrinsic<br />

fraud or fraud on the court. "…that species of fraud which does or attempts to, defile the court itself, or is a<br />

fraud perpetrated by officers of the court so that the judicial machinery can not perform in the usual manner<br />

its impartial task of adjudging cases that are presented for adjudication.” Great Coastal Exp., Inc. v.<br />

International Broth. of Teamsters, Chauffeurs, Warehousemen and Helpers of America, 675 F.2d 1349 at<br />

1356 (C.A.4 (Va.), 1982) “Fraud is regarded as extrinsic or collateral where it prevents a party from<br />

having a trial or from presenting his cause of action or his defense, or induces him to withdraw a defense,<br />

or operates upon matters pertaining not to the judgment itself, but to the manner in which it was procured.”<br />

Muncrief v. Mobil Oil Company, 421 F.2d 801 at fn 2 (10th Cir., 1970). Kansas courts have defined<br />

extrinsic fraud as "some act or conduct of the prevailing party which has prevented a fair submission of the<br />

controversy." Hood v. Hood, 335 F.2d 585 at 591 (10th Cir., 1964).<br />

The procurement of the order to compel was “fraud extrinsic to the matters tried and determined<br />

by the other court and which caused the court to render a wrong judgment, such as the successful party<br />

through fraud or deception preventing the unsuccessful from presenting his case " described in Johnson v.<br />

First National Bank in Wichita, Kansas, 223 F.2d 31 at 34 (10th Cir., 1955).<br />

In Knapp v. Kinsey, 232 F.2d 458, 465 (6th Cir.), cert. denied, 352 U.S. 892, 77 S.Ct. 131, 1<br />

L.Ed.2d 86 (1956), reversing a lower court because of bias appearing during the trial, the court recognized<br />

the 'close analogy' between bias developed during trial, which requires reversal, and bias evident prior to<br />

trial, which requires disqualification under Section 144. The critical formulation of bias sufficient to<br />

reverse was forcefully expressed by the court:<br />

“Whether unconsciously or otherwise, (the trial judge) failed from the start of the trial to view<br />

this case with the impartiality between litigants that the defendants were entitled to receive. His<br />

active participation in the case and in the questioning of witnesses exceeded what was reasonably<br />

necessary to obtain a clear understanding of what their testimony was and fully justifies appellants'<br />

complaint that at times 'he, figuratively speaking, stepped down from the bench to assume the role<br />

of advocate for the plaintiff.' Although appellees' counsel did not ask or need such assistance, and<br />

apparently at times realized the possible prejudice to their cause, the prejudicial effect to appellants'<br />

rights requires a reversal of the judgment.<br />

Id. at 467.<br />

6<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5690


Where such advocatory bias 'exist(s) before the trial it furnishes the basis for disqualification of<br />

the judge to conduct the trial. Section 144, Title 28, U.S. Code.' Id. at 465. Especially from a due process<br />

perspective, it seems clear that the 'judicial proceeding' rule can extend no further than is necessary to<br />

preserve the functional ability of the courts to try cases. Mitchell v. Sirica, 502 F.2d 375 (C.A.D.C., 1974)<br />

A favorable or unfavorable predisposition can also deserve to be characterized as "bias" or<br />

"prejudice" because, even though it springs from the facts adduced or the events occurring at trial, it is so<br />

extreme as to display clear inability to render fair judgment. (That explains what some courts have called<br />

the "pervasive bias" exception to the "extrajudicial source" doctrine. See, e. g., Davis v. Board of School<br />

Comm'rs of Mobile County, 517 F. 2d 1044, 1051 (CA5 1975), cert. denied, 425 U. S. 944 (1976).).<br />

CONCLUSION<br />

Whereas the trial judge has not reviewed the plaintiff’s affidavit of prejudice or has not made an<br />

order regarding that review, under 28 USC § 144 there are no further proceedings in this court and because<br />

this court lost jurisdiction due to the notice of appeal filed on July 11, 20<strong>08</strong>, the magistrate’s order is void<br />

for want of jurisdiction.<br />

Respectfully Submitted,<br />

S/ Samuel K. Lipari<br />

____________________<br />

Samuel K. Lipari<br />

297 NE Bayview<br />

Lee's Summit, MO 64064<br />

816-365-1306<br />

saml@medicalsupplychain.com<br />

Pro se<br />

CERTIFICATE OF SERVICE<br />

I certify I have sent a copy to the undersigned opposing counsel via electronic filing on 8/22/<strong>08</strong>.<br />

Mark A. Olthoff, Esq.,<br />

Jay E. Heidrick, Esq.<br />

Shughart Thomson & Kilroy, P.C.<br />

Twelve Wyandotte Plaza<br />

120 W. 12th Street<br />

Kansas City, MO 64105<br />

via email<br />

jheidrick@stklaw.com<br />

7<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5691


molthoff@stklaw.com<br />

ademarea@stklaw.com<br />

S/ Samuel K. Lipari<br />

____________________<br />

Samuel K. Lipari<br />

Attachments:<br />

Atch 1 email to Shughart Thomson Kilroy Disclosing Petition<br />

Atch 1 Part A Judicial Ethics Complaint<br />

Atch 1 Part B Petition<br />

Atch 1 Part C Exhibits<br />

Atch 1 Part D Exhibits 2<br />

Atch 2 Letter of July-22-<strong>08</strong><br />

Atch 2 Exb 1 02-3443 Order <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. v. US Bancorp, NA.<br />

Atch 2 Exb. 2 Authority for investgation research<br />

Atch 3 Response to Show Cause Order<br />

Atch 4 Order to Show Cause<br />

Atch 5 Lipari Motion For Order To Show Cause<br />

Atch 6 Missouri Notice of Appeal<br />

Atch 7 Lipari v GE Rule 59(e) Motion<br />

Atch 8 Lipari Rule 59(e) Reply Suggestion<br />

Atch 9 Reply Suggestion to Seyfarth Shaw<br />

8<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5692


Date: February, 1 st 20<strong>08</strong><br />

Office of the Circuit Executive<br />

United States Tenth Circuit<br />

Byron White United States Courthouse<br />

1823 Stout Street<br />

Denver, Colorado 80257<br />

Re: Judicial Ethics Complaint against US District for Kansas Court Judge Carlos Murguia<br />

Dear Honorable Chief Judge Deanell Reece Tacha<br />

I am making a judicial ethics complaint against US District for Kansas Court Judge Carlos<br />

Murguia and his conduct in the following cases: <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. v. US Bancorp, NA et al KS.<br />

Dist. Case No. 02-2539; <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. v. General Electric Company, et al.,<br />

case number 03-2324-CM, <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. v Novation, et al; KS Dist. Court Case No.: 05-2299<br />

(Formerly W.D. MO. Case No. 05-0210);<br />

I am forced to make this complaint against my litigation interests and risk the certain retribution<br />

despite the recent US History of judges not being disciplined regardless of the seriousness of their<br />

offenses. 1 The reason I am forced to make this complaint is the urgency that the misconduct is continuing<br />

and threatens my property and has prevented me from incorporating and for all practical purposes, from<br />

ever entering the market for hospital supplies. I was stopped from obtaining a case management hearing in<br />

2002 in the matter that I am still litigating today, just before I was to meet with the Hon. Magistrate Waxse.<br />

The discoverable and public documents clearly and conclusively prove my claims. A known fact that seems<br />

to necessitate repeated dismissals before discovery commences. I finally got to the January, 20<strong>08</strong> case<br />

management hearing and Hon. Magistrate Waxse set a schedule including a timetable for dispositive<br />

motions that the parties mutually agreed to.<br />

While working on the next exhaustive task of documenting my damages and the controlling case<br />

law governing discovery, Judge Carlos Murguia issued a minute order having the effect of over ruling the<br />

case management order and did so by a minute entry with no document, having the effect of giving me no<br />

notice of the accelerated deadline.<br />

As the party experiencing the repeated prejudice and misconduct of US District for Kansas Court<br />

Judge Carlos Murguia I am fully aware of what would have happened to my chances of ever entering the<br />

market to compete with Novation LLC and lower hospital supply costs and all I have ever worked for if I<br />

had missed the stealth deadline.<br />

Each time I have had my claims dismissed based on facially false and readily discernable<br />

misrepresentations about the contents of my pleadings. This has been coupled with decisions on law<br />

directly contradicting controlling authority or adopting the defendants’ false legal argument grounded in the<br />

misrepresentation of whether words stating elements are in my complaints. Each time I have sought<br />

rehearings, pointing out the clear error of contradicting US Supreme Court authority on the precise issue or<br />

demonstrating that a federal statute or public law expressly states language for a private right of action,<br />

Judge Carlos Murguia has denied them. Judge Carlos Murguia has also denied me opportunities to correct<br />

any deficiencies in my claims.<br />

Any prejudice against me or my claims by Judge Carlos Murguia cannot be based on an objective<br />

view of the law or the economic conditions resulting from restraint of trade in the market for hospital<br />

1 http://writ.news.findlaw.com/dean/2004<strong>08</strong>13.html<br />

Atch 1 Part A Judicial Ethics Complaint<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5693


supplies. Similarly, the defendant banking conglomerate US Bancorp has lost evidentiary hearings, been<br />

fined and settled with the New York Attorney General and the Securities and Exchange Commission for<br />

their conduct in extorting new healthcare technology companies to the hospital supply marketplace<br />

controlled by Novation LLC and for conduct in the capitalization of my competitor Neoforma, Inc. If Judge<br />

Carlos Murguia is acting on ex parte information from the law firms representing the defendants, their<br />

pleadings reveal a complete absence of knowledge of the crisis preventing Americans from receiving<br />

healthcare through artificial inflation and restraint of trade. The nation and even the defendants are being<br />

harmed by Judge Carlos Murguia’s lack of impartiality.<br />

I have sought judicial review of Judge Carlos Murguia’s misconduct through appeal in <strong>Medical</strong><br />

<strong>Supply</strong> <strong>Chain</strong>, Inc. v. US Bancorp, NA et al 10th Cir. Case No.: 02-3443; <strong>Medical</strong><br />

<strong>Supply</strong> <strong>Chain</strong>, Inc. v. General Electric Company, et al. No. 04-3075 and 04-3102 (10th Cir.) and <strong>Medical</strong><br />

<strong>Supply</strong> <strong>Chain</strong>, Inc. v. US Bancorp, NA et al 10th Cir. Case No.: 03-3342; 06- 3331. This has been frustrated<br />

by back channel communications fostered in Judge Carlos Murguia’s office that prejudice me and everyone<br />

associated with helping me in the eyes of the Tenth Circuit Court of Appeals and other courts. The most<br />

recent appeal decisively showed Judge Carlos Murguia’s error on every point sustaining his ruling and the<br />

statement of facts documented the blatantly false claims the required pleading elements were not stated<br />

clearly in my complaint. See Applt Br at pages 19-31, Applee Br.: 2 , 3<br />

The notice of appeal was not timely. My former counsel Bret D. Landrith never missed deadlines,<br />

only the defense counsel. I depended on his research and willingness to take my action on contingency as<br />

Congressional policy provided for. It became essential to the opposing law firms to have him prevented<br />

from helping me. My former counsel was disbarred over the ex parte communications to the Kansas state<br />

disciplinary authority fostered by Judge Carlos Murguia and reciprocally disbarred after by Judge Carlos<br />

Murguia vehement dismissal with sanctions of <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. v Novation, et al; KS Dist.<br />

Court Case No.: 05-2299 (Formerly W.D. MO. Case No. 05-0210) and threats to sanction me or my<br />

counsel for seeking reconsideration. The past unwillingness of the Tenth Circuit to exercise judicial review<br />

and the financial sanctions being issued for correctly stating the law made it very dangerous for Dennis<br />

Hawver and impossible to find replacement counsel.<br />

Shortly after the appeal was rejected, the national news covered the hospital supply restraint of<br />

trade problem. In "Blowing the Whistle, Many Times" The New York Times Cynthia Fitzgerald By Mary<br />

Williams Walsh, November 18, 2007 described hundreds of millions of dollars lost from Medicare by the<br />

misconduct. 4 http://www.nytimes.com/2007/11/18/business/18whistle.html. I have maintained the<br />

documentary evidence that is the basis for my claims in the above litigation online at<br />

http://www.medicalsupplychain.com/news.htm and includes four years of US Senate Judiciary Committee<br />

testimony on the restraint of trade I have raised in my complaint and the conduct of Novation LLC in<br />

keeping healthcare technology companies from being capitalized.<br />

The national interest and lives lost from increasing and unaffordable healthcare resulting in the<br />

lack of competition in hospital supplies has made Judge Carlos Murguia’s dereliction of his duty<br />

horrifically egregious. Not only I and the legal counsel and other business associates been injured but so<br />

have the defendants, some of which are publicly traded corporations. Despite Judge Carlos Murguia’s<br />

willingness to rule for the defendants’ local counsel regardless of their failure to research issues or even to<br />

be honest about the documents before the court in their written pleadings, the defendant corporations still<br />

are injured by the non law based outcomes and are unable to change their chargeable conduct and the avoid<br />

the consequences. Most of all, the integrity of the Kansas District Court and the people of the United States<br />

who provide for civil enforcement through the courts of Congresses laws against restraint of trade.<br />

I realize this begins a long road, first to the circuit Judicial Council’s likely unwillingness to<br />

investigate this complaint, then to the Judicial Conference. Afterwards, without relief I will be forced to<br />

then seek redress in the legislature and finally through popular sovereignty in changing the policy that<br />

2 http://www.medicalsupplychain.com/pdf/Novation%20Appeal%20Brief.pdf<br />

3 http://www.medicalsupplychain.com/pdf/Novation%20&%20US%20Bank%20Reply%20Brief.pdf<br />

4 http://www.nytimes.com/2007/11/18/business/18whistle.html.<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5694


permitted the repeated outcomes here that are contrary to fact and law. I know the Kansas District court and<br />

practitioners will wish me success. All of whom are hurt by the overt ness of Judge Carlos Murguia’s<br />

repeated misconduct and whom value our court system and its role in vindicating our national policies.<br />

I stand ready to provide all documentation and testimony any and every investigation of these<br />

events may require.<br />

Sincerely,<br />

Samuel K. Lipari<br />

Samuel Lipari<br />

<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong><br />

297 NE Bayview<br />

Lee's Summit, MO 64064<br />

Phone: 816.365.1306<br />

Saml@<strong>Medical</strong><strong>Supply</strong><strong>Chain</strong>.com<br />

www.<strong>Medical</strong><strong>Supply</strong><strong>Chain</strong>.com<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5695


JUDICIAL COUNCIL THE TENTH CIRCUIT<br />

UNITED STATES COURT OF APPEALS<br />

)<br />

In re Charge of Judicial Misconduct, )<br />

) Case No. 20<strong>08</strong>-10-372-<strong>08</strong><br />

)<br />

PETITION FOR REVIEW<br />

Comes now the petitioner Samuel K. Lipari and respectfully requests that<br />

this judicial council review the March 14, 20<strong>08</strong> order by the Hon. Robert H.<br />

Henry, Chief Circuit Judge dismissing the complaint against the respondent and<br />

take action to stop the continuing violations of Judicial Canons 1, 2A, 2B, 3A1,<br />

3A2, 3A3, 3A4, 3A6, 3B2, and 3B3 by the respondent.<br />

Introduction<br />

This petition seeks to review the dismissal of the judicial misconduct<br />

complaint made against the respondent for the ministerial act of withholding<br />

notice of an order that if neglected would have resulted in the petitioner’s loss of<br />

his remaining claims. The respondent has been presiding over the petitioner’s<br />

contract and pendant federal claims since 2002. The respondent’s name is omitted<br />

to permit publication of this petition.<br />

The petitioner realized his contract was breached to further the defendants’<br />

interest in the Novation LLC hospital supply cartel and first entered court through<br />

his Missouri corporation <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. appearing before the<br />

respondent to seek only prospective injunctive relief preventing the defendants<br />

1<br />

Atch 1 Part B Petition<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5696


from obstructing his entry into the hospital supply market. By breaching a<br />

contract to provide escrow accounts to the manufacturer’s representatives the<br />

petitioner had recruited for the purpose of funding the development of hospital<br />

customers, the defendants protected their underwriting of Neoforma, Inc the<br />

petitioner’s direct competitor which was openly a member of a hospital supply<br />

cartel published in securities filings as creating exclusionary long term<br />

anticompetitive contracts with more than 2500 hospitals nationwide and organized<br />

by General Electric under the leadership of Jeffry Immelt and Novation LLC, also<br />

published in securities filings.<br />

The respondent became convinced from sources other than the petitioner or<br />

any known filings that the defendants could not be liable for antitrust and the<br />

respondent began a pattern and practice of dismissing all the petitioner’s actions<br />

before discovery could commence. In the marketplace, the defendants were<br />

emboldened to commit subsequent antitrust felonies injuring consumers in the<br />

market and the petitioner.<br />

The petitioner reentered court seeking damages for the subsequent conduct<br />

violating antitrust law and for the misconduct of the defendants in committing<br />

extortion under color of official right to prevent the petitioner from being able to<br />

present his case to a jury through extrinsic fraud. The respondent again delayed<br />

and prevented discovery and delayed ruling on the petitioner’s partial summary<br />

judgment which contained the controlling law applied to evidentiary exhibits of<br />

the extortion until after the petitioner was successfully deprived of counsel, then<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5697


the respondent ordered dismissal of all federal claims, dismissing the partial<br />

summary judgment as moot and dismissing without prejudice the petitioner’s state<br />

law claims. The order written by the respondent also sanctioned the petitioner in<br />

the complete absence of jurisdiction and sanctioned the petitioner’s former counsel<br />

despite the respondent’s prior orders excluding the petitioner and from the action.<br />

I. Statement of Facts<br />

1. The petitioner made a complaint of judicial misconduct against the<br />

respondent, a district court judge on February 1, 20<strong>08</strong>. See Exb. 1.<br />

A. Conclusive Evidence of Respondent’s Ministerial Misconduct<br />

2. The complaint identified the ministerial conduct of failing to give the<br />

petitioner notice that the response due date for the defendants’ second Rule<br />

12(b)(6) motion for dismissal had been changed in an electronic minute order<br />

without a paper copy being mailed to the pro se petitioner:<br />

“While working on the next exhaustive task of documenting my<br />

damages and the controlling case law governing discovery, Judge Carlos<br />

Murguia issued a minute order having the effect of over ruling the case<br />

management order and did so by a minute entry with no document, having<br />

the effect of giving me no notice of the accelerated deadline.”<br />

Complaint of Judicial Misconduct, pg. 1 of Exb. 1.<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5698


3. The complaint clearly identifies the gravamen of the misconduct and the<br />

consequences that would have befallen the petitioner had he not discovered the<br />

electronic order had shortened the deadline from 4/24/20<strong>08</strong> 1 to 2/1/20<strong>08</strong>:<br />

“As the party experiencing the repeated prejudice and misconduct of US<br />

District for Kansas Court Judge Carlos Murguia I am fully aware of what<br />

would have happened to my chances of ever entering the market to compete<br />

with Novation LLC and lower hospital supply costs and all I have ever<br />

worked for if I had missed the stealth deadline.”<br />

Complaint of Judicial Misconduct, pg. 1 of Exb. 1<br />

4. After receiving an acknowledgement of the complaint, the petitioner was<br />

not contacted by the Judicial Council until receiving a cover letter (Exb. 2) and the<br />

order signed by the Hon. Robert H. Henry, Chief Circuit Judge dismissing the<br />

complaint. See Exb. 3.<br />

5. The record of the case confirms the respondent’s alteration of the parties’<br />

agreed upon schedule and the order of the Magistrate Judge. The Magistrate’s<br />

scheduling order electronically served on the defendants’ counsel and mailed to<br />

the plaintiff states: “Motions to dismiss for lack of personal jurisdiction,4/1/<strong>08</strong>”<br />

See Magistrate’s Order pg. 2 of Exb. 4.<br />

6. The respondent made an entry without a paper order:<br />

“1/24/20<strong>08</strong> 51 ORDER granting in part and denying in part 46 Motion for<br />

Extension of Time to File Response/Reply re 43 MOTION to Dismiss<br />

Pursuant to Rule 12(b)(6) and Rule 8 of the Federal Rules of Civil<br />

Procedure. Response deadline 2/1/20<strong>08</strong>. Signed by District Judge<br />

…[Respondent]… on 1/24/<strong>08</strong>.(This is a TEXT ENTRY ONLY. There is<br />

no.pdf document associated with this entry.) (js) (Entered: 01/24/20<strong>08</strong>)”<br />

1 KS. Dist. Court Local Rule 6.1(d)(2) provides 23 days to respond to dispositive<br />

motions.<br />

4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5699


Appearance Docket of the subject litigation.<br />

7. The petitioner avoided the effect of being deprived of notice and the<br />

respondent and the judicial council are able to readily verify the petitioner’s<br />

justifiable fear on the first page of the response to the dismissal:<br />

“The plaintiff is also aware of this court’s disposition toward him and his<br />

claims embodied by the court’s January 24th, 20<strong>08</strong> decision to over rule the<br />

Magistrate Judge’s case management schedule and require this answer by<br />

February 2, 20<strong>08</strong>.<br />

An impartial observer could find that the issuance of a minute order<br />

changing the schedule without accompanying documentation could prejudice<br />

a pro se defendant excluded from the electronic case management system.<br />

The plaintiff has no doubt as to what would have been in store for his<br />

claims or his future ability to enter the hospital supply market and compete<br />

against US Bancorp’s co-conspirator Novation LLC had he not made the<br />

deadline.”<br />

Petitioner’s Response to Second Dismissal, Exb. 5<br />

B. Respondent’s Retaliatory Obstruction of Rule 60(b) Proceedings<br />

8. On March 28, 20<strong>08</strong> following the March 18 letter transmitting the<br />

Judicial Council order dismissing the judicial ethics complaint, the respondent<br />

struck the petitioner’s Rule 60(b) motion and ordered the petitioner to show<br />

cause in an electronic filing of a Word Perfect Document the respondent<br />

entitled “Lipari sanctions.” See Exb. 6 .<br />

5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5700


(1) Causing The Kansas Clerk To Again Withhold Mailing An Order<br />

9. The respondent’s March 28 order was available as a pdf file and<br />

delivered via the court’s electronic case filing to the defendants and the Clerk of<br />

the Kansas District Court but was not mailed to the pro se petitioner (as other<br />

orders in this case and the petitioner’s Kansas District Court litigation with the<br />

exception of the 1/24/20<strong>08</strong> minute order above) who is not eligible for<br />

electronic filing.<br />

10. Like the 1/24/20<strong>08</strong> minute order, the March 28 order directed and<br />

required a response by the petitioner within a limited number of days or the<br />

petitioner would lose a significant property interest.<br />

11. The petitioner made a timely answer after accidentally discovering the<br />

order had been made. See Exb. 7<br />

(2) Complete Absence of Jurisdiction To Strike Rule 60(b) Motion<br />

12. Like the 1/24/20<strong>08</strong>, the March 28 order was contrary to the Federal<br />

Rules of Civil Procedure. The 1/24/20<strong>08</strong> order directed the petitioner to answer<br />

a second Rule 12 dismissal motion not permitted under F.R.Civ. P. Rule 12.<br />

The March 28 order struck a motion by the petitioner that was not a pleading<br />

that could be struck under Rule 12(f) as defined by Rule 7 and the controlling<br />

case law of this circuit. See Exb 7.<br />

13. The respondent’s prior dismissal order of federal claims in this action<br />

sanctions the petitioner and the petitioner’s former attorney, neither of whom<br />

6<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5701


were parties to the action at the time the order was made and over whom the<br />

court had a complete absence of jurisdiction. See Exb 8.<br />

14. The respondent’s order is harshly critical of the petitioner and his former<br />

counsel expressing a complete disbelief of the petitioner’s claims and related<br />

sworn affidavit as the basis for the dismissal under Rule 12(b)(6) even though<br />

there had been no discovery in any of the petitioner’s cases and no basis to<br />

question the petitioner’s factual averments except ex parte communications<br />

with defense counsel. See Exb 8.<br />

15. The order sanctions the petitioner for bringing subsequent claims that<br />

were not precluded under the transactional approach to res judicata that is the<br />

controlling law of this circuit and are materially identical to controlling US<br />

Supreme Court antitrust cases determining similar claims were not precluded.<br />

16. When the respondent realized his order dismissing the petitioner’s now<br />

dissolved Missouri corporation and sanctioning the petitioner made the<br />

petitioner a party in the action, the respondent attempted to refute the change he<br />

had created in a second order but ended up confirming the petitioner was<br />

ultimately liable. See Exb. 9.<br />

17. The reason the petitioner was being treated with open bias and prejudice<br />

by the respondent in his orders and the verifiable reason the federal claims were<br />

dismissed (even though the required elements were clearly and concisely pled<br />

with supporting factual averments at exactly where the complaint’s table of<br />

contents indicated ) is because the petitioner had subsequent conduct claims<br />

7<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5702


ased on the defendants’ misconduct in preceding litigation that included<br />

conduct the respondent witnessed and knew occurred. See Exb. 10.<br />

18. The petitioner had also filed a partial summary judgment briefing the<br />

respondent on the current state of the applicable federal law governing the<br />

petitioner’s claims on this misconduct and providing supporting evidentiary<br />

documents. See “Memorandum In Support Of First Plaintiff’s Motion For<br />

Partial Summary Judgment Under F. R. CIV. P. Local Rule 56.1”,Exb 11. And<br />

Exb 11 supporting attachments 1 thru 13.<br />

19. The conduct complained of in the complaint and documented in the<br />

motion for partial summary judgment concerned extrinsic fraud through<br />

Extortion Under Color of Official Right in depriving the petitioner of<br />

representation so that the petitioner would be forced to forfeit his claims. See<br />

Exb 10.<br />

20. The extrinsic fraud of Extortion Under Color of Official Right used to<br />

procure the decision in this case was also contained in the procedural history<br />

portion of the petitioner’s state law contract claims against US Bank and US<br />

Bancorp (see Exb. 29) filed by the petitioner in the 16 th Circuit Court of the<br />

State of Missouri at Independence, Missouri and is again before the respondent<br />

without alteration after fraudulently being removed and transferred to the<br />

respondent where he exercised jurisdiction over them while the Tenth Circuit<br />

appeal of their dismissal was proceeding and the respondent was in the<br />

complete absence of jurisdiction.<br />

8<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5703


21. The petitioner had opposed transfer of the antitrust case to the<br />

respondent and made an affidavit documenting the misconduct he witnessed in<br />

the Kansas District court, including the attempted extortion to deprive him of<br />

representation, the offer of $300,000.00 cash to replace the capital US Bank and<br />

US Bancorp deprived him of if he accepted substitute counsel provided by the<br />

Kansas Disciplinary Administrator’s agent Gene E. Schroer, the warrantless<br />

wiretapping related to the USA PATRIOT Act and the false testimony under<br />

oath and the accompanying ex parte communications of the respondent’s<br />

magistrate to the Kansas state tribunal witnessed by the petitioner. See Exb 12.<br />

22. This affidavit which never was contested and which no hearing ever<br />

resulted from was referred to with disbelief by the respondent in his order<br />

granting a rule 12(b)(6) dismissal of the petitioner’s federal claims and ordering<br />

sanctions of the petitioner.<br />

23. As directed by the Tenth Circuit, the petitioner and his former counsel<br />

made a criminal complaint based on this conduct to the Kansas City, Missouri<br />

regional office of the FBI. See Exb 13.<br />

C. Respondent’s Past Obstruction of Rule 59 Proceedings<br />

24. The respondent has previously ignored clear error over controlling US<br />

Supreme Court decisions and the express grant of private rights of action by the<br />

US Congress when brought to his attention by the petitioner in timely motions for<br />

reconsideration. See Exb 14 a motion struck because the petitioner had been by the<br />

9<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5704


espondent’s order deprived of the representation of Bret D. Landrith and by the<br />

threats of sanctions constructively deprived of the representation of Dennis<br />

Hawver and left unable to find replacement counsel.<br />

25. The respondent had previously failed to address the petitioner’s timely<br />

motion for reconsideration in <strong>Medical</strong> <strong>Supply</strong> I.<br />

26. The failure of the respondent to take into consideration the petitioner’s<br />

reconsiderations resulted in judgments that directly conflicted with controlling US<br />

Supreme Court and Tenth Circuit precedents and also repudiated the express<br />

language of the Congress in the USA PATRIOT Act creating private rights of<br />

action.<br />

D. Respondent’s Communications To Defeat Review<br />

27. Patrick Fisher, the former Clerk of the Tenth Circuit Court of Appeals<br />

developed a completely prejudiced view of the merits of the petitioner’s litigation<br />

despite no previous communications by the petitioner or his counsel to Mr. Fisher<br />

and no known involvement of Mr. Fisher in the hospital supply industry.<br />

28. The petitioner’s former attorney wrote Mr. Fisher a letter attempting to<br />

rectify some of the misunderstandings. See Exb. 16.<br />

29. The Tenth Circuit decided not to review the legal basis for the respondent’s<br />

<strong>Medical</strong> <strong>Supply</strong> I decision and issued an order upholding the respondent even<br />

adopting the respondent’s clear error declaration that there was no private right of<br />

action under the USA PATRIOT Act and this decision is used in the Missouri<br />

10<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5705


State Court and the Western District of Missouri to repeatedly attempt to prejudice<br />

the court’s into believing any claim by the petitioner is frivolous. See Exb17.<br />

30. The petitioner in shock answered the Show Cause and circulated it to<br />

members of the US Senate Judiciary Committee he had already been in contact<br />

with concerning the difficulty of addressing the anticompetitive practices of<br />

the Novation LLC cartel (the subject of two preceding US Senate Judiciary<br />

Antitrust subcommittee hearings ) See Exb 18.<br />

31. The Tenth Circuit upheld the dismissal violating the Rule 12(b)(6) standard<br />

and overtly expressed disbelief of the petitioner’s claims as a basis for the<br />

dismissal which the Tenth Circuit has since been over ruled on but materially, the<br />

Tenth Circuit adopted the respondent’s view that the claims were not researched<br />

when in fact the complaint contained sixteen sources listed in end notes citing to<br />

investigative journalism, government and academic support for the petitioner’s<br />

claims. See Exb 19.<br />

32. The Tenth Circuit in the person of the Chief Clerk of the Tenth Circuit<br />

Court of Appeals ordered the harshest possible sanctions for a frivolous appeal<br />

despite even acknowledging the district court and the appellate panel’s error that<br />

there were indeed private rights of action under the USA PATRIOT Act but<br />

refusing to change its approval of the trial court’s adoption of the defendants straw<br />

man fraud that the complaint did not identify other legally separate hospital supply<br />

cartel co-conspirators and their agreement which was identified in SEC required<br />

filings. See Exb 20.<br />

11<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5706


33. The petitioner’s brief in <strong>Medical</strong> <strong>Supply</strong> I had apprised the appellate court<br />

of the important national interest at stake in the appeal and the petitioner’s<br />

involvement of the US Senate in the issues before the Tenth Circuit Court of<br />

Appeals:<br />

After five years developing the technology, it attempted to capitalize its entry<br />

into the hospital supply market at the moment it saw hospitals were seeking<br />

alternatives to healthcare group purchasing organizations (“GPO’s”) as a<br />

result of a New York Times series exposing the harmful effects of GPO’s<br />

and a series of US Senate Judiciary Antitrust sub-committee hearings were<br />

critically reviewing the anti-kickback1 safe harbor under Medicare for<br />

GPO’s. Aplt. Apdx. v1 C 26,C En.vii and viii.<br />

The testimony related to the petitioner was even excerpted:<br />

“On July 16, 2003, the national policy debate on the appropriateness<br />

of the<br />

Medicare anti-kickback safe harbor for group purchasing convened<br />

again before the subcommittee of the Senate Committee on the Judiciary<br />

without <strong>Medical</strong> <strong>Supply</strong>’s presence as a competitor in the hospital supply<br />

marketplace:<br />

“How important is the E-Commerce monopoly to those who control<br />

it Over the past year one start-up company has been blocked twice from<br />

market entry. The first time, a bank tied to an investment house that has<br />

seventy percent of its holdings in health care suppliers refused to provide the<br />

company with simple escrow services through a blatant misapplication of the<br />

USA Patriot Act. Most recently an international conglomerate that is a<br />

founder of GHX was willing to take a $15 million dollar loss on a real estate<br />

deal just to keep this company out of the market.” Testimony Lynn James<br />

Everard, Hospital Group Purchasing: Has the Market Become More Open to<br />

Competition, United States Senate Committee on the Judiciary<br />

Subcommittee on Antitrust, Competition and Business and Consumer Rights<br />

July 16, 2003”<br />

See Exb. 21.<br />

34. The testimony described both the <strong>Medical</strong> <strong>Supply</strong> I case and the petitioner’s<br />

related case against the General Electric co-conspirators which the respondent also<br />

12<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5707


dismissed, contradicting controlling law of the US Supreme Court and the Tenth<br />

Circuit Court of Appeals on whether all antitrust Sherman I antitrust conspirators<br />

need to be named as defendants (the petitioner had identified each of the coconspirators<br />

and described in detail their agreement and conduct but chose to<br />

name only those directly injuring him in furtherance of the hospital supply cartel.<br />

35. The Tenth Circuit panel’s opinion reflected the respondent’s<br />

communication of disdain and admonishment contained in the respondent’s order<br />

of dismissal.<br />

36. The day after the Tenth Circuit panel’s decision in the petitioner’s GE case,<br />

the US Supreme Court docketed the petitioner’s former attorney’s petition for<br />

certiorari of the sanctions in <strong>Medical</strong> <strong>Supply</strong> I.<br />

37. The petitioner again brought to the attention of the Tenth Circuit the<br />

respondent’s dismissal of federal claims in <strong>Medical</strong> <strong>Supply</strong> II violation of<br />

controlling US Supreme Court precedent and the express language of the US<br />

Congress in granting private rights of action under the USA PATRIOT Act in<br />

claims based on the subsequent and continuing conduct of the defendants.<br />

38. The national interest in the issues affected by the litigation had grown. US<br />

Senator Sam Brownback was met with protestors demonstrating against<br />

unaffordable healthcare costs in Topeka and ultimately withdrew from the US<br />

Presidential race despite the absence of another social conservative with<br />

experience in the House and Senate. Both the US Senator who had chaired the US<br />

Senate Judiciary Committee’s Antitrust Sub Committee hearing described above<br />

13<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 57<strong>08</strong>


and the US Senator from Missouri had lost their seats due to public concern over<br />

the lack of affordable healthcare:<br />

“Hon. Senator Mike DeWine, the chair of the US Senate Judiciary<br />

Committee's Antitrust Subcommittee hearing that during the fourth year of<br />

antitrust hearings on the defendant Novation’s anticompetitive conduct in the<br />

hospital supply market concluded Novation’s abuses could be better<br />

corrected with private antitrust litigation than with new legislation 95 on<br />

pg.52. Senator Mike DeWine lost his re-election on November 4, 2006. The<br />

senator from Missouri, Hon. Jim Talent also lost his seat in part because of<br />

the healthcare issue.<br />

See KC Star Buzz Blog Sept 29, 2006 CAMPAIGN AD BUZZ | McCaskill<br />

criticizes Talent on Medicaid.”<br />

See Exb. 22.<br />

39. The harsh rebuke’s of the petitioner, sanctions overtly contrary to<br />

controlling law and the threats of more sanctions if any post trial motions are made<br />

had the foreseeable effect of making it difficult for the petitioner to obtain counsel<br />

for an appeal.<br />

40. The appeal was ultimately dismissed based on timeliness.<br />

E. Respondent’s Effect on Other Litigation<br />

41. The respondent’s dismissal of <strong>Medical</strong> <strong>Supply</strong> II which included the<br />

defendants Neoforma, Inc. and Novation LLC aggrevated the government’s False<br />

Claims Act investigation of Novation LLC.<br />

42. On November 17, 2007 the New York Times ran a feature interview on the<br />

newly unsealed case by a senior Novation LLC manager who witnessed the<br />

conduct described by the petitioner in the <strong>Medical</strong> <strong>Supply</strong> complaint: See Exb 23.<br />

14<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5709


(1) Respondent’s Effect On Litigation in the Eighth Circuit<br />

43. The respondent’s earlier decisions deceived or confused Western District of<br />

Missouri Chief Judge Fernando J. Gaitan, Jr. and he declined to remand the<br />

petitioner’s state law claims against US Bank and US Bancorp that had earlier<br />

been dismissed without prejudice by the respondent and transferred them back to<br />

the respondent despite the exclusive federal jurisdiction being exercised over those<br />

same claims by the Tenth Circuit Court of Appeals. See Exb. 25.<br />

44. The US Attorney for the Western District of Missouri was removed from<br />

office under a now repealed provision of the USA PATRIOT II to interfere in the<br />

Medicare Fraud investigation of Robert H. Bezanson and CoxHealth in<br />

Springfield, Missouri and to ensure the above mentioned FBI criminal complaint<br />

was not investigated, necessitating the petitioner’s press releasing of a USDOJ<br />

memo on the “Ninth US Attorney” and indirectly causing the defendants’ work to<br />

deprive the petitioner of a republican form of government being defeated through<br />

legislative redress. See Exb. 24.<br />

45. Western District of Missouri Judge Ortrie D. Smith was deceived or<br />

confused by the respondent’s rulings as used by the defendants and ordered the<br />

transfer of <strong>Medical</strong> <strong>Supply</strong> II to the Kansas District court despite the strong<br />

interests of the State of Missouri which was being forced to eliminate Medicaid,<br />

See Exb. 26.<br />

46. The complaint had stated clearly the pressing State of Missouri interest:<br />

15<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5710


President George Bush who has observed that there is an absence of<br />

competition in healthcare (47 on pg.43) came to St. Luke’s Health System<br />

in Lee’s Summit, Missouri with Secretary of Health and Human Services<br />

Michael Leavitt, two days after the State of the Union speech to personally<br />

initiate the administration’s plan to make healthcare affordable. Office of the<br />

President, January 25, 2007 press release.<br />

Governor Matt Blunt described in the complaint 85 at pg. 50 as having to<br />

cut Missouri citizens from Medicaid because of hospital supply cost<br />

increases, made healthcare the central priority of his State of the State speech<br />

but on January 25th chose to speak about healthcare at other Missouri<br />

communities rather than appear with President George Bush in Lee’s<br />

Summit. Office of the President, January 25, 2007 press release Comments<br />

of Secretary Leavitt.<br />

On the same day, the New York Times reported that the Attorney General<br />

for the State of Connecticut, Richard Blumenthal reached a settlement with<br />

H.R.D.I. that <strong>Medical</strong> <strong>Supply</strong> identified as a co-conspirator but did not name<br />

as a defendant over the commercial bribes given to hospital administrators<br />

141-143 pg. 61. H.R.D.I. agreed to end operations as a for profit<br />

company. “Group Settles Health Sales Conflict Case”, NY Times Jan. 25,<br />

2007<br />

See Exb. 22<br />

47. Western District of Missouri Judge Ortrie D. Smith could not have<br />

known that the respondent would be biased or that the earlier decision in<br />

<strong>Medical</strong> <strong>Supply</strong> I had been obtained through extrinsic influence.<br />

48. The Western District of Missouri Chief Judge Fernando J. Gaitan, Jr.<br />

could not have known that the prior rulings were unrelated to the merits of the<br />

petitioner’s claims against the GE co-conspirators who had breached the<br />

contract for the sale of the real estate lease to withhold a critical capital input<br />

for the purpose of continuing to exclude the hospital supply market and was<br />

surprised at the necessity for mandamus to restore the petitioner’s ability to<br />

16<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5711


enter the market where Missouri doctors had testified patients would die from<br />

the Medicaid cuts. See Exb 27.<br />

(2) Respondent’s Effect On Litigation in the State of Missouri<br />

49. The case was returned to the Missouri State Court which still appeared<br />

influenced by the respondent’s earlier decisions necessitating a second and third<br />

mandamus. See Exb. 28.<br />

50. The GE defendants continued the extrinsic fraud, even repeatedly<br />

making misrepresentations to the Missouri State Court that ultimately resulted<br />

in additional federal racketeering claims based on the GE defendants’<br />

subsequent conduct and the action is now removed again to the Western District<br />

of Missouri.<br />

51. The respondent exerted jurisdiction over the petitioner’s state contract<br />

claims filed in Independence, Missouri despite the repeated notice that the<br />

Tenth Circuit had exclusive federal jurisdiction during the pending petitioner’s<br />

appeal and the detailed procedural history on the face of the complaint. See<br />

Exb. 29.<br />

52. The petitioner was forced to file a separate concurrent state law antitrust<br />

case in Independence, Missouri against the current Kansas district Court<br />

antitrust defendants that the respondent dismissed without prejudice when the<br />

petitioner had more than adequately plead each of the elements of his federal<br />

antitrust and racketeering claims. See Exb. 30.<br />

17<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5712


53. Since the defendants law firms were not given meaningful guidance on<br />

antitrust law by the respondent’s clearly erroneous dismissals, the defendants<br />

continued the unlawful conduct and committed subsequent acts injuring<br />

Missourians and involving Missouri hospitals and executives in the restraint of<br />

trade.<br />

54. The defendants cannot now avail themselves of the advantages of a<br />

federal forum because the respondent struck the petitioner’s Rule 60(b) motion<br />

despite the complete absence of jurisdiction to do so under Rule 12(f). See<br />

Exbs. 7 and 8.<br />

F. Respondent As a Catalyst For New Federal Judicial Ethics Procedures<br />

55. When the respondent went beyond erroneous decisions and<br />

communicated admonishment of the petitioner’s research and diligence despite<br />

the respondent’s repeated demonstrations that the petitioner’s filings had been<br />

unread and that the adopted defendants’ legal arguments conflicted with<br />

controlling legal authorities, the petitioner began working to improve the<br />

federal justice system.<br />

56. On November 10, 2004 the petitioner wrote a letter to members of the<br />

US Senate Committee on the Judiciary including Senator Arlen Specter. See<br />

Exb. 32.<br />

57. After the failure of judicial review the petitioner wrote a second letter to<br />

members of the committee including Senator Arlen Specter. See Exb. 33.<br />

18<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5713


58. Through the petitioner’s lobbying and working for reform with the US<br />

Senate, the national Judicial Council redefined its role in judicial ethics<br />

complaints and the discipline of judges.<br />

59. Despite these changes, the respondent still continues to exercise open<br />

prejudice and bias defeating the Congressionally legislated public policy of<br />

having the petitioner with his knowledge of the hospital supply industry address<br />

anticompetitive practices that violate federal law.<br />

60. The petitioner has been forced to redouble his judicial reform efforts.<br />

See Exb. 34.<br />

61. When the petitioner complained about the misconduct of the<br />

respondent’s magistrate, the former Chief Judge of the Tenth Circuit<br />

determined that the ethics complaint was frivolous before the transcript of the<br />

magistrate’s testimony was available. See Exb. 35.<br />

62. However the former Chief Judge recognized the likelihood bias or<br />

prejudice against the petitioner’s cause existed. Id.<br />

63. The transcript clearly shows the magistrate at first misrepresented the<br />

record to the Kansas Disciplinary tribunal in regards to staying discovery in the<br />

petitioner’s litigation despite the absence of jurisdiction to do so. See Exb 13<br />

Atch 9. Transcript of Magistrate’s testimony and Exb 13 Atch 9A Order of<br />

Stay.<br />

64. The defendants’ law firm is aware of the changes made in the judicial<br />

council’s treatment of judicial misconduct complaints yet they still file<br />

19<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5714


pleadings that contain extrinsic fraud believing the respondent will grant them.<br />

See Exb 36.<br />

65. The US Bank and US Bancorp defendants are currently arguing before<br />

the respondent in the state contract based claims case for a protective order to<br />

evade having to turn over the email contract for the escrow accounts and the<br />

written loan application that are the writings of the subject contract dispute<br />

because the documents are not “relevant.”<br />

66. While this will no doubt lead to new sanctions against the petitioner for<br />

“frivolously” arguing the writings to a written contract are relevant and<br />

discoverable the danger to justice is that the respondent will severely restrict<br />

discovery of the records related to the extrinsic fraud in the preceding litigation<br />

used by the defendants to evade their liability under contract and which is<br />

inherent in a Missouri state law breach of contract claim as a breach in the UCC<br />

duty of good faith and fair dealing.<br />

67. Because the respondent and US Bancorp defense counsel failed to<br />

research the applicable law, they thought their plan of having the federal<br />

racketeering claims over misconduct in the litigation including extrinsic fraud<br />

and depriving the petitioner of counsel dismissed would prevent the petitioner<br />

from proving their unlawful behavior.<br />

67. The petitioner accidentally discovered the respondent’s subterfuges of<br />

twice preventing the petitioner from receiving notice through the mail of orders<br />

20<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5715


made by the respondent that would have resulted in the loss of the petitioner’s<br />

property.<br />

68. The danger now is that the respondent will again take additional actions<br />

to secure a dismissal through fraud of the petitioner’s remaining state law<br />

breach of contract, breach of fiduciary duty, tortuous interference and trade<br />

secret claims to conceal misconduct the respondent witnessed and did not report<br />

or participated in and otherwise act out of an interest in the outcome of the<br />

litigation.<br />

E. Respondent’s Previous Misuse of the Kansas District Court Clerk’s Office<br />

69. The respondent permitted judicial law clerks to make use of the Office of<br />

the Kansas Clerk of the Court to attempt to manufacture a further ethics complaint<br />

against the petitioner’s counsel to deprive the petitioner of representation.<br />

70. This was done because the petitioner witnessed the state disciplinary<br />

proceedings were failing to charge the petitioner’s counsel with anything but the<br />

conduct the Kansas Rules of Professional Ethics clearly required.<br />

71. The second concern was that the respondent’s magistrate who had used an<br />

unrelated case before another Kansas District Court Judge involving the<br />

petitioner’s counsel had made a mistake at law in targeting the petitioner.<br />

72. The petitioner’s antitrust and racketeering complaint averred the conduct<br />

that ultimately resulted in depriving the petitioner of counsel including the<br />

21<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5716


attempted extortion by the respondent’s magistrate and misuse of the District of<br />

Kansas Clerk’s office by the respondent’s staff:<br />

“28. When …[Magistrate]… returned to Kansas City, events still seemed to<br />

be set against Mr. Bolden’s cause. The notice that the record on appeal was<br />

complete was erroneously given to the Tenth Circuit, though the mistake was<br />

clear from the appearance docket that two transcripts that had been ordered<br />

still were not part of the record. The appeals clerk for Kansas District court<br />

would not correct the record, Bolden made a motion to correct the record,<br />

which was not addressed by …[Magistrate]…. See Atch. 10<br />

29. Bolden’s motion for an extension of time was sent to both the Tenth<br />

Circuit and the Kansas District Court. However it did not appear on the<br />

Tenth Circuit Court of Appeals appearance docket. Bolden’s counsel called<br />

the Tenth Circuit and a deputy clerk identified as Kathy stated that it had<br />

been received two days before but it was still not docketed. After the call<br />

Kathy reentered on the docket that Bolden’s brief was due January 26th. See<br />

Atch. 11<br />

30. On the same day, counsel called the Kansas District Court appeals clerk<br />

who stated she was working on the letter correcting the date the record was<br />

complete. However, this letter did not appear on the docket the 25th or even<br />

the 26th. Bolden’s counsel was forced to work without sleep to file an<br />

incomplete appellate brief on the 26th emailing the brief to the court and<br />

counsel for the City and turning in the briefs and appendixes to US Postal<br />

Delivery service for the Tenth Circuit and the City of Topeka. See Atch. 12<br />

31. Both the Kansas District Court correction of the record on appeal and the<br />

Tenth Circuit docketing of the motion for extension occurred after the brief<br />

and appendix was received, giving the appearance to an impartial observer<br />

that the events were coordinated to manufacture an ethics violation for<br />

Bolden’s counsel after the failure of previous attempts.”<br />

See Exb. 13, Exb 13 Atch 10, Exb 13 Atch 12 and Exb 13 Atch 13.<br />

II. Memorandum in Support<br />

The standard of proof to be applied in this inquiry is that of clear and<br />

convincing evidence. In re Rome, 218 Kan. 198, Syl. p 9, 542 P.2d 676 (1975).<br />

The petitioner’s complaint provided clear and convincing evidence that the<br />

ministerial act of the respondent withholding notice of the order accelerating the<br />

22<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5717


due date for a response to the defendants’ second motion for Rule 12 Dismissal<br />

violated the Judicial Ethics Cannons. The additional information regarding the<br />

highly unusual decisions of the respondent in the preceding litigation provides<br />

reason to infer that withholding notice of an order that is likely to result in the loss<br />

of the fundamental and substantial property rights the petitioner has been in court<br />

seeking to recover for more than six years was done out of an impermissible bias<br />

under the ethics cannons.<br />

The order signed by the Hon. Robert H. Henry, Chief Circuit Judge states<br />

that the petitioner is complaining about the respondents rulings and therefore the<br />

complaint is frivolous. This is a misrepresentation of the petitioner’s complaint<br />

and reproduces the results the petitioner receives from the respondent and upon<br />

appeal. This is simply straw man fraud, the complaint described the respondent’s<br />

ministerial act of preventing the petitioner from receiving notice of an order that if<br />

neglected would have caused him to lose the property of all his remaining claims.<br />

“Having erected this straw man, the appellants then shred it…”Limone v. Condon, 372<br />

F.3d 39 at 46 (1st Cir., 2004). “Courts must be equally careful, however, not to permit a<br />

defendant to hijack the plaintiff's complaint and recharacterize its allegations so as to<br />

minimize his or her liability.” Limone id., 372 F.3d 39 at 46.<br />

judiciary.<br />

A. Respondent’s Judicial Misconduct<br />

The respondent has failed to uphold the integrity and independence of the<br />

23<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5718


The respondent has repeatedly violated Canons 1, 2A, 2B, 3A1, 3A2, 3A3,<br />

3A4, 3A6, 3B2, and 3B3 and should be subjected to proceedings under the<br />

Judicial Councils Reform and Judicial Conduct and Disability Act of 1980 (28<br />

U.S.C. §§ 332(d)(1), 351 to 364). The seriousness of the violations, the intent of<br />

the respondent, the recurring pattern of improper activity, and the effect of the<br />

improper activity on not only the petitioner, but the defendants and their counsel<br />

and the judicial systems of the Eighth and Tenth Circuits and the states of Kansas<br />

and Missouri warrants action by the Judicial Council Tenth Circuit.<br />

The petitioner, twice by the most improbable chance, was able to learn of<br />

orders by the respondent that if missed would have resulted in the loss of all the<br />

petitioner’s claims. The petitioner was therefore not yet injured by the respondent<br />

in the loss of the fundamental right of access to the court. Maness v. Dist. Court,<br />

Logan County-Northern Div., 495 F.3d 943 at 944-945 (8th Cir., 2007).<br />

Comment to 2A to the federal judicial ethics canons states that the<br />

prohibition against behaving with impropriety or the appearance of impropriety<br />

applies to the professional conduct of a judge.<br />

The then Acting Kansas District Court Clerk may be liable to the petitioner<br />

for non-discretionary duty of providing the petitioner, a pro se litigant notice and<br />

service by mail at the petitioner’s address of record for orders by the respondent:<br />

“Ministerial duties are those of a clerical nature performed in obedience to<br />

mandate without the exercise of judgment and are therefore not immune<br />

from suit. Jackson v. Wilson, [581 S.W.2d 39 (Mo.App.1979) ] at 43, Yelton<br />

v. Becker, 248 S.W.2d 86, 89 (Mo.App.1952).”<br />

24<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5719


Head v. Platte County, Mo., 749 P.2d 6 at 12, 242 Kan. 442 (Kan., 1988).<br />

However such liability cannot make the petitioner whole and it is clear that she did<br />

not even know the petitioner or have any reason to keep him from competing with<br />

Novation LLC in the national market for hospital supplies. She was either directed<br />

to deviate from a policy of the court that the petitioner has observed repeatedly<br />

that she follows vigorously or otherwise improperly communicated to about the<br />

ongoing litigation. See Akbarnia v. Deming, 845 F.Supp. 788 at 789-790 (D. Kan.,<br />

1994)<br />

Since staff of the Clerk of the Kansas District court do not read pleadings<br />

they receive from parties or the court for the purpose of exercising discretion, her<br />

prejudice if any has come from the respondent and the law clerk’s or magistrate’s<br />

in this case over which the respondent is responsible for under the judicial canons.<br />

Smith v. State, 264 Kan. 348, 955 P.2d 1293 at 1301(Kan., 1998).<br />

The Judicial Conference’s comment on Canon 3A(4) states:<br />

“Canon 3A(4). The proscription against communications concerning a proceeding<br />

includes communications from lawyers, law teachers, and other persons who are<br />

not participants in the proceeding, except to the limited extent permitted. It does<br />

not preclude a judge from consulting with other judges, or with court personnel<br />

whose function is to aid the judge in carrying out adjudicative responsibilities. A<br />

judge should make reasonable efforts to ensure that this provision is not<br />

violated through law clerks or other staff court personnel.” [Emphasis added]<br />

The acting Clerk of the Kansas District Court no doubt capably did what she<br />

was caused to do by the respondent or his staff. However the respondent has still<br />

committed judicial misconduct. The Proposed Revised Code dated 02/29/<strong>08</strong><br />

contains a comment to Canon 3B(2) that states:<br />

25<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5720


“A judge is responsible for his or her own conduct and for the conduct of<br />

others, such as court personnel, when those persons are acting under the<br />

judge’s direction or control. A judge may not direct court personnel to<br />

engage in conduct on the judge’s behalf or as the judge’s representative<br />

when such conduct would violate the Code if undertaken by the judge.”<br />

The respondent’s magistrate communicated falsely while under oath to the<br />

Kansas Attorney Disciplinary Panel in January 20005 about the petitioner’s<br />

litigation which was still ongoing and in appeal. The comment to Canon 3A(6)<br />

states: “The admonition against public comment about the merits of a pending or<br />

impending action matter continues until completion of the appellate process.”<br />

The petitioner in his affidavit (itself attacked without basis by the respondent<br />

as untruthful in the respondent’s Memorandum and Order of Dismissal) described<br />

the magistrate staying back to talk ex parte to the tribunal members an extrinsic<br />

fraud used to procure the disbarment that the petitioner witnessed and no one<br />

disputes.<br />

It is well settled, of course, that a judge is not subject to discipline for<br />

exercising his discretion in performing a judicial act, even if his decision be<br />

erroneous (In re Laughlin, 153 Tex. 183, 265 S.W.2d 805, appeal dismissed,<br />

348 U.S. 859, 75 S.Ct. 84, 99 L.Ed. 677; In re McGarry, 380 Ill. 359, 44<br />

N.E.2d 7). However, not every act of a judge done in the performance of his<br />

duty is an act of judicial discretion. As the court said in Bar Assn. v. Franko,<br />

168 Ohio St. 17, 151 N.E.2d 17:<br />

“Although it is quite true that a mere mistake in the exercise of judicial<br />

discretion by a judge is not and should never be the cause or subject of a<br />

disciplinary proceeding under the Canons of Judicial Ethics prescribed by<br />

26<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5721


this court, we must call attention to the fact that nor everything a judge does<br />

in connection with his judgeship can be said to be an exercise of his 'judicial<br />

discretion."<br />

Bar Assn. v. Franko, 168 Ohio St. p. 30, 151 N.E.2d p. 27.<br />

The Nebraska Code of Judicial Conduct is based in part on the American<br />

Bar Association's Model Code of Judicial Conduct (1999). Nebraska recognizes<br />

courts have properly enforced judicial canons and disciplined judges for their<br />

official conduct:<br />

“Instances of misconduct during the performance of official duties have also<br />

resulted in disciplinary sanctions of varying degrees. In re McDonough, 296<br />

N.W.2d 648 (Minn.1979), involved a judge who was addicted to alcohol and,<br />

among other things, threatened county and state officers, was absent from his<br />

duties, and abused those appearing before him. He was censured, ordered to<br />

forfeit his salary for 3 months, and placed on probation for the remainder of<br />

his service as a judge. The judge in Matter of Inquiry Concerning a Judge<br />

No. 481, 251 Ga. 524, 307 S.E.2d 505 (1983), was suspended without pay<br />

for 15 days for making flippant or derogatory remarks, both in the presence<br />

of and outside the hearing of the jury during the course of a trial, and<br />

directing the reporter to "take down nothing further." In In re Romero, 100<br />

N.M. 180, 668 P.2d 296 (1983), a judge was suspended for 30 days because<br />

he lacked patience, dignity, and courtesy in dealing with those who appeared<br />

before him, and otherwise neglected his duties. In Gonzalez v. Com'n on<br />

Judicial Performance, 33 Cal.3d 359, 657 P.2d 372, 188 Cal.Rptr. 880<br />

(1983), appeal dismissed --- U.S. ----, 104 S.Ct. 690, 79 L.Ed.2d 158 (1984),<br />

a judge who used his judicial office in efforts to intercede in criminal matters<br />

involving his friends and benefactors, who required attorneys to post their<br />

own funds as a condition of granting bail to their clients, who held court in<br />

the absence of counsel for one or both of the parties, who left the bench<br />

while evidence was being adduced, and who failed to make a record of<br />

proceedings was removed<br />

from office.”<br />

1984).<br />

Kneifl, In re, 351 N.W.2d 693 at 700, 217 Neb. 472 at 484-485 (Neb.,<br />

B. Respondent’s Prejudicial Conduct<br />

27<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5722


The Judicial Conference’s comment on Canon 3A(3) states:<br />

“The duty to hear all proceedings fairly and with patience is not inconsistent<br />

with the duty to dispose promptly of the business of the court. Courts can be<br />

efficient and businesslike while being patient and deliberate. The duty under<br />

Canon 2 to act in a manner that promotes public confidence in the integrity<br />

and impartiality of the judiciary applies to all the judge’s activities, including<br />

the discharge of the judge’s adjudicative and administrative responsibilities.”<br />

The respondent has made orders containing false admonishments targeting<br />

the petitioner and his associates for the purpose of putting the petitioner’s cause in<br />

a bad light to evade review by a court looking at controlling precedent. The<br />

respondent is responsible for knowing this conduct is biased or prejudicial where<br />

the admonishments, threats and sanctions contradict controlling US Supreme<br />

Court and Tenth Circuit precedent and the express language of Congress that has<br />

been briefed before him by the petitioner and not refuted by the defendants:<br />

For example, an average judge would understand that violation of the Code<br />

of Judicial Conduct would fall within the meaning of "prejudicial conduct"<br />

even absent our recent decision in Worthen. See 926 P.2d at 868. As noted<br />

above, canon 3(B)(9) states that it is improper for a judge to "make any<br />

public comment that might reasonably be expected to affect [the] outcome"<br />

of a case before another court. Opining as to the ultimate issue before<br />

another judge is a public comment that may be reasonably expected to affect<br />

the outcome of that proceeding. In re Charge of Judicial Misconduct, 47 F.3d<br />

399, 400 (10th Cir.1995)”<br />

McCully, In re, 942 P.2d 327 at 332 (Utah, 1997).<br />

When the respondent communicates within orders or causes<br />

communications to be made to Mr. Fisher, former Clerk of the Tenth Circuit Court<br />

of Appeals for the purpose of negatively influencing judges reviewing the<br />

28<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5723


petitioner’s appeal or to other trial judges for the purpose of securing a prejudiced<br />

outcome in related litigation, the respondent is violating Canon 3B.<br />

“Canon 3B(9) also plainly states that a judge's public comments are<br />

restricted while a proceeding is pending or impending "in any court." Given<br />

this unambiguous language, we conclude that Canon 3B(9)'s limitations on<br />

public comments apply where a trial judge comments on a matter that is<br />

before another trial judge or has been taken to an appellate court. See, e.g.,<br />

Broadman v. Commission, 18 Cal. 4th 1079, 959 P.2d 715, 77 Cal. Rptr. 2d<br />

4<strong>08</strong> (1998); In re Inquiry of Broadbelt, 146 N.J. 501, 683 A.2d 543 (1996);<br />

Matter of Hey, supra; Ryan v. Com'n on Judicial Performance, 45 Cal. 3d<br />

518, 754 P.2d 724, 247 Cal. Rptr. 378 (1988). In limiting the scope of<br />

commentary regarding pending cases in any court, the rule precludes the<br />

possibility of undue influence on the judicial process and the threat to public<br />

confidence posed by a judge from one court or jurisdiction criticizing the<br />

rulings or technique of a judge from a different jurisdiction. See In re Inquiry<br />

of Broadbelt, supra. Such comments could affect the outcome of the case,<br />

appear to exert pressure on a judge to decide a certain way, and undermine<br />

public confidence in judicial decisions. See id.”<br />

In re Complaint Against White, 264 Neb. 740 at 67-68 (NE, 2002).<br />

At the very least the respondent’s admonishments and threats of sanctions<br />

are a violation of Canon 3A:<br />

“(3) A judge should be patient, dignified, and courteous to litigants, jurors,<br />

witnesses, lawyers, and others with whom he deals in his official capacity . .<br />

..' (Rule No. 601, 214 Kan. xciv-xcv.)”<br />

Rome, In re, 542 P.2d 676, 218 Kan. 198 (Kan., 1975).<br />

This circuit has the leading federal case In re Charge of Judicial<br />

Misconduct 47 F.3d 399 for addressing the circumstances where a trial judge<br />

actually becomes involved in procuring an outcome through extrinsic conduct and<br />

has determined such conduct violates Canon 2:<br />

“Canon 2 provided at the time of the events in question that "[a] judge should<br />

avoid impropriety and the appearance of impropriety in all of the judge's<br />

29<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5724


activities." A judge should be above the fray; he or she should not be<br />

influenced by, or appear to be caught up in or contribute to, public clamor.<br />

When a judge becomes embroiled in a controversy, the line between the<br />

judge and the controversy before the court becomes blurred, and the judge's<br />

impartiality or appearance of impartiality may become compromised. Here,<br />

the Judge's public comments presented the risk of involving the Judge as an<br />

actor in the events, and, at least in the public's perception, could present the<br />

appearance that the Judge's impartiality and objectivity had been<br />

compromised.<br />

Indeed, the Judge's comments led the Tenth Circuit to vacate and<br />

remand several of the decisions relating to this case because the Court of<br />

Appeals found an appearance that the Judge was biased so as to necessitate<br />

recusal. As a result of the Judge's public comments, each of these cases had<br />

to be reheard in front of a new judge.”<br />

Charge of Judicial Misconduct, In re, 47 F.3d 399 (C.A.10 (Jud.C.), 1995).<br />

C. Vacatur Under 455 Is Appropriate<br />

The damage done by the respondent is to great for the judicial counsel to<br />

avoid taking action:<br />

(a) risk of injustice to the parties in the particular case<br />

The sole reason the defendants to the petitioner’s Missouri State Law<br />

Antitrust action are not in a federal court and now cannot obtain removal to a<br />

federal court is the respondent’s failure to follow controlling US Supreme Court<br />

and Tenth Circuit case law adopting the transactional approach to preclusion or res<br />

judicata. The petitioner fully briefed the controlling precedent and quoted<br />

treatises and even traced this principle from Lawlor to the current decisions of the<br />

Tenth Circuit.<br />

Instead, the respondent colluded with the defendants’ local counsel who<br />

were even unaware of the conduct or interests of their clients and the respondent<br />

30<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5725


adopted their poorly concealed false misrepresentations of the applicable law to<br />

accomplish the local firm’s short sited extrinsic fraud strategy.<br />

US Bank and US Bancorp have been inexplicably divorced from the<br />

petitioner’s appeal of the dismissal of federal claims and isolated in the<br />

respondent’s court under a new case number that effectively prevents them from<br />

sharing their liability with the very profitable healthcare monopolist co-defendants<br />

that manipulated the into injuring the petitioner in conduct subject to joint and<br />

several liability.<br />

(b) the risk that the denial of relief will produce injustice in other cases<br />

The decisions of the respondent have been used repeatedly in Missouri<br />

State Court and the Western District of Missouri to attempt to prejudice outcomes<br />

against the petitioner, even on subsequent conduct and different defendants. Many<br />

of which are represented by counsel that write motions to dismiss based on the<br />

respondent’s orders without realizing the seriousness of the case law the petitioner<br />

diligently subjected his claims to.<br />

The former Chief Bankruptcy Judge of the Northern District of Illinois<br />

turned up sharing information in an investigation that resulted because the defense<br />

firms relying on the respondent’s un-reviewed decisions counseled their clients<br />

that is was okay to further the hospital supply monopoly by tortuous interference.<br />

The defendants continued interfering with the petitioner’s attempts to mediate his<br />

losses from US Bank and US Bancorp’s breach by attempting substitute<br />

arrangements with third parties. The defendants counsel subjecting their clients to<br />

31<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5726


this per se liability in the absence of any legal interest, solely to prevent mediating<br />

or covering damages to lessen the judgment for breach of contract is actually<br />

beyond belief and defies explanation. The conduct ould only happen in a<br />

complete vacuum of civil enforcement, a condition nearly created in the national<br />

market for hospital supplies by the respondent.<br />

(c) the risk of undermining the public's confidence in the judicial process<br />

The petitioner was the only remaining electronic marketplace for hospital<br />

supplies that US Bancorp Piper Jaffray, Novation LL and GE did not effectively<br />

buy or put out of business. Besides four consecutive years of hearings in the US<br />

Senate Judiciary Committee, Sub-Committee on Antitrust, six articles in the New<br />

York Times, a BBC television Channel 4 special and every major presidential<br />

candidate calling for antitrust enforcement in healthcare it is difficult to imagine a<br />

more serious set of circumstances that could create impending loss of public<br />

confidence in the judicial process.<br />

B. Relief<br />

In Lauer v. Strang, 788 F.2d 135, 138 (8th Cir.1985), the Eighth Circuit<br />

concluded that appellate review of judicial conduct obviated the need for<br />

disciplinary action by the Judicial Council. The respondent has deliberately<br />

communicated prejudicial information against the petitioner and contrary to<br />

controlling law in his memorandum and orders despite the absence of any<br />

discovery that twice resulted in the Tenth Circuit upholding the respondent<br />

32<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5727


without independent review resulting in orders that contradict the Tenth Circuit’s<br />

own precedent.<br />

The Tenth Circuit was unable to review the respondent’s denial of<br />

injunctive relief that would have prevented all defendants from monetary liability<br />

because the respondent continued to assert jurisdiction over the <strong>Medical</strong> <strong>Supply</strong> I<br />

case during the interlocutory appeal. Despite the Moot Dismissal of the Appeal<br />

calling the respondent’s attention to the improperness of this trial court conduct<br />

after the notice of appeal, the respondent again asserted federal trial court<br />

jurisdiction over the petitioner’s pendant state law contract claims against US<br />

Bank and US Bancorp during the Tenth Circuit’s jurisdiction over those same<br />

claims in the petitioner’s <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> v. Neoforma appeal.<br />

That appeal was ultimately dismissed over timeliness of the Notice of<br />

Appeal, however the respondent’s open threatening of the petitioner and his<br />

representation for any attempt to make post judgment motions or continue the case<br />

had the foreseeable and intended effect of making it very difficult for the<br />

petitioner to obtain counsel for the appeal, hence the delay filing the notice.<br />

(1) Disqualification<br />

The respondent must now disqualify himself for his conduct under Section<br />

28 U.S.C. 455(a):<br />

“Disqualification is mandatory for conduct that calls a judge's impartiality<br />

into question. See 28 U.S.C. 455(a); In re School Asbestos Litig., 977 F.2d<br />

764, 783 (3d Cir. 1992). Section 455 does not prescribe the scope of<br />

disqualification. Rather, Congress "delegated to the judiciary the task of<br />

33<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5728


fashioning the remedies that will best serve the purpose" of the<br />

disqualification statute. Liljeberg, 486 U.S. at 862.<br />

At a minimum, 455(a) requires prospective disqualification of the<br />

offending judge, that is, disqualification from the judge's hearing any further<br />

proceedings in the case. United States v. Microsoft Corp., 56 F.3d 1448,<br />

1463-65 (D.C. Cir. 1995) (per curiam) ("Microsoft I"). Microsoft urges<br />

retroactive disqualification of the District Judge, which would entail<br />

disqualification antedated to an earlier part of the proceedings and vacatur of<br />

all subsequent acts. In re School Asbestos Litig., 977 F.2d at 786 (discussing<br />

remedy options).<br />

"There need not be a draconian remedy for every violation of 455(a)."<br />

Liljeberg, 486 U.S. at 862. Liljeberg held that a district judge could be<br />

disqualified under 455(a) after entering final judgment in a case, even though<br />

the judge was not (but should have been) aware of the grounds for<br />

disqualification before final judgment. The Court identified three factors<br />

relevant to the question whether vacatur is appropriate: "in determining<br />

whether a judgment should be vacated for a violation of 455(a), it is<br />

appropriate to consider the risk of injustice to the parties in the particular<br />

case, the risk that the denial of relief will produce injustice in other cases,<br />

and the risk of undermining the public's confidence in the judicial process."<br />

Id. at 864. Although the Court was discussing 455(a) in a slightly different<br />

context (the judgment there had become final after appeal and the movant<br />

sought to have it vacated under Rule 60(b)), we believe the test it<br />

propounded applies as well to cases such as this in which the full extent of<br />

the disqualifying circumstances came to light only while the appeal was<br />

pending. In re School Asbestos Litig., 977 F.2d at 785.”<br />

USA. v. Microsoft Corp., 253 F.3d 34 at 116 (D.C. Cir., 2001).<br />

(2) Effect of Entitled Rule 60(b) relief<br />

The petitioner is entitled to Rule 60(b) relief restoring his antitrust action<br />

against the defendants Neoforma, Novation LLC, US Bank and US Bancorp so<br />

that discovery can proceed and the claims modified accordingly. Alternatively the<br />

judicial council can direct the appropriate relief of vacatur of all subsequent acts<br />

from when the respondent should have recused himself.<br />

34<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5729


The action has the petitioner’s motion to rewind the proceedings back and<br />

return to the Western District of Missouri where the important interests of the<br />

State of Missouri and the interpretation of its laws can be protected. The<br />

defendants would also be protected by unbiased and competent federal<br />

proceedings and could seek to retain federal jurisdiction over the pendant Missouri<br />

state law antitrust claims dismissed by the respondent without prejudice.<br />

The action could be postponed for the Kansas District court to consider the<br />

denial of a hearing in the reciprocal disbarment of the petitioner’s counsel by the<br />

State of Kansas for advocacy of federal rights in the Kansas District court, upheld<br />

by the Tenth Circuit and subsequent rulings by Kansas District Court Chief Judge<br />

Vratil.<br />

(3) Discipline<br />

The fact of reversal, however, only partially corrects the problem and is<br />

limited to just those cases. At every step for the last six years there have been well<br />

educated, adequately trained and compensated personnel of the Tenth Circuit’s<br />

courts who should have protected the petitioner from this conduct. Instead they<br />

took no action or worse helped to conceal it.<br />

If the Tenth Circuit is unwilling to<br />

publicly state that some of this conduct was wrong, it is unlikely to do anything<br />

but increase in the future.<br />

CONCLUSION<br />

35<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5730


Whereas for the following reasons the petitioner respectfully requests that<br />

the judicial council stop the continuing violations of Judicial Canons 1, 2A, 2B,<br />

3A1, 3A2, 3A3, 3A4, 3A6, 3B2, and 3B3 by the respondent.<br />

Respectfully Submitted,<br />

S/ Samuel K. Lipari<br />

Samuel K. Lipari<br />

297 NE Bayview<br />

Lee's Summit, MO 64064<br />

816-365-1306<br />

saml@medicalsupplychain.com<br />

Pro se<br />

36<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5731


Date: February, 1 st 20<strong>08</strong><br />

Office of the Circuit Executive<br />

United States Tenth Circuit<br />

Byron White United States Courthouse<br />

1823 Stout Street<br />

Denver, Colorado 80257<br />

Re: Judicial Ethics Complaint against US District for Kansas Court Judge Carlos Murguia<br />

Dear Honorable Chief Judge Deanell Reece Tacha<br />

I am making a judicial ethics complaint against US District for Kansas Court Judge Carlos<br />

Murguia and his conduct in the following cases: <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. v. US Bancorp, NA et al KS.<br />

Dist. Case No. 02-2539; <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. v. General Electric Company, et al.,<br />

case number 03-2324-CM, <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. v Novation, et al; KS Dist. Court Case No.: 05-2299<br />

(Formerly W.D. MO. Case No. 05-0210);<br />

I am forced to make this complaint against my litigation interests and risk the certain retribution<br />

despite the recent US History of judges not being disciplined regardless of the seriousness of their<br />

offenses. 1 The reason I am forced to make this complaint is the urgency that the misconduct is continuing<br />

and threatens my property and has prevented me from incorporating and for all practical purposes, from<br />

ever entering the market for hospital supplies. I was stopped from obtaining a case management hearing in<br />

2002 in the matter that I am still litigating today, just before I was to meet with the Hon. Magistrate Waxse.<br />

The discoverable and public documents clearly and conclusively prove my claims. A known fact that seems<br />

to necessitate repeated dismissals before discovery commences. I finally got to the January, 20<strong>08</strong> case<br />

management hearing and Hon. Magistrate Waxse set a schedule including a timetable for dispositive<br />

motions that the parties mutually agreed to.<br />

While working on the next exhaustive task of documenting my damages and the controlling case<br />

law governing discovery, Judge Carlos Murguia issued a minute order having the effect of over ruling the<br />

case management order and did so by a minute entry with no document, having the effect of giving me no<br />

notice of the accelerated deadline.<br />

As the party experiencing the repeated prejudice and misconduct of US District for Kansas Court<br />

Judge Carlos Murguia I am fully aware of what would have happened to my chances of ever entering the<br />

market to compete with Novation LLC and lower hospital supply costs and all I have ever worked for if I<br />

had missed the stealth deadline.<br />

Each time I have had my claims dismissed based on facially false and readily discernable<br />

misrepresentations about the contents of my pleadings. This has been coupled with decisions on law<br />

directly contradicting controlling authority or adopting the defendants’ false legal argument grounded in the<br />

misrepresentation of whether words stating elements are in my complaints. Each time I have sought<br />

rehearings, pointing out the clear error of contradicting US Supreme Court authority on the precise issue or<br />

demonstrating that a federal statute or public law expressly states language for a private right of action,<br />

Judge Carlos Murguia has denied them. Judge Carlos Murguia has also denied me opportunities to correct<br />

any deficiencies in my claims.<br />

Any prejudice against me or my claims by Judge Carlos Murguia cannot be based on an objective<br />

view of the law or the economic conditions resulting from restraint of trade in the market for hospital<br />

1 http://writ.news.findlaw.com/dean/2004<strong>08</strong>13.html<br />

Exb 1<br />

Atch 1 Part C Exhibits<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5732


supplies. Similarly, the defendant banking conglomerate US Bancorp has lost evidentiary hearings, been<br />

fined and settled with the New York Attorney General and the Securities and Exchange Commission for<br />

their conduct in extorting new healthcare technology companies to the hospital supply marketplace<br />

controlled by Novation LLC and for conduct in the capitalization of my competitor Neoforma, Inc. If Judge<br />

Carlos Murguia is acting on ex parte information from the law firms representing the defendants, their<br />

pleadings reveal a complete absence of knowledge of the crisis preventing Americans from receiving<br />

healthcare through artificial inflation and restraint of trade. The nation and even the defendants are being<br />

harmed by Judge Carlos Murguia’s lack of impartiality.<br />

I have sought judicial review of Judge Carlos Murguia’s misconduct through appeal in <strong>Medical</strong><br />

<strong>Supply</strong> <strong>Chain</strong>, Inc. v. US Bancorp, NA et al 10th Cir. Case No.: 02-3443; <strong>Medical</strong><br />

<strong>Supply</strong> <strong>Chain</strong>, Inc. v. General Electric Company, et al. No. 04-3075 and 04-3102 (10th Cir.) and <strong>Medical</strong><br />

<strong>Supply</strong> <strong>Chain</strong>, Inc. v. US Bancorp, NA et al 10th Cir. Case No.: 03-3342; 06- 3331. This has been frustrated<br />

by back channel communications fostered in Judge Carlos Murguia’s office that prejudice me and everyone<br />

associated with helping me in the eyes of the Tenth Circuit Court of Appeals and other courts. The most<br />

recent appeal decisively showed Judge Carlos Murguia’s error on every point sustaining his ruling and the<br />

statement of facts documented the blatantly false claims the required pleading elements were not stated<br />

clearly in my complaint. See Applt Br at pages 19-31, Applee Br.: 2 , 3<br />

The notice of appeal was not timely. My former counsel Bret D. Landrith never missed deadlines,<br />

only the defense counsel. I depended on his research and willingness to take my action on contingency as<br />

Congressional policy provided for. It became essential to the opposing law firms to have him prevented<br />

from helping me. My former counsel was disbarred over the ex parte communications to the Kansas state<br />

disciplinary authority fostered by Judge Carlos Murguia and reciprocally disbarred after by Judge Carlos<br />

Murguia vehement dismissal with sanctions of <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. v Novation, et al; KS Dist.<br />

Court Case No.: 05-2299 (Formerly W.D. MO. Case No. 05-0210) and threats to sanction me or my<br />

counsel for seeking reconsideration. The past unwillingness of the Tenth Circuit to exercise judicial review<br />

and the financial sanctions being issued for correctly stating the law made it very dangerous for Dennis<br />

Hawver and impossible to find replacement counsel.<br />

Shortly after the appeal was rejected, the national news covered the hospital supply restraint of<br />

trade problem. In "Blowing the Whistle, Many Times" The New York Times Cynthia Fitzgerald By Mary<br />

Williams Walsh, November 18, 2007 described hundreds of millions of dollars lost from Medicare by the<br />

misconduct. 4 http://www.nytimes.com/2007/11/18/business/18whistle.html. I have maintained the<br />

documentary evidence that is the basis for my claims in the above litigation online at<br />

http://www.medicalsupplychain.com/news.htm and includes four years of US Senate Judiciary Committee<br />

testimony on the restraint of trade I have raised in my complaint and the conduct of Novation LLC in<br />

keeping healthcare technology companies from being capitalized.<br />

The national interest and lives lost from increasing and unaffordable healthcare resulting in the<br />

lack of competition in hospital supplies has made Judge Carlos Murguia’s dereliction of his duty<br />

horrifically egregious. Not only I and the legal counsel and other business associates been injured but so<br />

have the defendants, some of which are publicly traded corporations. Despite Judge Carlos Murguia’s<br />

willingness to rule for the defendants’ local counsel regardless of their failure to research issues or even to<br />

be honest about the documents before the court in their written pleadings, the defendant corporations still<br />

are injured by the non law based outcomes and are unable to change their chargeable conduct and the avoid<br />

the consequences. Most of all, the integrity of the Kansas District Court and the people of the United States<br />

who provide for civil enforcement through the courts of Congresses laws against restraint of trade.<br />

I realize this begins a long road, first to the circuit Judicial Council’s likely unwillingness to<br />

investigate this complaint, then to the Judicial Conference. Afterwards, without relief I will be forced to<br />

then seek redress in the legislature and finally through popular sovereignty in changing the policy that<br />

2 http://www.medicalsupplychain.com/pdf/Novation%20Appeal%20Brief.pdf<br />

3 http://www.medicalsupplychain.com/pdf/Novation%20&%20US%20Bank%20Reply%20Brief.pdf<br />

4 http://www.nytimes.com/2007/11/18/business/18whistle.html.<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5733


permitted the repeated outcomes here that are contrary to fact and law. I know the Kansas District court and<br />

practitioners will wish me success. All of whom are hurt by the overt ness of Judge Carlos Murguia’s<br />

repeated misconduct and whom value our court system and its role in vindicating our national policies.<br />

I stand ready to provide all documentation and testimony any and every investigation of these<br />

events may require.<br />

Sincerely,<br />

Samuel K. Lipari<br />

Samuel Lipari<br />

<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong><br />

297 NE Bayview<br />

Lee's Summit, MO 64064<br />

Phone: 816.365.1306<br />

Saml@<strong>Medical</strong><strong>Supply</strong><strong>Chain</strong>.com<br />

www.<strong>Medical</strong><strong>Supply</strong><strong>Chain</strong>.com<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5734


Exb 2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5735


JUDICIAL COUNCIL OF THE<br />

TENTH CIRCUIT<br />

IN RE: CHARGE OF JUDICIAL<br />

MISCONDUCT<br />

No. 20<strong>08</strong>-10-372-<strong>08</strong><br />

Before HENRY, Chief Judge.<br />

ORDER OF DISMISSAL<br />

Complainant has filed a complaint of judicial misconduct against a district<br />

judge in this circuit. My consideration of this complaint is governed by 1) the<br />

misconduct rules issued by the Judicial Council of the Tenth Circuit, entitled<br />

Rules Governing Complaints of Judicial Misconduct and Disability; 2) the federal<br />

statute dealing with judicial misconduct, 28 U.S.C. § 351 et seq., and 3) the<br />

“Breyer Report,” a study by the Judicial Conduct and Disability Act Study<br />

Committee, headed by Supreme Court Justice Stephen Breyer, entitled<br />

Implementation of the Judicial Conduct and Disability Act of 1980. The Breyer<br />

Report may be found at: http://www.supremecourtus.gov/<br />

publicinfo/breyercommitteereport.pdf. To the extent that any relevant prior<br />

decisions of the full Judicial Council of this circuit consistent with those<br />

authorities exist, they may also govern my consideration of this complaint.<br />

Complainant has received or has access to a copy of this circuit’s<br />

misconduct rules. In accord with those rules, the names of the complainant and<br />

subject judge shall not be disclosed in this order. See Misconduct Rule 4(f)(1).<br />

Exb 3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5736


Complainant takes issue with various rulings by the respondent judge,<br />

alleging resulting prejudice in multiple underlying cases and related appeals. Any<br />

claims based solely on the judge’s rulings are not cognizable as misconduct<br />

because they are “directly related to the merits of a decision or procedural<br />

ruling.” See Misconduct Rule 4(c)(2). The policy behind this rule is that “the<br />

complaint procedure cannot be a means for collateral attack on the substance of a<br />

judge’s rulings.” Breyer Report, App. E., 2. As explained in this circuit’s<br />

misconduct rules, only a court has the power to change a judge’s ruling.<br />

Misconduct Rule 1(e). Neither I, acting as Chief Judge, nor the Judicial Council<br />

of the circuit - both charged with the determination of judicial misconduct matters<br />

under the federal statute - can do that.<br />

Complainant also appears to imply that the respondent judge is biased<br />

against complainant and comments in passing that the judge may have relied on<br />

ex parte communications with opposing parties in the underlying suits in reaching<br />

the rulings complained of. These implied claims lack support of any kind, and are<br />

therefore dismissed pursuant to Misconduct Rule 4(c)(3) (directing dismissal of<br />

claims that are “wholly unsupported or lacking sufficient evidentiary support to<br />

raise an inference that some kind of cognizable misconduct has occurred”).<br />

Accordingly, this complaint is dismissed. The Circuit Executive is directed<br />

to transmit this order to complainant and a copy to the respondent judge. To seek<br />

review of this order, complainant must file a petition for review by the Judicial<br />

-2-<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5737


Council. As set out in the misconduct rules, the petition should be in the form of<br />

a letter, and need not include a copy of the original complaint or this order. See<br />

Misconduct Rule 6. The petition must be filed with the Office of the Circuit<br />

Executive, at the address set out in the rules, within 30 days of the date of the<br />

letter transmitting this order. Id.<br />

So ordered this 14th day of March, 20<strong>08</strong>.<br />

/s/ Robert H. Henry<br />

Honorable Robert H. Henry<br />

Chief Circuit Judge<br />

-3-<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5738


DJW:mmh<br />

SAMUEL K. LIPARI,<br />

IN THE UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

Plaintiff,<br />

v. Case No. 07-2146-CM-DJW<br />

US BANCORP, NA, et al.,<br />

Defendant.<br />

SCHEDULING ORDER<br />

On January 11, 20<strong>08</strong>, pursuant to Fed. R. Civ. P. 16(b), the court conducted a telephone<br />

scheduling conference with the parties. 1<br />

Plaintiff appeared pro se. Defendants appeared<br />

through counsel Jay E. Heidrick and Mark A. Olthoff.<br />

After consultation with the parties, the court enters this scheduling order, summarized<br />

in the table that follows:<br />

1<br />

As used in this scheduling order, the term “plaintiff” includes plaintiffs as well as<br />

counterclaimants, cross-claimants, third-party plaintiffs, intervenors, and any other parties<br />

who assert affirmative claims for relief. The term “defendant” includes defendants as well<br />

as counterclaim defendants, cross-claim defendants, third-party defendants, and any other<br />

parties who are defending against affirmative claims for relief.<br />

O:\ECFDocs\Orders for Signature\07-2146 Sch Ord.wpd<br />

Exb 4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5739


SUMMARY OF DEADLINES AND SETTINGS<br />

Event<br />

Deadline/Setting<br />

Plaintiff's settlement proposal 2/4/<strong>08</strong><br />

Defendants' settlement counter-proposal 2/18/<strong>08</strong><br />

Confidential settlement reports to magistrate judge,<br />

with identification of agreed-upon mediator or other<br />

ADR neutral<br />

Mediation or other ADR process completed<br />

Settlement conference with court<br />

3/3/<strong>08</strong><br />

N/A<br />

N/A<br />

Initial disclosures exchanged 1/15/<strong>08</strong><br />

All discovery completed 7/1/<strong>08</strong><br />

Early discovery completed<br />

N/A<br />

Experts disclosed by plaintiff 4/1/<strong>08</strong><br />

Experts disclosed by defendant 5/1/<strong>08</strong><br />

Rebuttal experts disclosed 6/2/<strong>08</strong><br />

Independent medical examinations<br />

Supplementation of disclosures<br />

N/A<br />

40 days before the deadline for<br />

completion of discovery<br />

Preliminary witness and exhibit disclosures 5/16/<strong>08</strong><br />

Jointly proposed protective order submitted to court 2/15/<strong>08</strong><br />

Motion and brief in support of proposed protective<br />

order (only if parties disagree about need for and/or<br />

scope of order)<br />

Motions to join additional parties or otherwise<br />

amend the pleadings<br />

Motions to dismiss for lack of personal jurisdiction,<br />

venue, propriety of the parties, or failure to state a<br />

claim<br />

All other potentially dispositive motions (e.g.,<br />

summary judgment)<br />

Motions challenging admissibility of expert<br />

testimony<br />

2/15/<strong>08</strong><br />

3/1/<strong>08</strong><br />

4/1/<strong>08</strong><br />

8/15/<strong>08</strong><br />

8/15/<strong>08</strong><br />

Comparative fault identification 3/1/<strong>08</strong><br />

Status conference<br />

Final pretrial conference<br />

N/A<br />

7/30/<strong>08</strong> @ 10:00 a.m.<br />

Proposed pretrial order due 7/23/<strong>08</strong><br />

Trial<br />

3/2/09 @ 1:30 p.m.<br />

O:\ECFDocs\Orders for Signature\07-2146 Sch Ord.wpd<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5740


PLAINTIFF’S REPLY TO DEFENDANTS’ MOTION TO DISMISS<br />

Comes now the plaintiff Samuel K. Lipari appearing pro se and makes the following response to the<br />

defendants’ second motion to dismiss the plaintiff’s initial and un-amended complaint.<br />

The plaintiff renews his objection to a second motion to dismiss where the Federal Rules of Civil<br />

Procedure permit only one. The defendants’ current dismissal is a prohibited second Rule 12 motion to<br />

dismiss. Palermo, Federal Pretrial Practice: Basic Procedure & Strategy 2001 states at page 21; “Rules<br />

12(g) and 12(h), read together, provide in general, there shall not be more than one Rule 12 motion to<br />

dismiss....All defenses and grounds “then available” shall be asserted in the one motion; certain defenses<br />

shall be asserted in the Rule 12 motion, or in the initial responsive pleading (or amendment thereof) under<br />

threat of waiver.”<br />

The plaintiff is also aware of this court’s disposition toward him and his claims embodied by the<br />

court’s January 24 th , 20<strong>08</strong> decision to over rule the Magistrate Judge’s case management schedule and<br />

require this answer by February 2, 20<strong>08</strong>.<br />

An impartial observer could find that the issuance of a minute order changing the schedule without<br />

accompanying documentation could prejudice a pro se defendant excluded from the electronic case<br />

management system.<br />

The plaintiff has no doubt as to what would have been in store for his claims or his future ability to<br />

enter the hospital supply market and compete against US Bancorp’s co-conspirator Novation LLC had he<br />

not made the deadline.<br />

I. Plaintiff's Complaint states colorable claims and demonstrates a plausible entitlement to relief:<br />

The defendants through their agents the law firm of Shughart Thomson & Kilroy, PC and the firm’s<br />

State of Missouri licensed attorneys Mark A. Olthoff KS # 70339, Andrew M. Demarea KS #16141, and<br />

Jay E. Heidrick KS #20770 have misrepresented to the court the content and words clearly on the face of<br />

the plaintiff’s complaint and have falsely stated the complaint does not state elements that it clearly does. 1<br />

1 The court would have been reversed on the most recent appeal for adopting Mark A. Olthoff KS # 70339,<br />

and Andrew M. Demarea KS #16141 repeated misrepresentations that the elements of the plaintiff’s<br />

antitrust and racketeering claims were not pled when in fact they were and appeared where the table of<br />

contents stated they were. The defense counsel were unable to support this court’s rulings in total.<br />

See Applt Br at pages 19-31: http://www.medicalsupplychain.com/pdf/Novation%20Appeal%20Brief.pdf<br />

Applee Br at http://www.medicalsupplychain.com/pdf/Novation%20&%20US%20Bank%20Reply%20Brief.pdf<br />

1<br />

Exb 5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5741


UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

MEDICAL SUPPLY CHAIN, INC., )<br />

(Through assignee Samuel K. Lipari) )<br />

SAMUEL K. LIPARI )<br />

Plaintiff, )<br />

v. ) Case No. 05-2299<br />

NOVATION, LLC )<br />

NEOFORMA, INC. )<br />

ROBERT J. ZOLLARS )<br />

VOLUNTEER HOSPITAL ASSOCIATION )<br />

CURT NONOMAQUE )<br />

UNIVERSITY HEALTHSYSTEM CONSORTIUM )<br />

ROBERT J. BAKER )<br />

US BANCORP, NA )<br />

US BANK )<br />

JERRY A. GRUNDHOFER )<br />

ANDREW CECERE )<br />

THE PIPER JAFFRAY COMPANIES )<br />

ANDREW S. DUFF )<br />

SHUGHART THOMSON & KILROY, P.C. )<br />

Defendants. )<br />

PLAINTIFF’S FED. R. CIV. P. 59(e), TO ALTER OR AMEND THE JUDGMENT<br />

AND ANSWER TO ORDER TO SHOW CAUSE<br />

Comes now the plaintiff Samuel K. Lipari in his individual capacity and as an assignee of all<br />

rights of <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. a dissolved Missouri corporation and respectfully submits this motion<br />

under Fed.R.Civ.P. 59(e), to alter or amend the judgment. The plaintiff seeks to alter or amend the court’s<br />

order striking the plaintiff’s motion to reopen the present action under F.R.Civ. P. Rule 60(b). The plaintiff<br />

also answer’s the court Show Cause Order.<br />

Statement of Facts<br />

1. The plaintiff filed a pro se motion on February 13, 20<strong>08</strong> for new trial on this court’s dismissal<br />

order denying the plaintiff’s pro se standing and dismissing the plaintiff’s federal claims with prejudice<br />

under F.R.Civ. P. Rule 60(b). See Exb 1 Motion for New Trial and Exb 2 Plaintiff’s Response to<br />

Defendant’s Opposition.<br />

2. The plaintiff filed his motion after this court recognized his standing to proceed pro se as the<br />

assignee of his dissolved corporation’s claims under Missouri State Law governing corporations in styled<br />

Lipari v. US Bancorp et al. Case no. 07-cv-02146-CM-DJW, the same case or controversy as Case No. 05-<br />

2299 as defined by Article III of the U.S. Constitution and 28 U.S.C. § 1367:<br />

“Missouri law does, however, allow a dissolved corporation to assign its claims to a third-<br />

1<br />

Exb. 7<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5742


party. See, e.g., Smith v. Taylor-Morley, Inc., 929 S.W.2d 918 (Mo. Ct. App. 1996) (upholding<br />

dissolved corporation’s written assignment of rights to a purchase contract). The assignee may sue<br />

to recover damages for the dissolved corporation’s claims. Id. (holding assignee of dissolved<br />

corporation’s rights under a purchase contract could sue for injuries to dissolved corporation for<br />

breach of the purchase contract). Here, plaintiff alleges that he is the assignee of all rights and<br />

interests of <strong>Medical</strong> <strong>Supply</strong>, including the claims in this lawsuit. Accepting as true all material<br />

allegations of the complaint and construing the complaint in favor of plaintiff, the court finds that<br />

plaintiff has met his burden at this stage of the proceeding. Defendant’s motion is denied with<br />

respect to standing.”<br />

Order signed by Judge Carlos Murguia recognizing plaintiff’s standing as assignee of MSC’s<br />

claims. Exb 3 Order Lipari v. US Bancorp et al. Case no. 07-cv-02146-CM-DJW at page 2.<br />

3. This court’s order recognizing the plaintiff’s status as assignee of his federal claims occurred after<br />

this court’s decision on August 7, 2006, striking four motions filed by the plaintiff.<br />

4. A reasonable conclusion can be drawn by a reviewing court that the plaintiff’s materially identical<br />

arguments supporting pro se standing as an assignee of MSC’s claims produced two different results<br />

because of the intervening decision of the US Supreme Court in Erickson v. Pardus, No. 06-7317<br />

(U.S. 6/4/2007) (2007) overruling the Tenth Circuit and requiring facts pled in a complaint to be accepted<br />

as true.<br />

5. The February 13, 20<strong>08</strong> Rule 60(b) filing was a motion and not a pleading.<br />

6. This court ordered the plaintiff’s F.R.Civ. P. Rule 60(b) motion struck without a hearing.<br />

7. This court’s order to show cause threatens sanctions against the plaintiff that violate the court’s<br />

authority and jurisdiction under the Federal Rules of Civil Procedure.<br />

8. The court’s void order striking the plaintiff’s Rule 60(b) if not reversed is a participation in the<br />

defendants’ unlawful actions to deprive the plaintiff of the representation of an unimpaired attorney<br />

documented at length in the plaintiff’s complaint dismissed by the court.<br />

9. Judge Carlos Murguia’s repeated sanctioning of the plaintiff for being correct on the application of<br />

controlling law of this circuit and in direct contradiction of the express language of Congress providing<br />

multiple private rights of action in the USA PATRIOT Act and in contradicting the US Supreme Court on<br />

the lack of preclusion for subsequent antitrust and RICO acts in the <strong>Medical</strong> <strong>Supply</strong> litigation has the<br />

foreseeable ad terrorem effect of depriving the plaintiff of counsel and of capital to enter the market for<br />

hospital supplies monopolized by the Novation LLC cartel.<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5743


MEMORANDUM IN SUPPORT<br />

The plaintiff’s motion is within ten days of the court’s order striking the plaintiff's Rule 60(b)<br />

motion and therefore is properly a motion pursuant to Fed.R.Civ.P. 59(e), to alter or amend the judgment:<br />

“A motion to alter or amend presents the court with the opportunity to rectify manifest errors of law<br />

or fact and to review evidence newly discovered. White v. New Hampshire Dep't of Employment<br />

Sec., 455 U.S. 445, 450-51, 102 S.Ct. 1162, 71 L.Ed.2d 325 (1982); Brown v. Presbyterian<br />

Healthcare Servs., 101 F.3d 1324, 1332 (10th Cir. 1996), cert. denied, ___ U.S. ___, 117 S.Ct.<br />

1461, 137 L.Ed.2d 564 (1997); Barrett v. Fields, 941 F.Supp. 980, 984-85 (D.Kan. 1996).”<br />

Fields v. Atchison, Topeka, and Santa Fe Railway Company, 5 F.Supp.2d 1160 at 1161 (D. Kan., 1998).<br />

The plaintiff has conformed to Rule 7.3 of the local rules for the District of Kansas.<br />

A Rule 59(e) motion may be granted if any of the following three conditions are presented to the<br />

court: (1) an intervening change in the controlling law; (2) the availability of new evidence; or (3) the need<br />

to correct clear error or prevent manifest injustice. Brumark Corp. v. Samson Resources Corp., 57 F.3d<br />

941, 948 (10th Cir.1995).<br />

The plaintiff seeks relief from the striking of his motion for new trial based on (3) “the need to<br />

correct clear error or prevent manifest injustice.”<br />

The plaintiff answer’s this court’s Show Cause Order by citing to controlling case law that the<br />

plaintiff’s Rule 60(b) motion is proper.<br />

I. Standard of review<br />

The Tenth Circuit will review the district court's denial of a Rule 60(b)(6) motion for abuse of<br />

discretion. Cashner v. Freedom Stores, Inc., 98 F.3d 572, 576 (10th Cir.1996) Simply stated, for the<br />

appeals court to find an abuse of district court's discretion and reverse, the appellate court must have a<br />

definite and firm conviction that the district court made a clear error of judgment or exceeded the bounds of<br />

permissible choice in the circumstances. Moreover, relief under Rule 60(b) is discretionary and is<br />

warranted only in exceptional circumstances. Van Skiver v. United States, 952 F.2d 1241, 1243 (10th<br />

Cir.1991), cert. denied, 506 U.S. 828, 113 S.Ct. 89, 121 L.Ed.2d 51 (1992).<br />

Denial of the plaintiff’s Motion for New Trial over changes in law since the dismissal of the<br />

plaintiff’s federal claims can be appealed. See John E. Smith's Sons Co. v. Lattimer Foundry & Mach. Co.,<br />

239 F.2d 815 at 816-817 (3rd Cir., 1956).<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5744


II.<br />

Clear Errors of the Court<br />

The court lacks the authority or power to strike the plaintiff’s motion under Rule 12(f) and<br />

Rule 37. The striking violates the plaintiff's fourteenth amendment right to a hearing, and a judgment of<br />

sanctions in such a case would be void for want of jurisdiction.<br />

A. Plaintiff’s Motion For New Trial Properly Before The Court<br />

The plaintiff sought a new trial on the order dismissing his claims based on intervening<br />

decisions by this court and the US Supreme Court, including Judge Carlos Murguia’s determination he<br />

had standing as the assignee of <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>’s Claims in this same case or controversy.:<br />

“A Rule 60(b) motion addresses the district court's judgment and must be presented<br />

initially to the district court. 12 James Wm. Moore, et al., Moore's Federal Practice § 60.60[1] and<br />

authorities cited therein. Thus, the Respondent's Rule 60(b) motion challenges a judgment of this<br />

Court and is properly before this Court.”<br />

Mitchell v. Rees, 430 F.Supp.2d 717 at 721 (M.D. Tenn., 2006). Also “…a motion might contend<br />

that a subsequent change in substantive law is a "reason justifying relief," Fed. Rule Civ. Proc. 60(b)(6),<br />

from the previous denial of a claim. E.g., Dunlap v. Litscher, 301 F.3d 873, 876 (C.A.7 2002).” Mitchell v.<br />

Rees, id 430 F.Supp.2d 717 at 722 (M.D. Tenn., 2006).<br />

Under Rule 60(b), a court may set aside a default judgment "on motion and under such terms as<br />

are just" for any of the following reasons:<br />

“(1) mistake, inadvertence, surprise, or excusable neglect;(2) newly discovered evidence which by<br />

due diligence could not have been discovered in time to move for a new trial under Rule 59(b); (3)<br />

fraud, (whether heretofore denominated intrinsic or extrinsic), misrepresentation, or other<br />

misconduct of an adverse party; (4) the judgment is void; (5) the judgment has been satisfied,<br />

released, or discharged, or a prior judgment upon which it is based has been reversed or otherwise<br />

vacated, or it is no longer equitable that the judgment should have prospective application; or (6) or<br />

any other reason justifying relief from the operation of the judgment. Fed.R.Civ.P. 60(b).”<br />

In re Wallace, 298 B.R. 435 at 439 (B.A.P. 10th Cir., 2003)<br />

The difference in rulings regarding the plaintiff’s standing to pursue his claims pro se are exactly<br />

the exceptional or “extraordinary circumstances” in which a New Trial under Rule 60(b) is appropriate:<br />

“Moreover, an inconsistent application of the law that deprives a party of a right<br />

accorded to other similarly situated parties presents, "extraordinary circumstances"<br />

warranting post-judgment relief, including under Rule 60(b)(6). See e.g., Gondeck v. Pan<br />

American World Airways Inc., 382 U.S. 25, 26-27, 86 S.Ct. 153, 15 L.Ed.2d 21 (1965)(granting<br />

post-judgment relief on rehearing, in the interest of justice to remedy a misinterpretation of the<br />

4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5745


law); Cincinnati Insurance Co. v. Byers, 151 F.3d 574, 580 (6th Cir.1998)(extraordinary<br />

circumstances based upon a post-judgment change in the law); Overbee v. Van Waters & Rogers,<br />

765 F.2d 578, 580 (6th Cir.1985)(finding extraordinary circumstances and granting relief from<br />

judgment based on intervening decision of Ohio Supreme Court); Jackson v. Sok, 65 Fed. Appx.<br />

46, 49 (6th Cir.2003)(per curiam)(upholding grant of Rule 60(b) motion based on intervening<br />

change in the applicable law).” [Emphasis added]<br />

Mitchell v. Rees, 430 F.Supp.2d 717 at 725 (M.D. Tenn., 2006).<br />

This action is the same case or controversy currently before the court in Lipari v. US Bancorp et<br />

al. Case no. 07-cv-02146-CM-DJW under Article III of the U.S. Constitution and 28 U.S.C. § 1367 and<br />

which this court continued to exercise jurisdiction over even during the plaintiff’s appeal as this court also<br />

did during the interlocutory appeal in <strong>Medical</strong> <strong>Supply</strong> I.<br />

By dismissing <strong>Medical</strong> <strong>Supply</strong>’s state claims without prejudice, a determination not opposed or<br />

appealed at the time by the defendants, the trial court elected not to make a preclusive final judgment: “A<br />

final judgment embodying the dismissal would eventually have been entered if the state claims had been<br />

later resolved by the court.” Avx Corp. v. Cabot Corp., 424 F.3d 28 at pg 32 (Fed. 1st Cir., 2005). As a non-<br />

final judgment, the Memorandum & Order granting dismissal was a mere interim order. Id.<br />

B. Court Lacked Power to Strike Plaintiff’s Motion Under Rule 12(f)<br />

The court lacks the authority or power to strike the plaintiff’s motion under Rule 12(f). Rule 12(f)<br />

of the Federal Rules of Civil Procedure ("Rule 12(f)") provides that a "court may order stricken from any<br />

pleading any insufficient defense or any redundant, immaterial, impertinent, or scandalous matter."<br />

Fed.R.Civ.P. 12(f). According to the language of Rule 12(f), motions to strike apply only to pleadings and<br />

not to motions. See Knight v. United States. 845 F. Supp. 1372, 1374 (D. Ariz. 1993); Krass v. Thomson-<br />

CGR Med. Corp., 665 F. Supp. 844, 847 (N.D. Cal. 1987).<br />

It is clearly established that the plaintiff’s motion was not a pleading the court could strike:<br />

“On its own initiative or on a party's motion, the court may strike from a pleading any<br />

insufficient defense or any redundant, immaterial, impertinent, or scandalous matter in order to<br />

avoid the time, effort, and expense necessary to litigate spurious issues. FED.R.CIV.P. 12(f);<br />

Fantasy, Inc. v. Fogerty, 984 F.2d 1524, 1527 (9th Cir.1993), rev'd on other grounds, 510 U.S. 517,<br />

114 S.Ct. 1023, 127 L.Ed.2d 455 (1994). A "pleading" includes a complaint, answer, reply to a<br />

counterclaim, answer to a cross-claim, third-party complaint, or third-party answer. FED.R.CIV.P.<br />

7(a). Motions to strike are a drastic remedy, which courts generally disfavor. Stabilisierungsfonds<br />

Fur Wein v. Kaiser Stuhl Wine Distribs. Pty. Ltd., 647 F.2d 200, 201 (D.C.Cir.1981) (citing 5 C<br />

FED. PRAC. & PROC. 2d § 1380 at 783); Morse v. Weingarten, 777 F.Supp. 312, 319<br />

(S.D.N.Y.1991); Mirshak v. Joyce, 652 F.Supp. 359, 370 (N.D.Ill.1987); Schramm v. Krischell, 84<br />

F.R.D. 294, 299 (D.Conn.1979).”<br />

5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5746


Naegele v. Albers, 355 F.Supp.2d 129 (D.D.C., 2005).<br />

Judge Carlos Murguia is responsible for knowing this is the controlling law of this circuit:<br />

“Moreover, there is no provision in the Federal Rules of Civil Procedure for motions to<br />

strike motions and memoranda; only motions to strike unsigned papers under Rule 11, third-party<br />

claims under Rule 14(a), and certain matters in pleadings under Rule 12(f) are contemplated by the<br />

Federal Rules of Civil Procedure. Motions and memoranda are not included within the definition of<br />

"pleading" under F.R.C.P. 7(a). See James Moore & Jo Desha Lucas, 2A Moore's Federal Practice p<br />

12.21 at 12-164 (Matthew Bender, 2d ed 1991) ("a Rule 12(f) motion to strike is not appropriate<br />

with regard to affidavits, parties, or any other matter other than that contained in the actual<br />

pleadings").”<br />

Searcy v. Social Sec. Admin.(Unpublished), 956 F.2d 278 (C.A.10 (Utah), 1993). See Exb. 4<br />

C. Court Lacked Power to Strike Plaintiff’s Motion Under Rule 37<br />

The other source for a court’s striking authority under the Federal Rules of Civil Procedure is Rule<br />

37. Rule 37(b), Federal Rules of Civil Procedure, authorizes courts to employ various sanctions, including<br />

"striking out pleadings or parts thereof ... or rendering a judgment by default," Rule 37(b)(2)(C), when "a<br />

party ... fails to obey an order to permit or provide discovery, including an order made under subdivision<br />

(a) of this rule," Rule 37(b)(2). But, there has been no discovery in this case or controversy (the defendants<br />

have not even produced requested documents in the continuing state contract claims litigation).<br />

In similar circumstances as this case, the US Supreme Court found a trial court could not strike a<br />

filing to punish a party. In Hovey v. Elliott, 167 U.S. 409, 413, 444, 17 S.Ct. 841, 843, 854, 42 L.Ed. 215<br />

(1897), the court held that a court may not strike an answer and enter a default merely to punish a contempt<br />

of court. The contempt involved in that case was the failure to pay into the registry of the court a fund<br />

which was the subject of the litigation. The Court held that the entry of default in those circumstances<br />

violated the defendant's fourteenth amendment right to a hearing, and held further that the judgment in such<br />

a case would be "void for want of jurisdiction, and may therefore be collaterally attacked," id. at 444, 446-<br />

47, 17 S.Ct. at 854, 855.<br />

Hovey v. Elliott was subsequently limited by the decision Hammond Packing Co. v. Arkansas, 212<br />

U.S. 322, 349-54, 29 S.Ct. 370, 379-81, 53 L.Ed. 530 (1909). Hammond only held, however, that a court<br />

had the power to strike an answer and enter default when a party failed to produce evidence. "(T)he<br />

6<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5747


generating source of the power (to strike the answer and enter default) was the right to create a presumption<br />

flowing from the failure to produce." Id. at 351, 29 S.Ct. at 380. See also Norman v. Young :<br />

“Hammond pared the Hovey decision by holding that a court could properly strike an answer and<br />

enter default judgment under circumstances where a party fails to produce documents as ordered.<br />

The court stated that trial courts have inherent power to presume the bad faith and untruth of an<br />

answer where the proof was suppressed provided it was essential to the disposition of the case.”<br />

Norman v. Young, 422 F.2d 470 at 473 (10th Cir., 1970)<br />

Here the court was not resolving a dispute over discovery which has not yet occurred in the<br />

<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> litigation and could make no competent judgments on facts in dispute.<br />

III.<br />

Court’s Order Striking Rule 60(b) is Void<br />

The court’s denial or striking of plaintiff’s Rule 60(b) motion deprives the plaintiff of an important<br />

federal right, warranting a certificate of probable cause. See Smith, 50 F.3d at 821 (citing Barefoot v.<br />

Estelle, 463 U.S. 880, 893, 103 S.Ct. 3383, 77 L.Ed.2d 1090 (1983)).<br />

This court’s order striking the plaintiff’s Rule 60(b) motion is void:<br />

“For a judgment to be void under Rule 60(b)(4), it must be determined that the rendering court was<br />

powerless to enter it. If found at all, voidness usually arises for lack of subject matter jurisdiction or<br />

jurisdiction over the parties. It may also arise if the court's action involves a plain usurpation of<br />

power or if the court has acted in a manner inconsistent with due process of law. 11 In the interest of<br />

finality, the concept of setting aside a judgment on voidness grounds is narrowly restricted. ”<br />

V. T. A., Inc. v. Airco, Inc., 597 F.2d 220 at 224-225 (C.A.10 (Colo.), 1979)<br />

Judge Carlos Murguia has usurped power denied him under the Federal Rules of Civil<br />

Procedure. The plaintiff has the clearly established right to seek relief from any post judgment order<br />

including an award of attorney fees that might result from the court’s previous sanctions or threatened<br />

show cause sanctions:<br />

“Here, the judgment against Pinckney was void. Thus, Pinckney was entitled to restitution under<br />

Section 60(b)(4). Jordan v. Gilligan, 500 F.2d 701, 704 (6th Cir.1974), cert. denied, 421 U.S. 991,<br />

95 S.Ct. 1996, 44 L.Ed.2d 481 (1975) (a Rule 60(b) motion is proper where appellants failed to<br />

object to an award of attorney's fees and expenses until after the judgment is entered and execution<br />

proceedings were undertaken); Vander Zee v. Karabatsos, 683 F.2d 832 (4th Cir.1982) (garnisher<br />

entitled to restitution of payment made on void judgment).”<br />

Watts v. Pinckney, 752 F.2d 406 at 410 (C.A.9 (Ariz.), 1985).<br />

7<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5748


IV.<br />

Court Must Vacate Strike and Show Cause Order<br />

Judge Carlos Murguia unlawfully instructed the Kansas District Court Clerk to violate the<br />

established policies of the Kansas District Court and not to give the plaintiff notice of its present Show<br />

Cause Order through service by mail or by emailing the order to the plaintiff’s email address included<br />

by the plaintiff in every filing expressly for the purpose of taking property from the plaintiff without<br />

Due Process and to violate his oath of office and become a participant in the defendants’ conspiracy to<br />

artificially inflate hospital supplies through the Novation LLC cartel and to commit racketeering acts to<br />

extrinsically deprive the plaintiff of the opportunity to present hiss evidence.<br />

Judge Carlos Murguia unlawfully instructed the Kansas District Court Clerk not to mail the<br />

plaintiff notice after the plaintiff observed that the failure to give notice of a minute order accelerating<br />

the deadline to respond to the defendants’ motion to dismiss in Lipari v. US Bancorp et al. Case no. 07-<br />

cv-02146-CM-DJW would have similarly deprived the plaintiff of his property. It is now recognized<br />

Judge Carlos Murguia unlawfully instructed the Kansas District Court Clerk to violate the established<br />

policies of the Kansas District Court and not to give the plaintiff notice of its Minute Order through<br />

service by mail or by email in Lipari v. US Bancorp et al. Case no. 07-cv-02146-CM-DJW.<br />

When Judge Carlos Murguia acts overtly to deny the plaintiff of Due Process whether by<br />

violating the Federal Rules of Civil Procedure and striking the plaintiff’s Rule 60(b) Motion or by<br />

depriving the plaintiff of notice and an opportunity to oppose sanctions, Judge Carlos Murguia’s orders<br />

are void and must be set aside as a consequence of the plaintiff’s present Motion for Reconsideration.<br />

"A void judgment is a legal nullity and a court considering a motion to vacate has no discretion<br />

in determining whether it should be set aside." 7 J. Moore, Moore's Federal Practice, p 60.25 at 301 (2d<br />

ed. 1973). See also Barkley v. Toland:<br />

"Rule 60(b)(4) authorizes relief from void judgments. Necessarily a motion under this part<br />

of the rule differs markedly from motions under the other clauses of Rule 60(b). There is no<br />

question of discretion on the part of the court when a motion is under Rule 60(b)(4). Nor is there<br />

any requirement, as there usually is when default judgments are attacked under Rule 60(b), that the<br />

moving party show that he has a meritorious defense. Either a judgment is void or it is valid.<br />

Determining which it is may well present a difficult question, but when that question is resolved, the<br />

court must act accordingly.”<br />

Barkley v. Toland, 7 Kan.App.2d 625, 646 P.2d 1124 at 1127-1128 (Kan. App., 1982).<br />

8<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5749


Judge Carlos Murguia’s prior decisions in this litigation appear to be the product of similar<br />

unlawful conduct against the plaintiff who was sanctioned previously in the order dismissing his federal<br />

claims on conduct subsequent to <strong>Medical</strong> <strong>Supply</strong> I that violated clearly established law on preclusion:<br />

“The preclusion of claims that "could have been brought" does not include claims that<br />

arose after the original complaint was filed in the prior action, unless the plaintiff actually asserted<br />

the claim in an amended pleading, but res judicata does not bar the claim simply because the<br />

plaintiff elected not to amend his complaint. Pleming v. Universal-Rundle Corp., 142 F.3d 1354,<br />

1357 (11th Cir. 1998). This is true even if the plaintiff discussed the facts supporting the subsequent<br />

claim in support of his claims in the prior case. Id. at 1358-59.”<br />

20<strong>08</strong>).<br />

Sherrod v. School Board of Palm Beach County, No. 07-13747 (11th Cir. 4/7/20<strong>08</strong>) (11th Cir.,<br />

Judge Carlos Murguia violated the show cause notice requirement. The Rule to Show Cause<br />

requires a reasonable opportunity to respond. “Under Federal Rule of Civil Procedure 11(c), a court may,<br />

after notice and reasonable opportunity to respond, impose an "appropriate sanction" upon attorneys, law<br />

firms, or parties if the court finds they have violated subdivision (b) of that Rule. Fed.R.Civ.P. 11(c). Rule<br />

11(b) provides that by presenting a motion to the court, the attorney is certifying that the document (1) "is<br />

not being presented for any improper purpose, such as to harass;" and (2) the legal claims made are<br />

nonfrivolous. Fed.R.Civ.P. 11(b). An attorney's conduct is evaluated objectively when it is challenged<br />

under Rule 11: the applicable standard is that of the reasonable attorney admitted to practice before this<br />

court. See Adamson v. Bowen, 855 F.2d 668, 673 (10th Cir. 1988).<br />

CONCLUSION<br />

Whereas for the above reasons, the plaintiff respectfully requests that the court grant the plaintiff<br />

relief from the order striking the plaintiff’s Motion to reopen its Memorandum and Order dismissing the<br />

plaintiff’s claims, and from the Order to Show Cause recognizing the plaintiff had standing and properly<br />

filed a motion for New Trial.<br />

Respectfully Submitted,<br />

S/ Samuel K. Lipari<br />

____________________<br />

Samuel K. Lipari<br />

297 NE Bayview<br />

9<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5750


Lee's Summit, MO 64064<br />

816-365-1306<br />

saml@medicalsupplychain.com<br />

Pro se<br />

CERTIFICATE OF SERVICE<br />

I certify I have caused a copy to be sent via electronic case filing to the undersigned opposing counsel on<br />

4/8/<strong>08</strong>.<br />

Mark A. Olthoff, Esq.,<br />

Jay E. Heidrick, Esq.<br />

Shughart Thomson & Kilroy, P.C.<br />

Twelve Wyandotte Plaza<br />

120 W. 12th Street<br />

Kansas City, MO 64105<br />

Stephen N. Roberts, Esq.<br />

Natausha Wilson, Esq. Nossaman,<br />

Guthner, Knox & Elliott<br />

34th Floor<br />

50 California Street<br />

San Francisco, CA 94111<br />

Bruce Blefeld, Esq.<br />

Kathleen Bone Spangler, Esq.<br />

Vinson & Elkins L.L.P.<br />

2300 First City Tower<br />

1001 Fannin<br />

Houston, TX 77002<br />

via email<br />

jheidrick@stklaw.com<br />

molthoff@stklaw.com<br />

ademarea@stklaw.com<br />

S/ Samuel K. Lipari<br />

____________________<br />

Samuel K. Lipari<br />

10<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5751


Case 2:05-cv-02299-CM-GLR Document 78 Filed 03/07/2006 Page 24 of 30<br />

and attorneys’ fees reasonably incurred because of such conduct.” 28 U.S.C. § 1927. Sanctions may be<br />

imposed under § 1927 “for conduct that, viewed objectively, manifests either intentional or reckless<br />

disregard of the attorney’s duties to the court.” Braley v. Campbell, 832 F.2d 1504, 1512 (10 th Cir.<br />

1987). Like Rule 11, the court must apply an objective standard, and subjective bad faith is not a necessary<br />

showing for application of § 1927 sanctions. Because § 1927 is penal in nature, an award should only be<br />

made “‘in instances evidencing a serious and standard disregard for the orderly process of justice’” and the<br />

court must be aware of the “need to ensure that the statute does not dampen attorneys’ zealous<br />

representation of their clients’ interests.” Ford Audio Video Sys., Inc. v. AMX Corp., Inc., 1998 WL<br />

658386, at *3 (10 th Cir. Sept. 15, 1998) (quoting Dreiling v. Peugeot Motors of Am., Inc., 768 F.2d<br />

1159, 1165 (10 th Cir. 1985) (internal quotations omitted)).<br />

The court notes that, pursuant to Rule 11(c)(1)(A), both groups of defendants requesting sanctions<br />

gave plaintiff at least twenty-one days notice before filing their motions for sanctions. “The basic<br />

requirements of due process with respect to the assessment of costs, expenses, or attorney’s fees are notice<br />

that such sanctions are being considered by the court and a subsequent opportunity to respond.” Braley, at<br />

1514. Plaintiff responded to defendants’ motions by arguing that claim and issue preclusion do not bar<br />

plaintiff’s claims, and that defendants violated Rule 11 and § 1927 by requesting sanctions. Plaintiff chose<br />

not to withdraw or amend its complaint.<br />

The court finds that sanctions against plaintiff in the form of attorney fees and costs are appropriate<br />

and necessary pursuant to both Rule 11 and § 1927 for four reasons. First, the mere fact that plaintiff filed a<br />

nearly unintelligible 115 page complaint, which the court already found violates Rule 8, suggests that<br />

plaintiff’s complaint, and the instant suit as a whole, was brought for the purpose of harassing defendants or<br />

-24-<br />

Exb 8<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5752


Case 2:05-cv-02299-CM-GLR Document 78 Filed 03/07/2006 Page 25 of 30<br />

the court, causing unnecessary delay and/or needlessly increasing the cost of litigation in violation of Rule<br />

11(b)(1). Second, as discussed above, not one of plaintiff’s federal claims supports a viable claim for which<br />

relief can be granted pursuant to Rule 12(b)(6). As such, plaintiff’s complaint consists of frivolous claims in<br />

violation of Federal Rule of Civil Procedure 11(b)(2). Moreover, each of plaintiff’s federal claims lack the<br />

evidentiary support needed to avoid violating Rule 11(b)(3). Third, plaintiff’s insistence on re-litigating<br />

claims barred by claim preclusion “unreasonably and vexatiously” “multiplies the proceedings” in violation of<br />

§ 1927.<br />

Fourth, and most importantly, plaintiff failed to heed the court’s previous admonitions and sanctions,<br />

choosing instead to proceed with the instant suit and attempt another bite at the proverbial apple. Plaintiff’s<br />

previous two claims in this court were dismissed for failure to state a claim pursuant to Rule 12(b)(6).<br />

<strong>Medical</strong> <strong>Supply</strong> I, 2003 WL 21479192, at *9; <strong>Medical</strong> <strong>Supply</strong> II, 2004 WL 956100, at *5. In <strong>Medical</strong><br />

<strong>Supply</strong> I, the undersigned judge advised plaintiff’s counsel to “take greater care in ensuring that the claims he<br />

brings on his clients’ behalf are supported by the law and the facts.” Id. at *6. In the same Order, the<br />

undersigned judged found plaintiff’s allegations “completely divorced from rational thought.” Id. at *8. In<br />

<strong>Medical</strong> <strong>Supply</strong> II, the undersigned judge noted that “at the most fundamental level, plaintiff’s antitrust<br />

claims fail.” 2004 WL 956100, at *3.<br />

Both prior dismissals were affirmed by the Tenth Circuit. <strong>Medical</strong> <strong>Supply</strong> I, 112 Fed. Appx. at<br />

731-32; <strong>Medical</strong> <strong>Supply</strong> II, 144 Fed. Appx. at 716. In <strong>Medical</strong> <strong>Supply</strong> I, the Tenth Circuit ordered<br />

plaintiff to show cause why sanctions should not be imposed. 112 Fed. Appx. at 731-32. The undersigned<br />

judge imposed attorney fees totaling $23,956 and double costs as a sanction against Mr. Landrith. <strong>Medical</strong><br />

-25-<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5753


Case 2:05-cv-02299-CM-GLR Document 78 Filed 03/07/2006 Page 26 of 30<br />

<strong>Supply</strong> I, 2005 WL 2122675, at *1. In <strong>Medical</strong> <strong>Supply</strong> II, the Tenth Circuit reversed and remanded on<br />

the issue of sanctions against plaintiff, and the issue of sanctions remains pending. 144 Fed. Appx. at 716<br />

Plaintiff and its counsel have had plenty of warning about filing frivolous claims from both this court<br />

and the Tenth Circuit. But plaintiff persisted, filing a third lawsuit against many of the same defendants and<br />

alleging many of the same claims. Enough is enough. See Brooks v. Couchman, 2006 WL 137415, at *1<br />

(10 th Cir. Jan. 19, 2006) (affirming the district court’s dismissal of plaintiff’s third attempt at the same<br />

argument, stating that “we have expended valuable court resources on at least two occasions dealing with<br />

[plaintiff] and his various meritless theories. We repeat our sentiment . . . : ‘We will spend no more judicial<br />

time or resources addressing his frivolous claims.’” (internal citation omitted)); Sweeney v. Resolution Trust<br />

Corp., 16 F3d 1, 6-7 (1 st Cir. 1994) (finding that the district court did not abuse its discretion in imposing<br />

sanctions on plaintiffs for filing a third and “repetitive” motion to remand when the court had previously<br />

denied two “almost identical motions and made detailed findings of fact”).<br />

The court may impose sanctions against plaintiff, plaintiff’s counsel, or against both with joint and<br />

several liability. White, 9<strong>08</strong> F.2d at 685-86. However, “the sanctioning of a party requires specific findings<br />

that the party was aware of the wrongdoing.” Id. at 685 (citations omitted); Barrett v. Tallon, 30 F.3d<br />

1296, 1303 (10 th Cir. 1993) (“Thus, in the case of a frivolously pleaded RICO claim, it seems that the court<br />

should sanction the responsible attorneys rather than the plaintiffs, unless it finds that the plaintiffs insisted,<br />

against the advice of counsel, that the RICO claim be asserted, or that the plaintiffs had a sufficient<br />

understanding of the nature, elements, and limitations of the attempted RICO claim to independently evaluate<br />

its applicability to the alleged facts.”).<br />

-26-<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5754


Case 2:05-cv-02299-CM-GLR Document 78 Filed 03/07/2006 Page 27 of 30<br />

Certainly plaintiff’s former counsel, Bret D. Landrith, is culpable. Mr. Landrith was the attorney of<br />

record when each of the sanctionable motions were filed, and Mr. Landrith signed and authored the<br />

complaint and each of the motions before the court. Nonetheless, sanctions against plaintiff are also<br />

appropriate for two reasons. First, plaintiff’s CEO and sole shareholder, Samuel Lipari, takes responsibility<br />

for the decisions to knowingly bring the instant lawsuit after the result of plaintiff’s previous attempts at<br />

litigation. For instance, Mr. Lipari’s affidavit, entitled “Affidavit of Sam Lipari on The Unsuitability of<br />

Transfer,” states:<br />

I chose to bring this new action in Missouri District court because I have a<br />

responsibility to <strong>Medical</strong> <strong>Supply</strong>’s stakeholders . . . to adjudicate these claims.<br />

I brought two earlier and related actions to Kansas District court based on the<br />

advice of my counsel. I have witnessed first hand that no decision or outcome in<br />

either case including from the Tenth Circuit Court of Appeals had any<br />

relationship to the pleadings of my company or applicable law. I make this<br />

determination based on my considerable personal experience as a clerk and<br />

researcher for a Missouri legal firm and upon discussion with what I believe are<br />

the foremost healthcare antitrust authorities in our nation.<br />

(Doc. 30, exh. 1). Mr. Lipari’s affidavit continues with a litany of conspiracy theories involving defendants,<br />

this court, and other government agencies and employees. Significantly, however, Mr. Lipari’s affidavit also<br />

discusses numerous instances when he actively participated in prior and current litigation. Mr. Lipari’s<br />

affidavit also discusses attending one of Mr. Landrith’s disciplinary conferences. Thus, Mr. Lipari was wellaware<br />

of the legal arguments and allegations being brought by his attorney, as well as the disciplinary<br />

allegations against Mr. Landrith prior to his disbarment. Even so, plaintiff chose to continue vigorously<br />

litigating the instant case. Second, after Mr. Landrith was disbarred, plaintiff chose to retain new counsel<br />

and continue litigating this case. Therefore, sanctioning plaintiff as well as Mr. Landrith serves to deter both<br />

from future frivolous filings.<br />

-27-<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5755


Case 2:05-cv-02299-CM-GLR Document 78 Filed 03/07/2006 Page 28 of 30<br />

In sum, the court finds that defendants’ reasonable attorney fees and costs against plaintiff and Mr.<br />

Landrith jointly and severally is the minimum amount of sanctions necessary to “adequately deter the<br />

undesirable behavior.” White v. Gen. Motors, 977 F.2d 499, 502 (10 th Cir. 1992) (internal quotations and<br />

citations omitted).<br />

E. Plaintiff’s Motion for Clarification of Order in Case No. 03-2324 (Doc. 45)<br />

Plaintiff’s motion for clarification seems to request this court to clarify its ruling in a separate case,<br />

case number 03-2324, which found that plaintiff’s request to consolidate case number 03-2324 with the<br />

instant case is moot. Case number 03-2324 was closed as of February 13, 2004, with attorney fees the<br />

only remaining issue. The court need not address this motion for two reasons. First, plaintiff has previously<br />

requested the court to “clarify” its decision in case number 03-2324, and the court found plaintiff’s request<br />

moot in light of the posture of the case. Second, plaintiff’s instant case will soon be closed, as the instant<br />

Memorandum and Order’s holdings dismiss plaintiff’s entire complaint. Therefore, the issue of whether to<br />

consolidate two closed cases is a moot one.<br />

IT IS THEREFORE ORDERED that defendant Robert Zollars’ Motion to Dismiss for Lack of<br />

Personal Jurisdiction (Doc. 2); Defendant Neoforma, Inc.’s Motion to Dismiss, [sic] Complaint, or<br />

Alternatively to Require Amendment, Pursuant to F.R.C.P. Rules 8 and 9 (Doc. 4); Defendants US<br />

Bancorp, U.S. Bank National Association, Piper Jaffray Companies, Jerry A. Grundhofer, Andrew Cesare<br />

and Andrew S. Duffs’ Motion to Transfer, Dismiss and/or Strike (Doc. 6); Defendants Curt Nonomaque<br />

and Robert Baker’s Motion to Dismiss Plaintiff’s Complaint for Lack of Personal Jurisdiction and for Failure<br />

to State a Claim (Doc. 11); Defendant Shughart Thomson & Kilroy, P.C.’s Motion to Transfer, Dismiss<br />

and/or Strike (Doc. 13); Defendants US Bancorp, U.S. Bank National Association, Piper Jaffray<br />

-28-<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5756


Case 2:05-cv-02299-CM-GLR Document 104 Filed <strong>08</strong>/07/2006 Page 4 of 5<br />

S.W.2d 171, 176 (Mo. App. E.D. 1993). Therefore, even though <strong>Medical</strong> <strong>Supply</strong> was dissolved, its<br />

corporate existence continues for purposes of proceeding with this litigation. <strong>Medical</strong> <strong>Supply</strong><br />

remains the sole plaintiff in this case.<br />

Moreover, Mr. Lipari cannot proceed pro se on behalf of <strong>Medical</strong> <strong>Supply</strong> because a pro se<br />

individual may not represent a corporation. See Nato Indian Nation v. State of Utah, 76 Fed. Appx.<br />

854, 856 (10 th Cir. 2003) (“Individuals may appear in court pro se, but a corporation, other business<br />

entity, or non-profit organization may only appear through a licensed attorney.”) (citations omitted).<br />

The court also finds that Mr. Lipari may not substitute himself for <strong>Medical</strong> <strong>Supply</strong>. Federal<br />

Rule of Civil Procedure 25(c), which governs the procedural substitution of a party after a transfer of<br />

interest, states: “In case of any transfer of interest, the action may be continued by or against the<br />

original party, unless the court upon motion directs the person to whom the interest is transferred to<br />

be substituted in the action.” Fed. R. Civ. P. 25(c) (emphasis added). As evidenced by the plain<br />

language of Rule 25(c), the court has discretion to allow Mr. Lipari to substitute. Prop-Jets, Inc. v.<br />

Chandler, 575 F.2d 1322, 1324 (10 th Cir. 1978). The court declines to exercise its discretion,<br />

however, because this case has been dismissed, and substitution will not change that outcome.<br />

Mr. Lipari also argues that because the court sanctioned him personally, the court should<br />

allow him to represent himself pro se. Mr. Lipari is mistaken. The court sanctioned <strong>Medical</strong> <strong>Supply</strong>,<br />

not Mr. Lipari. Although the court discussed Mr. Lipari’s personal involvement in the litigation in its<br />

ruling opposing sanctions against plaintiff and plaintiff’s counsel, it did so for the purpose of<br />

demonstrating plaintiff’s culpability. It is irrelevant that Mr. Lipari, as <strong>Medical</strong> <strong>Supply</strong>’s sole<br />

shareholder, is ultimately liable for plaintiff’s sanctions.<br />

For the above-mentioned reasons, the court strikes each of Mr. Lipari’s pending motions,<br />

including Documents 80, 92, 95 and 102. Consistent with this ruling, the court cautions Mr. Lipari<br />

-4-<br />

Exb 9<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5757


Case 2:05-cv-02299-CM-GLR Document 104 Filed <strong>08</strong>/07/2006 Page 5 of 5<br />

against filling additional motions. Of course, plaintiff may allow Mr. Hawver or other counsel to<br />

represent it. But the court reiterates that it dismissed plaintiff’s case with prejudice and sanctioned<br />

plaintiff for violations of Federal Rule of Civil Procedure 11(b) and 28 U.S.C. § 1927. Plaintiff has a<br />

history of filing frivolous lawsuits and motions, for which the court has sanctioned plaintiff on<br />

several occasions. Future attempts to resurrect this case could result in the court imposing additional<br />

sanctions.<br />

IT IS THEREFORE ORDERED that Ira Dennis Hawver’s Motion to Withdraw (Doc. 81)<br />

is denied.<br />

IT IS FURTHER ORDERED that plaintiff’s Motion for Reconsideration (Doc. 80);<br />

plaintiff’s Motion Under Rule 15 for Leave to Rewrite and Amend Complaint to Cure Any Defects<br />

Requiring Dismissal Remaining After Outcome of Reconsideration Motion (Doc. 92); plaintiff’s<br />

Motion to Strike Documents # 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 93 (Doc. 95); and plaintiff’s<br />

Motion to Rewind Action and Return Proceeding to the Western District of Missouri in the Interest<br />

of Justice Under 28 U.S.C. [§] 1631 (Doc. 102) are hereby stricken from the record.<br />

Dated this 7 th day of August 2006, at Kansas City, Kansas.<br />

s/ Carlos Murguia<br />

CARLOS MURGUIA<br />

United States District Judge<br />

-5-<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5758


560. Plaintiff is entitled to recover their actual damages in the amount of in excess of $500,000,000.00<br />

for their actions resulting in the loss of trust accounts, and actual damages in the amount of in excess of<br />

$500,000,000.00 for their actions resulting in the loss of the lease sale together with the costs of suit, and<br />

attorney fees.<br />

561. Defendants’ actions were willful, wanton, malicious and oppressive.<br />

562. Plaintiff is also entitled to recover punitive damages in an amount in excess of $10,000.00.<br />

563. Plaintiff realleges paragraphs 1 through 562.<br />

COUNT XIV<br />

DAMAGES FOR PRIMA FACIE TORT<br />

564. To whatever extent said activities of Defendants may not violate antitrust laws or tortuously<br />

interfere with contract or business expectancy, said acts and activities of Defendants are still unlawful and<br />

fraudulent.<br />

565. Said activities were intended by Defendants and performed by Defendants.<br />

566. Said activities were intended by Defendants to cause injury to Plaintiff.<br />

567. Said activities did directly and proximately cause injury to Plaintiff.<br />

568. Said activities were and are unjustified.<br />

569. Plaintiff is entitled to recover their actual damages in the amount of in excess of $500,000,000.00<br />

for their actions resulting in the loss of trust accounts, and actual damages in the amount of in excess of<br />

$500,000,000.00 for their actions resulting in the loss of the lease sale together with the costs of suit, and<br />

attorney fees.<br />

570. Defendants’ actions were willful, wanton, malicious and oppressive.<br />

571. Plaintiff is also entitled to recover punitive damages in an amount in excess of $10,000.00.<br />

COUNT XV<br />

DAMAGES FOR RACKETEERING<br />

INFLUENCED CORRUPT ORGANIZATION (RICO) CONDUCT<br />

(18 U.S.C. § 1962(c), 18 U.S.C. § 1962(d))<br />

572. Plaintiff realleges paragraph 1 through 571.<br />

573. On January 21, 2005 <strong>Medical</strong> <strong>Supply</strong> discovered the Defendants’ pattern of inflicting injuries on<br />

the plaintiff to obstruct its entry into the market for hospital supplies and hospital supplies in e-commerce.<br />

An important component of the Defendants’ scheme was to interdict capital required by <strong>Medical</strong> <strong>Supply</strong> to<br />

107<br />

Exb 10<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5759


enter the market. The Defendants targeted <strong>Medical</strong> <strong>Supply</strong>’s founder in 1995 and targeted <strong>Medical</strong> <strong>Supply</strong><br />

upon its incorporation in 2000. From the outset, the Defendants have maintained a continuous pattern of<br />

preventing an independent clearinghouse electronic market place from interfering with their common<br />

enterprise to to artificially inflate prices paid by Medicare, Medicaid and Champus.<br />

574. The Defendants violated 18 U.S.C. § 1962(c) by conducting a RICO enterprise (the hospital group<br />

purchasing enterprise to artificially inflate prices paid by Medicare, Medicaid and Champus) through a<br />

pattern of racketeering activity.<br />

575. The Defendants violated 18 U.S.C. § 1962(d) through participation in a RICO conspiracy.<br />

576. The Defendants engaged in (1) conduct (2) of an enterprise (3) through a pattern (4) of<br />

racketeering activity.<br />

577. The Defendants participated in the operation and management of the hospital group purchasing<br />

enterprise to artificially inflate prices paid by Medicare, Medicaid and Champus itself.<br />

578. When <strong>Medical</strong> <strong>Supply</strong> sought to appeal the outcomes in the Kansas District Court, the Defendants<br />

sought the assistance of Shughart Thomson & Kilroy to intimidate, harass and obstruct <strong>Medical</strong> <strong>Supply</strong> and<br />

prevent <strong>Medical</strong> <strong>Supply</strong> and its agents from testifying and preventing evidence in federal court.<br />

579. To realize that goal the Defendants directly and tacitly caused Shughart Thomson & Kilroy to<br />

create and arrange for <strong>Medical</strong> <strong>Supply</strong>’s counsel to receive repeated ethics complaints and to be prosecuted<br />

by the State of Kansas Disciplinary Administrator based on the false and misleading testimony of Shughart<br />

Thomson & Kilroy’s former managing partner, a federal magistrate judge and a sham complaint made by<br />

the Shughart Thomson & Kilroy counsel defending US Bancorp and Piper Jaffray.<br />

580. Shughart Thomson & Kilroy through its employees and past employees created the plan to<br />

retaliate against and intimidate and harass <strong>Medical</strong> <strong>Supply</strong>’s counsel when they discovered <strong>Medical</strong> <strong>Supply</strong><br />

could not obtain outside counsel due to conflicts of interest in law firms the plaintiff had approached.<br />

581. Shughart Thomson & Kilroy through its employees and past employees implemented the plan and<br />

carried out its operations with the intent and motive of making sure that the Defendants could continue the<br />

enterprise to monopolize the markets in hospital supplies, hospital supplies sold in e-commerce and the<br />

capitalization of healthcare technology and supply chain management companies without challenge by the<br />

US District Court.<br />

1<strong>08</strong><br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5760


582. The Defendants implicitly ratified Shughart Thomson & Kilroy’s conduct on their behalf and<br />

relied on the conduct to attempt to avoid <strong>Medical</strong> <strong>Supply</strong>’s intention to seek redress. Shughart Thomson &<br />

Kilroy engaged in "racketeering activity" as that term has been defined by Congress, see 18 U.S.C. §<br />

1961(1).<br />

583. The Defendant Shughart Thomson & Kilroy through its officers, employees and agents injured<br />

<strong>Medical</strong> <strong>Supply</strong> in violation of 18 USC § 1503 when it caused false and misleading testimony to be given<br />

against <strong>Medical</strong> <strong>Supply</strong>’s counsel and again when it caused its employee to file a facially void ethics<br />

complaint against <strong>Medical</strong> <strong>Supply</strong>’s counsel. The purpose of the Defendant Shughart Thomson & Kilroy’s<br />

complaint was intimidation and harassment of <strong>Medical</strong> <strong>Supply</strong>’s counsel to interfere with the<br />

administration of justice in the federal antitrust action against the Defendants.<br />

584. 18 USC § 1503 entitled “Influencing or injuring officer or juror generally” provides:<br />

“(a) Whoever corruptly, or by threats or force, or by any threatening letter or communication,<br />

endeavors to influence, intimidate, or impede any grand or petit juror, or officer in or of any court of<br />

the United States,… in the discharge of his duty…or injures any such officer,… in his person or<br />

property on account of the performance of his official duties, or corruptly or by threats or force, or<br />

by any threatening letter or communication, influences, obstructs, or impedes, or endeavors to<br />

influence, obstruct, or impede, the due administration of justice, shall be punished as provided in<br />

subsection (b).”<br />

585. The Defendant Shughart Thomson & Kilroy through its officers, employees and agents injured<br />

<strong>Medical</strong> <strong>Supply</strong> in violation of 18 USC § 1513 when it caused false and misleading testimony to be given<br />

against <strong>Medical</strong> <strong>Supply</strong>’s counsel and again when it caused its employee to file a facially void ethics<br />

complaint against <strong>Medical</strong> <strong>Supply</strong>’s counsel to deprive him of property in the form of his license to practice<br />

law. The purpose of the Defendant Shughart Thomson & Kilroy’s retaliation against <strong>Medical</strong> <strong>Supply</strong>’s<br />

counsel was to interfere with the administration of justice in the federal antitrust action against the<br />

Defendants.<br />

586. 18 USC § 1513 entitled “Retaliating against a witness, victim, or an informant” provides:<br />

“(e) [2] Whoever knowingly, with the intent to retaliate, takes any action harmful to any person,<br />

including interference with the lawful employment or livelihood of any person, for providing to a<br />

law enforcement officer any truthful information relating to the commission or possible commission<br />

of any Federal offense, shall be fined under this title or imprisoned not more than 10 years, or both.<br />

(b) Whoever knowingly engages in any conduct and thereby causes bodily injury to another person<br />

or damages the tangible property of another person, or threatens to do so, with intent to retaliate<br />

against any person for—<br />

109<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5761


(1) the attendance of a witness or party at an official proceeding, or any testimony given or any<br />

record, document, or other object produced by a witness in an official proceeding; or<br />

(2) any information relating to the commission or possible commission of a Federal offense or a<br />

violation of conditions of probation [1] supervised release,,[1] parole, or release pending judicial<br />

proceedings given by a person to a law enforcement officer;”<br />

587. In furtherance of their enterprise to artificially inflate healthcare costs, the Defendants stole<br />

copyrighted works to keep <strong>Medical</strong> <strong>Supply</strong> from realizing its plan to enter the market for hospital supplies.<br />

The Defendants stole copyrighted works that included business plans, algorithms, confidential proprietary<br />

business models, customer and associate lists from <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. in 2002 and from its<br />

predecessor company <strong>Medical</strong> <strong>Supply</strong> Management in 1995 and 1996 in violation of 17 USC § 506 entitled<br />

“Criminal offenses” providing:<br />

“(a) Criminal Infringement.— Any person who infringes a copyright willfully either— for purposes<br />

of commercial advantage or private financial gain, or<br />

by the reproduction or distribution, including by electronic means, during any 180-day period, of 1<br />

or more copies or phonorecords of 1 or more copyrighted works, which have a total retail value of<br />

more than $1,000, shall be punished as provided under section 2319 of title 18, United States Code.<br />

For purposes of this subsection, evidence of reproduction or distribution of a copyrighted work, by<br />

itself, shall not be sufficient to establish willful infringement.”<br />

588. The Defendants violation falls under 18 USC § 2319 entitled “Criminal infringement of a<br />

copyright” which provides:<br />

“(a) Whoever violates section 506 (a) (relating to criminal offenses) of title 17 shall be punished<br />

as provided in subsections (b) and (c) of this section and such penalties shall be in addition to any<br />

other provisions of title 17 or any other law.”<br />

589. Defendants violated The Hobbs Act prohibition against racketeering by preventing <strong>Medical</strong><br />

<strong>Supply</strong>’s entry into commerce under color of official right in violation of 18 U.S.C. 1951, which states:<br />

“Section 1951. Interference with commerce by threats or violence<br />

Whoever in any way or degree obstructs, delays, or affects<br />

commerce or the movement of any article or commodity in commerce,<br />

by robbery or extortion or attempts or conspires so to do, or<br />

commits or threatens physical violence to any person or property in<br />

furtherance of a plan or purpose to do anything in violation of<br />

this section shall be fined under this title or imprisoned not more<br />

than twenty years, or both.<br />

b) As used in this section – The term ''extortion'' means the obtaining of property from another,<br />

with his consent, induced by wrongful use of actual or<br />

threatened force, violence, or fear, or under color of official<br />

right.”<br />

590. Defendants interfered with and obstructed <strong>Medical</strong> <strong>Supply</strong>’s entry into market by threatening the<br />

plaintiff with the filing of a USA PATRIOT Act suspicious activity report which would destroy the<br />

110<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5762


plaintiff’s ability to make financial wire transactions with corresponding banks required to effectively<br />

compete in the market for hospital supplies.<br />

591. As a direct result Defendants’ unlawful activities, Plaintiff has suffered and will continue to suffer<br />

substantial injuries and damages to their businesses and property.<br />

592. Plaintiff is entitled to recover actual damages in the amount of approximately $500,000,000.00,<br />

multiplied by three for total damages of approximately $1,500,000,000.00, and the cost of suit including a<br />

reasonable attorney’s fee.<br />

COUNT XVI<br />

DAMAGES FOR MALICIOUS FILING OF A SUSPICIOUS ACTIVITY<br />

REPORT (SAR) UNDER THE USA PATRIOT ACT<br />

(Pub. L. No. 107-56 (2001),18 U.S.C.§1030 (e), 31 U.S.C. § 5318 (g)(3))<br />

593. Plaintiff realleges paragraphs 1 through 592.<br />

594. On information and belief the Defendants through US Bank and US Bancorp NA and maliciously<br />

filed a suspicious activity report (“SAR”) concerning <strong>Medical</strong> <strong>Supply</strong> and its founder Samuel Lipari with<br />

federal authorities for the purpose of securing a financial benefit for the Defendants including US Bank and<br />

US Bancorp NA and were not protected by the safe harbor provisions of 31 U.S.C. § 5318 (g)(3).<br />

595. The USA PATRIOT Act § 310. Financial Crimes Enforcement Network requires the maintenance<br />

of a government wide data access service and data banks for financial crime reporting including suspicious<br />

activity reports. In threatening to cause a malicious suspicious activity report or in causing a malicious<br />

suspicious activity report t be filed against <strong>Medical</strong> <strong>Supply</strong>, the defendants have violated 18 U.S.C.§1030.<br />

596. The Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept<br />

and Obstruct Terrorism Act of 2001 (The USA PATRIOT Act) Pub. L. No. 107-56 (2001), 115 Stat. 272.<br />

at § 814 of the USA PATRIOT Act entitled DETERRENCE AND PREVENTION OF<br />

CYBERTERRORISM created a private right of action for <strong>Medical</strong> <strong>Supply</strong> to address the conduct of the<br />

Defendants in gaining access to the FINCEN network for the purpose of filing a suspicious activity report<br />

to prevent <strong>Medical</strong> <strong>Supply</strong> from providing hospital supplies and reducing healthcare costs.<br />

597. The USA PATRIOT Act amended 18 U.S.C.§1030 to include a cause of action for impairment, or<br />

potential impairment of medical diagnosis, treatment or care, physical injury, a threat to public health or<br />

safety.<br />

111<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5763


598. The USA PATRIOT Act reaffirmed the civil liability and private rights of action provisions of 18<br />

U.S.C.§1030 (e) DAMAGES IN CIVIL ACTIONS- to include civil liability for any person may maintain<br />

a civil action for damages and injunctive relief.<br />

599. 18 U.S.C.§1030 provides:<br />

18 U.S.C.§1030. Fraud and related activity in connection with computers<br />

Whoever - knowingly and with intent to defraud, accesses a protected<br />

computer without authorization, or exceeds authorized access, and<br />

by means of such conduct furthers the intended fraud and obtains<br />

anything of value,<br />

(5)<br />

(iii) intentionally accesses a protected computer without<br />

authorization, and as a result of such conduct, causes damage;<br />

and<br />

(B) by conduct described in clause (i), (ii), or (iii) of<br />

subparagraph (A), caused (or, in the case of an attempted<br />

offense, would, if completed, have caused) -<br />

(ii) the modification or impairment, or potential<br />

modification or impairment, of the medical examination,<br />

diagnosis, treatment, or care of 1 or more individuals;<br />

(iii) physical injury to any person;<br />

(iv) a threat to public health or safety;<br />

(g) Any person who suffers damage or loss by reason of a<br />

violation of this section may maintain a civil action against the<br />

violator to obtain compensatory damages and injunctive relief or<br />

other equitable relief. A civil action for a violation of this<br />

section may be brought only if the conduct involves 1 of the<br />

factors set forth in clause (i), (ii), (iii), (iv), or (v) of<br />

subsection (a)(5)(B). Damages for a violation involving only<br />

conduct described in subsection (a)(5)(B)(i) are limited to<br />

economic damages. No action may be brought under this subsection<br />

unless such action is begun within 2 years of the date of the act<br />

complained of or the date of the discovery of the damage.”<br />

600. The USA PATRIOT Act) Pub. L. No. 107-56 (2001), 115 Stat. 272. at § 351 modified 31 U.S.C. §<br />

5318 (g)(3) to eliminate immunity from civil liability for malicious suspicious activity reporting:<br />

“(g) Reporting of suspicious transactions.--<br />

In General.-The Secretary may require any financial institution, and any director, officer, employee,<br />

or agent of any financial institution, to report any suspicious transaction relevant to a possible<br />

violation of law or regulation.<br />

* *<br />

Liability for disclosures.--<br />

In general.-Any financial institution that makes a voluntary disclosure of any possible violation of<br />

law or regulation to a government agency or makes a disclosure pursuant to this subsection or any<br />

other authority, and any director, officer, employee, or agent of such institution who makes, or<br />

requires another to make any such disclosure, shall not be liable under law or regulation of the<br />

United States, any constitution, law, or regulation of any State or political subdivision of any State,<br />

or under any contract or other legally enforceable agreement (including any arbitration agreement),<br />

112<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5764


for such disclosure or for any failure to provide notice of such disclosure to the person who is<br />

subject of such disclosure or any other person identified in the disclosure.”<br />

601. The Act specifies that financial institutions are to report" any possible violation of law or<br />

regulation." Congress did not intend the Act's safe harbor to give banks blanket immunity for malicious,<br />

willful criminal and civil violations of law.<br />

602. Importantly, the Act requires there to be a "possible" violation of law-"possible" being the<br />

operative word-before a financial institution can claim protection of the statute.<br />

603. The Defendants knew there was no possible violation and that the USA PATRIOT Act know your<br />

customer provision did not apply to the subject escrow accounts.<br />

604. US Bank and US Bancorp did not file a report of a "possible violation" of the law but rather acted<br />

maliciously and willfully in an attempt to have <strong>Medical</strong> <strong>Supply</strong> deprived of high level banking services<br />

including international wire fund transactions on information the defendants knew to be false.<br />

605. Said activities aforementioned by Defendants were done in concert and in secret with the intention<br />

to injure Plaintiff all the while knowing that the lack of candor and disclosure of the true acts and activities<br />

by Defendants would give Defendants an economic advantage over Plaintiff. Defendants were engaged in<br />

concealed fraudulent conduct.<br />

606. Said malicious suspicious activity reporting against <strong>Medical</strong> <strong>Supply</strong> and its founder Samuel Lipari<br />

was done with the purpose of restricting the availability of and access to hospital supplies and resulted in<br />

impairment and potential impairment of medical diagnosis, treatment and care, along with physical injury,<br />

and constituted a threat to public health and safety<br />

607. Said activities were intended by Defendants to cause injury to Plaintiff by and through intentional<br />

misrepresentations to third parties concerning Plaintiff.<br />

6<strong>08</strong>. Said activities did directly and proximately cause injury to Plaintiff.<br />

609. Said activities were and are unjustified.<br />

610. Plaintiff is entitled to recover their actual damages in the amount of in excess of $500,000,000.00<br />

for their actions resulting in the loss of trust accounts, and actual damages in the amount of in excess of<br />

$500,000,000.00 for their actions resulting in the loss of the lease sale together with the costs of suit, and<br />

attorney fees.<br />

113<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5765


611. Defendants’ actions were willful, wanton, malicious and oppressive.<br />

612. Plaintiff is also entitled to recover punitive damages in an amount in excess of $10,000.00.<br />

TOLLING OF APPLICABLE STATUTES OF LIMITATIONS<br />

613. Plaintiff could not have reasonably discovered its injuries, or that its injuries were wrongfully<br />

caused, until January 21st, 2005, when Shughart Thomson & Kilroy’s former managing partner testified<br />

under oath in the Kansas Attorney Disciplinary Prosecution of the plaintiff’s counsel.<br />

PRAYER FOR RELIEF<br />

WHEREFORE Plaintiff demands:<br />

(1) That Defendants, their agents and servants, be enjoined during the pungency of this action and<br />

permanently from their activities in unreasonable restraint of trade or commerce and in monopolizing,<br />

attempting to monopolize, or combining or conspiring to monopolize.<br />

(2) That Defendants be required to pay to Plaintiff such damages as Plaintiff has sustained in<br />

consequence of Defendants’ activities in unreasonable restraint of trade or commerce and in<br />

monopolizing, attempting to monopolize, or combing or conspiring to monopolize, in the amount of<br />

approximately $500,000,000.00, multiplied by three for total damages of approximately<br />

$1,500,000,000.00 for the conduct related to the refusal to provide trust accounts and approximately<br />

$500,000,000.00, multiplied by three for total damages of approximately $1,500,000,000.00 for the<br />

conduct related to preventing <strong>Medical</strong> <strong>Supply</strong> from selling the office building lease to General Electric<br />

Transportation Co. for a total of approximately $3,000,000,000.00.<br />

(3) That Defendants be required to pay to Plaintiff such damages as Plaintiff has sustained in<br />

consequence of Defendants’ activities in tortuous interference with contract or business expectancy and/or<br />

in prima facie tort, in the amount of approximately $1,000,000.00, together with punitive or exemplary<br />

damages for the same, in an amount in excess of $10,000.00.<br />

(4) <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. seeks damages for the injury of its business associates and<br />

stakeholders, including Blue Springs, Missouri, loss of good will and the injury of the 2000 hospitals<br />

loosing money due to high supply costs under Mid Atl. Telecom, Inc. v. Long Distance Servs., Inc., 18<br />

F.3d 260, 263 (4th Cir.1994)’s interpretation of standing on a RICO statutes having a common antitrust<br />

basis.<br />

114<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5766


(5) That Defendants be required to pay to Plaintiff such damages as Plaintiff has sustained in<br />

consequence of Defendants’ activities in violation of civil racketeering laws, in the amount of<br />

approximately $500,000.00, multiplied by three for total damages of approximately $1,500,000.00.<br />

(6) That Defendants be required to pay to Plaintiff such damages as Plaintiff has sustained in<br />

consequence of Defendants’ activities in violation of the USA PATRIOT Act, in the amount of<br />

approximately $500,000.00.<br />

(7) That Defendants pay to Plaintiff the costs of this action and reasonable attorney’s fees to be<br />

allowed to the Plaintiff by the Court.<br />

(8) That Plaintiffs have such other and further relief as is just.<br />

CONCLUSION<br />

Whereas for the above reasons, the plaintiff respectfully request that the court award damages and<br />

provide other relief, attorneys fees and costs.<br />

Respectfully Submitted<br />

S/Bret D. Landrith<br />

Bret D. Landrith<br />

Kansas Supreme Court ID # 20380<br />

2961 SW Central Park, # G33,<br />

Topeka, KS 66611<br />

1-785-876-2233<br />

1-785-267-4<strong>08</strong>4<br />

landrithlaw@cox.net<br />

DEMAND FOR TRIAL BY JURY<br />

Comes now plaintiff and makes demand for a trial before 8 jurors.<br />

S/Bret D. Landrith<br />

Bret D. Landrith<br />

Kansas Supreme Court Number 20380<br />

DESIGNATION OF PLACE OF TRIAL<br />

Comes now plaintiff and designates Kansas City, Missouri as the place of trial.<br />

S/Bret D. Landrith<br />

Bret D. Landrith<br />

Kansas Supreme Court Number 20380<br />

115<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5767


UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

KANSAS CITY, KANSAS<br />

MEDICAL SUPPLY CHAIN, INC., )<br />

Plaintiff, )<br />

v. ) Case No. 05-2299-KHV<br />

NOVATION, LLC ) Formerly W.D. MO. Case No. 05-0210<br />

NEOFORMA, INC.<br />

) Attorney Lien<br />

ROBERT J. ZOLLARS )<br />

VOLUNTEER HOSPITAL ASSOCIATION )<br />

CURT NONOMAQUE )<br />

UNIVERSITY HEALTHSYSTEM CONSORTIUM )<br />

ROBERT J. BAKER )<br />

US BANCORP, NA )<br />

US BANK )<br />

JERRY A. GRUNDHOFFER )<br />

ANDREW CESERE )<br />

THE PIPER JAFFRAY COMPANIES )<br />

ANDREW S. DUFF )<br />

SHUGHART THOMSON & KILROY )<br />

WATKINS BOULWARE, P.C. )<br />

Defendants. )<br />

MEMORANDUM IN SUPPORT OF FIRST PLAINTIFF’S MOTION FOR PARTIAL SUMMARY<br />

JUDGMENT UNDER F. R. CIV. P. LOCAL RULE 56.1<br />

Comes now the plaintiff <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc., through its counsel Bret D. Landrith and<br />

makes the above captioned memorandum in support of plaintiff’s first motion for partial summary<br />

judgment. <strong>Medical</strong> <strong>Supply</strong> respectfully requests rulings that each defendant is distinct from the RICO<br />

enterprise, that a defendant's liability for RICO conspiracy does not require that defendant to participate in<br />

the operation or management of the enterprise, that RICO liability extends to aiders and abettors and that<br />

the law firm Shughart, Thomson & Kilroy, Watkins, Boulware, P.C. (Shughart, Thomson & Kilroy) is<br />

properly a RICO Defendant. The plaintiff’s suggestion that summary judgment motions be bifurcated was<br />

not controverted and the plaintiff expects to file fact based summary judgment motions based on the<br />

defendants’ per se antitrust violations. <strong>Medical</strong> <strong>Supply</strong> respects the court grant this pure legal question<br />

summary judgment for the following reasons:<br />

STATEMENT OF FACTS FOR PARTIAL SUMMARY JUDGMENT ON LEGAL ISSUES<br />

1. On September 2, 2005, The Kansas City Business Journal published an article about the racketeering<br />

conduct of Shughart Thomson & Kilroy’s nearest Kansas City competitor Shook, Hardy and Bacon<br />

LLP. See Exb. 1<br />

1<br />

Exb 1<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5768


2. The Notre Dame law School Professor G. Robert Blakey was interviewed and stated it was wrong for<br />

the law firm not to be made a defendant in the civil RICO action against the tobacco companies. See<br />

Exb. 1, pg. 1<br />

3. On August 15, 2005, the US Justice Department filed a post trial proposed finding of fact in the civil<br />

racketeering case against tobacco companies mentioning at least 15 Shook Hardy lawyers by name and<br />

referring to the firm more than 250 times. See Exb. 1, pg. 1, Exb 2 generally.<br />

4. On August 24, 2005, the US Justice Department filed a post trial brief arguing with controlling legal<br />

authority that the law firm Shook, Hardy and Bacon LLP had the requisite intent to be liable as a RICO<br />

person. See Exb 3 generally.<br />

5. <strong>Medical</strong> <strong>Supply</strong> filed an amended complaint against Unknown Healthcare, for Brian Kabbes, for Lars<br />

Anderson, for Susan Paine, for Andrew Cesere, for Piper Jaffray, for Mutual Fund Services, for<br />

Institutional Trust, for Corporate Trust, for US Bank Private and for US Bancorp, NA some of whom<br />

are the current defendants on See Exb 4 generally.<br />

6. The complaint described the defendants’ conduct violating the Hobbs Act against racketeering in<br />

keeping <strong>Medical</strong> <strong>Supply</strong> out of the market to further the defendants’ monopolization of the hospital<br />

supplies by falsely using the USA Patriot Act “know your customer” provision and the US Bank’s<br />

official role enforcing the USA Patriot Act. See Exb 4 pg. s 44-47<br />

7. The witnessed conduct was attested to by Sam Lipari in an affidavit at the end of the complaint. See<br />

Exb 4 pg.68<br />

8. The plaintiff was unsuccessful in obtaining injunctive relief to prevent the defendants’ monopolization.<br />

9. <strong>Medical</strong> <strong>Supply</strong> notified the non defendant hospital supply cartel members participating in the<br />

agreement to boycott <strong>Medical</strong> <strong>Supply</strong> in December 2004. See Novation Complaint Exb 5 pg.s 85-86.<br />

10. Shughart Thomson & Kilroy a law firm stepped up their efforts to obstruct justice and prevent medical<br />

<strong>Supply</strong> from having representation and legal resources to expose the cartel’s monopolization of<br />

hospital supplies. See Novation Complaint Exb 5 pg. 1<strong>08</strong>-111<br />

11. The Shughart Thomson & Kilroy lawyer Andrew DeMarea filed a fraudulent Kansas Disciplinary<br />

complaint against <strong>Medical</strong> <strong>Supply</strong>’s counsel for appealing a trial court ruling the Tenth Circuit panel<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5769


admitted was incorrect about the USA Patriot Act statute. See De Marea Complaint Exb 6 pg.1, See<br />

also Tenth Circuit Sanction order, Exb 7.<br />

12. Andrew DeMarea’s former boss, Kansas US District Court Magistrate James P. O’Hara altered his<br />

testimony on the stand on January 21, 2005 revealing for the first time the defendants’ continuing<br />

pattern and practice of racketeering to <strong>Medical</strong> <strong>Supply</strong>’s President and counsel. See Novation<br />

Complaint Exb 5 pg., See also Magistrate O’Hara Testimony Sup 1 Atch 9 pg.s 609-669<br />

13. <strong>Medical</strong> <strong>Supply</strong> then documented the newly discovered pattern events and incorporated the into the<br />

complaint filed against the defendants for damages resulting from the earlier injury <strong>Medical</strong> <strong>Supply</strong><br />

had tried to enjoin. See Supplement 1, Federal Bureau of Investigation Complaint and Sup.1 Atch 1<br />

thru 13.<br />

14. The extra legal or outside of court racketeering to obstruct justice, intimidate and retaliate against<br />

witnesses and victims is still continuing and has led to injury of <strong>Medical</strong> <strong>Supply</strong> principals. See<br />

affidavit of Sam Lipari Exb. 8 generally.<br />

ARGUMENTS AND AUTHORITIES<br />

Under Rule 56 of the Federal Rules of Civil Procedure, summary judgment is appropriate if the<br />

pleadings, depositions, answers to interrogatories and admissions on file, together with the affidavits, if<br />

any, show that there is no genuine issue as to any material fact and that the moving party is entitled to<br />

judgment as a matter of law. Fed. R. Civ. P. 56(c). Material facts are those that “might affect the outcome<br />

of the suit under the governing law.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248 (1986).<br />

In considering a summary judgment motion, “the evidence of the non-movant is to be believed, and all<br />

justifiable inferences are to be drawn in his favor.” Id. at 255; see also Washington Post Co. v.United<br />

States Dep’t of Health and Human Servs., 865 F.2d 320, 325 (D.C. Cir. 1989).<br />

Additionally, summary judgment is appropriate for purely legal questions. See generally Moore's<br />

Federal Practice, P56.20(3.-2)(2ded. 1976). A determination on a strict legal issue can "narrow the issues<br />

in [a] case, advance the progress of the litigation, and provide the parties with some guidance as to how<br />

they proceed with the case." Warner v. United States, 698 F. Supp. 877, 879 (S.D. Fla. 1988). "Summary<br />

judgment can thus serve to set the issues for trial .... The outcome of [the] dispute will have an immediate<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5770


impact on the proofs to be offered at trial in support of the elements of the statutory causes of action."<br />

Disandro v. Makahuena Corp., 588 F. Supp. 889, 892 (D. Haw. 1984); see also Lies v.<br />

Farrell Lines, Inc., 641 F.2d 765, 768-69 (9th Cir. 1981).<br />

The party opposing the motion "'may not rest upon the mere allegations or denials of his pleadings'<br />

to avoid summary judgment. Bacchus, 939 F.2d at 891 (quoting Anderson, 477 U.S. at 248, 106 S. Ct. at<br />

2510).” Bancoklahoma Mortgage Corp. v. Capital Title Co., 194 F.3d 1<strong>08</strong>9 at 1097-1098 (10th Cir., 1999).<br />

Plaintiff, <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. (<strong>Medical</strong> <strong>Supply</strong>),has brought this suit against the<br />

Defendants1 pursuant to Sections 1962(c) and (d) of the Racketeer Influenced and Corrupt Organizations<br />

Act ("RICO"), 18 U.S.C. § 1961, et seq.. <strong>Medical</strong> <strong>Supply</strong> alleges violations of both Sections 1962(c)<br />

and (d). 1<br />

To prove the alleged violations of Section 1962(c), <strong>Medical</strong> <strong>Supply</strong> must show: (1) the conduct<br />

(2) of an enterprise (3) through a pattern of racketeering activity." Salinas v. United States, 522 U.S. 52,<br />

62 (1997). S. P. R.L. v. Imrex Co., Inc., 473 U. S. 479, 496 (1985); BancOklahoma Mortgage Corp. v.<br />

Capital Title Co. Inc., 194 F.3d 1<strong>08</strong>9, 1100 (10th Cir. 1999). Robbins v. Wilkie, 2002 C10 944 20<br />

(USCA10, 2002).<br />

Whether § 1962(c) should be interpreted to require a substantial effect on interstate commerce is<br />

an open question in Tenth circuit. However, neither the Supreme Court nor any courts of appeals have held<br />

that the effect must be substantial, and a number of our sister circuits have held that a de minimis effect on<br />

interstate commerce is sufficient to satisfy this statutory requirement. See United States v. Shyrock, 342<br />

F.3d 948, 984 (9th Cir. 2003) (holding that the district court properly instructed the jury that § 1962(c)'s<br />

jurisdictional element was satisfied if the jury found "a de minimis affect [sic] on interstate commerce");<br />

United States v. Marino, 277 F.3d 11, 35 (1st Cir. 2002) (holding that "the government does not need to<br />

show that the RICO enterprise's effect on interstate commerce is substantial"); United States v. Riddle, 249<br />

F.3d 529, 537 (6th Cir. 2001) (holding that a "RICO enterprise's necessary relationship to interstate<br />

commerce" is "de minimis"); United States v. Miller, 116 F.3d 641, 674 (2d Cir. 1997) (holding that "the<br />

1 Sections 1962(c) and (d) provide:<br />

(c) It shall be unlawful for any person employed by or<br />

associated with any enterprise engaged in, or the activities of which affect, interstate or foreign commerce,<br />

to conduct or participate, directly or indirectly, in the conduct of such enterprise's affairs through a pattern<br />

of racketeering activity or collection of unlawful debts.<br />

(d) It shall be unlawful for any person to conspire to violate any of the provisions of subsection (a), (b), or<br />

(c) of this section. 18 U.S.C. §§ 1962(c)-(d).<br />

4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5771


government need only prove that the individual subject transaction has a de minimis effect on interstate<br />

commerce" in order to satisfy § 1962(c)).<br />

An enterprise "includes any individual, partnership, corporation, association, or other legal<br />

entity, and any union or group of individuals associated in fact though not a legal entity." 18 U.S.C. §<br />

1961(4). Racketeering activity includes, among other things, acts prohibited by any one of a number of<br />

criminal statutes. 18 U.S.C. § 1961(1). A "pattern" is demonstrated by two or more instances of<br />

"racketeering activity" that occur within 10 years of one another. 18 U.S.C. § 1961(5). In this case, the<br />

alleged racketeering acts are violations of 18 U.S.C. §§ 1341 (mail fraud) and 1343 (wire fraud).<br />

To demonstrate violations of Section 1962(d), <strong>Medical</strong> <strong>Supply</strong> must prove: (1) that two more<br />

people agreed to violate Section 1962(c), and (2) that the defendant knew of and agreed to the overall goal<br />

of the violation. United States v. Philip Morris Inc., 130 F.Supp.2d 96 (D.D.C. 2001).<br />

In the present Motion, <strong>Medical</strong> <strong>Supply</strong> seeks partial summary judgment striking certain<br />

affirmative defenses of Defendants and on particular issues of law relating to proof of liability. <strong>Medical</strong><br />

<strong>Supply</strong> argues first that, as a matter of law, each Defendant is distinct from the alleged RICO enterprise.<br />

Second, <strong>Medical</strong> <strong>Supply</strong> argues that, as a matter of law, aDefendant's liability for RICO conspiracy under<br />

Section 1962(d) does not require proof that such Defendant participated in the operation or management of<br />

the alleged enterprise. Finally, <strong>Medical</strong> <strong>Supply</strong> argues that, as a matter of law, liability for committing a<br />

racketeering act under Section 1962(c) extends to those Defendants who aided and abetted the commission<br />

of that act.<br />

A. EACH DEFENDANT IS DISTINCT FROM THE ALLEGED RICO ENTERPRISE<br />

<strong>Medical</strong> <strong>Supply</strong> seeks partial summary judgment that each Defendant is distinct from the RICO<br />

enterprise. 2 To establish an enterprise under Section 1962(c), a plaintiff must allege and prove the existence<br />

of two distinct entities: (1) a 'person' and (2) an 'enterprise' that is not simply the same 'person' referred to<br />

by a different name. Cedric Kushner Promotions, Ltd. v. King, 533 U.S.158, 161 (2001). In King, the<br />

Court concluded that a RICO defendant, or 'person', must be distinct from the RICO 'enterprise' that the<br />

defendant is associated with or employed by. Id. at 161-62.<br />

2 <strong>Medical</strong> <strong>Supply</strong> seeks summary judgment not on some abstract issue, as Defendants argue, but rather on<br />

its request to strike the affirmative defenses denying distinctness. Thus, the Court's conclusion on the<br />

distinctness element and is proper under Fed.R.Civ.P. 56.<br />

5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5772


Regardless of how the enterprise is defined (if at all), <strong>Medical</strong> <strong>Supply</strong> has proven the distinctness<br />

element in this case. Courts have already held that an "association-in-fact" enterprise can be a group of<br />

corporations. See Philip Morris, 116 F.Supp.2d at 152-53. Moreover, there is no dispute that each<br />

individual Defendant is a separate legal entity or an individual with the capacity of being a RICO person.<br />

Thus, if this Court should find an enterprise comprised of at least two of the Defendants, the Defendants<br />

will be distinct from the enterprise itself. Of course, <strong>Medical</strong> <strong>Supply</strong> must also prove, as it acknowledges,<br />

the requirements of the alleged enterprise –- common purpose, organization, and continuity –- in order to<br />

prevail on its RICO claims. United States v. Perholtz, 842 F.2d 343, 362 (D.C. Cir. 1988)). However, there<br />

is no reason to postpone a definitive determination on distinctness.<br />

Accordingly, <strong>Medical</strong> <strong>Supply</strong>'s Motion for partial summary judgment removing potential<br />

affirmative defenses of failure to identify a RICO enterprise separate and distinct from the Defendants<br />

themselves should be granted.<br />

B. A DEFENDANT'S LIABILITY FOR CONSPIRACY UNDER 18 U.S.C. § 1962(d) DOES<br />

NOT REQUIRE THAT DEFENDANT TO PARTICIPATION THE OPERATION OR<br />

MANAGEMENT OF THE ENTERPRISE<br />

In Salinas, the Supreme Court held that liability under Section 1962(c) is not a prerequisite to<br />

finding liability under Section 1962(d). See Salinas, 522 U.S. at 66. In that case, the defendant was<br />

charged with criminal violations of Sections 1962(c) and (d) but was convicted on the conspiracy charge<br />

alone. In concluding that a RICO conspiracy defendant need not commit a substantive RICO offense under<br />

Section 1962(c), the Court explained that "it is sufficient that the [defendant] adopt the goal of furthering or<br />

facilitating the criminal endeavor." Id. at 65. The Court noted that RICO's conspiracy section is to be<br />

interpreted in light of the common law of criminal conspiracy. See id. 3 The tenth Circuit stated:<br />

“Because this conspiracy provision lacks an overt act requirement, a defendant can be convicted<br />

under § 1962(d) upon proof that the defendant knew about or agreed to facilitate the commission of<br />

acts sufficient to establish a § 1962(c) violation. See Salinas v. United States, 522 U.S. 52, 63-66<br />

(1997).”<br />

United States v. Smith, No. 03-4240 at pg.1 (Fed. 10th Cir. 7/6/2005) (Fed. 10th Cir., 2005).<br />

3 "If conspirators have a plan which calls for some conspirators to perpetrate a crime and others to provide<br />

support, the supporters are as guilty as the perpetrators ... so long as they share a common purpose,<br />

conspirators are liable for the acts of their co-conspirators." Salinas, 522 U.S. at 64.<br />

6<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5773


Accordingly, one who opts into or participates in a Section 1962(d) conspiracy to violate Section<br />

1962(c) is liable for the acts of his co-conspirators even if that defendant did not personally agree to<br />

commit, or to conspire with respect to, any particular one of those acts. Id.<br />

This liability for the “passive conspirator” exists notwithstanding Reves v. Ernst & Young, 507<br />

U.S. 170, 185 (1993). Some defendants claim that the law requires a showing of "operation or management<br />

of the enterprise" to demonstrate a RICO conspiracy under Section 1962(d).Even though the Supreme<br />

Court did hold in Reves that, to "conduct or participate, directly or indirectly, in the conduct of such<br />

enterprise's affairs, one must participate in the operation or management of the enterprise itself," the<br />

passive conspirator immunity argument fails for the following reasons.<br />

First, Reves involved a Section 1962(c) substantive RICO offense not a Section 1962(d) RICO<br />

conspiracy offense. In Reves, the Supreme Court held that an accounting firm could not be liable<br />

under Section 1962(c) for incorrectly valuing a farm cooperative's assets listed on its financial statements.<br />

Reves, 507 U.S. at 179. The Court reasoned that the firm had not "conduct[ed] or participated ... in the<br />

conduct" of the enterprise's affairs because it did not participate in the "operation or management of the<br />

enterprise itself." Id.<br />

All circuits but the Ninth have concluded that Reves addressed only the extent of conduct or<br />

participation necessary to violate Section 1962(c), and did not address the principles of conspiracy law<br />

under Section 1962(d). 4 See Smith v. Berg, 247 F.3d 532 (3d Cir. 2001); United States v. Posada-Rios, 158<br />

F.3d 832, 857 (5 th Cir. 1998); Napoli v. United States, 45 F.3d 680, 683-84 (2d Cir. 1995); MCM Partners,<br />

Inc. v. Andrews-Bartlett & Assoc., 62 F.3d 967, 979 (7th Cir. 1995); United States v. Starrett, 55 F.3d 1525,<br />

1547 (11th Cir. 1995); United States v. Quintanilla, 2 F.3d 1469, 1485 (7th Cir. 1993) ("to hold that under<br />

section 1962(d) the government must show that an alleged coconspirator ... participated to the extent<br />

required in Reves would add an element to RICO conspiracy that Congress did not direct"). The tenth<br />

Circuit stated:<br />

4 As noted, only the Ninth Circuit has ruled that Reves' on or management" test applies to RICO<br />

conspiracy charges. See Neibel v. Trans World Assurance Co., 1<strong>08</strong> F.3d 1123, 1128-29 (9th Cir. 1997).<br />

However, Neibel was decided before Salinas, and the Ninth Circuit has not yet revisited its ruling.<br />

Moreover, Neibel relied upon United States v. Antar, 53 F.3d 568, 581 (3d Cir. 1995), another pre-Salinas<br />

decision, which the Third Circuit subsequently ruled was no longer good Smith v. Berg, 247 F.3d at 534.<br />

7<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5774


"[T]he word 'participate' makes clear that RICO liability is not limited to those with primary<br />

responsibility for the enterprise's affairs, just as the phrase 'directly or indirectly' makes clear that<br />

RICO liability is not limited to those with a formal position in the enterprise, but some part in<br />

directing the enterprise's affairs is required." Reves II, 507 U.S. at 179, 113 S.Ct. at 1170 (footnote<br />

omitted). Id. (footnote omitted). Outsiders, such as the Title Companies, who are associated with a<br />

RICO enterprise and participate in the operation or management of the enterprise may also be liable<br />

under 1962(c). Reves II, 507 U.S. at 185, 113 S. Ct. at 1173.”<br />

BancOklahoma Mortgage Corp. v. Capital Title Co. Inc., 194 F.3d 1<strong>08</strong>9, 1100 (10th Cir. 1999).<br />

Thus, Reves' "operation or management" standard applies only to substantive RICO offenses under Section<br />

1962(c) and not to a conspiracy to violate RICO under Section 1962(d).<br />

Second, after Reves, the Supreme Court specifically set forth in Salinas the standard for liability<br />

under Section 1962(d). See Salinas, 522 U.S. at 65. Such conspiracy liability requires a showing that: (1)<br />

two or more people agreed to commit a substantive RICO offense, and (2) the defendant knew of and<br />

agreed to the overall objective of the violation. Id.; See Posada-Rios, 158 F.3d at 857 (citing Salinas);<br />

Brouwer v. Raffensperger, Hughes & Co., 199 F.3d 961, 967 (7th Cir. 2000) (same). There can be no<br />

question that the Supreme Court was aware of its decision in Reves when it decided Salinas, and there is<br />

nothing inconsistent between the two decisions.<br />

Thus, reading Reves and Salinas together, it is clear that a defendant may be held liable for<br />

conspiracy to violate Section1962(c) if it knowingly agrees to violate the elements of Section<br />

1962(c), one of which is the "operation or management" of a RICO enterprise. 5<br />

However, liability for a<br />

RICO conspiracy under Section 1962(d) does not require the same proof of participation in the "operation<br />

or management" of the alleged RICO enterprise, just as it does not require proof of commission of all the<br />

5 Relying upon Beck v. Prupis, 529 U.S. 494 (2000), Defendants could assert that Salinas is irrelevant for<br />

the purpose of civil RICO claims. Beck involved a chief executive officer whose employment was<br />

terminated when he discovered that certain of his company's officers were engaged in racketeering. The<br />

Court ruled that the termination, allegedly in furtherance of a RICO conspiracy, was not independently<br />

wrongful under any substantive RICO provision and did not give rise to a cause of action under Section<br />

1962(c). In Beck, the only mention of Salinas appears in a footnote:<br />

"[w]e have turned to the common law of criminal conspiracy to define what constitutes a violation of §<br />

1962(d), .... This case,however, does not present simply the question of what constitutes a violation of §<br />

1962(d), but rather the meaning of a civil cause of action for private injury by reason of such a violation."<br />

Beck, 529 U.S. at 501 n.6. However, this sentence does not in any way repudiate or undercut the Salinas<br />

holding. The Beck decision turns rather on the injury requirement of Section 1964(c). Id. Thus, violations<br />

of Section 1962(d) continue to be defined under and governed by Salinas.<br />

8<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5775


other elements of the Section 1962(c) substantive offense. Salinas, 522 U.S. at 65; see also Smith, 247 F.3d<br />

at 537.<br />

Accordingly, <strong>Medical</strong> <strong>Supply</strong>'s Motion for partial summary judgment that a Defendant's liability<br />

for RICO conspiracy does not require that Defendant to participate in the operation or management of the<br />

enterprise should be granted.<br />

C. WHETHER LIABILITY FOR A PARTICULAR RACKETEERING ACT EXTENDS TO<br />

AIDERS AND ABETTORS MUST BE DETERMINED AT TRIAL<br />

To establish a "pattern of racketeering activity" for purposes of Section 1962(c), <strong>Medical</strong> <strong>Supply</strong><br />

must show that each Defendant committed at lease two acts of racketeering, "the last of which occurred<br />

within ten years ... after the commission of a prior racketeering act." 18 U.S.C. § 1961(5). <strong>Medical</strong> <strong>Supply</strong><br />

argues that a defendant's liability for a particular racketeering act may be established by proof that the<br />

Defendant aided and abetted the commission of that racketeering act. Pereira v. United States, 347 U.S. 1,<br />

9 (1954) (a person who aids and abets another in the commission of mail fraud, a violation of § 1341, also<br />

violates §1341); United States v. Shifman, 124 F.3d 31, 36 (1st Cir. 1997).<br />

Aiding and abetting is no longer applicable to securities fraud under RICO after Central Bank of<br />

Denver, N.A. v. First Interstate Bank of Denver, N.A., 511 U.S. 164 (1994). In Central Bank, the Supreme<br />

Court held that there can be no private civil liability for aiding and abetting securities fraud under Section<br />

10(b) of the 1934 Securities Exchange Act and Rule 10b-5. Central Bank, 511 U.S. at 185.<br />

After<br />

examining the language and structure of the Act, the Court concluded that "the text of the 1934 Act does<br />

not itself reach those who aid and abet a Section 10(b) violation." Id. At 183.<br />

However, the plaintiff does not raise securities law based claims. It is clear from the averments in<br />

the complaint that Neoforma, Inc. (NEOF) and Robert Zollars are subject to civil liability under the<br />

securities laws to shareholders. Neoforma, Inc. (NEOF) and Robert Zollars have previously defended<br />

against shareholder liability lawsuits without disclosing that Neoforma, Inc.’s technology and market<br />

potential described in its prospectuses and quarterly reports was compromised against the interests of the<br />

company’s shareholders in agreements to enforce the artificially inflated prices of the established “bricks<br />

and mortar” distributors UHC, VHA and Novation, LLC.<br />

9<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5776


An argument can be made that Central Bank eliminates aiding and abetting in non securities fraud<br />

based RICO claims. See the discussion of American Honda Motor Co., Inc., Dealerships Relations<br />

Litigation. 958 F.Supp. 1045 (D. Md. 1997) under Law firm RICO liability infra. However in the Tenth<br />

Circuit this issue does not yet appear to be resolved against civil aiding and abetting liability and RICO<br />

aiding and abetting is still liberally applied in criminal cases.<br />

The Tenth Circuit has clearly set out the elements of aiding and abetting:<br />

“The elements of aiding and abetting are also well-settled. Jones, 44 F.3d at 869.[ United States v.<br />

Jones, 44 F.3d 860, 869 (10th Cir. 1995).] Under 18 U.S.C. § 2, the Government must prove beyond<br />

a reasonable doubt the defendant: (1) "willfully associate[d] with the criminal venture," and (2)<br />

"aid[ed] such venture through affirmative action." Jones, 44 F.3d at 869. Mere presence at a crime<br />

scene is insufficient to prove aiding and abetting. See id. Although knowledge a crime is being<br />

committed is relevant, some showing of intent to further the criminal venture must be introduced at<br />

trial. See id.”<br />

United States v. Delgado-Uribe, No. 03-8003 (10th Cir. 4/13/2004) (10th Cir., 2004). The Tenth<br />

Circuit still applies the shared intent standard for aiding and abetting in criminal acts:<br />

“This Court has held that, in order to be convicted of aiding and abetting, a defendant must "share[]<br />

in the intent to commit the [underlying] offense." U.S. v. Thurmond, 7 F.3d 947, 950 (10th Cir.<br />

1993)...We agree with the First Circuit and therefore conclude that Mr. Vallejos possessed the intent<br />

necessary to be found guilty of aiding and abetting a carjacking if he "shared some knowledge" of<br />

Mr. Sanchez's intent to commit the carjacking.”<br />

United States v. Vallejos, No. 04-2216 (Fed. 10th Cir. 8/19/2005) (Fed. 10th Cir., 2005). The<br />

Tenth Circuit’s most extensive defining of the elements required for aiding and abetting liability is<br />

contained in USA v. Jackson, 213 F.3d 1269 (10th Cir., 2000)<br />

"Whoever ... aids, abets, counsels, commands, induces or procures [the] commission [of a crime] is<br />

punishable as a principal." 18 U.S.C. 2(a). "To be guilty of aiding and abetting the commission of a<br />

crime, the defendant must willfully associate himself with the criminal venture and seek to make the<br />

venture succeed through some action of his own." United States v. Anderson, 189 F.3d 1201, 1207<br />

(10th Cir. 1999). United States v. Smith, 133 F.3d 737, 742 (10th Cir. 1997) ("To be liable as an<br />

aider and abettor under 18 U.S.C. 2, the evidence must establish a defendant associated himself with<br />

a criminal venture; participated in the venture as something he wished to bring about; sought by his<br />

actions to make the venture succeed; and the evidence must establish both the commission of the<br />

offense by someone and the aiding and abetting by the defendant."), cert. denied, 524 U.S. 920<br />

(1998). Thus, the crime of aiding and abetting is a specific intent crime because it requires the<br />

defendant to act willfully by participating in the venture and also requires the defendant to have the<br />

specific intent to make the venture succeed through his or her acts.”<br />

USA v. Jackson, 213 F.3d 1269 at 1292 (10th Cir., 2000). The Jackson court also discussed the<br />

participation requirement for furthering the RICO enterprise:<br />

"[A]cts committed in furtherance of the commission of a crime by another constitute 'abetting.'"<br />

Slater, 971 F.2d at 632 (citation omitted). "Participation in the criminal venture may be established<br />

10<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5777


y circumstantial evidence and the level of participation may be of 'relatively slight moment.'"<br />

United States v. Leos-Quijada, 107 F.3d 786, 794 (10th Cir. 1997).<br />

In Slater, we rejected the same argument raised by Mr. Jackson and pointed out one<br />

"may 'abet' the crime of possession with intent to distribute by procuring the customers and<br />

maintaining the market in which the possession is profitable, even though you do nothing else to<br />

help the possessor get or retain possession. Middlemen aid and abet the offense of possession with<br />

intent to distribute."<br />

971 F.2d at 632 (quoting with approval United States v. Wesson, 889 F.2d 134, 135 (7th Cir.<br />

1989)). Furthermore, if we were to hold one cannot be convicted of aiding and abetting the<br />

possession of a controlled substance with the intent to distribute without proving possession, this<br />

would be tantamount to holding one cannot be convicted of aiding and abetting without committing<br />

the principal offense. Such a result would dismantle the crime of aiding and abetting. Id. at 632-33.<br />

While the government must show that a defendant engaged in two or more predicate acts to<br />

state a claim under one of RICO's substantive provisions (Section 1962(a), (b), or (c)), Salinas<br />

rejected such a requirement with respect to RICO's conspiracy provision (Section 1962(d)), Philip<br />

Morris, 130 F.Supp.2d at 99, although it did not specifically address the role of the Reves'<br />

"operation or management" test in assessing liability under Section 1962(d).”<br />

USA v. Jackson, 213 F.3d 1269 at 1299 (10th Cir., 2000).<br />

Accordingly, RICO aiding and abetting liability is appropriately defined and does not have to be<br />

determined at trial. <strong>Medical</strong> <strong>Supply</strong>'s Motion for partial summary judgment that a Defendant's liability for<br />

RICO aiding and abetting liability does not have to be determined at trial.<br />

D. WHETHER A LAW FIRM IS IMMUNE FROM CIVIL RICO CLAIMS.<br />

The defendants have argued that the defendant Shughart Thomson and Kilroy is immune from<br />

liability as a RICO defendant. While no law supporting this assertion has been advanced, it would appear<br />

from the renewed motions to dismiss and motions to sanction <strong>Medical</strong> <strong>Supply</strong> and its attorney that law firm<br />

RICO liability is an issue to be resolved in this action.<br />

<strong>Medical</strong> <strong>Supply</strong> researched its claims before filing its complaint in the Western District of<br />

Missouri and found that the Eight Circuit had resolved the issue of whether an inherent civil immunity to<br />

private RICO liability existed for law firms. There is no immunity and a law firm is properly a RICO<br />

defendant.<br />

1. Claims against Law Firms under Section 1962(c) and (d)<br />

The law firm sued for RICO violations in Handeen v. Lemaire 12 F.3d 1339 (8th Cir. 1997)<br />

represented a client who had been convicted of aggravated assault. The victim of the aggravated assault<br />

had obtained a civil judgment against the client. The attorneys counseled the client and his family to avoid<br />

liability on the judgment by filing bankruptcy and then inflating his debts and concealing earnings. The<br />

victim sued the family and the law firm under RICO, alleging that they had violated section 1962(c) by<br />

11<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5778


conducting the affairs of the bankruptcy estate (the enterprise) through a pattern of racketeering activity.<br />

The district court dismissed the RICO claims (as well as related state law causes of action). The Eighth<br />

Circuit reversed.<br />

The Handeen court conceded that after Reves, RICO liability did not attach to those who<br />

furnished a client (even one engaged in a RICO enterprise) "with ordinary professional assistance" and<br />

that "RICO is not a surrogate for professional malpractice actions." Id. at 1348. Nevertheless, the court<br />

found that Reves did not insulate the law firm from liability fro RICO where the firm, in representing its<br />

clients in a bankruptcy proceeding, allegedly directed the clients to create false promissory notes and other<br />

sham debts to dilute the estate; defended the family's fraudulent claims against objections; prepared filing<br />

and schedules with the court which contained erroneous information; formulated and promoted fraudulent<br />

repayment plans; participated in a scheme to conceal the client's new job (and increased earnings); and<br />

otherwise controlled the bankruptcy estate to permit the client to avoid the judgment against him. Id. at<br />

1350.<br />

“T]his would not be a case where a lawyer merely extended advice on possible ways to manage an<br />

enterprise's affairs . . . Instead, if the Firm truly did associate with the enterprise to the degree<br />

encompassed by the Complaint, we would not hesitate to hold that the attorneys "participated in<br />

the core activities that constituted the affairs of the [estate]. . ."<br />

Id. A multidistrict proceeding arose as a result of allegations that high level executives of<br />

American Honda received kickbacks from various dealers in exchange for favors, primarily increased<br />

allocates of automobiles or the award of new dealerships, in American Honda Motor Co., Inc.,<br />

Dealerships Relations Litigation. 958 F.Supp. 1045 (D. Md. 1997). The claims were not dissimilar to<br />

<strong>Medical</strong> <strong>Supply</strong>’s claims against the defendants for monopolizing hospital supplies through kickbacks from<br />

manufacturers and bribes paid to hospital administrators. Included among the defendants was the law<br />

firm of yon & Lyon, which was accused of participating in the concealment of the illegal scheme. The<br />

plaintiffs asserted RICO violations under section 1962(c) based on acts of alleged mail fraud arising from<br />

the mailing of false statements that American Honda would deal with the plaintiffs fairly and distribute<br />

Honda products to them in a fair and reasonable manner.<br />

The plaintiffs alleged that Lyon & Lyon was not only American Honda's general counsel but also<br />

had attorneys serving as voting directors of the company. Lyon & Lyon conducted training sessions at<br />

sales meetings and handled allegations of misconduct, including conflict of interest complaints involving<br />

12<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5779


dealers or potential dealers. The plaintiffs alleged that after Lyon & Lyon received dealer complaints<br />

about the kickback scheme, it took action s to conceal the scheme, amounting to obstruction of justice.<br />

Lyon & Lyon attorneys allegedly counseled witnesses to give evasive or incomplete testimony and<br />

intentionally limited an investigation of the kickback allegations by not interviewing key witnesses. Lyon<br />

& Lyon attorneys also allegedly directed American Honda to make false and misleading assertions about<br />

the results of its investigation in a hearing. Id. at 1056-57.<br />

Lyon & Lyon's motion to dismiss the section 1962(c) claim against it was denied. In denying<br />

the motion, the American Honda court initially found that Lyon & Lyon had a sufficient role in the<br />

enterprise's activities to satisfy the Reves "operation or control" test:<br />

[F]or over ten years Lyon & Lyon took on the responsibility of pretending to enforce American<br />

Honda's conflict of interest policy and of not following up on dealer complaints in order to<br />

perpetuate the kickback scheme. Concealment is a necessary element of any ongoing illegal<br />

activity, and a person who is in charge of the coverup plays an operational and management role in<br />

the enterprise conducting that activity.<br />

Id. at 1057. However, the American Honda court did not feel that Lyon & Lyon's participation in<br />

the management of the racketeering enterprise was in and of itself sufficient to impose RICO liability on<br />

the law firm. It is not enough, however, for a defendant to have 'conduct[ed] or participate[d] directly or<br />

indirectly, in the conduct of [an] enterprise's affairs' in order for him to be held liable under § 1962(c). He<br />

also must have done so 'through a pattern of racketeering activity.'" Id. The American Honda court noted<br />

that the predicate acts of racketeering charged by the plaintiffs were acts of mail fraud, and that Lyon &<br />

Lyon did not mail any of the fraudulent materials involved. Id. Moreover, the court did not dispute the<br />

"conventional wisdom that feels that aiding and abetting liability under § 1962(c) does not survive the<br />

Supreme Court's ruling in Central Bank of Denver v. First Interstate Bank of Denver..." Id. at 1057-58.<br />

Nevertheless, the American Honda court concluded that "[t]his does not mean, however, that<br />

aiding and abetting principles do not apply in considering whether a defendant has participated in the<br />

enterprise 'through a pattern of racketeering activity,' i.e., whether he has committed at least two predicate<br />

acts." Id. at 1058.<br />

Rather, where a person involved in the management or control of a racketeering<br />

enterprise aids and abets in the commission of predicate acts, the person faces liability under § 1962(c),<br />

because a distinction must be made between aiding and abetting a violation of section 1962(c) (an offense<br />

13<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5780


which does not survive the holding of Reves and Central Bank of Denver) and aiding and abetting in the<br />

commission of a substantive offense constituting a predicate act.<br />

“Unless the distinction is recognized, in most cases there would be no principled basis for<br />

imposing § 1962(c) liability upon a class of defendants whom Congress surely intended should be<br />

within the statute's purview: leaders of enterprises who do not themselves commit predicate acts<br />

but who cause others to do so. Id.<br />

. .<br />

Although Lyon & Lyon may only have aided and abetted the commission of the predicate acts of<br />

mail fraud, as indicated above its management role in concealing the scheme is sufficient to meet<br />

the "operation and management" test of Reves. Plaintiffs have therefore stated a viable § 1962(c)<br />

claim against Lyons & Lyons.”<br />

American Honda Motor Co., Inc., Dealerships Relations Litigation. 958 F.Supp. 1045 at 1059 (D.<br />

Md. 1997). American Honda thus suggests that the concealment of a pattern of racketeering by one who<br />

also exercises some element of control over the racketeering enterprise is sufficient to impose section<br />

1962(c) liability.<br />

2. Conspiracy Claims against Law Firms under Section 1962(c) and (d)<br />

Where a plaintiff is able to establish that the professional conspired by agreeing to commit at least<br />

two predicate cats of racketeering in violation of section 1962(d), the plaintiff may be able to state a RICO<br />

violation even without satisfying the "operation or management" standard enunciated in Reves as required<br />

for a claim under section 1962(c). <strong>Medical</strong> <strong>Supply</strong>’s complaint avers Shughart Thomson & Kilroy’s control<br />

over the RICO acts designed to protect and conceal the enterprise’s ongoing scheme to artificially inflate<br />

prices of hospital supplies in the national market in furtherance of the defendants’ scheme to overcharge<br />

Medicare, Medicaid and Champus.<br />

Obviously, to the extent that <strong>Medical</strong> <strong>Supply</strong>’s artful pleading avoids dismissal of a section<br />

1962(d) conspiracy claim against an outside professional firm who cannot be held liable under section<br />

1962(c) because he or she has no voice in directing the affairs of the enterprise, the protections of Reves<br />

may be severely curtailed.<br />

"[C]ourts risk eviscerating Reves by blanketly approving conspiracy convictions when<br />

substantive convictions under section 1962(c) are unavailable . . . As one commentator has<br />

explained, '[i]f Congress' restriction of section 1962(c) liability to those who operate or manage the<br />

enterprise can be avoided simply by alleging that a defendant aided and abetted or conspired with<br />

someone who operated or managed the enterprise, Reves would be rendered almost nugatory.'"<br />

United States v. Antar, 53 F.3d 568, 580-82 (3d Cir. 1995) (citing Smith and Reed, Civil RICO, §<br />

504 at 5-39 (1994)).However, the extent of <strong>Medical</strong> <strong>Supply</strong>’s allegations against Shughart Thomson and<br />

14<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5781


Kilroy reveal the law firm was the primary agency in securing the objectives of the unlawful enterprise in<br />

artificially inflating hospital supply prices for another three years. The complaint alleges the law firm<br />

conspired with other defendants in the cartel and was the architect of the racketeering campaign against<br />

<strong>Medical</strong> <strong>Supply</strong>’s legal representation outside of court and also the extra legal influence over the Kansas<br />

District Court and the Tenth Circuit.<br />

3.The Parallel to Shook Hardy & Bacon’s Tobacco RICO Conduct<br />

<strong>Medical</strong> <strong>Supply</strong>’s allegations against Shughart Thomson & Kilroy closely parallel the nature of<br />

unlawful racketeering acts committed by Shook Hardy and Bacon LLP and described by US Department of<br />

Justice. U.S. Justice Department attorneys alleged lawyers from Shook Hardy & Bacon LLP acted with<br />

"fraudulent intent" in past efforts to protect cigarette manufacturers from lawsuits. Post-trial documents<br />

filed Aug. 15 and Aug. 24 in a civil racketeering case against tobacco companies mention at least 15 Shook<br />

Hardy lawyers by name and refer to the firm more than 250 times.<br />

A September 2, 2005 Kansas City Business Journal print edition article quoted the Notre Dame<br />

Law School professor G. Robert Blakey who stated the government's many mentions of the lawyers in the<br />

case are "an indication they could have sued them," "Lawyers should not be above the law, but in practice<br />

they are," He said tobacco lawyers were defendants in just two of the 50 states' cases against tobacco<br />

companies. Professor Blakey said it's routine practice to excuse lawyers from conspiracy suits, in part<br />

because of the extra cost of litigating against a law firm's defenses. Professor G. Robert Blakey’s comments<br />

as printed in the Kansas City Business Journal are however critical of the US Department of Justice for not<br />

including the private law firm or its attorneys as civil defendants, saying: "It's an indefensible practice,"<br />

and "It's indefensible if lawyers could have been sued but they were not." See “U.S. attorneys take some<br />

shots at Shook Hardy” Mark Kind, Kansas City Business Journal - September 5, 2005 Exb 1.<br />

Because of the continuing racketeering conduct directed at <strong>Medical</strong> <strong>Supply</strong> and its counsel by<br />

Shughart Thomson & Kilroy, <strong>Medical</strong> <strong>Supply</strong> had to name Shughart Thomson & Kilroy as a defendant<br />

even at the cost of the diversity jurisdiction that would have guaranteed all of its claims are resolved in<br />

federal court. The racketeering controlled and furthered by Shughart Thomson & Kilroy’s employees, past<br />

employees and agents has denied <strong>Medical</strong> <strong>Supply</strong> access to the US Supreme Court and is in imminent<br />

danger of depriving <strong>Medical</strong> <strong>Supply</strong> of its counsel.<br />

15<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5782


The US Department of Justice’s Proposed Findings of Fact and and Post Trial Brief reveal that the<br />

attorneys including those of the law firm Shook Hardy and Bacon, representing the tobacco companies<br />

expanded litigation fraud to even controlling the nation’s scientific research relating to tobacco for the<br />

purpose of conducting and furthering the goals of the unlawful enterprise. The US Justice Department’s<br />

Post Trial Brief summarizes the RICO conduct of the tobacco companies in a way that makes it clear that<br />

the essential controlling agency and chief instrument of furthering the RICO enterprise were the<br />

management of the fraud by law firms including Shook Hardy and Bacon.<br />

“As indicated previously, however, litigation exposure was not the only reason for the<br />

suppression of scientific information. See Wigand WD, 80:24-81:5. The suppression also acted to<br />

directly support Defendants’ enterprise by utilizing numerous means of concealing information that<br />

would have allowed the American public to learn the truth about smoking, both its addictiveness as<br />

well as its negative health consequences.<br />

• First, Defendants destroyed documents to prevent them from being released outside<br />

of the companies. See, e.g., US 21677 (O) (RJR scientists confirm they will remove documents<br />

from the research and development files if it becomes clear the documents will expose RJR in<br />

litigation); US 34839 (A) at 3682 (in notes of a BATCo meeting in 1986 it was reported that<br />

research documents would be destroyed under the guise of “spring cleaning”).<br />

• Second, Defendants encouraged their employees, particularly scientists, not to create<br />

documents that contained sensitive information, particularly information related to smoking and<br />

health and addiction. BATCO and B&W implemented the “mental copy rule” to prevent the<br />

creation of sensitive documents. The “mental copy” rule asked employees to “imagine that the<br />

memo, note or letter you are about to write will be seen by the person that you would least like to<br />

read it.” The employee is then to “send a ‘mental copy’ of your document to a newspaper, one of<br />

your competitors, a government agency, or potential plaintiff. Now: would you still write the<br />

memo If so -would you still write it in the same way” US 87012 at 4434 (A). See also, US 87003<br />

at 1805-1806 (O) (setting forth Philip Morris’s company policy encouraging employees not to<br />

create sensitive documents because they may one day have to answer for the contents of the<br />

document “while sitting in a witness chair in a court room in a lawsuit”).<br />

• Third, Defendants employed lawyers to review and edit scientific documents to<br />

ensure that no contentious information was included in company files. See, e.g., US FF § III.E, <br />

5116-5127, 5184-5221.<br />

• Fourth, Defendants established company policies to ship or secret scientific<br />

information outside of the United States. For example, Philip Morris established a foreign research<br />

facility known as INBIFO and established company policies to prevent research documents from<br />

the foreign research facility from entering or being kept in the United States. Farone WD, 21:16-<br />

22:9, 147:11-152:15; Farone TT, 10/07/04, 1938:2-1939:16. Similarly in 1994, Tommie Sandefur,<br />

the CEO and Chairman of B&W ordered that its sister companies around the world stop sending<br />

research materials to the United States. Read PD, U.S. v. Philip Morris, 05/01/02, 178:5-16, 179:2-<br />

181:4; (US 47616) (A); Read TT, 3/22/05, 16437:22-16441:12.<br />

• Fifth, Defendants employed company lawyers as repositories or conduits for<br />

scientific documents in an attempt to shield documents from production, even though they were not<br />

truly protected by the attorney-client privilege. One of the most notorious of these arrangements<br />

involved the shipment of BATCo documents to B&W through outside counsel by the name of<br />

Robert Maddox. See US FF § III.E(3), 5136-5179.”<br />

16<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5783


US Department Of Justice Post Trial Brief Exb 3 Page 85-86. The brief is informed of the outside<br />

professional liability requirement of control or management of the unlawful enterprise and it is clear that<br />

discovery and trial testimony revealed outside lawyers committed conduct meeting the liability standard:<br />

”And as the Court is well aware, Defendants utilized their outside lawyers to further the goals of the<br />

Enterprise, including attorneys such as Janet Brown at Chadbourne & Parke, John Rupp at<br />

Covington & Burling, Andrew Foyle at Lovells, and others at Shook, Hardy & Bacon, Jones Day,<br />

and other firms.”<br />

US Department Of Justice Post Trial Brief Exb 3 Page 12. Like Sam Lipari and his counsel Bret<br />

Landrith ( see affidavit of Sam Lipari Exb. 8), key witnesses were made to fear for their lives in the defense<br />

firm efforts to obstruct justice:<br />

“Defendants also seek to have the Court make an affirmative finding that Robert<br />

McDermott of Jones Day and Lee Stanford of Shook, Hardy and Bacon acted appropriately in their<br />

conversations with Dr. Huber before his 1997 deposition. JD FF, ch. 3, 547. The Court should<br />

reject Defendants’ request. Dr. Huber specifically testified that McDermott and Stanford implied to<br />

Huber that he did not “fully appreciate the full weight of Shook, Hardy & Bacon and Jones Day”<br />

representatives of the tobacco industry; the calls caused Huber to fear for the safety and financial<br />

security of his family. Huber PD, Texas v. American Tobacco, 9/20/97, , 101:4-8, 10-21.”<br />

US Department Of Justice Post Trial Brief Exb 3 FN 22 Page 44.<br />

Another parallel with the <strong>Medical</strong> <strong>Supply</strong> litigation is the role defense law firms directly played in<br />

cutting <strong>Medical</strong> <strong>Supply</strong>’s access to financial inputs in order to starve out the cartel’s opposition and prevent<br />

the litigation from being funded. A critical role of defense counsel in furthering the unlawful enterprise was<br />

in cutting off funding to projects that the Tobacco defense perceived as a threat:<br />

“Defendants’ use of biased research for public relations and litigation purposes is well<br />

documented in the form of funding for CTR Special Projects, CIAR Applied Studies, and other Defendantfinanced<br />

research initiatives such as ETS consultants recruited and managed by Covington & Burling and<br />

Shook, Hardy & Bacon. See US FF §§ I, III.A(1), III.A(2) and III.B. Evidence also unequivocally<br />

demonstrates Defendants’ successful efforts to terminate funding that they found threatening to the<br />

Enterprise. For example:<br />

• When researchers at Microbiological Associates made progress with inhalation research<br />

funded by CTR, Defendants expressed dire concern. Philip Morris scientist Thomas Osdene wrote: “I am<br />

forced of the opinion that the program seems to be misdirected since its main mission seems to be to prove<br />

that smoking causes cancer.” US 247<strong>08</strong> at 3038 (O). Defendants discontinued their funding and, before<br />

publication of results from the work, manipulated the report from the scientists involved and added an<br />

introduction that omitted the scientists’ conclusion that there was carcinogenic response in animals after<br />

exposure to cigarette smoke. See US FF § III.B(2)(ii)(bb).<br />

• Dr. Gary Huber performed research at Harvard University pursuant to a contractual<br />

agreement with B&W, Liggett, Lorillard, RJR, and Philip Morris, and produced humantype diseases in the<br />

lungs of animals that inhaled cigarette smoke. After Huber reported to his tobacco company sponsors that<br />

his research demonstrated a response to inhaled cigarette smoke, including disease mechanisms similar to<br />

those associated with diseases in humans, Defendants cut off funding to Huber. In a 1980 meeting at a<br />

Boston hotel, Defendants’ attorneys told Huber that the reason funding for his research had been<br />

discontinued was because he was “getting too close to some things.” See generally Huber PD, Texas v.<br />

American Tobacco, 9/20/97; US FF § III.A. As the Court is well aware, Defendants subsequently fought to<br />

17<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5784


keep the Huber story from the public by first, urging to “keep the faith, to hold the line,” when he was<br />

subpoenaed for deposition in 1997, and then employing every strategy at their lawyers’ disposal to keep<br />

the deposition under seal. Seven years after Huber’s deposition, the United States was finally able to obtain<br />

the transcript, over vigorous opposition by Defendants, by initiating a court action in the Eastern District<br />

of Texas. In re United States’ Motion to Modify Sealing Orders, 5:03MC-2 (E.D. Tex. June 8, 2004).”<br />

US Department Of Justice Post Trial Brief Exb 3 Page 43-44.<br />

Conversely, the Department of Justice’s proposed finding of facts illustrate that the law firms<br />

identified as RICO co-conspirators including Shook Hardy and Bacon directed financing so that projects<br />

that would further the unlawful enterprise and perpetuate the deception and death causing fraud received<br />

funds:<br />

“Attorneys at Jacob, Medinger & Finnegan and Shook, Hardy & Bacon kept the<br />

Committee of Counsel apprised of the status of CTR Special Projects and also made<br />

recommendations to Defendants' General Counsel and to each other as to whether projects should be<br />

conducted through CTR Special Projects. TIMN261386-1387 (US 21288) (A); 1005048374-8374<br />

(US 35939) (A). See also Lisanti PD, Arch v. American Tobacco, 6/10/97, 80:9-81:19, 82:10-19.”<br />

US Department Of Justice Proposed Findings of Facts Exb 2 289. Also paralleling medical<br />

<strong>Supply</strong>’s experience with Shughart, Thomson & Kilroy, the Justice Department described Shook, Hardy &<br />

Bacon’s advice, guidance and direction to defendant corporate counsel to deliberately commit fraud in<br />

publicized research and to misrepresent the law:<br />

“For example, on May 19, 1967, William Shinn of Shook, Hardy & Bacon, sent a letter to<br />

Alexander Holtzman, Philip Morris General Counsel, regarding CTR Special Projects, outlining a<br />

proposal to support and publicize research advancing the theory of smoking as beneficial to health<br />

as a stress reducer, even for "coronary prone" persons; representing that stress (rather than nicotine<br />

addiction) explains why smoking clinics fail; and proposing to publicize the "image of smoking as<br />

'right' for many people . . . as a scientifically approved 'diversion' to avoid disease causing stress."<br />

1005<strong>08</strong>3882-3882 (US 20204) (O).<br />

US Department Of Justice Proposed Findings of Facts Exb 2 290. Unfortunately, our legal<br />

system that could not justly resolve the misconduct of tobacco firms for decades is pretty hard wired for<br />

resolving the intentional false statements given investors in the publicly traded NASDQ stock Neoforma,<br />

LLC (NEOF) and our legal system will also quickly allow hospitals to recover funds fraudulently placed in<br />

Novation LLC by VHA and UHC. The outside law firm coordinating the defense ends up approving or<br />

disproving funding commitments in the same way GE and Jeffrey Immelt were directed by the unlawful<br />

cartel’s legal defense (including chief counsel for the separate non defendant GE <strong>Medical</strong> Inc, and the<br />

Chief Counsel for GHX, LLC ) not to honor GE’s real estate contract with <strong>Medical</strong> <strong>Supply</strong>:<br />

“On June 3, 1986, Patrick Sirridge of Shook, Hardy & Bacon sent a letter to the ollowing<br />

General Counsel: Alexander Holtzman of Philip Morris; Wayne Juchatz of Reynolds; Josiah Murray<br />

18<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5785


of Liggett; Ernest Pepples of B&W; Paul Randour of American; and Arthur Stevens of Lorillard,<br />

recommending approval for additional funding of Henry Rothschild through CTR Special Projects.<br />

507878840-8840 (US 2<strong>08</strong>02) (A).”<br />

US Department Of Justice Proposed Findings of Facts Exb 2 292. The Justice Department’s<br />

brief on page 86 reveals why <strong>Medical</strong> <strong>Supply</strong> was required to make Shughart Thomson & Kilroy a<br />

defendant and why Notre Dame Law School Professor G. Robert Blakey faults the DOJ for not making<br />

Shook, Hardy and Bacon defendants in the tobacco litigation:<br />

“Joint Defendants’ Proposed Findings suggest that the United States’ claims of suppression of<br />

information fail because the evidence adduced at trial represented only disparate actions taken by<br />

individual Defendants, not concerted actions by the Defendants taken together. See, e.g., JD FF, ch. 8, <br />

811, 934. First, this assertion is simply wrong. The evidence at trial confirms that many of the actions to<br />

suppress information were joint efforts by all of the Defendants through the Committee of Counsel,<br />

through other joint organizations, or through Defendants’ law firms, including Covington & Burling and<br />

Shook, Hardy & Bacon. Second, Defendants apply a legal standard that does not exist. There is no<br />

requirement that each and every action taken in furtherance of the enterprise involve more than one<br />

Defendant. It is sufficient that the acts of suppression and destruction were undertaken in furtherance of<br />

the goals of the Enterprise (chiefly, denying causation and addiction and seeking protection against legal<br />

judgments). Contrary to Defendants! contention, no Court has held that a racketeering act must be<br />

“engaged in jointly by Defendants” to constitute a racketeering act that is actionable under RICO.<br />

Instead, it has long been the law under RICO that “it is irrelevant that each Defendant participated<br />

in the enterprise’s affairs through different, even unrelated crimes, so long as [the fact finder] may<br />

reasonably infer that each crime was intended to further or [was related to] the enterprise’s affairs.”<br />

United States v. Elliot, 571 F.2d 880, 902-03 (5th Cir. 1978). Moreover, acts taken in furtherance of the<br />

Enterprise, even before an individual Defendant joined the conspiracy are actionable under Section<br />

1962(d) if they further the objectives of the Enterprise. Salinas v. United States, 522 U.S. 52, 63-64<br />

(1997).”[Emphasis added]<br />

US Department Of Justice Post Trial Brief Exb 3 Page 86. The Justice Department argues that the<br />

findings of fact force a conclusion that the law firms themselves had the requisite fraudulent intent because<br />

individuals at these law firms and other entities undertook actions that were intended to protect against<br />

disclosure of Defendants’ fraudulent scheme and actions to promote its unlawful objectives. This argument<br />

is equally applicable to Shughart Thomson & Kilroy through their lawyer Andrea DeMarea fraudulently<br />

making a Kansas Disicplinary complaint against <strong>Medical</strong> <strong>Supply</strong>’s counsel Bret Landrith when his former<br />

managing and employing partner, now Magistrate James P. O’Hara’s sabotage of the African American<br />

James Bolden’s civil rights case and altered testimony was failing to remove medical <strong>Supply</strong>’s<br />

representation. The purpose of the defendant Shughart Thomson & Kilroy’s action was clearly to starve out<br />

<strong>Medical</strong> <strong>Supply</strong>’s counsel by fixing other unrelated cases and to cause his disbarment all in a deliberate<br />

ongoing scheme to prevent the defendants’ unlawful hospital supply cartel from being exposed and to<br />

19<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5786


promote the cartel’s continued ability to steal money from Medicare, Medicaid and Champus through false<br />

claims:<br />

“Further, there is substantial undisputed evidence in the record that over the years,<br />

numerous executives and scientists of Defendants participated actively in the oversight and control<br />

of industry activities that were undertaken in execution of and in furtherance of the fraudulent<br />

scheme. These include, for example, the Chief Executive Officers of Philip Morris, Reynolds,<br />

B&W, Lorillard, American, and Liggett who served on the Board of Directors and/or the Executive<br />

Committee of the Tobacco Institute; the General Counsels of the Cigarette Company Defendants<br />

who were members of the Committee of Counsel; the Boards of Directors of CTR and CIAR, both<br />

of which were comprised of employees of Defendants; and the numerous other bodies whose<br />

structures, functions, and activities are described throughout the United States’ Findings of Fact.<br />

See, e.g., US FF §§ I.B (CTR) & I.C (Tobacco Institute).<br />

Similarly, the evidence shows that members of the Enterprise who are not Defendants in<br />

this case – including law firms such as Shook, Hardy & Bacon and Covington & Burling, and other<br />

agents of Defendants – also possessed the requisite fraudulent intent. Individuals at these law<br />

firms and other entities undertook actions that were intended to protect against disclosure of<br />

Defendants’ fraudulent scheme and actions to promote its unlawful objectives. The evidence<br />

of this is identified throughout the United States’ Findings.” [Emphasis added]<br />

US Department Of Justice Post Trial Brief Exb 3 Page 106.<br />

Accordingly, law firms have no special immunity for acts of fraud and racketeering. This court<br />

should summarily resolve that Shughart, Thomson & Kilroy has the capacity to be a RICO person.<br />

CONCLUSION<br />

Whereas the plaintiff has in its supporting memorandum shown that the controlling authority for our<br />

jurisdiction defines each defendant under the facts averred in the complaint to be distinct from the RICO<br />

enterprise, that a defendant's liability for RICO conspiracy does not require that defendant to participate in<br />

the operation or management of the enterprise, that RICO liability extends to aiders and abettors and that<br />

the law firm Shughart, Thomson & Kilroy, Watkins, Boulware, P.C. (Shughart, Thomson & Kilroy) is<br />

properly a RICO Defendant, the plaintiff <strong>Medical</strong> <strong>Supply</strong> respectfully requests the court grant this partial<br />

summary judgment.<br />

Respectfully Submitted<br />

S/Bret D. Landrith<br />

Bret D. Landrith<br />

Kansas Supreme Court ID # 20380<br />

2961 SW Central Park, # G33,<br />

Topeka, KS 66611<br />

1-785-876-2233<br />

1-785-267-4<strong>08</strong>4<br />

landrithlaw@cox.net<br />

20<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5787


Certificate of Service<br />

I certify that on September 6 th , 2005 I have served the foregoing with the clerk of the court by<br />

using the CM/ECF system which will send a notice of electronic filing to the following:<br />

Mark A. Olthoff , Jonathan H. Gregor, Logan W. Overman, Shughart Thomson & Kilroy, P.C. 1700<br />

Twelve Wyandotte Plaza 120 W 12th Street Kansas City, Missouri 64105-1929<br />

Andrew M. Demarea, Corporate Woods Suite 1100, Building #32 9225 Indian Creek Parkway Overland<br />

Park, Kansas 66210 (913) 451-3355 (913) 451-3361 (FAX)<br />

John K. Power, Esq. Husch & Eppenberger, LLC 1700 One Kansas City Place 1200 Main Street Kansas<br />

City, MO 64105-2122 ( Also attorney for the General Electric defendants and Jeffrey Immelt.)<br />

Stephen N. Roberts, Esq. Natausha Wilson, Esq. Nossaman, Guthner, Knox & Elliott 34th Floor 50<br />

California Street San Francisco, CA 94111<br />

Bruce Blefeld, Esq. Kathleen Bone Spangler, Esq. Vinson & Elkins L.L.P. 2300 First City Tower 1001<br />

Fannin Houston, TX 77002<br />

Attorneys for Defendants<br />

S/Bret D. Landrith<br />

Bret D. Landrith<br />

21<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5788


UNITED STATES DISTRICT COURT<br />

FOR THE WESTERN DISTRICT OF MISSOURI<br />

KANSAS CITY, MISSOURI<br />

<strong>Medical</strong> <strong>Supply</strong> CHAIN, INC., )<br />

Plaintiff, )<br />

v. ) Case No. 05-0210-CV-W-ODS<br />

NOVATION, LLC<br />

) Attorney Lien<br />

NEOFORMA, INC. )<br />

ROBERT J. ZOLLARS )<br />

VOLUNTEER HOSPITAL ASSOCIATION )<br />

CURT NONOMAQUE )<br />

UNIVERSITY HEALTHSYSTEM CONSORTIUM )<br />

ROBERT J. BAKER )<br />

US BANCORP, NA )<br />

US BANK )<br />

JERRY A. GRUNDHOFFER )<br />

ANDREW CESERE )<br />

THE PIPER JAFFRAY COMPANIES )<br />

ANDREW S. DUFF )<br />

SHUGHART THOMSON & KILROY )<br />

WATKINS BOULWARE, P.C. )<br />

Defendants. )<br />

Affidavit of Sam Lipari on The Unsuitability of Transfer<br />

1. My name is Samuel Lipari, I reside at 297 Bayview in Lee’s Summit Missouri. I am<br />

the chief executive officer of <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc., a company I incorporated in<br />

May of 2000. I chose to bring this new action in Missouri District court because I have a<br />

responsibility to <strong>Medical</strong> <strong>Supply</strong>’s stakeholders and to the shareholders of US Bancorp<br />

NA, The Piper Jaffray Companies and Neoforma, Inc. to adjudicate these claims in<br />

accordance with laws of the United States. I brought two earlier and related actions to<br />

Kansas District court based on the advice of my counsel. I witnessed first hand that no<br />

decision or outcome in either case including from the Tenth Circuit Court of Appeals had<br />

any relationship to the pleadings of my company or applicable law. I make this<br />

determination based on my considerable personal experience as a clerk and researcher for<br />

a Missouri legal firm and upon discussions with what I believe are the foremost<br />

healthcare antitrust authorities in our nation.<br />

1<br />

Exb 12<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5789


2. I know first hand the consequences to <strong>Medical</strong> <strong>Supply</strong> and the additional liabilities<br />

US Bancorp NA, The Piper Jaffray Companies and Neoforma, Inc. have incurred as a<br />

result of the Kansas District court outcomes and the Tenth Circuit delays. I believe<br />

several of these defendants will no longer be viable after a judgment at law is made on<br />

their conduct.<br />

3. I received a confidential decision by Chief Judge Deanell R. Tacha dated March 23,<br />

2005; a complaint with extensive documented evidence including official court<br />

transcripts and affidavits I made to the Tenth Circuit about the conduct of the Kansas<br />

District Court Magistrate James P. O’Hara and the attorneys of the law firm Shughart,<br />

Thomson & Kilroy described in the lawsuit before this court. Chief Justice Tacha<br />

determined that the conduct described presented an issue about the bias of the forum<br />

<strong>Medical</strong> <strong>Supply</strong> suffered. Included in the complaint was evidence that the bias reached<br />

the Office of the Clerk for the Tenth Circuit Court of Appeals and the person of Patrick<br />

Fischer, Chief Clerk.<br />

4. Early in the Kansas District Court case against the US Bancorp defendants, I<br />

instructed my counsel to write a letter to the Chief Administrative Judge of the Kansas<br />

District Court inquiring as to weather the Kansas District court had the resources to<br />

adjudicate an antitrust matter based on a Sherman Act refusal to deal claim and if we<br />

should transfer the action to a different forum. The Kansas District Court never had the<br />

time, resources or manpower to answer my inquiry and it is my belief after observing first<br />

hand that the Kansas District Court does not have the resources required for me to<br />

prosecute my claims against these defendants.<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5790


5. Beyond the lack of sufficient resources, I was repeatedly struck by the bias and<br />

open hostility exhibited by the Kansas District Court and Tenth Circuit personnel against<br />

the claims of my company and how Kansas government attorneys were enlisted to<br />

retaliate against my counsel for bringing these actions. I believe this is the bias that Chief<br />

Judge Deanell R. Tacha described in her decision dated March 23, 2005. I became<br />

concerned and attended the trial phase of my counsel’s representation of James Bolden,<br />

an African American small business man who had sought out my counsel when Kansas<br />

government attorneys had discouraged or intimidated four of his previous attorneys, the<br />

last of which still has not been found. I assisted in the trial preparation for this case<br />

believing it would be good practice for <strong>Medical</strong> <strong>Supply</strong>’s jury trials.<br />

6. I have now known James Bolden for some time and believe him to be an<br />

extraordinarily honest god-fearing man. I also know that his work vehicle was<br />

firebombed while it was parked next to his home and the Topeka Police Department<br />

refused to even take a police report and that he feared for his life while his case was being<br />

litigated in the Kansas District Court. The injuries and threats made against his witnesses<br />

who I also know and believe are honest made affidavits of the incidents, including the<br />

opposing city attorney, Sherri Price’s threat to criminally prosecute the Topeka business<br />

owner Fred Sanders if he testified in federal court on behalf of James Bolden.<br />

7. The City of Topeka and the Topeka office of the US Attorney threatened and<br />

intimidated other witnesses I have met because of their testimony in Mr. Landrith’s cases.<br />

Affidavits of these incidents were filed in the various Kansas District Court cases and the<br />

response of the Kansas judicial branch was to increase its threats against Mr. Landrith,<br />

one of which was mailed the afternoon Mr. Landrith had called Mark Hunt a former US<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5791


Army officer and an African American to testify in a Topeka Federal courtroom. Mark<br />

Hunt was severely retaliated against for that testimony and Melvin Johnson, a retired US<br />

Postal worker client of Mr. Landrith was also retaliated against by city officials that<br />

night, leaving him homeless. The Topeka office of Eric Melgran the US Attorney caused<br />

Melvin Johnson’s key witness, Rosemary Price to be retaliated against for her<br />

participation in a deposition held in the Topeka federal courthouse a week later.<br />

8. The Kansas District court repeatedly rebuked Mr. Landrith for documenting the<br />

obstruction and deliberate interference of justice that seems to be commonplace in the<br />

Kansas legal culture. Magistrate James P. O’Hara issued a very harsh report against Mr.<br />

Landrith in the Bolden case that seems to be more about <strong>Medical</strong> <strong>Supply</strong>’s case and what<br />

has happened to Shughart, Thomson and Kilroy. The Kansas Disciplinary Administrator<br />

Stanton Hazlett used the report to justify his investigation and prosecution of Mr.<br />

Landrith.<br />

9. I advised Mr. Landrith to file in Kansas District Court to stop the state disciplinary<br />

administrator from prosecuting him for representing an African American and his<br />

American Indian witness. Affidavits in both cases revealed that Kansas state officials<br />

repeatedly obstructed justice and that the opposing counsel Sherri Price had threatened<br />

minority business men with criminal prosecution if they testified in Kansas District court<br />

against the City of Topeka. I knew that since none of this testimony was ever disputed the<br />

District of Kansas would certainly prevent the state from retaliating against Mr. Landrith<br />

for his protected speech on behalf of an African American and his American Indian<br />

witness. Surprisingly, however the District of Kansas judges recused themselves and the<br />

4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5792


Tenth Circuit assigned the Chief Judge Dee Benson of the District of Utah who made no<br />

findings of fact or law and dismissed the case with prejudice.<br />

10. I attended the pre trial order conference of the Kansas Disciplinary Administrator<br />

before a three-attorney panel consisting of Sally H. Harris, Michael K. Schmitt and<br />

presided over by Randall D. Grisell. Stanton Hazlett admitted to the panel that the secret<br />

probable cause hearing had excluded official court records and evidence including a reply<br />

brief in the adoption appeal that matched court transcripts refuting each evidentiary point<br />

raised by the adoption attorney seeking to terminate Mr. Price’s parental rights. Stanton<br />

Hazlett admitted he had secured the probable cause to prosecute Mr. Landrith by stating<br />

there was no evidence behind the appeal.<br />

11. Randall D. Grisell and the panel ruled that Mr. Landrith would not be able to<br />

present any evidence or witnesses related to the discriminatory prosecution of himself<br />

while the felony threats to obstruct justice documented in the case and including<br />

opposing counsel were being ignored. Strangely, the panel also ordered the exclusion of<br />

any evidence or witnesses supporting the truth of the underlying litigations. Randall D.<br />

Grisell also ruled that the substantial family interest of Stanton Hazlett in the private<br />

adoption industry and that the chief complaining witness, Kansas state Judge G. Joeseph<br />

Pierron, Jr. held a position on the board of directors of a private $40 million dollar<br />

commercial adoption contractor with the State of Kansas, Kansas Children’s Service<br />

League, Inc. did not require the dismissal and reinvestigation of the complaint. Judge G.<br />

Joeseph Pierron, Jr. had refused to disqualify himself when Mr. Price’s appeal raised<br />

questions about widespread Kansas adoption law violations and the failure of the Kansas<br />

5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5793


Social and Rehabilitation Services to ensure compliance with laws designed to prevent<br />

interstate child trafficking.<br />

12. A few days after Mr. Landrith asked to call Frank D. Williams as a witness to<br />

Stanton Hazlett’s pattern and practice of not reading or familiarizing himself with the case<br />

before seeking to prosecute an individual, Kansas state officials in the judicial branch<br />

attempted to seize $50,000.00 in Southwestern Bell stock owned by Frank D. Williams<br />

on a ten year old judgment that had expired without being renewed or served on Mr.<br />

Williams. I believe this was an effort by state officials in the Kansas legal community to<br />

retaliate against witnesses and to threaten and harass witnesses with their misconduct.<br />

Since the <strong>Medical</strong> <strong>Supply</strong> complaint addresses misconduct related to influencing the<br />

Kansas District court, I believe that similar efforts will be made against <strong>Medical</strong> <strong>Supply</strong>’s<br />

witnesses if the case is tried in a Kansas forum.<br />

13. I witnessed the stress mount on Mr. Landrith leading up to the pretrial conference<br />

for the ethics prosecution. It was a dark holiday season as he had to spend an enormous<br />

amount of time preparing evidence for the ethics trial in January. I offered to clerk for Mr.<br />

Landrith during the trial and sat with him during its entirety at the counsel table.<br />

14. On January 19 th 2005 Stanton Hazlett sent another disciplinary complaint letter to<br />

Mr. Landrith. I saw that the ethics trial was not going well for Stanton Hazlett who<br />

seemed entirely unfamiliar with the evidence and exhibited shock and surprise when the<br />

testimony of Hazlett’s own witnesses revealed that court records had been withheld from<br />

Mr. Landrith violating the due process and Sixth Amendment rights of his clients and that<br />

actions had been taken to deceive the court in the underlying cases.<br />

6<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5794


15. Even though the bad faith basis for the prosecution had become overwhelmingly<br />

clear, Stanton Hazlett argued (looking to Andrew DeMarea’s complaint for the<br />

inspiration that an appeal could be frivolous even though the ruling contradicts both<br />

statue and controlling case law and in the face of documented trial court misconduct) that<br />

Mr. Landrith should never have accepted the appeal of the indigent David Price when his<br />

appointed attorney had withdrawn before the conclusion of the trial court case and the<br />

trial court had refused to hear any of Mr. Price’s pro se motions or allow him access to<br />

records required for post trial representation. This struck me as a living nightmare that the<br />

State of Kansas was so far removed from lawfulness and the constitution that I was<br />

thankful I don’t live there.<br />

16. At the conclusion of Mr. Landrith’s ethics trial, Sally H. Harris, Michael K. Schmitt<br />

and Randall D. Grisell stated that they had found Mr. Landrith guilty of something but<br />

were not sure yet what it was. Stanton Hazlett then argued that the only possible<br />

punishment was disbarment.<br />

17. Following the hearing I observed Magistrate O’Hara lagging behind in an effort to<br />

communicate with Stanton Hazlet and the three judge panel. Throughout this hearing<br />

there were several occasions were Stanton Hazlet and the three-judge panel had what<br />

appeared to be private off the record conversations.<br />

18. Mr. Landrith asked me to accompany him to a meeting with John Ambrosio, a<br />

Topeka attorney Stanton Hazlett had directed to investigate the complaint made by<br />

Andrew DeMarea of Shughart Thomson and Kilroy who was representing counsel for the<br />

defendant US Bank in the <strong>Medical</strong> <strong>Supply</strong> case. Mr. Landrith had told me he had<br />

7<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5795


answered the complaint and sent additional documents, but John Ambrosio had sent<br />

several letters threatening disbarment if Mr. Landrith did not attend a meeting.<br />

19. Bret Landrith also arranged for Mr. Dennis Hawver to accompany us to the meeting<br />

since Mr. Hawver was investigating filing a legislative claim on behalf of Mr. Landrith<br />

for the enormous burden the repeated bad faith prosecutions by Stanton Hazlett in<br />

retaliation for Mr. Landrith’s representing minority Kansans who were injured by state<br />

officials violating Kansas law. When we got there John Ambrosio’s wife Kathleen<br />

Ambrosio who Janice King, a voluntary process server for Mr. Landrith told me had been<br />

assigned by the Kansas Judicial branch to assist a divorce attorney opposing her claims<br />

for child support in the Tenth Circuit stood around listening to our conversations. Then<br />

we were taken to John Ambrosio’s office.<br />

20. John Ambrosio was introduced to me and did not recognize my name even though<br />

he had insisted Mr. Landrith attend this meeting to be questioned about the <strong>Medical</strong><br />

<strong>Supply</strong> case. I heard Mr. Landrith call his attention to the fact that he had been threatened<br />

several times by John Ambrosio if he did not make himself available for questioning<br />

about the case yet Ambrosio had clearly made no preparations and was unfamiliar with<br />

the complaint or the documents furnished by Stanton Hazlett. Furthermore Mr. Landrith<br />

complained that Stanton Hazlett had been prosecuting him for over two years, making it<br />

impossible to earn a living and that he had been told he would be disbarred on the earlier<br />

claims.<br />

21. John Ambrosio insisted I leave and that I not witness the meeting but Mr. Hawver<br />

could stay. Mr. Landrith declined to be interviewed without my presence and I heard<br />

John Ambrosio threaten Mr. Landrith again with disbarment stating that if Mr. Landrith<br />

8<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5796


didn’t cooperate he would respond to Stanton Hazlett stating that everything Andrew<br />

DeMarea had alleged would be reported as true since Mr. Landrith was unwilling to<br />

refute it.<br />

22. At that moment I knew the meeting had been arranged solely to harass Mr. Landrith<br />

for representing me. Despite being paid by the State of Kansas to do an ethics<br />

investigation, John Ambrosio had not even bothered to read Andrew DeMarea’s<br />

complaint. Like Sherri Price, the City of Topeka attorney relaying Magistrate James<br />

O’Hara’s order, Andrew DeMarea was smart enough to sign his name only to the cover<br />

page relaying without subjective comment a ruling designed to injure Mr. Landrith for his<br />

representation, neither alleged any wrongdoing against Mr. Landrith. I could see that<br />

despite John Ambrosio’s visible intent to severely frighten Mr. Landrith if he did not<br />

meet without a witness, John Ambrosio had not bothered to review the case.<br />

23. When the defendants realized they had to answer my action in Missouri, I<br />

experienced the intensified presence of law enforcement officials. Including uniformed<br />

and plain-clothes surveillance. I believe two plain clothes officers arranged to meet and<br />

question me. I was questioned extensively about GPO practices and how I was able to<br />

finance my litigation. I believe the justification for this investigation was the USA<br />

PATRIOT Act suspicious activity report filed against my company and me over two<br />

years ago.<br />

24. I know the suspicious activity reports were filed because my father has my same<br />

name and the secret reports disrupted the financial operations of my father’s trucking<br />

company at the time causing him significant loses in income and stress arising from the<br />

decreased income and the threats of foreclosure on the home he and my stepmother<br />

9<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5797


shared. The stress aggravated their physical health and my stepmother died from a stroke<br />

later that year.<br />

25. I believe the impetuous for the investigation however was the requests made by the<br />

defendants to government officials in Missouri starting once the Missouri action was<br />

filed. I went to the FBI office in Kansas City, Missouri with supporting documentation<br />

and the information described in the complaint about the defendants actions to retaliate<br />

against my attorney Mr. Landrith in their plan to impede the administration of justice.<br />

26. No action was taken on my complaint and the law enforcement officials did not<br />

start surveillance of my home until the defendants requested it. I believe the surveillance<br />

was unproductive in that it did not serve the goals of the government officials who had<br />

attempted to accommodate the defendants. I believe this resulted in my fiancé who I lived<br />

with for four years and whose daughter we were arraigning for me to adopt as father was<br />

being targeted. When she was pressured repeatedly to find something unlawful I was<br />

doing, it led to our relationship being canceled and I lost my home.<br />

27. I moved in with my father and live in his basement. I believe that this residence and<br />

my office in it has been searched while we were out, again under the justification of the<br />

USA PATRIOT Act suspicious activity report filed against my company and me over<br />

two year ago but for the purpose of finding something that could be used to stop my<br />

litigation.<br />

28. I continue to experience Internet research interruption and email delays even though<br />

I believe the Missouri officials are satisfied as to <strong>Medical</strong> <strong>Supply</strong>’s claims and the<br />

lawfulness of our litigation against the defendants. I am hopeful they will enforce the law<br />

and protect the witnesses of every party. The events that appeared to have occurred in<br />

10<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5798


Texas, California and Kansas when persons have challenged the defendants’ monopoly<br />

make this action’s location in Missouri necessary for all the safety of all involved.<br />

29. Unfortunately, I am experiencing the fallout from law enforcement officials on the<br />

Missouri side discovering that <strong>Medical</strong> <strong>Supply</strong>’s claims were justified and that nothing<br />

unlawful is being done in my litigation against the defendants. Kansas state officials in<br />

the judicial branch, including Stanton Hazlett have contacted persons in the last two<br />

weeks to relay their intentions to me. This is on its face unlawful because Stanton Hazlett<br />

is required to keep that information confidential until the complaint is filed. One such<br />

person who had a conversation with Stanton Hazlett has made it clear that Mr. Landrith<br />

will be disbarred regardless of the law or evidence in the record. While this threat<br />

imperils <strong>Medical</strong> <strong>Supply</strong>’s chance for justice in this litigation, the threat accompanied<br />

offers to “save” <strong>Medical</strong> <strong>Supply</strong>. This involves replacing <strong>Medical</strong> <strong>Supply</strong>’s counsel with<br />

a Kansas attorney as lead counsel I feel Stanton Hazlett believes he and Magistrate<br />

O’Hara can control. I was offered the $300,000.00 US Bancorp deprived <strong>Medical</strong> <strong>Supply</strong><br />

of to capitalize my company’s entry to market if I would agree to this arrangement. While<br />

this is being suggested to me repeatedly to the point that it is becoming a pressure, the<br />

suggested attorneys have no antitrust experience or familiarity with the present actions.<br />

30. I believe Stanton Hazlett and Magistrate O’Hara are acting in the interests of the<br />

defendant Shughart Thomson & Kilroy to use their control over the enforcement of<br />

Kansas Attorney Ethics rules to change counsel so that evidence of Shughart Thomson &<br />

Kilroy’s actions in furtherance of the defendant’s conspiracy will not be subjected to<br />

discovery, accomplishing the conspiracy’s short term objective of concealing what was<br />

done to influence the Kansas District Court and the defendant conspiracy’s long term<br />

11<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5799


objective of eliminating liability for their conduct. Because the conspiracy so overtly<br />

seeks to control and prevent the presentation of evidence regarding the occurrences in<br />

Kansas District court and the motivations for what was done to Mr. Landrith while<br />

suppressing evidence of misconduct including felony obstruction of justice, witness<br />

intimidation and harassment related to Mr. Bolden and Mr. Price’s entirely unrelated<br />

cases.<br />

31. Chief Judge Deanell R. Tacha’s confidential decision clearly casts the Sherman<br />

Antitrust Act and 18 U.S.C.§ 241 as “frivolous” laws. This also comports with the Tenth<br />

Circuit’s formal opinions regarding <strong>Medical</strong> <strong>Supply</strong>’s antitrust claims. Since my<br />

company cannot enter the market unless the conspirators exerting monopolistic control<br />

over the market are enjoined from further planned actions to exclude competition and<br />

discouraged from the belief that US antitrust law will not be enforced in the ecommerce<br />

delivery of hospital supplies, I must bring my company’s claims to a jurisdiction that will<br />

follow US Antitrust law. I believe that excludes the Kansas District court and its<br />

appellate circuit.<br />

32. At the time my counsel has twelve days to answer about 20 motions seeking the<br />

dismissal and transfer of this case, Stanton Hazlett is misleading the Tenth Circuit into<br />

dismissing the motion to enjoin further disbarment proceedings during the pendancy of<br />

Mr. Landrith’s civil rights cases (he still has to represent Mr. James Bolden) based on<br />

Stanton Hazlett’s misrepresentations that the appeal is moot because Mr. Landrith is not<br />

being disciplined, then, Stanton Hazlett filed a recommendation of disbarment against<br />

Mr. Landrith in the Kansas Supreme Court on April 14, 2005 without retracting his Tenth<br />

Circuit Motion to dismiss.<br />

12<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5800


33. The defendants seek to transfer <strong>Medical</strong> <strong>Supply</strong>’s case to Kansas. I have feared for<br />

my life during parts of this litigation especially after calling the Ft. Worth, TX office of<br />

the US Attorney to ask to speak to the attorney that issued the criminal subpoenas against<br />

my cases defendants and being told she was dead and then finding out that the FCA<br />

attorney had died shortly before her. It is my belief that I would be putting witnesses in<br />

jeopardy if this action were conducted in Kansas and that would principally be a result of<br />

the hostility the Kansas District court has for victims of witness intimidation and<br />

harassment and the obvious willingness of the Kansas judicial branch to assist in the<br />

harassment and intimidation. Certainly, it would be unlikely that law enforcement<br />

officials could bring anyone to justice in that environment.<br />

34. I do believe the State of Missouri will uphold the laws against witness and victim<br />

harassment and secure the protection of all parties. In Missouri, law enforcement officials<br />

appear to have already looked into this litigation at the request of the defendants and I<br />

also have my up most confidence in them<br />

13<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5801


14<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5802


CITIZEN’S CRIMINAL COMPLAINT<br />

This complaint is made by Bret Landrith, counsel for <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc.,<br />

(herein “<strong>Medical</strong> <strong>Supply</strong>”), a Missouri Corporation located at 1300 NW Jefferson Court,<br />

Blue Springs, MO 64015.<br />

<strong>Medical</strong> <strong>Supply</strong> has been the victim of Hobbs Act extortion, obstruction of justice<br />

and Sherman Act §§1 and 2. <strong>Medical</strong> <strong>Supply</strong> was the last ecommerce hospital supply<br />

marketplace not controlled or acquired by Novation, LLC or Premier Purchasing<br />

Partners. <strong>Medical</strong> <strong>Supply</strong> attempted to enjoin the actions being taken against it with two<br />

civil law suits filed in Kansas District Court. Unfortunately, <strong>Medical</strong> <strong>Supply</strong> continued to<br />

suffer extortion, and its counsel was subjected to intimidation and harassment. Both cases<br />

were compromised by the defendants corrupt influence over forum.<br />

This complaint outlines the conduct committed against <strong>Medical</strong> <strong>Supply</strong> during the<br />

prosecution of the case. Outside of corruptly influencing the court, US Bancorp NA filed<br />

a malicious suspicious activity report under the USA PATRIOT Act to prevent <strong>Medical</strong><br />

<strong>Supply</strong> from having access to banking services and effectively kept it from entering the<br />

market for hospital supplies.<br />

Two US Attorneys that appeared connected to the criminal investigation of<br />

Novation, LLC have died and three more in the Ft Worth office of the US Department of<br />

Justice with antitrust expertise have been dismissed. <strong>Medical</strong> <strong>Supply</strong> does not believe<br />

there is currently an active criminal investigation of the supplier side of hospital<br />

Medicare false claims.<br />

1<br />

Exb 13<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5803


The Hon. Magistrate Judge James P. O’Hara engaged in conduct prejudicial to the<br />

effective and expeditious administration of the business of the courts. The complainant<br />

believes that Judge James P. O’Hara used his magistrate’s office to obtain special<br />

treatment for his former law firm Shughart, Thomson & Kilroy and improperly engaged<br />

in discussions with lawyers or parties to cases in the absence of representatives of<br />

opposing parties, and other abuses of judicial office.<br />

TENTH CIRCUIT CASES EFFECTED<br />

<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> v US Bancorp, NA.; Case No. 02-3443, 03-3342<br />

<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> v General Electric Co.; Case No. 04-3075, 04-3102<br />

Bolden v City of Topeka; Case No. 04-3306<br />

STATEMENT OF FACTS<br />

1. The. Hon. Judge James P. O’Hara is a magistrate in the District of Kansas with an<br />

office in Kansas City, Kansas federal courthouse.<br />

2. Before becoming a magistrate, Judge O’Hara was the managing partner and<br />

shareholder in the law firm Shughart, Thomson & Kilroy where he worked for 18 years<br />

and managed the firm’s Overland Park, Kansas office. The firm’s website continues to<br />

list him in a biographical press release giving the impression they have significant<br />

influence in the Kansas District Court. Atch. 1<br />

3. The Kansas District Court biography of Judge O’Hara states that he started in the legal<br />

profession as a law clerk for the Kansas Attorney Disciplinary Administrator’s office and<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5804


states that he has served on several Kansas attorney disciplinary committees while<br />

working for Shughart, Thomson & Kilroy.<br />

4. The complainant, Bret D. Landrith, Esq. undertook the representation of <strong>Medical</strong><br />

<strong>Supply</strong> <strong>Chain</strong>, Inc. in an action against U.S. Bancorp NA, several of its subsidiaries and<br />

officers, an independent legal identity named as Unknown Healthcare Supplier and<br />

several identified coconspirators which were not to be named as defendants until<br />

discovery. The complaint sought injunctive and declaratory relief for Sherman §§ 1and 2<br />

antitrust violations and pendant state claims related to the theft of intellectual property<br />

and contract.<br />

5. The firm Shughart, Thomson & Kilroy (STK) represented all the defendants except the<br />

Unknown Healthcare Supplier and the defense was argued by STK’s Overland Park<br />

office attorney Andrew M. DeMarea at two preliminary injunctive relief hearings.<br />

6. DeMarea did not appear familiar with the subject matter of the case, believing it to be<br />

about health insurance instead of hospital supplies and did not refute that he had not read<br />

the motions from the case in the second hearing:<br />

“The transcripts added to the record confirm that US Bancorp’s counsel was<br />

unfamiliar with the motions and pleadings that were the subject of the two<br />

hearings. US Bancorp’s counsel stated repeatedly and erroneously the issues were<br />

health insurance and pricing and appeared at all times to be very far a field from<br />

the subject matter of the case.”<br />

<strong>Medical</strong> <strong>Supply</strong> Reply Brief, pg. 2, Case No. 02-3443.<br />

7. The case is of great importance to the 1.8 trillion dollar hospital supply industry where<br />

<strong>Medical</strong> <strong>Supply</strong> was the last remaining independent electronic marketplace for hospital<br />

supplies in a national market controlled by a hospital supply group purchasing monopoly<br />

that has been the subject of three US Senate Judiciary Antitrust Sub Committee hearings.<br />

The second of which discussed the conduct committed against <strong>Medical</strong> <strong>Supply</strong> by US<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5805


Bancorp and its investment bank subsidiary and also described the later conduct<br />

committed against <strong>Medical</strong> <strong>Supply</strong> by General Electric. Atch. 2<br />

8. The denial of preliminary injunctive relief resulted in <strong>Medical</strong> <strong>Supply</strong> seeking an<br />

interlocutory appeal, which surprised both the presiding judge, Hon. Carlos Murguia and<br />

visibly angered Andrew M. DeMarea even though this outcome was extensively briefed<br />

in the motion being heard.<br />

9. The denial of temporary relief caused <strong>Medical</strong> <strong>Supply</strong> to lose the $350,000.00 it had<br />

raised from its representative candidates to enter the market for hospital supplies.<br />

<strong>Medical</strong> <strong>Supply</strong> also lost its intellectual property including its proprietary trade secrets,<br />

business models and algorithms. Some of the intellectual property was later incorporated<br />

into the US Bancorp’s hospital supplier co-conspirator’s business practices.<br />

10. A series of state disciplinary actions started to be taken against <strong>Medical</strong> <strong>Supply</strong>’s<br />

counsel, who had attempted to earn a living as a solo civil rights practioner while<br />

awaiting the Tenth Circuit’s ruling on the <strong>Medical</strong> <strong>Supply</strong> case.<br />

11. Hon. Judge James P. O’Hara had knowledge of the first two disciplinary complaints<br />

made against Bret Landrith for representing an African American James Bolden and his<br />

chief witness, David Price in separate Kansas Court of Appeals case. The complaints<br />

were not made by the clients but instead by a motions attorney for the state court and in<br />

later testimony it was discovered that it was the conduct accurately describing denial of<br />

equal protection and due process rights suffered by the clients in bringing the appeal that<br />

prompted the complaint. Atch. 3.<br />

12. With knowledge of the discriminatory treatment depriving James Bolden of access to<br />

Shawnee District Court records and an opportunity to litigate his appeal, Hon. Judge<br />

4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5806


James P. O’Hara at a pre trial order conference in the concurrent federal civil rights<br />

action attacked Bret Landrith as incompetent, inviting James Bolden to sue his counsel<br />

for malpractice and suggesting that Bolden could better represent himself pro se. Atch. 4.<br />

13. Judge O’Hara reiterated these same statements in his report and recommendation to<br />

the presiding judge, which he directed to be mailed in certified delivery to James Bolden.<br />

Atch. 5.<br />

14. The basis for these attacks on Bret Landrith turned out to be pretextual. Controlling<br />

law clearly makes the City responsible for the conduct of its officers in their official<br />

capacity. A fact Judge O’Hara well knew and in an unrelated pretrial order conference<br />

the following day accepted the voluntary stipulation of parties that all officials be<br />

voluntarily dismissed. Judge O’Hara also stated as much in a footnote to his report. Atch.<br />

5.<br />

15. The reason for Judge O’Hara’s targeting of Bret Landrith appears to be in retaliation<br />

for his representation of <strong>Medical</strong> <strong>Supply</strong> where SKT’s failure to appreciate the extreme<br />

risk to their clients resulted in a litigation record that clearly made SKT the guarantor of<br />

any damages that might be awarded against US Bancorp. This is consistent with his sua<br />

sponte pretrial order statements about malpractice insurance when it was clear that even<br />

if Bolden was deprived of individual defendants, the City was the party financially liable.<br />

Piper Jaffray conducted a study showing a web based electronic marketplace like <strong>Medical</strong><br />

<strong>Supply</strong> would save over $20 billion dollars in hospital supply costs.<br />

16. Sherri Price the counsel for the City of Topeka who relied entirely on Magistrate<br />

O’Hara to represent her clients during the pretrial order conference filed an ethics<br />

“complaint” against Bret Landrith. The “complaint” stated that Mr. Landrith had included<br />

5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5807


the earlier ethics complaint as an attachment to Bolden’s pleadings which is not a<br />

violation of the Kansas Rules of Professional Conduct and Sherri Price incorporated by<br />

reference Magistrate O’Hara’s Report and Recommendation, making no observations of<br />

assertions of Mr. Landrith’s misconduct of her own. Atch. 6.<br />

16. Andrew DeMarea failed to file a reply brief in the interlocutory appeal for the US<br />

Bancorp appellees. The Tenth Circuit court clerk called him two days later to remind him<br />

and urged him to file for an extension one day beyond the date the brief was due and<br />

seven days beyond the deadline for a motion for extension of time under 10th Cir. R.<br />

27.4(F). Atch. 7.<br />

17. Andrew DeMarea refused to turn in a parties case management conference report on<br />

the form required by local rule in the Kansas District Court. He repeatedly assured<br />

Magistrate Waxe during the first case management conference that the <strong>Medical</strong> <strong>Supply</strong><br />

case would be dismissed.<br />

18. Mark Olthoff, an attorney for SKT in their Kansas City, MO office appeared to write<br />

all pleadings and briefs for the defendants until the second appeal where he appears to<br />

have been replaced by Susan C. Hascall of the Kansas City, MO office who was a Tenth<br />

Circuit Court of Appeals law clerk through 2000.<br />

19. Mark Olthoff’s trial pleadings repeatedly misstated and misrepresented <strong>Medical</strong><br />

<strong>Supply</strong>’s Amended Complaint and pleadings to the court, even after it had been<br />

repeatedly drawn to the court’s attention that Mr. Olthoff was exploiting the court’s<br />

reliance on the experience of SKT and was neglecting to read or consider <strong>Medical</strong><br />

<strong>Supply</strong>’s pleadings. In its order, the court even admonished Bret Landrith for failing to<br />

research law and facts that the record evidences had been researched. The negligence was<br />

6<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 58<strong>08</strong>


entirely that of Mr. Olthoff and the court’s or a result of the court’s misplaced reliance on<br />

Mr. Olthoff.<br />

20. The <strong>Medical</strong> <strong>Supply</strong> action against US Bancorp was dismissed but not on arguments<br />

or authorities presented by SKT’s dismissal memorandum. The first findings of law and<br />

fact made by the court in the case were sua sponte and both were clearly erroneous.<br />

21. The court did not respond to <strong>Medical</strong> <strong>Supply</strong>’s arguments for reconsideration or<br />

correct its factual errors. It is believed that Judge O’Hara obtained the magistrate<br />

assignment to <strong>Medical</strong> <strong>Supply</strong>’s case against General Electric because of his relationship<br />

to SKT and it provided an opportunity to address the same fact pattern as the earlier case<br />

because GE breached its contract with <strong>Medical</strong> <strong>Supply</strong> once the electronic marketplace<br />

GHX, LLC created by GE and its hospital supplier competitors discovered <strong>Medical</strong><br />

<strong>Supply</strong> was attempting again to enter the market for hospital supplies.<br />

22. On January 14 th , 2005, Andrew DeMarea was directed to file an ethics complaint<br />

against Bret Landrith. Like the “complaint” filed by Sherri Price, no allegations of<br />

misconduct appear in DeMarea’s complaint, it merely incorporates by reference attached<br />

<strong>Medical</strong> <strong>Supply</strong> filings in the District Court and the Tenth Circuit and the appellate<br />

panel’s sanction of Bret Landrith for a “frivolous appeal.” The “complaint” also<br />

contained <strong>Medical</strong> <strong>Supply</strong>’s motion for en banc review of the sanctions. See Atch. 8 The<br />

sanction order itself admitted the trial court and the hearing panel were mistaken in<br />

stating there was no private right of action contained in the USA PATRIOT Act.<br />

However, it is unfortunately clear that Judge O’Hara, Olthoff and DeMarea have no<br />

interest in the law, only in perpetuating a smear of <strong>Medical</strong> <strong>Supply</strong>’s counsel, despite<br />

clear Tenth Circuit and Supreme Court authority that the sole check on judicial<br />

7<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5809


misconduct that can remedy its effect is appeal. Ramirez v. Oklahoma Dept. of Mental<br />

Health, 41 F.3d 584 at 589-90 (C.A.10 (Okl.), 1994).<br />

23. Judge O’Hara used his position as magistrate assigned to the <strong>Medical</strong> <strong>Supply</strong> action<br />

against General Electric to deny <strong>Medical</strong> <strong>Supply</strong> discovery. A decision he also made in<br />

the Bolden case. On January 20, 2005 Judge O’Hara testified under oath that he had only<br />

denied discovery in a few cases. He stated he was unaware of any other case he was<br />

assigned where Bret Landrith was an attorney. He visibly winced when he was then<br />

questioned if he was a magistrate in <strong>Medical</strong> <strong>Supply</strong> v. General Electric et. al. where Bret<br />

Landrith was the sole counsel for the plaintiff. See Atch. 9. ( transcript to be<br />

supplemented)<br />

24. The disciplinary tribunal heard arguments that Judge O’Hara was the complaining<br />

witness in fact for the complaint made by the assistant city attorney against Bret Landrith.<br />

Sherri Price made no independent allegations or observations of misconduct against Bret<br />

Landrith and merely incorporated by reference Magistrate O’Hara’s report and<br />

recommendation from Bolden’s pretrial conference. The disciplinary tribunal ordered<br />

Judge O’Hara to drive to Topeka and testify under oath. See Atch. 9.<br />

25. Judge O’Hara added to his attacks against Bret Landrith with further statements<br />

impugning Bret Landrith’s competence. . Judge O’Hara testified that James Bolden’s<br />

counsel was the worst attorney he had seen in 20 years. Magistrate O’Hara alleged that<br />

Mr. Landrith did not have the skill or knowledge of the law a first year law student would<br />

possess. See Atch. 9.<br />

26. Judge O’Hara made a point of addressing facts that weakened the Kansas<br />

Disciplinary Administrator’s case from the previous two days and made these assertions<br />

8<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5810


unsolicited from the questioning of the Disciplinary Administrator and demonstrated a<br />

pre appearance coaching or consultation with Stanton Hazlett, especially on the point<br />

about Bret Landrith’s competence being less than that of a first year law student. Judge<br />

O’Hara could not have known that Landrith had testified the previous day that many<br />

states permit law students to represent clients in civil rights actions because of the<br />

shortage of counsel willing to undertake this difficult and unlucrative work. See Atch. 9.<br />

27. Judge Vratil, the presiding Judge on Bolden’s case upheld Magistrate O’Hara’s<br />

recommendations which cut out many claims based on City of Topeka policies that had a<br />

negative impact on members of a protected class. Judge Vratil relied on Magistrate<br />

O’Hara’s judgment that the affidavits of misconduct against process servers and Bolden’s<br />

witnesses provided no basis for relying on the City’s unqualified appearance as effective<br />

service under the alternative use of Kansas serevice of process rules and provided no<br />

basis for extending discovery. Judge Vratil also demonstrated an impression that Bret<br />

Landrith was mentally incapable of arguing motions before the court in the final case<br />

management conference before trial which appeared to be the result of Magistrate<br />

O’Hara’s influence. Later Judge Vratil was able to make an independent judgment of<br />

Bret Landrith’s competence demonstrated by Bolden prevailing on some motions<br />

disputed before trial.<br />

28. When Judge O’Hara returned to Kansas City, events still seemed to be set against Mr.<br />

Bolden’s cause. The notice that the record on appeal was complete was erroneously given<br />

to the Tenth Circuit, though the mistake was clear from the appearance docket that two<br />

transcripts that had been ordered still were not part of the record. The appeals clerk for<br />

9<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5811


Kansas District court would not correct the record, Bolden made a motion to correct the<br />

record, which was not addressed by Magistrate O’Hara. See Atch. 10<br />

29. Bolden’s motion for an extension of time was sent to both the Tenth Circuit and the<br />

Kansas District Court. However it did not appear on the Tenth Circuit Court of Appeals<br />

appearance docket. Bolden’s counsel called the Tenth Circuit and a deputy clerk<br />

identified as Kathy stated that it had been received two days before but it was still not<br />

docketed. After the call Kathy reentered on the docket that Bolden’s brief was due<br />

January 26 th . See Atch. 11<br />

30. On the same day, counsel called the Kansas District Court appeals clerk who stated<br />

she was working on the letter correcting the date the record was complete. However, this<br />

letter did not appear on the docket the 25 th or even the 26 th . Bolden’s counsel was forced<br />

to work without sleep to file an incomplete appellate brief on the 26 th emailing the brief<br />

to the court and counsel for the City and turning in the briefs and appendixes to US Postal<br />

Delivery service for the Tenth Circuit and the City of Topeka. See Atch. 12<br />

31. Both the Kansas District Court correction of the record on appeal and the Tenth<br />

Circuit docketing of the motion for extension occurred after the brief and appendix was<br />

received, giving the appearance to an impartial observer that the events were coordinated<br />

to manufacture an ethics violation for Bolden’s counsel after the failure of previous<br />

attempts.<br />

32. James Bolden is unable to find counsel to represent him in defending against the final<br />

steps of the City of Topeka to take his two properties for a public use without<br />

compensating him.<br />

10<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5812


33. Bret Landrith is unable to take civil rights clients because his speech has been chilled<br />

by the action of Judge O’Hara through the Kansas Office of the Disciplinary<br />

Administrator and he is likely to be disbarred for conduct required by the Kansas Rules<br />

of Professional Conduct.<br />

34. In an order where Bret Landrith was neither a party or attorney, Magistrate James P.<br />

P’Hara stated Bret Landrith was incompetent. During testimony under oathe, Magistrate<br />

O’Hara stated he could not recall ever stating in an order where Mr. Landrith was not an<br />

attorney that Mr. Landrith was incompetent. See Atch 13.<br />

STATEMENT OF VIOLATIONS<br />

Allegations of Conduct Violating Judicial Cannons:<br />

I. Judge James P. O’Hara’s name is being used in the Shughart, Thomson & Kilroy<br />

corporate web site, falling within the proscription of Kansas Judicial Canon 2B wherein it<br />

is stated . . . “a judge . . . should not lend the prestige of his office to advance the private<br />

interests of others.”<br />

II. Judge James P. O’Hara has violated Kansas Judicial Canon 2, which in substance,<br />

provides that the judge not only must avoid impropriety, but also the appearance of<br />

impropriety.<br />

III. Judge James P. O’Hara has violated Kansas Judicial Canon 3C(1)(b), which in<br />

substance, provides that a judge should disqualify himself in a proceeding in which his<br />

impartiality might reasonably be questioned, including but not limited to instances where<br />

11<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5813


he served as a lawyer in the matter in controversy, or a lawyer with whom he previously<br />

practiced law served during such association as a lawyer concerning the matter.<br />

IV. Judge James P. O’Hara has violated Kansas Judicial Canon 3C(1)(c) which provides,<br />

in substance, that a judge should disqualify himself when he knows that he has a financial<br />

interest in the subject matter in controversy, or any other interest that could be<br />

substantially affected by the outcome of the proceeding. “Financial interest” is defined in<br />

Canon 3C(3)(c) as ownership of a legal or equitable interest, however small. Judge James<br />

P. O’Hara<br />

V. Judge James P. O’Hara has violated Kansas Judicial Canon 2, which in substance,<br />

provides that the judge not only must avoid impropriety, but also the appearance of<br />

impropriety.<br />

Allegations of criminal conduct:<br />

VI. Judge James P. O’Hara has violated James Bolden’s civil rights in causing the<br />

intimidation and harassment of James Bolden’s counsel Bret Landrith and by<br />

encouraging the intimidation and harassment of James Bolden and his witnesses under<br />

the color of Kansas law to deprive them of the right to representation, redress, freedom of<br />

speech and to give testimony by City of Topeka officials. Judge O’Hara’s conduct<br />

violates 18 U.S.C.§ 241, 18 U.S.C. §1513(b).<br />

VII. Judge James P. O’Hara has participated in a conspiracy between Shughart, Thomson<br />

& Kilroy, US Bancorp NA, The Piper Jaffray Companies, Novation LLC and Neoforma,<br />

Inc. to obstruct <strong>Medical</strong> <strong>Supply</strong>’s entry into the national market for hospital supplies by<br />

12<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5814


attempting to intimidate and harass <strong>Medical</strong> <strong>Supply</strong>’s counsel and deprive the company<br />

of the means to assert its legal rights. The Hobbs Act 18 U.S.C.§1951, The Sherman<br />

Antitrust Act 15 U.S.C. §1 and Retaliating Against a Victim Witness or Informant 18<br />

U.S.C. §1513(b).<br />

S/ Bret D. Landrith<br />

S/ Sam K. Lipari<br />

13<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5815


Attorney James P. O'Hara Named U.S. Magistrate Judge<br />

James P. O'Hara, managing partner of the Shughart Thomson & Kilroy law firm's Overland Park<br />

office, has been appointed U.S. Magistrate Judge in Topeka, Kansas.<br />

O'Hara, 44, of Overland Park, will succeed Ronald C. Newman, who died in September 1999. He will<br />

be one of four U.S. Magistrate Judges in Kansas, and will have a split docket between Topeka and<br />

Kansas City, Kansas. O'Hara was selected from among 24 applicants by U.S. District Judges in<br />

Kansas with the assistance of a merit selection panel of 11 Kansas lawyers and laypersons.<br />

"I'll miss my colleagues at Shughart Thomson & Kilroy," said O'Hara. "It's been a real pleasure to be<br />

associated with such a talented and experienced team of attorneys."<br />

John M. Kilroy, Jr., managing partner of the firm, commended O'Hara.<br />

"We feel lucky to have practiced law with Jim for the last 18 years. He will be an outstanding<br />

Magistrate and we are fortunate that he is willing to make this commitment to public service."<br />

As a U.S. Magistrate Judge, O'Hara will handle pre-trial scheduling and procedures for civil cases and<br />

will preside over settlement conferences, mediation and, with consent of the litigants, disposition of<br />

civil cases. Magistrate Judges also prepare criminal cases for trial and try misdemeanor cases.<br />

O'Hara joined Shughart Thomson & Kilroy in 1982 and was named a shareholder and director in 1987.<br />

During his 18-year career as a trial attorney, he has handled primarily business litigation and complex<br />

divorce cases. He has served on the firm's executive, associates and hiring committees, and has been<br />

managing partner of its 12-lawyer Overland Park office since 1998.<br />

O'Hara earned his bachelor's degree from the University of Nebraska in 1977 and his law degree with<br />

honors from Creighton University School of Law in 1980. He served as a law clerk for two Federal<br />

Judges: the late Robert V. Denney, U.S. District Judge in Nebraska; and C Arlen Beam, formerly U.S.<br />

District Judge in Nebraska, now a U.S. Circuit Judge on the U.S. Court of Appeals for the 8th Circuit.<br />

He has served as a member of the Bench Bar Committee of the U.S. District Court in Kansas and as a<br />

member of the Kansas Board for Discipline of Attorneys, a 20-member board appointed by the Kansas<br />

Supreme Court to conduct evidentiary hearings and adjudicate disciplinary complaints.<br />

Effective immediately, O'Hara has resigned as a shareholder and director of Shughart Thomson &<br />

Kilroy, a leading Kansas City law firm. The firm announced Tuesday that Lawrence A. Swain, Chair<br />

of the Intellectual Property and Technology Group, has been named the new partner in charge of the<br />

Overland Park office.<br />

About the Firm Practice Groups Attorneys News & Events Symposium<br />

###<br />

Exb 13<br />

Atch 1<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5816


Click below...<br />

Welcome<br />

Company<br />

Industry<br />

Communication<br />

Web Services<br />

FAQ's<br />

News<br />

Register<br />

Sign In<br />

CONGRESSIONAL HEARINGS<br />

Hearing Before the Committee on the Judiciary Subcommittee on Antitrust, Competition Policy<br />

and Consumer Rights of the United States Senate on "Hospital Group Purchasing: How to<br />

Maintain Innovation and Cost Savings"<br />

September 14, 2004<br />

Hearing Before the Committee on the Judiciary United States Senate Subcommittee on<br />

Antitrust, Competition Policy and Consumer Rights on "Hospital Group Purchasing: Has the<br />

Market Become More Open to Competition<br />

July 16, 2003<br />

Hearing before the Senate Committee on the Judiciary Subcommittee on Antitrust, Business<br />

Rights and Competition on Hospital Group Purchasing: Lowering Costs at the Expense of<br />

Patient Health and <strong>Medical</strong> Innovations<br />

April 30, 2002<br />

LITIGATION<br />

<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. vs. US Bancorp Piper Jaffray<br />

MSC vs. US Bancorp Piper Jaffray Amended Complaint<br />

MSC vs. US Bancorp Piper Jaffray Appeal Brief<br />

MSC vs. US Bancorp Piper Jaffray Order and Show Cause<br />

MSC vs. US Bancorp Piper Jaffray Letter to the Senate November 10 2004<br />

MSC vs. US Bancorp Piper Jaffray Show Cause Reply<br />

MSC vs. US Bancorp Piper Jaffray Letter to the Senate November 23 2004<br />

MSC vs. US Bancorp Piper Jaffray En Banc Motion<br />

MSC vs. US Bancorp Piper Jaffray En Banc Motion Attachment 1<br />

MSC vs. US Bancorp Piper Jaffray En Banc Motion Attachment 2<br />

MSC vs. US Bancorp Piper Jaffray En Banc Motion Attachment 3<br />

MSC vs. US Bancorp Piper Jaffray En Banc Motion Attachment 4<br />

MSC vs. US Bancorp Piper Jaffray Sanction Order<br />

Motion for En Banc Rehearing of Sanctions<br />

Exb. 1 Order of Sanctions Pg. 17-25<br />

Exb. 2 En Banc Motion Pg. 26-43<br />

Exb. 3 Sherman Claims Pg. 44-55<br />

Exb. 4 Letter To Chief Clerk Patrick Fisher Pg. 56-58<br />

Exb. 5 Excerpt From Motion For New Trial Pg. 59-70<br />

Exb. 6 Trial Court Order Pg. 71-86<br />

Exb. 7 USA Patriot Act Claims Pg. 87-94<br />

Exb. 8 Appelate Show Cause Order Pg. 95-97<br />

<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. vs. General Electric Company<br />

MSC vs. General Electric Company Amended Complaint<br />

MSC vs. General Electric Company Appeal Brief<br />

MSC vs. General Electric Company Answer Brief<br />

PRESS RELEASE<br />

"<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> Enables Interactive eBusiness Communications; A Strategy to Remove<br />

Artificially Inflated Health Care Cost" Exb 13<br />

Atch 2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5817


Kansas City, MO. -- January 26, 2005<br />

"<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> Targets Health Care’s Out of Control and Artificially Inflated <strong>Supply</strong> Costs With<br />

The Next Generation of e-Commerce"<br />

Kansas City, MO. -- January 11, 2005<br />

"Second US Attorney Death in Novation Medicare Fraud Case"<br />

Kansas City, MO. -- September 17 2004<br />

"General Electric Faces Ruling as Novation Medicare Co-Conspirator"<br />

Kansas City, MO. -- August 26 2004<br />

"General Electric Ordered Into Antitrust Mediation"<br />

Kansas City, MO. -- April 7 2004<br />

"Healthcare Marketplace <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. Announces Bid to Acquire US Bank’s Troubled<br />

Investment Banking Unit US Bancorp Piper Jaffray"<br />

Kansas City, MO. -- January 27 2003<br />

"Healthcare Reform Suffers A Massive Blow From Improper Use of The USA Patriot Act"<br />

Kansas City, MO. -- February 6 2003<br />

"<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. is Raising the Standards in Healthcare E-Commerce, Defining Efficiencies<br />

for the Healthcare <strong>Supply</strong> <strong>Chain</strong>."<br />

Kansas City, MO. -- March 21 2001<br />

"<strong>Medical</strong><strong>Supply</strong><strong>Chain</strong>.com Launches Global Trade Exchange for Institutional Healthcare Enterprises"<br />

Kansas City, MO. -- May 30 2000<br />

"<strong>Medical</strong><strong>Supply</strong><strong>Chain</strong>.com Selects the<strong>Supply</strong><strong>Chain</strong>.com to Enable Independent Trading Exchange"<br />

Newport Beach, CA. -- May 25 2000<br />

PUBLICATIONS<br />

October 18 2004 "US Atorney's Office Loses 3 Go-To Guys'"<br />

By MATT STILES<br />

August 21, 2004 "Wide U.S. Inquiry Into Purchasing for Health Care"<br />

By MARY WILLIAMS WALSH<br />

September 4, 2002 "A Persistent Small Supplier Gets Contract for Hospitals"<br />

By BARRY MEIER<br />

August 15, 2002 "3 <strong>Medical</strong> <strong>Supply</strong> Companies Receive U.S. Agency Subpoenas"<br />

By MARY WILLIAMS WALSH<br />

August 9, 2002 "Buying Group for Hospitals Vows Change"<br />

By BARRY MEIER with MARY WILLIAMS WALSH<br />

August 6, 2002 "Buying Group for Hospitals Changes Ways"<br />

By BARRY MEIER and MARY WILLIAMS WALSH<br />

August 4, 2002 "Hospitals Strut in a Lurching Market"<br />

By REED ABELSON<br />

August 1, 2002 "Accusation of Conflicts at a Supplier to Hospitals"<br />

By MARY WILLIAMS WALSH<br />

July 24, 2002 "Audits Scrutinized at Operator of Hospital-Supplies Web Site"<br />

By MARY WILLIAMS WALSH<br />

July 19, 2002 "Questioning $1 Million Fee in a Needle Deal"<br />

By BARRY MEIER with MARY WILLIAMS WALSH<br />

June 7, 2002 "A Mission to Save Money, a Record of Otherwise"<br />

By MARY WILLIAMS WALSH<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5818


May 1, 2002 "Senate Panel Criticizes Hospital Buying Groups"<br />

By BARRY MEIER and MARY WILLIAMS WALSH<br />

April 30, 2002 "Hospitals Sometimes Lose Money by Using a <strong>Supply</strong> Buying Group"<br />

By MARY WILLIAMS WALSH and BARRY MEIER<br />

April 27, 2002 "Hospital Group's Link to Company Is Criticized"<br />

By MARY WILLIAMS WALSH<br />

April 23, 2002 "Hospital Products Get Seal of Approval at a Price"<br />

By BARRY MEIER<br />

March 26, 2002 "When a Buyer for Hospitals Has a Stake in Drugs It Buys"<br />

By MARY WILLIAMS WALSH<br />

March 4, 2002 "Medicine's Middlemen; 2 Powerful Groups Hold Sway Over Buying at Many Hospitals"<br />

By WALT BOGLANICH<br />

REPORTS<br />

United States General Accounting Office Tuesday April 30, 2002 Testimony Before the Subcommittee<br />

on Antitrust, Competition, and Business and consumer Rights, Committee on the judiciary, U.S.<br />

Senate<br />

GAO GPO Report<br />

Blue Print For An Efficient <strong>Supply</strong> <strong>Chain</strong> Wednesday January 10, 2001<br />

Lynn James Everard, C.P.M., C.B.M Healthcare <strong>Supply</strong> <strong>Chain</strong> Strategist<br />

Blueprint for an Efficient Health Care <strong>Supply</strong> <strong>Chain</strong><br />

The Exclusion of Competition For Hospital Sales Through Group Purchasing Organization Tuesday<br />

June 25, 2002 Harvard Law Professor Einer Elhauge<br />

Harvard Law Study<br />

MEDICAL NEWS<br />

Orange Juice Can Help Promote Health...<br />

-- Ad - http://www.floridajuice.com, Sat Jan 29 2005 00:<strong>08</strong>:00 GMT-0600<br />

Vietnam's 11th Bird-Flu Death Under Probe for Possible Human Transmission...<br />

-- Bloomberg, Sat Jan 29 2005 00:<strong>08</strong>:00 GMT-0600<br />

A 13-year-old girl becomes 11th bird flu death in Vietnam in a month (updated PM 02:03)...<br />

-- China Post, Fri Jan 28 2005 23:59:00 GMT-0600<br />

1 more bird flu patient in Vietnam dies, Cambodian suspected¡¡...<br />

-- China Economic Net, Fri Jan 28 2005 23:57:00 GMT-0600<br />

One more bird flu patient dies in Vietnam...<br />

-- Peoples Daily Online, Fri Jan 28 2005 23:56:00 GMT-0600<br />

ASCO-GI: Advanced Pancreatic Cancer Patients Respond to FOLFOX-6 Regimen...<br />

-- Doctors Guide, Fri Jan 28 2005 23:42:00 GMT-0600<br />

Study Confirms ICDs More Effective In Preventing Sudden Cardiac Death Than <strong>Medical</strong> Therapies...<br />

-- Science Daily, Fri Jan 28 2005 23:30:00 GMT-0600<br />

NIAID Begins Enrolling Volunteers For Novel HIV Vaccine Study...<br />

-- Science Daily, Fri Jan 28 2005 23:30:00 GMT-0600<br />

Copyright © 2000-2005 <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. All rights reserved.<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5819


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5820


Locations Publications Recruiting Archives Home<br />

Contact us by email at solutions@stklaw.com.<br />

©Shughart Thomson & Kilroy. All rights reserved.<br />

Click here to read our Disclaimer.<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5821


Exb 13<br />

Atch 3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5822


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5823


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5824


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5825


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5826


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5827


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5828


IN THE UNITED STATES MAGISTRATE COURT<br />

FOR THE DISTRICT OF KANSAS<br />

2 TOPEKA, KANSAS<br />

3<br />

4 JAMES L. BOLDEN, )<br />

24 sloppy way.<br />

25 I'm not sure, Mr. Bolden, that you'd<br />

been<br />

NORA LYON & ASSOCIATES, INC.<br />

-------------------- Plaintiff, )<br />

5 )<br />

vs.<br />

) Case No.<br />

6 ) 02-CV-2635<br />

CITY OF TOPEKA, et al., )<br />

7 -------------------- Defendant. )<br />

8<br />

9 TRANSCRIPT OF TAPE-RECORDED<br />

FINAL PRETRIAL CONFERENCE<br />

10 BEFORE<br />

HONORABLE JAMES P. O'HARA<br />

11 on<br />

November 20, 2003<br />

12<br />

13<br />

APPEARANCES:<br />

14<br />

For the Plaintiff: Mr. Bret D. Landrith<br />

15 Attorney at Law<br />

12820 SW Highway 4<br />

16 Topeka, Kansas 66610<br />

17 For the Defendant: Ms. Sherri L. Price<br />

City of Topeka<br />

18 Legal Department<br />

215 Southeast 7th<br />

19 Topeka, Kansas 66603<br />

20 Court Reporter: Jana L. Willard, CSR,<br />

RPR<br />

Nora Lyon & Associates<br />

21 1515 South Topeka Avenue<br />

Topeka, Kansas 66612<br />

But, Mr.<br />

14 Bolden, you ought to be aware of the fact that<br />

15 if these six defendants are ultimately<br />

16 dismissed from the case by Judge Vratil that<br />

17 you would have certain remedies that you<br />

might<br />

66612<br />

2720<br />

1515 S.W. Topeka Blvd., Topeka, KS<br />

Phone: (785) 232-2545 FAX: (785) 232-<br />

41<br />

1 doing any worse if you were to represent<br />

2 yourself. And I have a lot of folks in civil<br />

3 rights case that do represent themselves. But<br />

4 this case, in this Court and based on what is<br />

5 of public record in the Kansas Court of<br />

6 Appeals, is disturbing to say the least.<br />

you<br />

18 want to discuss with another lawyer that<br />

19 could exercise against Mr. Landrith, who's<br />

20 charged with responsibly and<br />

professionally<br />

21 representing you in this case. And I-- I don't<br />

22 mean to be uncharitable to either of you, but<br />

23 this case has been handled in an<br />

exceptionally<br />

ATTACHMENT 8<br />

Exb 13<br />

Atch 4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5829


19 In contrast, as a practical matter, it appears that plaintiff probably would suffer little,<br />

if any, prejudice if the individual defendants were dismissed.<br />

Fn 19, Magistrate O’Hara’s Report and Recommendation pg. 10<br />

Stated more directly, the court is deeply troubled by Mr. Landrith’s apparent<br />

incompetence. The pleadings he has filed (see, e.g., docs. 1, 13, 23, 35, 37, & 42), and<br />

his non-responsive, rambling, ill-informed legal arguments during the pretrial conference,<br />

suggest that he is not conversant with even the most basic aspects of the Federal Rules of<br />

Civil Procedure. The court doubts that Mr. Landrith has any better grasp of the<br />

substantive law that applies to this case. Based on what transpired at the pretrial<br />

conference, plaintiff appears more articulate than Mr. Landrith. Plaintiff may be better<br />

served by representing himself without any attorney if indeed Mr. Landrith is the only<br />

attorney willing to take the case.<br />

Magistrate O’Hara’s Report and Recommendation pg. 12<br />

The Clerk’s Office shall serve copies of this report and recommendation on all counsel of<br />

record, and shall also send a copy via certified mail, return receipt requested, to the<br />

plaintiff, Mr. James L. Bolden, at 4218 S.E. Ridgeview Terrace, Topeka, Kansas 66609.<br />

Magistrate O’Hara’s Report and Recommendation pg. 13<br />

Exb 13<br />

Atch 5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5830


Exb 13<br />

Atch 6<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5831


02-3443 <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> v. US Bancorp, NA., et al<br />

1/6/03 [1577139] Appellant's corrected brief filed by <strong>Medical</strong><br />

<strong>Supply</strong> <strong>Chain</strong>. Original and 7 copies. c/s: y. Served on<br />

1/6/03. Oral argument n. Appendix filed. Original and 2<br />

appendix copies. Appellee's brief due 2/10/03 for Unknown<br />

Healthcare, for Brian Kabbes, for Lars Anderson, for Susan<br />

Paine, for Andrew Cesere, for Piper Jaffray, for Mutual<br />

Fund Services, for Institutional Trust, for Corporate<br />

Trust, for US Bank Private and for US Bancorp, NA. (kf)<br />

[02-3443]<br />

1/8/03 [1576827] Appellant's motion for preliminary injunction<br />

pending appeal submitted to court. (mt) [02-3443]<br />

1/9/03 [1577188] Order filed by Judges Seymour & O'Brien denying<br />

appellant's motion for preliminary injunction pending<br />

appeal. Parties served by mail. (mt) [02-3443]<br />

Docket as of April 27, 2004 11:02 am Page 5<br />

Proceedings include all events.<br />

02-3443 <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> v. US Bancorp, NA., et al<br />

1/10/03 [1577795] Notice of appearance filed by Mark A. Olthoff<br />

and Andrew M. DeMarea as attorney for defendants US<br />

Bancorp, NA., US Bank Private, Corporate Trust,<br />

Institutional Trust, Mutual Fund Services, Piper Jaffray,<br />

Andrew Cesere, Susan Paine, Lars Anderson, Brian Kabbes,<br />

except "Unknown Healthcare Supplier". CERT. OF INTERESTED<br />

PARTIES (y/n): y. (mt) [02-3443]<br />

1/10/03 [1577801] Appellees' Rule 26.1 Disclosure Statement<br />

(Corporate Disclosure Statement) filed by all defendants<br />

other than "Unknown Healthcare Supplier". Original and 3<br />

copies. c/s: y. (mt) [02-3443]<br />

1/13/03 [1578207] Appellees' response filed by US Bancorp, NA., et<br />

al., to Appellant's motion for preliminary injunction<br />

pending appeal. Original and 3 copies. c/s: y (kjs)<br />

[02-3443]<br />

1/21/03 [1580331] Filed notice record is complete 1/10/03. (mt)<br />

[02-3443]<br />

2/12/03 [1587114] Appellee's motion to extend time to file<br />

appellee's brief until 3/12/03 filed by US Bancorp, NA., US<br />

Bank Private, Corporate Trust, Institutional Trust, Mutual<br />

Fund Services, Piper Jaffray, Andrew Cesere, Susan Paine,<br />

Lars Anderson, Brian Kabbes. Original and 3 copies. c/s:<br />

y (kjs) [02-3443]<br />

2/13/03 [1587526] Order filed by PF granting Appellees motion to<br />

extend time to file eres brief until [1587114-1] 3/12/03<br />

for Brian Kabbes, et al. No further extensions. Parties<br />

served by mail. (kjs) [02-3443]<br />

3/13/03 [1595409] Appellee's brief filed by US Bancorp, NA., et<br />

al.. Original and 7 copies. c/s: y. Served on 3/12/03.<br />

Oral Argument n, Appendix filed. Original and 1 appendix<br />

copy. Appendix Pages: 44. Appellant's optional reply brief<br />

due 3/31/03 for <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>. (sl) [02-3443]<br />

3/31/03 [1599620] Appellant's reply brief filed by <strong>Medical</strong> <strong>Supply</strong><br />

<strong>Chain</strong>. Original and 7 copies. c/s: y (kjs)<br />

ATTACHMENT 7<br />

Exb 13<br />

Atch 7<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5832


Exb 13<br />

Atch 8<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5833


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5834


Exb 9<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5835


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5836


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5837


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5838


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5839


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5840


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5841


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5842


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5843


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5844


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5845


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5846


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5847


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5848


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5849


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5850


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5851


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5852


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5853


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5854


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5855


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5856


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5857


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5858


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5859


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5860


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5861


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5862


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5863


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5864


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5865


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5866


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5867


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5868


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5869


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5870


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5871


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5872


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5873


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5874


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5875


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5876


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5877


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5878


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5879


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5880


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5881


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5882


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5883


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5884


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5885


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5886


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5887


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5888


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5889


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5890


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5891


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5892


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5893


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5894


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5895


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5896


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5897


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5898


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5899


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5900


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5901


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5902


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5903


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5904


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5905


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5906


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5907


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 59<strong>08</strong>


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5909


IN THE UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

MEDICAL SUPPLY CHAIN, INC., )<br />

)<br />

Plaintiff, )<br />

)<br />

v. ) Case No. 03-2324-CM<br />

)<br />

GENERAL ELECTRIC COMPANY, et al., )<br />

)<br />

Defendants. )<br />

ORDER<br />

This case comes before the court on defendants’ motion to stay all proceedings<br />

pending resolution of their separate motion to dismiss (doc. 15). Plaintiff opposes<br />

defendants’ motion to stay. After reviewing the defendants’ motion and plaintiff’s response<br />

(doc. 19), the court is prepared to rule. Defendants’ reply is not yet due. However, it is clear<br />

to the court that the instant motion should be granted. Therefore, the court will address the<br />

motion without awaiting further briefing.<br />

The court may stay discovery if: (1) the case is likely to be finally concluded via the<br />

dispositive motion; (2) the facts sought through discovery would not affect the resolution of<br />

the dispositive motion; or (3) discovery on all issues posed by the complaint would be<br />

wasteful and burdensome. 1 The decision whether to stay discovery rests in the sound<br />

1<br />

Wolf v. United States, 157 F.R.D. 494, 495 (D. Kan. 1994) (citing Kutilek v.<br />

Gannon, 132 F.R.D. 296, 297-98 (D. Kan. 1990)).<br />

O:\ORDERS\03-2324-CM-15.wpd<br />

Exb 9A<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5910


discretion of court. As a practical matter, this calls for a case-by-case determination. Upon<br />

reviewing the record in this case, the court concludes that a stay of all proceedings is<br />

warranted. Defendants’ motion to dismiss is based on the facts as plead in plaintiff’s<br />

complaint, so the facts sought through discovery will not affect the resolution of that motion.<br />

In the event U.S. District Judge Carlos Murguia grants the motion to dismiss, the discovery<br />

sought would be wasteful and burdensome. Most notably, while not presuming to predict<br />

whether Judge Murguia will grant the motion to dismiss, it appears from the undersigned<br />

magistrate judge’s review of the briefs filed in connection with motion to dismiss that<br />

defendants may very well prevail.<br />

In opposition to defendants’ motion, plaintiff oddly cites the incorrect standard for<br />

the court’s decision to stay discovery, and then proceeds to make an argument that makes<br />

little sense to the court. In any event, it is clear to the court that a stay is appropriate in this<br />

case.<br />

In consideration of the foregoing,<br />

IT IS HEREBY ORDERED:<br />

1. Defendants’ motion to stay all discovery and other pretrial proceedings<br />

pending resolution of their separate motion to dismiss (doc. 15) is granted.<br />

2. A copy of this order shall be served upon all counsel of record and all<br />

unrepresented parties. The scheduling conference that was set for October 31,<br />

2003 is cancelled.<br />

O:\ORDERS\03-2324-CM-15.wpd<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5911


Dated this 24th day of October, 2003, at Kansas City, Kansas.<br />

s/ James P. O’Hara<br />

James P. O’Hara<br />

U.S. Magistrate Judge<br />

O:\ORDERS\03-2324-CM-15.wpd<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5912


Exb 9B<br />

CASE NO.: 2:03-cv-2324<br />

____________________________________________<br />

MEDICAL SUPPLY CHAIN, INC.,<br />

Plaintiff,<br />

vs.<br />

JEFFREY R. IMMELT<br />

GENERAL ELECTRIC COMPANY<br />

GENERAL ELECTRIC CAPITAL BUSINESS ASSET FUNDING CORPORATION<br />

GE TRANSPORTATION SYSTEMS GLOBAL SIGNALING, L.L.C.<br />

Defendants.<br />

____________________________________________<br />

PLAINTIFF’S REPLY TO MOTION FOR STAY OF DISCOVERY<br />

The defendants seek a stay of the implementation of the federal civil procedure statutes regarding discovery. The<br />

standards for a stay are (a) the likelihood of success on appeal; (b) the threat of irreparable harm if the stay is<br />

not granted; (c) the absence of harm to opposing parties; and (d) the risk of harm to the public interest. See,<br />

e.g., Spain v. Podrebarac, 68 F.3d 1246, 1247 (10th Cir. 1995).<br />

1. The defendants will not suffer irreparable injury if the stay is not granted and have made no argument or<br />

showing that they will. The GE defendants had the opportunity to avoid antitrust discovery when the<br />

consequences of their actions in the present circumstances were explained to them and they chose under the<br />

advice of their present counsel to commit a felony per se refusal to deal and injure <strong>Medical</strong> <strong>Supply</strong> and the<br />

market for hospital supplies in conduct the U. S. Supreme Court has repeatedly found cannot be excused by<br />

business motive and to which there is no defense.<br />

2. The public interest in respecting affordable access to healthcare weighs against a stay of discovery. See, e.g.,<br />

Frisby v. Schultz, 487 U.S. 474, 484 (1988); Rowan v. United States Post Office Dept, 397 U.S. 728, 737<br />

(1970). Second, the census data showing the previous year saw a more than 2 million person increase in the<br />

number of Americans without healthcare insurance due to the weakened economy and the inability of employers<br />

and insurance companies to absorb the inflationary cost increases of healthcare endangers more than 43 million<br />

Americans. The latest data presented in this action indicates 18,000 Americans die each year because of their<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5913


lack of health insurance and the consequential loss of access to adequate healthcare. This data does not include<br />

the under insured Americans who because of healthcare’s inflated or non efficient costs have had their health<br />

insurance reduced to catastrophic coverage without funding for regular preventative care. The <strong>Medical</strong> <strong>Supply</strong><br />

counsel’s own brother in law is representative of an additional cohort of victims that may be many times<br />

18,000. A noted Wichita sculptor, Bart Ewonus died in these circumstances in December 2002 at age 43 after<br />

this court denied <strong>Medical</strong> <strong>Supply</strong>’s relief against GE’s coconspirators as a result of failing to go to the<br />

emergency room when he thought he could recover on his own from the flu. When he did go to the doctor’s<br />

office during regular hours, it was found he had severe pneumonia. Although he was immediately hospitalized,<br />

it was two late. The public has an expectation interest that the federal antitrust laws will be enforced including<br />

those that shift the burden of discovery onto the defendants.<br />

3. There is no likelihood of success on the merits of their motion for dismissal, (which must be now converted<br />

to a motion for summary judgment necessitating discovery). They have by mistake or deception, failed to<br />

address the plaintiff’s charge that the GE Defendants have acted in combination and in conspiracy with<br />

Neoforma, Inc., a company that is not a subsidiary of GE. The goal of that conspiracy was to deprive <strong>Medical</strong><br />

<strong>Supply</strong> of the capital to enter the healthcare market, an integrel part of the antitrust violation antitrust injury<br />

recognized in the Tenth Circuit case Reazin v. Blue Cross And Blue Shield of Kansas, 663 F. Supp. 1360 at<br />

1414 (D. Kan. 1987).<br />

4. <strong>Medical</strong> <strong>Supply</strong> and the American healthcare market has been injured, though under a per se to deal, no<br />

injury need be shown. The defendants’ heightened standard of pleading for contracts is incorrect for Missouri<br />

and Kansas where, even under fact based pleading, both states apply liberal rules to what the court must infer or<br />

examine in the entire contents of a pleading before dismissing a claim prior to discovery. The defendants’<br />

theory, that a condition precedent is inadequately pled is itself wrong on its face under Missouri contract law.<br />

The recognition of a condition precedent imposes an enforceable contract with duties for both parties.<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5914


Repudiation and the defendants’ failure to verify whether they were observing the contract excuse <strong>Medical</strong><br />

<strong>Supply</strong> of any duty. See plaintiff’s reply to motion to dismiss.<br />

5. <strong>Medical</strong> <strong>Supply</strong> under antitrust and contract law is clearly entitled to its expectations under Missouri and<br />

Kansas law in its deal with the GE defendants, where they had knowledge of those expectations before<br />

committing an antitrust violation against <strong>Medical</strong> <strong>Supply</strong> or breaching the contract to purchase the lease from<br />

<strong>Medical</strong> <strong>Supply</strong>. The GE conspirators have committed a separate and distinct predicate act from the previous<br />

acts committed by US Bancorp/Neoforma. Depending on the length of this action and whether <strong>Medical</strong><br />

<strong>Supply</strong>’s market opportunity still exists at the conclusion, that injury is 4 to 6 million dollars a day. Both the<br />

defendants (notwithstanding the advice of their otherwise capable counsel) and <strong>Medical</strong> <strong>Supply</strong> are injured by<br />

any delay in the prosecution of this matter.<br />

Whereas, the injury suffered by <strong>Medical</strong> <strong>Supply</strong> and the American market for healthcare supplies and the related<br />

market for healthcare services in which costs are dependent on supplies is immense, and increases exponentially<br />

as <strong>Medical</strong> <strong>Supply</strong> is denied relief, the plaintiff respectfully requests the court deny the defendants motion for<br />

stay of discovery.<br />

Respectfully Submitted<br />

S/-----------<br />

Bret D. Landrith, Esq<br />

Supreme Court No. 20380<br />

12820 SW Hwy 4<br />

Topeka, KS 66614<br />

Cell 816-365-1306<br />

CERTIFICATE OF SERVICE<br />

I certify that on October 10th, 2003, emailed this document to the defense counsel named below:<br />

Jonathan L. Glecken<br />

Ryan Z. Watts<br />

Arnold & Porter<br />

555 Twelfth Street, N.W.<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5915


Washington, DC 20004-1206<br />

John K. Power<br />

Husch & Eppenberger, LLC.<br />

1200 Main Street<br />

Suite 1700<br />

Kansas City, MO 64105<br />

Counsel for:<br />

JEFFREY R. IMMELT<br />

GENERAL ELECTRIC COMPANY<br />

GENERAL ELECTRIC CAPITAL BUSINESS ASSET FUNDING CORPORATION<br />

GE TRANSPORTATION SYSTEMS GLOBAL SIGNALING, L.L.C.<br />

S/-----------<br />

Bret D. Landrith, Esq<br />

Supreme Court No. 20380<br />

12820 SW Hwy 4<br />

Topeka, KS 66614<br />

Cell 816-365-1306<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5916


Bolden v. Topeka City of, et al<br />

Assigned to: Judge Kathryn H. Vratil<br />

Demand: $0<br />

Case in other court:<br />

10CCA, 04-03306<br />

Cause: 42:1983 Civil Rights Act<br />

Date Filed: 12/20/2002<br />

U.S. District Court<br />

District of Kansas (Kansas City)<br />

CIVIL DOCKET FOR CASE #: 2:02-cv-02635-KHV<br />

10/25/2004<br />

122<br />

TRANSCRIPT ORDER FORM by Court Reporter Theresa Hallberg ordering transcripts of 6/10/04, 11/24/03, 7/9/04 re 118 Notice<br />

of Appeal - Final Judgment filed by James L Bolden ( Appeal No. 04-3306) Transcript due by 12/14/2004. (trs) (Entered:<br />

10/25/2004)<br />

11/23/2004<br />

123<br />

TRANSCRIPT ORDER FORM by Court Reporter Nora Lyon ordering transcripts of Pretrial Conference re 118 Notice of Appeal -<br />

Final Judgment filed by James L Bolden ( Appeal No. 04-3306) Transcript due by 12/15/2004. (km) (Entered: 11/30/2004)<br />

12/10/2004<br />

124<br />

TRANSCRIPT of proceedings held 11-20-03 before Judge James P. O'Hara,Transcript of Tape-Recorded Final Pretrial<br />

Conference, 68 pgs., Court Reporter: Jana L. Willard.<br />

(Nora Lyon & Associates, ) (Entered: 12/10/2004)<br />

12/14/2004<br />

125<br />

Letter to Court of Appeals from Court Reporter, Nora Lyon, stating that all transcripts ordered in this case have been filed with the<br />

Clerk of the District Court as of 12/8/04. (km) (Entered: 12/17/2004)<br />

12/17/2004<br />

126<br />

LETTER TO 10CCA stating record is complete re 118 Notice of Appeal - Final Judgment ( Appeal No. 04-3306) (km, ) (Entered:<br />

12/19/2004)<br />

01/14/2005<br />

127<br />

MOTION to Amend/Correct Record on Appeal Status by Plaintiff James L Bolden(Landrith, Bret) (Entered: 01/14/2005)<br />

01/20/2005<br />

128<br />

NOTICE of Appeal Brief Extension by James L Bolden (Attachments: # 1 Exhibit Motion for Extension# 2 Supplement<br />

Attached Motion to Correct)(Landrith, Bret) (Entered: 01/20/2005)<br />

01/24/2005<br />

129<br />

TRANSCRIPT of proceedings held 6-10-04 before Judge khv, Court Reporter: teh.<br />

(Hallberg, Teri) (Entered: 01/24/2005)<br />

01/24/2005<br />

130<br />

TRANSCRIPT of proceedings held 7-9-04 before Judge khv, Court Reporter: teh.<br />

(Hallberg, Teri) (Entered: 01/24/2005)<br />

01/27/2005<br />

131<br />

Letter to 10CCA stating the record is not complete. A new letter notifying the Court of Appeals will be transmitted when all<br />

requested transcripts have been filed. re 118 Notice of Appeal - Final Judgment (Appeal No. 04-3306) (km) (Entered:<br />

01/27/2005)<br />

ATTACHMENT 10<br />

Exb 13<br />

Atch 10<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5917


United States Court of Appeals for the 10th Circuit<br />

Case Summary<br />

Court of Appeals Docket #: 04-3306 Filed: 8/18/04<br />

Nsuit: 3440<br />

Bolden v. City of Topeka<br />

Appeal from: United States District Court for the District of Kansas<br />

9/23/04 [1742810] Fee paid. Date paid in District Court on 9/1/04.<br />

(mt)<br />

9/24/04 [1743271] Case referred for mediation conferencing. (sl)<br />

9/28/04 [1743929] Order filed by PF - Transcript order form due<br />

10/13/04 for attorney for Bolden. Parties served by mail.<br />

(kf)<br />

9/30/04 [1745690] Appellant's motion filed by Appellant James L.<br />

Bolden to extend time to file appellant's brief until<br />

12/5/04. Original and 3 copies. c/s: y. (mt)<br />

10/5/04 [1745967] Order filed by PF (eas) denying appellant's<br />

motion to extend time to file appellant's brief as<br />

unnecessary. - Transcript order form is due 10/13/04 for<br />

Theresa E. Hallberg pursuant to Rule 42. The briefing<br />

schedule will commence when the district court issues a<br />

notice that the record is complete. 10th Cir.R. 31.1(A)(1).<br />

To the extent ongoing state court proceedings will impact<br />

counsel's representation in this matter, he shall keep this<br />

court fully apprised of those proceedings. Parties served<br />

by mail. (mt)<br />

10/12/04 [1747837] Acknowledgement of transcript order filed by<br />

James L. Bolden. Transcript order due 10/22/04 for Theresa<br />

E. Hallberg. (sl)<br />

10/27/04 [1752410] Transcript order form filed by Theresa E.<br />

Hallberg and Bret D. Landrith. Transcript due 12/14/04 for<br />

Theresa E. Hallberg. (Trial proceedings 6/10/04, 11/24/03,<br />

7/9/04, and motion hearing only 7/9/04) (mt)<br />

11/1/04 [1754014] Acknowledgement of transcript order filed by<br />

James L. Bolden. Transcript order due 11/12/04 for Nora<br />

Lyon. (Pre trial conference) (mt)<br />

11/15/04 [1756693] Case mediation conferencing terminated. (sl)<br />

11/22/04 [1758914] Transcript order form filed by Nora Lyon and Bret<br />

D. Landrith. Transcript of pretrial conference held 11/20/03<br />

due 12/15/04 for Nora Lyon. (mt)<br />

12/13/04 [1764637] Notice filed that the transcript was filed by<br />

Nora Lyon in district court on 12/8/04. (kjs)<br />

12/27/04 [1768263] Filed notice record is complete 12/17/04.<br />

Appellant's brief and appendix due 1/26/05 for James L.<br />

Bolden. (kjs)<br />

1/24/05 [1776865] Appellant's motion filed by James L. Bolden to<br />

restart the briefing schedule 40 days from date of amended<br />

notice from district court or to extend time 20 days from<br />

January 26, 2005, until 2/15/05 [04-3306]. Original and 3<br />

copies. c/s: y (mt)<br />

PACER ATTACHMENT 11<br />

Exb 13<br />

Atch 11<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5918


From: eposone@mobil1.net<br />

Subject: Bolden v. City of Topeka, et al Case No. 04-3306<br />

Date: January 26, 2005 10:34:35 PM CST<br />

To:<br />

esubmission@ca10.uscourts.gov<br />

Cc:<br />

SPrice@Topeka.org<br />

1 Attachment, 388 KB<br />

January 26th, 2005<br />

TO: Clerk of the Tenth Circuit Court<br />

Byron White U.S. Courthouse<br />

1823 Stout Street<br />

Denver, CO 80257.<br />

RE: Bolden v. City of Topeka, et al Case No. 04-3306, Kan. Dist. Ct. Case 02-02635<br />

Dear Clerk of the Tenth Circuit Court,<br />

Your office has received my January 20th, 2005 motion requesting an extension of time in which to file the opening brief. This<br />

Tenth Circuit motion is also entered in the District Court appearance docket of the Bolden case on January 20th, 2005.<br />

On January 25th, after several weeks of inquiries, I was informed by the district court clerk that handles appeals that the erroneous<br />

notice the record on appeal was complete sent to you previously was being corrected and that the letter was being prepared for<br />

you.<br />

Today, however I observe that neither the entry of the correction appears yet on the district court docket and my motion requesting<br />

an extension of time does not appear on your appearance docket.<br />

I am filing a brief today for James Bolden via US Mail delivery service and via email in pdf format. I am mailing you today via US<br />

Mail delivery service two copies of the appendix which is the complete and final appendix for the brief, it is unfortunately larger<br />

than your email file size limit.<br />

If the record on appeal correction or the motion for extension gives more time for Bolden to file an appellant brief, please disregard<br />

today’s brief, but retain the appendix and I will serve on you and opposing counsel the final version of the opening brief by its new<br />

due date.<br />

Respectfully Submitted<br />

S/Bret D. Landrith<br />

___________________<br />

Bret D. Landrith<br />

Kansas Supreme Court ID # 20380<br />

# G33,<br />

2961 SW Central Park,<br />

Topeka, KS 66611<br />

1-785-267-4<strong>08</strong>4<br />

landrithlaw@cox.net<br />

Certificate of Service<br />

I certify I have sent a copy of this cover letter and the appendix via U.S. Mail delivery service to opposing counsel for the<br />

City of Topeka on January 26th, 2005:<br />

Sprice@topeka. org<br />

Sherri Price<br />

City of Topeka<br />

215 E. 7th<br />

Topeka, KS 66603<br />

S/Bret D. Landrith<br />

___________________<br />

Bret D. Landrith<br />

Kansas Supreme Court Number 20380<br />

ATTACHMENT 12<br />

Exb 13<br />

Atch 12<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5919


“Defendant's second allegation is that an attorney for the defendants in the Bolden case,<br />

Sherri Price, filed an ethics complaint against the plaintiff's attorney, Bret<br />

Landrith, and that Ms. Price filed the complaint at the direction of the undersigned<br />

magistrate judge. While the undersigned did comment on the record that there<br />

were serious doubts about Mr. Landrith's competency to practice law, the<br />

undersigned did not direct anyone to file an ethics complaint. Even if that were the case,<br />

however, the ethics complaint filed by Ms. Price deals with the behavior of Mr. Landrith<br />

in his practice of law in that matter, and has no bearing on the instant case.” [ emphasis<br />

added]<br />

Magistrate Judge James P. O’Hara’s July 29, 2004 order at page 3 denying pro se<br />

plaintiff Melvin Johnson’s motion seeking recusal in the pro se plaintiff Melvin Johnson<br />

v.Topeka Housing Authority, Kansas District Court Case No. 04-4062-SAC.<br />

ATTACHMENT 13<br />

Exb 13<br />

Atch 13<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5920


UNITED STATES DISTRICT COURT<br />

FOR THE DISTRICT OF KANSAS<br />

KANSAS CITY, KANSAS<br />

MEDICAL SUPPLY CHAIN, INC., )<br />

(Party in interest Samuel K. Lipari) )<br />

Plaintiff, )<br />

v. ) Case No. 05-2299<br />

NEOFORMA, INC. et al<br />

) Formerly W.D. MO.<br />

) Case No. 05-0210<br />

MOTION FOR RECONSIDERATION<br />

Comes now, the plaintiff <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Samuel<br />

K. Lipari appearing pro se and respectfully requests the<br />

court reconsider it dismissal order, (Doc. 78 ). The order<br />

in clear error contradicts controlling US Supreme Court<br />

authority.<br />

STATEMENT OF FACTS<br />

1. The federally actionable conduct complained of in<br />

the current case occurred after the date federally<br />

actionable conduct was averred in <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>,<br />

Inc. v. US Bancorp, NA, et al, case number 02-2539-CM<br />

(“<strong>Medical</strong> <strong>Supply</strong> I”)<br />

2. The merger of the two remaining web based hospital<br />

supply distributor competitors of <strong>Medical</strong> <strong>Supply</strong> averred in<br />

the current complaint as an agreement made by the<br />

defendants to monopolize the hospital supply market did not<br />

take place until March of 2006, a year after the current<br />

complaint.<br />

1<br />

Exb 14<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5921


3. The defendants were not parties in <strong>Medical</strong> <strong>Supply</strong><br />

<strong>Chain</strong>, Inc. v. General Electric Company, et al., case<br />

number 03-2324-CM (“<strong>Medical</strong> <strong>Supply</strong> II”).<br />

MEMORANDUM OF LAW<br />

A court will alter or amend judgment or reconsider its<br />

ruling when there is a need to correct clear error or<br />

prevent manifest injustice. Brumark Corp. v. Samson Res.<br />

Corp., 57 F.3d 941, 948 (10th Cir. 1995); Priddy v.<br />

Massanari, 2001 WL 1155268, at *2 (D. Kan. Sept. 28, 2001).<br />

1. The prior case outcomes cannot determine the present<br />

action<br />

The defendants Novation, LLC (“Novation”), VHA Inc.<br />

(“VHA”), University Healthsystem Consortium (“UHC”), Robert<br />

Baker, Curt Nonomaque, Neoforma and Robert J. Zollars were<br />

not defendants or plaintiffs in either of the preceding<br />

cases. The defendant Shughart Thomson & Kilroy, P.C.while<br />

in recognizable privity as counsel to defendants in <strong>Medical</strong><br />

<strong>Supply</strong> I, 1<br />

were not parties in <strong>Medical</strong> <strong>Supply</strong> II and the<br />

conduct averred in the present complaint did not take place<br />

1<br />

B-S Steel of Kansas, Inc. v. Texas Industries, 327<br />

F.Supp.2d 1252 (D. Kan., 2004) “But, privity does not<br />

require the plaintiff and defendant to be parties to an<br />

agreement. "Privity requires, at a minimum, a substantial<br />

identity between the issues in controversy and showing<br />

[that] the parties in the two actions are really and<br />

substantially in interest the same." Quoting Lowell Staats<br />

Mining Co. v. Philadelphia Elect. Co., 878 F.2d 1271, 1275<br />

(10th Cir.1989).<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5922


until after the filing of the plaintiff’s averments in<br />

<strong>Medical</strong> <strong>Supply</strong> I.<br />

The Supreme Court case of Lawlor v. National Screen<br />

Service Corp., 349 U.S. 322, 75 S.Ct. 865, 99 L.Ed. 1122<br />

(1955), is controlling. In Lawlor, the plaintiffs brought<br />

an antitrust action in 1942 alleging that the defendants,<br />

National Screen and three producers, had conspired to<br />

establish a monopoly in the distribution of advertising<br />

posters to motion picture exhibitors through the use of<br />

exclusive licenses, and that the plaintiffs' business had<br />

been injured as a result. In 1943, prior to trial, that<br />

suit was settled and dismissed with prejudice. Id. at 324,<br />

75 S.Ct. at 866. The settlement was based upon an agreement<br />

by National Screen to furnish plaintiffs with all standard<br />

accessories distributed by National Screen pursuant to its<br />

exclusive license agreements. In 1949, the plaintiffs<br />

brought another antitrust action, this time alleging that<br />

the prior settlement was merely a device used by the<br />

defendants to perpetuate their conspiracy and monopoly.<br />

Plaintiffs also alleged that five other producers had<br />

joined the conspiracy since the 1943 dismissal, that<br />

defendant National Screen had deliberately made slow and<br />

erratic deliveries of advertising materials in an effort to<br />

destroy plaintiffs' business, and that defendant had used<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5923


tie-in sales and other means of exploiting its monopoly<br />

power. Id. at 325, 75 S.Ct. at 867. The Supreme Court held<br />

that the latter suit was not barred by res judicata because<br />

the two suits were not based on the same cause of action.<br />

Id. at 327, 75 S.Ct. at 868. The Court noted:<br />

“That both suits involved "essentially the same course<br />

of wrongful conduct" is not decisive. Such a course of<br />

conduct--for example, an abatable nuisance--may<br />

frequently give rise to more than a single cause of<br />

action.... While the 1943 judgment precludes recovery<br />

on claims arising prior to its entry, it cannot be<br />

given the effect of extinguishing claims which did not<br />

even then exist and which could not possibly have been<br />

sued upon in the previous case.”<br />

Id. at 327-28, 75 S.Ct. at 868 (footnote omitted).<br />

See also Cellar Door Productions, Inc. of Michigan v. Kay,<br />

897 F.2d 1375 at 1376-77 (C.A.6 (Mich.), 1990).<br />

The Seventh Circuit has also followed Lawlor insofar<br />

as it held that "[i]n the context of a continuing scheme to<br />

violate the antitrust laws, a cause of action accrues to<br />

the plaintiff each time the defendant engages in antitrust<br />

conduct that harms the plaintiff." Ohio-Sealy Mattress Mfg.<br />

Co. v. Sealy, Inc., 669 F.2d 490, 494 (7th Cir.), cert.<br />

denied, 459 U.S. 943, 103 S.Ct. 257, 74 L.Ed.2d 201 (1982).<br />

The Fifth Circuit explored Lawlor’s application in<br />

Exhibitors Poster Exchange, Inc. v. National Screen Service<br />

Corp., 421 F.2d 1313 (5th Cir.1970).<br />

4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5924


“On appeal, the Fifth Circuit first examined the<br />

meaning of "cause of action" for res judicata purposes<br />

and found that the doctrine did not apply to a liberal<br />

reading of the third complaint. The court distinguished<br />

cases in which damages came from a prior act, such as<br />

breach of contract, or series of acts that have been<br />

completed except in their consequences and cases in<br />

which damages arose from actions subsequently<br />

occurring, either alone or in combination with the<br />

completed actions. On the facts before it, the court<br />

held that "significant actions ... occurring subsequent<br />

to 1961, either alone or in combination with acts<br />

[completed prior to 1961] except for their<br />

consequences" may be the basis for new damage claims<br />

since the harm currently alleged by plaintiff did not<br />

arise out of the particularized activities previously<br />

adjudicated. 421 F.2d at 1318. As for collateral<br />

estoppel, the court examined the issues raised in the<br />

earlier cases and held that the effect of the orders<br />

granting summary judgment was to wipe out all claims<br />

against the defendants arising out of the 1961 actions.<br />

Plaintiff was entitled, however, to establish antitrust<br />

violations and damages by proof covering post-1961<br />

activities.”<br />

Harkins Amusement v. Harry Nace Co., 648 F.Supp. 1212<br />

at 1215 (Ariz., 1986) The Harkins court ultimately found<br />

that consumer fraud claims brought against the defendants<br />

later conduct could not be precluded. Id. At 1216.<br />

The facts of the <strong>Medical</strong> <strong>Supply</strong> case before us are<br />

similar to those of Cream Top Creamery v. Dean Milk Co.,<br />

383 F.2d 358 (6th Cir.1967). Cream Top involved an action<br />

alleging a continuing scheme to violate antitrust laws<br />

subsequent to a prior dismissal with prejudice. In that<br />

case, the court relied upon Lawlor in reversing the<br />

District Court's order granting summary judgment on res<br />

5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5925


judicata grounds. The court noted, "[a]t least insofar as<br />

the complaint alleges violations since the dismissal of the<br />

[first] case, the judgment in that case cannot be given the<br />

effect of extinguishing a claim which arose subsequent to<br />

that judgment." Id. at 363 (citing Lawlor, 349 U.S. 322, 75<br />

S.Ct. 865).<br />

The Cellar Door court stated:<br />

“In the case before us, Olympia and Brass Ring's course<br />

of conduct could give rise to more than one cause of<br />

action. Each time the arrangement precluded Cellar Door<br />

from competitively bidding for an event, a cause of<br />

action may have accrued to Cellar Door. Therefore, as<br />

in Lawlor and Cream Top, those causes of action that<br />

arose subsequent to the 1983 dismissal are not barred<br />

by res judicata. Accordingly, we must reverse the<br />

District Court's order granting summary judgment in<br />

favor of appellees.”<br />

Cellar Door Productions, Inc. of Michigan v. Kay, 897<br />

F.2d 1375 at 1378 (C.A.6 (Mich.), 1990).<br />

2. Claim preclusion<br />

Claim preclusion clearly does not apply to the<br />

Novation defendants who were not parties to the previous<br />

action. The Novation defendants were not in privity or<br />

controlling the previous actions. The US Supreme Court in<br />

Lawlor v. National Screen Service Corporation resolved<br />

these issues:<br />

a. Privity<br />

6<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5926


The Novation defendants are not parties in privity for<br />

the purposes of collateral estoppel. “Restatement,<br />

Judgments, § 83, Comment a: 'those who control an action<br />

although not parties to it * * *; those whose interests are<br />

represented by a party to the action * * *; successors in<br />

interest. * * *' “Id ar fn 19 “It is sufficient here to<br />

point out that the five defendants do not fall within the<br />

orthodox categories of privies;” Id. at pg. 329<br />

b. prior outcome of injunction no bar<br />

Nor does the plaintiff’s failure to prevail against<br />

the previous defendants estop the present action:<br />

“There is no merit, therefore, in the respondents'<br />

contention that petitioners are precluded by their<br />

failure in the 1942 suit to press their demand for<br />

injunctive relief. Particularly is this so in view of<br />

the public interest in vigilant enforcement of the<br />

antitrust laws through the instrumentality of the<br />

private treble-damage action. Acceptance of the<br />

respondents' novel contention would in effect confer on<br />

them a partial immunity from civil liability for future<br />

violations. Such a result is consistent with neither<br />

the antitrust laws nor the doctrine of res judicata.”<br />

Id. at pg. 329.<br />

c. Necessary Parties<br />

Nor does the plaintiff’s failure to prevail against<br />

the previous defendants estop the present action:<br />

“in any event there was no obligation to join them<br />

in the 1942 case since as joint tort-feasors they were<br />

not indispensable parties; and that their liability was<br />

not 'altogether dependent upon the culpability' of the<br />

defendants in the 1942 suit.”<br />

7<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5927


Id pg. 328.<br />

d. Identity of claims<br />

Under federal law, collateral estoppel may be invoked<br />

only if "the issue previously decided is identical with the<br />

one presented in the action in question." Frandsen v.<br />

Westinghouse Corp., 46 F.3d 975, 978 (10th Cir.1995).<br />

The current complaint states claims for subsequent<br />

conduct and conduct not yet ripe in the earlier litigation.<br />

“...if future damages are unascertainable, a cause of<br />

action for such damages does not accrue until they occur.<br />

Zenith, 401 U.S. at 339, 91 S.Ct. at 806.” Kaw Valley Elec.<br />

Co-op. Co., Inc. v. Kansas Elec. Power Co-op., Inc., 872<br />

F.2d 931 at FN4 (C.A.10 (Kan.), 1989). See also Barnosky<br />

Oils Inc., v. Union Oil Co., 665 F.2d 74, 82 (6th Cir.<br />

1981). US Bank was still attempting to perform the<br />

financing part of the contract after <strong>Medical</strong> <strong>Supply</strong> filed<br />

its injunctive relief. If “the initial refusal is not<br />

final, each time the victim seeks to deal with the violator<br />

and is rejected, a new cause of action accrues. See Pace<br />

Indus., 813 F.2d at 237-39; Midwestern Waffles, Inc. v.<br />

Waffle House, Inc., 734 F.2d 705, 714-15 (11th<br />

Cir.1984).”Kaw Valley Elec. Co-op. Co., Inc. v. Kansas<br />

8<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5928


Elec. Power Co-op., Inc., 872 F.2d 931 at 933-4 (C.A.10<br />

(Kan.), 1989).<br />

Lawlor v. National Screen also clarifies this issue:<br />

“The conduct presently complained of was all<br />

subsequent to the 1943 judgment. In addition, there are<br />

new antitrust violations alleged here—deliberately slow<br />

deliveries and tie-in sales, among others—not present<br />

in the former action. While the 1943 judgment precludes<br />

recovery on claims arising prior to its entry, it<br />

cannot be given the effect of extinguishing claims<br />

which did not even then exist and which could not<br />

possibly have been sued upon in the previous case. In<br />

the interim, moreover, there was a substantial change<br />

in the scope of the defendants' alleged monopoly; five<br />

other producers had granted exclusive licenses to<br />

National Screen, with the result that the defendants'<br />

control over the market for standard accessories had<br />

increased to nearly 100%. Under these circumstances,<br />

whether the defendants' conduct be regarded as a series<br />

of individual torts or as one continuing tort, the 1943<br />

judgment does not constitute a bar to the instant<br />

suit.” [ emphasis added]<br />

Lawlor v. National Screen Service Corporation, 349<br />

U.S. 322 at 328, 75 S.Ct. 865, 99 L.Ed. 1122 (1955)<br />

Collateral Estoppel Is Inapplicable To The Novation<br />

Defendants<br />

The defense has no clothes. Clearly the three required<br />

elements for claim preclusion or collateral estoppel do not<br />

exist:<br />

“The three requirements for application of claim<br />

preclusion are: (1) identity or privity of the parties;<br />

(2) identity of the cause of action; and (3) a final<br />

judgment on the merits. Id. Where these three<br />

requirements are met, claim preclusion applies to bar<br />

the maintenance of a subsequent suit.”<br />

9<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5929


Heard v. Board of Pub. Util. of Kansas City, Ks, 316<br />

F.Supp.2d 980 at 982 (D. Kan., 2004).<br />

3. Antitrust Conspiracy Sufficiently Pled<br />

There is no heightened pleading standard for<br />

conspiracy or antitrust conspiracy. The claims adequately<br />

apprise the defendants of the gravamen of their conduct:<br />

Under the law, a conspiracy may consist of any mutual<br />

agreement or arrangement, knowingly made, between two or<br />

more competitors. Law v. Nat'l Collegiate Athletic Ass'n<br />

185 F.R.D. 324, 336, n.19 (D. Kan. 1999). The plaintiff has<br />

met the burden of pleading a conspiracy by "identif[ying]<br />

the co-conspirators and describ[ing] the nature and effect<br />

of the alleged conspiracy." Alco Standard Corp. v. Schmid<br />

Bros., 647 F.Supp. 4, 6 (S.D.N.Y.1986).<br />

The hospital supply competitors VHA and UHC’s joint<br />

ownership and agreement to exclusively use the electronic<br />

marketplace Neoforma is such a prohibited combination and<br />

conspiracy.<br />

The hospital supply competitors VHA and UHC’s<br />

formation of the defendant limited liability company<br />

Novation is identified in the complaint as a conspiracy to<br />

restrain trade specifically prohibited under Dagher v.<br />

Saudi Refining Inc., No. 02-56509 (Fed. 9th Cir. 6/1/2004)<br />

(Fed. 9th Cir., 2004).<br />

10<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5930


The plaintiffs other Sherman 1 claims are equally<br />

undismissable. See Eastman Kodak Co. v. Image Tech. Servs.<br />

Inc., 504 U.S. 451, 478, 112 S.Ct. 2072, 119 L.Ed.2d 265<br />

(1992) ("The alleged conduct — higher service prices and<br />

market foreclosure — is facially anticompetitive and<br />

exactly the harm that antitrust laws aim to prevent.");<br />

United States v. VISA U.S.A., Inc., 344 F.3d 229, at 241-43<br />

(2d Cir.2003) (rules for vendor participation causing<br />

reduction in output and consumer choice had anticompetitive<br />

effect); Primetime 24 Joint Venture v. National<br />

Broadcasting Co., 219 F.3d 92, 103-04 (2d Cir.2000)<br />

(refusing to dismiss where complaint alleged agreement<br />

resulting in denial of a necessary input to a competitor).<br />

There is no heightened pleading standard for<br />

conspiracy or antitrust conspiracy. The claims adequately<br />

apprise the defendants of the gravamen of their conduct:<br />

Under the law, a conspiracy may consist of any mutual<br />

agreement or arrangement, knowingly made, between two or<br />

more competitors. Law v. Nat'l Collegiate Athletic Ass'n<br />

185 F.R.D. 324, 336, n.19 (D. Kan. 1999). The plaintiff has<br />

met the burden of pleading a conspiracy by "identif[ying]<br />

the co-conspirators and describ[ing] the nature and effect<br />

of the alleged conspiracy." Alco Standard Corp. v. Schmid<br />

Bros., 647 F.Supp. 4, 6 (S.D.N.Y.1986).<br />

11<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5931


The hospital supply competitors VHA and UHC’s joint<br />

ownership and agreement to exclusively use the electronic<br />

marketplace Neoforma is such a prohibited combination and<br />

conspiracy.<br />

The hospital supply competitors VHA and UHC’s<br />

formation of the defendant limited liability company<br />

Novation is identified in the complaint as a conspiracy to<br />

restrain trade specifically prohibited under Dagher v.<br />

Saudi Refining Inc., No. 02-56509 (Fed. 9th Cir. 6/1/2004)<br />

(Fed. 9th Cir., 2004).<br />

The plaintiffs other Sherman 1 claims are equally<br />

undismissable. See Eastman Kodak Co. v. Image Tech. Servs.<br />

Inc., 504 U.S. 451, 478, 112 S.Ct. 2072, 119 L.Ed.2d 265<br />

(1992) ("The alleged conduct — higher service prices and<br />

market foreclosure — is facially anticompetitive and<br />

exactly the harm that antitrust laws aim to prevent.");<br />

United States v. VISA U.S.A., Inc., 344 F.3d 229, at 241-43<br />

(2d Cir.2003) (rules for vendor participation causing<br />

reduction in output and consumer choice had anticompetitive<br />

effect); Primetime 24 Joint Venture v. National<br />

Broadcasting Co., 219 F.3d 92, 103-04 (2d Cir.2000)<br />

(refusing to dismiss where complaint alleged agreement<br />

resulting in denial of a necessary input to a competitor).<br />

12<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5932


4. Plaintiff sufficiently alleged monopoly power or the<br />

elements of attempt to monopolize<br />

The complaint alleges and Neoforma and the Novation<br />

defendant parties surprisingly subsequently proved the<br />

plaintiff’s claims for Sherman 1 combination and conspiracy<br />

in restraint of trade antitrust violations through their<br />

conduct and official press releases. See Exbs. 3 and 4:<br />

“The current 10-year exclusive outsourcing agreement<br />

was originally entered into in March 2000 and was most<br />

recently amended in August 2003 as a result of<br />

negotiations between the parties to the contract. Under<br />

the terms of that amendment, the quarterly maximum<br />

payment from Novation to Neoforma was established at<br />

$15.25 million, or $61.0 million per year, beginning in<br />

2004.”<br />

Exb 3 Neoforma SEC disclosure press release pg. 1<br />

“In addition, at the effective time of the Merger, VHA<br />

and UHC, which respectively owned 8,611,217 and<br />

2,130,302 shares of Neoforma common stock prior to the<br />

Merger, representing approximately 41.5% and 10.3% of<br />

Neoforma outstanding common stock, respectively had<br />

2,004,190 and 495,810 of their shares of Neoforma<br />

common stock converted into the right to receive $10.00<br />

per share in cash in the Merger. The remainder of the<br />

shares that they held were exchanged, immediately prior<br />

to the closing of the Merger, for membership interests<br />

in GHX representing approximately an 11.6% ownership<br />

interest in GHX for VHA and a 2.9% ownership interest<br />

in GHX for UHC, pursuant to exchange agreements.”<br />

Exb 4 Neoforma SEC disclosure press release pg. 1<br />

The complaint does describe the Novation defendant’s<br />

market power in many places. The following three paragraphs<br />

from the complaint are an example:<br />

13<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5933


56 states: “By 8/21/04 The NY Times reported that the<br />

Justice Department had opened a broad criminal<br />

investigation of the medical-supply industry revealing that<br />

Novation is being subjected to a criminal inquiry:<br />

“Novation's primary business is to pool the<br />

purchasing volume of about 2,200 hospitals, as well as<br />

thousands of nursing homes, clinics and physicians'<br />

practices, and to use their collective power to<br />

negotiate contracts with suppliers at a discount. In<br />

many cases, the contracts offer special rebates to<br />

hospitals that meet certain purchasing targets.<br />

Although Novation is not well known outside the<br />

industry, it wields formidable power because it can<br />

open, or impede, access to a vast institutional market<br />

for health products.” [emphasis added]<br />

433 states:<br />

“The defendant Novation LLC is the largest<br />

Hospital Group Purchasing Organization selling over 30<br />

billion dollars in hospital supplies a year and<br />

controlling the purchasing in 2000 hospitals<br />

nationwide.”<br />

434 states:<br />

“The defendants possess market power having the<br />

power to exclude competitors from 2000 of the nation’s<br />

hospitals, which Novation controls under long term<br />

purchasing contracts. The defendants possess market<br />

power in the ability to charge manufacturers and<br />

suppliers fees to have their products sold to<br />

Novation’s members and additional fees to manufacturers<br />

and suppliers for allowing their products to be sold<br />

though the web where member hospitals are required to<br />

purchase products through Neoforma, Inc. The defendants<br />

possess market power in having exclusive access to<br />

Piper Jaffray’s investor research coverage and annual<br />

healthcare conferences, elements essential to<br />

effectively obtain capitalization through an initial<br />

public offering. The defendants possess market power in<br />

having exclusive access to the commercial banking<br />

facilities of US Bancorp NA.”<br />

14<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5934


The complaint identifies the defendant Neoforma and<br />

the nondefendant coconspirator GHX, LLC as the only other<br />

electronic marketplaces for hospital supplies (40) besides<br />

<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> and that Neoforma will be merged with<br />

GHX, LLC to monopolize the web based market for hospital<br />

supplies.<br />

The complaint adequately alleges a conspiracy to<br />

monopolize under Section 2. To establish such a claim,<br />

plaintiff must plead and prove (1) a combination or<br />

conspiracy to monopolize; (2) overt acts done in<br />

furtherance of the combination or conspiracy; (3) an effect<br />

upon an appreciable amount of interstate commerce; and (4)<br />

a specific intent to monopolize. Multistate Legal Studies.<br />

Inc. v. Harcourt Brace Jovanovich Legal & Prof'l Publ'ns,<br />

Inc., 63 F.3d 1540, 1556 (10th Cir. 1995).<br />

5. Plaintiff adequately alleges harm to competition<br />

The plaintiff’s complaint documents harm to the market<br />

from the defendants’ artificial inflation of hospital<br />

supply prices. A trilogy of recent Supreme Court decisions<br />

reflect that it is unnecessary at the pleading stage to<br />

state every element of a claim, See Swierkiewicz v. Sorema<br />

N.A., 534 U.S.<br />

15<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5935


506 (2002); Crawford-El v. Britton, 523 U.S. 574 (1998);<br />

Leatherman v. Tarrant County Narcotics Intelligence &<br />

Coordination Unit, 507 U.S. 163 (1993).<br />

6. Plaintiff has standing<br />

The plaintiff <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc., like the<br />

sole proprietorship <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> and Sam Lipari the<br />

founder and CEO of <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. ( a statutory<br />

trustee of the corporation under Missouri § 351.525 RSMo)<br />

and now the proprietor of <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, a hospital<br />

supply business excluded from the market by the continuing<br />

acts of the defendants has standing.<br />

Missouri’s rule 52.13(e) states "When a corporation<br />

has been sued and served with a process or has appeared<br />

while in being, and is thereafter disolved or its charter<br />

forfeited, the action shall not be affected thereby ...."<br />

Accordingly, under § 351.525, "[t]he statutory trustees<br />

succeed to the interest of the corporation by operation of<br />

law ". Sab Harmon Indus. v. All State Bldg. Sys., 733<br />

S.W.2d 476, 483 (Mo.App.1987).<br />

It has been asserted that like the trial court in case<br />

World of Sleep’s conclusion that World of Sleep's lost<br />

profits from potential sales to the licensee stores were<br />

too speculative because "there is no history at all of any<br />

profit or loss on these dealings during the years involved<br />

16<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5936


in this case World of Sleep, Inc. v. La-Z-Boy Chair Co.,<br />

756 F.2d 1467 at 1478 (C.A.10 (Colo.), 1985). This error<br />

contradicts established Tenth Circuit and US Supreme Court<br />

law:<br />

“If proof of a profit and loss history were required,<br />

no plaintiff could ever<br />

recover for losses resulting from his inability to<br />

enter a market. However,<br />

such recoveries are clearly available under section 4<br />

of the Clayton Act.<br />

See, e.g., Zenith, 395 U.S. at 129, 89 S.Ct. at 1579. (<br />

Zenith Radio Corp. v.<br />

Hazeltine Research, Inc., 395 U.S. 100, 123-24, 89<br />

S.Ct. 1562, 1576-77, 23<br />

L.Ed.2d 129 (1969) )”<br />

World of Sleep, Inc. v. La-Z-Boy Chair Co., 756 F.2d<br />

1467 at 1478 (C.A.10).<br />

7. Plaintiff pled he required elements for an antitrust<br />

claim based on interlocking directors<br />

The defendants omit that Rule 8 of the federal rules<br />

of civil procedure governs. No special pleading<br />

requirements attach in antitrust cases, beyond those<br />

specifically set out by Congress; antitrust plaintiffs thus<br />

enjoy the same general standard for stating a claim as<br />

other litigants. See Radovich v. National Football League,<br />

352 U.S. 445, 453-54, 77 S.Ct. 390, 1 L.Ed.2d 456 (1957);<br />

Nagler v. Admiral Corporation, 248 F.2d 319, 323-24 (2d<br />

Cir.1957).<br />

17<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5937


The burden to state a claim for interlocking directors<br />

is exceedingly low:<br />

“Defendant also maintains that plaintiff has failed to<br />

state a claim under § 8 of the Clayton Act, 15 U.S.C. §<br />

19. Section 8 prohibits interlocking directorates of<br />

competing corporations if elimination of competition<br />

between them by agreement would violate any of the<br />

antitrust laws. Defendant intends to seek majority<br />

representation on plaintiff's board of directors after<br />

the acquisition of seventy five percent of the<br />

plaintiff's stock (SEC FORM S-7 at 16). United States<br />

v. Sears, Roebuck & Co., 111 F.Supp. 614<br />

(S.D.N.Y.1953), the district court granted summary<br />

judgment against the defendant, ordering the<br />

resignation of a director from the board of one or both<br />

of two competitor corporations upon which he sat,<br />

because of a potential anticompetitive agreement.10 In<br />

light of Sears, we hold that plaintiff has adequately<br />

stated a claim under § 8 of the Clayton Act.”<br />

American Medicorp, Inc. v. Humana, Inc., 445 F.Supp.<br />

573 at 587 (E.D. Pa., 1977). At footnote 10, the American<br />

Medicorp court goes on to explain the purpose for easily<br />

triggering interlocking directorate liability:<br />

“[w]hat Congress intended by § 8 was to nip in the<br />

bud incipient violations of the antitrust laws by<br />

removing the opportunity or temptation to such<br />

violations through interlocking directorates. The<br />

legislation was essentially preventative.<br />

* * * * * *<br />

While it may be acknowledged that the<br />

clause is not crystal clear, to infuse it with the<br />

meaning contended for by the defendants would defeat<br />

the Congressional purpose "to arrest the creation of<br />

trusts, conspiracies and monopolies in their incipiency<br />

and before consummation." This conclusion is compelled<br />

because of the futility of trying to decide whether a<br />

given hypothetical merger would violate the pertinent<br />

sections of the antitrust laws. Sears, supra, at 616-<br />

617. (Footnotes omitted).”<br />

18<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5938


The complaint states the defendants had interlocking<br />

directors to facilitate their monopoly and that antitrust<br />

law violations occurred:<br />

235 states:<br />

“The May 25, 2000 announcement also revealed the<br />

interlocking directors used by the Defendants to<br />

restrain trade in hospital supplies. In connection with<br />

the new agreements, two of the seven seats on the<br />

Neoforma.com Board of Directors will be filled by VHA<br />

designees after closing of the transaction.”<br />

368 states:<br />

“(US Bancorp has interlocking directorships and an<br />

exchange of directors with the two dominant GPO founders of<br />

GHX LLC.; the Defendant Novation and Premier. US Bancorp<br />

helped the Defendant Novation acquire control of the<br />

Defendant Neoforma and partner it with GHX LLC. creating a<br />

monopoly of over 80% of healthcare e-commerce).”<br />

424 states:<br />

“<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. has been excluded from the<br />

hospital supply market with agreements between UHA and<br />

VHA’s Novation in combination with their electronic<br />

marketplace Neoforma, Inc. US Bancorp NA, and The Piper<br />

Jaffray Companies exchanged directors with Novation and<br />

participated in exclusive agreements with Novation and<br />

Neoforma to keep hospitals using technology products from<br />

companies US Bancorp NA and Piper Jaffray had an interest<br />

in. The purpose of these agreements was to injure the<br />

hospital supply consumers with artificially inflated<br />

prices.”<br />

500 states:<br />

“The Defendants use of interlocking directors in<br />

joint ventures and LLC’s formed by competing suppliers,<br />

manufacturers and distributors and use of interlocking<br />

directors on the boards of healthcare technology and<br />

supply chain management companies violate Section 8 of<br />

the Clayton Act, 15 U.S.C. § 19.”<br />

19<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5939


502 states:<br />

“Defendants through the use of interlocking<br />

directors collectively have at all times material to<br />

this complaint maintained, attempted to achieve and<br />

maintain, or combined or conspired to achieve and<br />

maintain, a monopoly over the sale of hospital<br />

supplies, the sale of hospital supplies in e-commerce,<br />

and over the capitalization of healthcare technology<br />

companies and supply chain management companies in the<br />

several Stated of the United States; and have used,<br />

attempted to use, or combined and conspired to use,<br />

their monopoly power and interlocking directors to<br />

affect competition in the sale of hospital supplies,<br />

the sale of hospital supplies in e-commerce, and over<br />

the capitalization of healthcare technology companies<br />

and supply chain management companies sale of the same<br />

in the several States of the United States in violation<br />

of 15 U.S.C. § 19.”<br />

8. Plaintiff attempts to assert a RICO claim, but fails to<br />

allege a racketeering act, a pattern of racketeering, or a<br />

RICO injury;<br />

The plaintiff has adequately alleged the existence of<br />

a RICO enterprise and that the Novation defendants is part<br />

of the association in fact that comprises the enterprise.<br />

a. Enterprise<br />

Allegations of the existence of a RICO enterprise must<br />

meet only the "notice pleading" requirements of Fed.R.Civ.<br />

Pro. 8. Trustees of Plumbers and Pipefitters 886 F.Supp.<br />

1134, 1144-45 (S.D.N.Y.1995)' Nat'l Pension Fund v.<br />

Transworld Mech., Inc., 886 F.Supp. 1134, 1144-45<br />

(S.D.N.Y.1995); Azurite Corp. v. Amster & Co., 730 F.Supp.<br />

571 (S.D.N.Y.1990).<br />

20<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5940


The enterprise was alleged to have committed predicate<br />

acts in violation of 18 U.S.C. § 1962(c) and they were<br />

alleged with the required specificity and identified which<br />

defendants committed which acts.<br />

"To sufficiently state a RICO claim, [p]laintiffs must<br />

plead `(1) conduct, (2) of an enterprise, (3) through a<br />

pattern, (4) of racketeering activity.'" Cyber Media Group,<br />

Inc. v. Island Mortgage Network, Inc., 183 F.Supp.2d 559,<br />

578 (E.D.N.Y. 2002) (quoting Sedima, S.P.R.L. v. Imrex Co.,<br />

Inc., 473 U.S. 479, 496, 105 S.Ct. 3275, 87 L.Ed.2d 346<br />

(1985)).”<br />

Calabrese v. Csc Holdings, Inc., 283 F.Supp.2d 797 at<br />

807 (E.D.N.Y., 2003). See also Krear v. Malek, 961 F.Supp.<br />

1065 (E.D. Mich., 1997):<br />

“Regardless, plaintiffs have sufficiently alleged an<br />

"enterprise" in that they have alleged an associationin-fact<br />

between Lease Equities, NBF, NBF Cable, Turner<br />

and Malek. See Frank v. D'Ambrosi, 4 F.3d 1378, 1386<br />

(6th Cir.1993). In Frank, the Sixth Circuit stated<br />

that: "To satisfy the enterprise requirement, an<br />

association-in-fact must be an ongoing organization,<br />

its members must function as a continuing unit, and it<br />

must be separate from the pattern of racketeering<br />

activity in which it engages." Id. (citing United<br />

States v. Turkette, 452 U.S. 576, 583, 101 S.Ct. 2524,<br />

2528-29, 69 L.Ed.2d 246 (1981)).<br />

Plaintiffs have properly alleged that the<br />

racketeering activity, i.e., the sale of notes through<br />

Lease Equities to perpetuate the alleged Ponzi scheme,<br />

is distinct from the association-in-fact which<br />

associated for legitimate business purposes, to wit:<br />

Lease Equities entered into legitimate leases with<br />

third parties; NBF Cable entered into legitimate cable<br />

television contracts; and Lease Equities was a secured<br />

creditor of NBF Cable.<br />

Third, plaintiffs have sufficiently alleged,<br />

under § 1962(d), that defendants conspired to violate<br />

§§ 1962(b) and (c). To state a claim under § 1962(d), a<br />

plaintiff must plead that the defendant agreed to join<br />

21<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5941


the conspiracy, agreed to commit predicate acts, and<br />

knew that those acts were part of a pattern of<br />

racketeering activity. See Glessner v. Kenny, 952 F.2d<br />

702, 714 (3rd Cir. 1991). While plaintiffs have not<br />

used the word "agreement" per se, they have stated that<br />

defendants Malek, Turner and Lease Equities "have<br />

conspired to violate RICO," and have well-pleaded a set<br />

of facts from which a conspiracy can be inferred in the<br />

FARCS. See Baumer v. Pachl, 8 F.3d 1341, 1346 (9th<br />

Cir.1993); Manning v. Stigger, 919 F.Supp. 249, 254<br />

(E.D.Ky.1996).”<br />

Krear v. Malek, 961 F.Supp. 1065 at 1070-1071 (E.D.<br />

Mich., 1997).<br />

b. RICO Conspiracy<br />

The complaint alleges the Novation defendants are part<br />

of a RICO conspiracy. Plaintiffs have alleged that the<br />

defendant First Franklin engaged in a conspiracy to commit<br />

the acts mentioned above in violation of 18 U.S.C. §<br />

1962(d). 18 U.S.C. § 1962(d) states: "It shall be unlawful<br />

for any person to conspire to violate any of the provisions<br />

of subsection (a), (b), or (c) of this section." 18 U.S.C.<br />

§ 1962(d).<br />

c. No Overt Act Required<br />

The Supreme Court's 1997 decision Salinas v. United<br />

States, 522 U.S. 52, 118 S.Ct. 469, 139 L.Ed.2d 352, is<br />

controlling. The Supreme Court held that plaintiffs need<br />

only allege that defendants "knew of and agreed to<br />

facilitate the scheme." Id. at 478.<br />

22<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5942


There is no requirement of some overt act or<br />

specific act in the [RICO] statute before us, unlike the<br />

general conspiracy provision applicable to federal crimes,<br />

which requires that at least one of the conspirators have<br />

committed an `act to effect the object of the conspiracy.'<br />

§ 371:<br />

“A [RICO] conspirator must intend to further an<br />

endeavor which, if completed, would satisfy all of the<br />

elements of a substantive criminal offense, but it<br />

suffices that he adopt the goal of furthering or<br />

facilitating the criminal endeavor ... One can be a<br />

conspirator by agreeing to facilitate only some of the<br />

acts leading to the substantive offense. It is<br />

elementary that a [RICO] conspiracy may exist and be<br />

punished whether or not the substantive crime ensues,<br />

for the conspiracy is a distinct evil, and so<br />

punishable in itself.”<br />

Salinas, 118 S.Ct. at 476-77.<br />

The Novation defendants do not refute the conduct of<br />

the other defendants. Having established a RICO conspiracy,<br />

the Novation defendants must make a factual showing to<br />

escape. "Once a conspiracy is shown to exist, the evidence<br />

sufficient to link another defendant to it need not be<br />

overwhelming." United States v. Diaz, 176 F.3d 52, 97 (2d<br />

Cir.1999) (quoting United States v. Amato, 15 F.3d 230, 235<br />

(2d Cir.1994)). Plaintiff’s § 1962(d) allegations suffice<br />

to satisfy Salinas.<br />

"[o]nce a RICO enterprise is established, a defendant<br />

may be found liable even if he does not have specific<br />

knowledge of every member and component of the<br />

23<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5943


enterprise." Mason Tenders District Council Pension<br />

Fund v. Messera, 1996 WL 351250 at *6 (S.D.N.Y.1996)<br />

("Whether or not this conduct is viewed as being at the<br />

core of the enterprise ..."). Furthermore, "[t]he RICO<br />

statute has been repeatedly construed to cover both<br />

insiders as well as those peripherally connected to a<br />

RICO enterprise, particularly where the "outsiders" are<br />

alleged to have engaged in kick-backs in order to<br />

influence the enterprise's decision." Id. Azrielli v.<br />

Cohen Law Offices, 21 F.3d 512, 514-15, 521 (2d<br />

Cir.1994) (Judge Kearse held that the district court<br />

should not have dismissed the § 1962(c) claim against<br />

defendant who served as "the middle person in [a] flip<br />

sale" of a building "`by allowing his name to be used<br />

on the bogus contract and showing up at the<br />

closing.'").”<br />

In re Sumitomo Copper Litigation, 104 F.Supp.2d 314<br />

(S.D.N.Y., 2000).<br />

To be convicted of conspiracy to violate RICO under §<br />

1962(d), the conspirator need not himself have committed or<br />

agreed to commit the two or more predicate acts, as long as<br />

each agreed to act in furtherance of the scheme. Salinas v.<br />

United States, 522 U.S. 52, 63, 118 S.Ct. 469, 139 L.Ed.2d<br />

352 (1997). Under this statute, there is no requirement of<br />

some overt act in furtherance of the conspiracy. Id.<br />

9. Plaintiff’s USA Patriot Act claim is a legally valid<br />

private cause of action under that Act as a matter of law.<br />

There are numerous expressly stated private causes of<br />

action under USA PATRIOT Act Public Law 107–56 ‘‘Uniting<br />

and Strengthening America by Providing Appropriate Tools<br />

Required to Intercept and Obstruct Terrorism (USA PATRIOT<br />

ACT) Act of 2001’’ contains private rights of action even<br />

24<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5944


expressly stated in the acts subheadings; SEC. 223. CIVIL<br />

LIABILITY FOR CERTAIN UNAUTHORIZED DISCLOSURES and the<br />

plaintiff’s averred malicious reporting to which there is a<br />

private right in SEC. 355 which states:<br />

‘‘(3) MALICIOUS INTENT.—Notwithstanding any other<br />

provision of this subsection, voluntary disclosure made<br />

by an insured depository institution, and any director,<br />

officer, employee, or agent of such institution under<br />

this subsection concerning potentially unlawful<br />

activity that is made with malicious intent, shall not<br />

be shielded from liability from the person identified<br />

in the disclosure.” [ emphasis added ].<br />

Additional private rights of action are communicated in<br />

sections that immunize “good faith” disclosure of<br />

information from third parties. The qualifying of immunity<br />

to third parties’ causes of action for civil liability are<br />

expressions of Congressional intent for private rights of<br />

action; i.e. § 215 of USA Patriot amends FISA § 501(e) (as<br />

amended): “A person who, in good faith, produces tangible<br />

things under an order pursuant to this section shall not be<br />

liable to any other person for such production.”<br />

10. US District Courts Recognize USA PATRIOT Act Private<br />

Rights of Action<br />

It is unclear how the Novation defendants state such a<br />

clearly erroneous assertion as the non existence of private<br />

rights of action under the USA PATRIOT Act when it is<br />

contradicted by case law:<br />

25<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5945


“Section 315 of the Patriot Act amends and expands 18<br />

U.S.C. § 1956(c)(7), a RICO provision that establishes<br />

money-laundering as a predicate act. Pub.L. No. 107-56,<br />

§ 315; or 18 U.S.C. § 1961(1).”<br />

European Community v. Japan Tobacco, Inc., 186<br />

F.Supp.2d 231 at pg. 238 (E.D.N.Y., 2002).<br />

“…as part of the USA-PATRIOT Act, the Congress again<br />

amended § 2520 to add that an aggrieved party could<br />

recover from an intercepting "person or entity, other<br />

than the United States." Pub.L. No. 107-56, § 223, 115<br />

Stat. 293, 384”<br />

Williams v. City of Tulsa, Ok, 393 F.Supp.2d 1124<br />

(N.D. Okla., 2005)<br />

“Finally, section 2520(a) was again amended in 2001 by<br />

the USA Patriot Act, which added the phrase "other than<br />

the United States" following "person or entity." See<br />

Uniting and Strengthening America by Providing<br />

Appropriate Tools Required to Intercept and Obstruct<br />

Terrorism (USA PATRIOT ACT) Act of 2001, Pub. L. No.<br />

107-56, 115 Stat. 272 (2001). Thus, as currently<br />

enacted, section 2520(a) states that "any person whose<br />

wire, oral, or electronic communication is intercepted,<br />

disclosed, or intentionally used in violation of this<br />

chapter may in a civil action recover from the person<br />

or entity, other than the United States, which engaged<br />

in that violation such relief as may be appropriate."<br />

18 U.S.C.A. § 2520(a) (West Supp. 2003) (emphasis<br />

added).”<br />

Huber v. North Carolina State University, No. COA03-<br />

145 (N.C. App. 4/20/2004) (N.C. App., 2004).<br />

11. Plaintiff’s case has been brought in good faith.<br />

The complaint alleges the Novation defendants knew of<br />

and participated in the efforts to deny the plaintiff legal<br />

representation. The Novation defendants overtly<br />

26<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5946


participated in a pleading to prevent Sam Lipari from being<br />

substituted. In evaluating a dismissal the allegations in<br />

the complaint are taken as true. The question of dismissal<br />

does not concern the conduct of the plaintiff to avoid<br />

injustly being deprived of redress through representation.<br />

12. Plaintiff Has an Unresolved/Unripe Antitrust Merger<br />

Claim<br />

The court’s present ruling if unchanged would lead to<br />

another year’s delay when the plaintiff files his antitrust<br />

claim for injury from the merger of Neoforma, Inc. and<br />

GHX,LLC. The defendants would no doubt claim res judicata<br />

and claim preclusion and seek to have the plaintiff<br />

sanctioned without once identifying the transaction date<br />

and whether it was subsequent to the present complaint.<br />

Conclusion<br />

The plaintiff respectfully requests the court<br />

reconsider its opinion and issue a revised opinion in<br />

conformance with controlling applicable law. If the court<br />

follows controlling case law and the express language of<br />

federal statutes, there is no basis for sanctioning the<br />

plaintiff or his former counsel.<br />

Respectfully Submitted,<br />

____________________<br />

Samuel K. Lipari<br />

297 NE Bayview<br />

Lee's Summit, 816-365-1306<br />

27<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5947


saml@medicalsupplychain.com<br />

Pro se<br />

Certificate of Service<br />

I certify that on March 14 th , 2006 I mailed a copy of the<br />

following to:<br />

Mark A. Olthoff , Jonathan H. Gregor, Logan W. Overman,<br />

Shughart Thomson & Kilroy, P.C. 1700 Twelve Wyandotte<br />

Plaza 120 W 12th Street Kansas City, Missouri 64105-1929<br />

Andrew M. Demarea, Corporate Woods Suite 1100, Building<br />

#32 9225 Indian Creek Parkway Overland Park, Kansas<br />

66210 (913) 451-3355 (913) 451-3361 (FAX)<br />

John K. Power, Esq. Husch & Eppenberger, LLC 1700 One<br />

Kansas City Place 1200 Main Street Kansas City, MO<br />

64105-2122 ( Also attorney for the General Electric<br />

defendants and Jeffrey Immelt.)<br />

Stephen N. Roberts, Esq. Natausha Wilson, Esq. Nossaman,<br />

Guthner, Knox & Elliott 34th Floor 50 California Street<br />

San Francisco, CA 94111<br />

Bruce Blefeld, Esq. Kathleen Bone Spangler, Esq. Vinson &<br />

Elkins L.L.P. 2300 First City Tower 1001 Fannin Houston,<br />

TX 77002<br />

____________________<br />

Samuel K. Lipari<br />

297 NE Bayview<br />

Lee's Summit, 816-365-1306<br />

saml@medicalsupplychain.com<br />

Pro se<br />

28<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5948


!"#$%&'%()*+",$-%<br />

.$$/"*#0%)$%()1%<br />

23435%67%8,9-1)0%:;%)%6%@@@25%<br />

2AB4CA3C@A@C54%%%%%#=/D/*#EF/G,H2'*#$%%<br />

%<br />

!<br />

!<br />

"#$%!&'!())*!<br />

!<br />

+,-!./0123$!4#55$%!67!84!93:2;


!"#$%&"'()&$*'+,$&-(%'()!('()&.'/01,"'-0('&#&-')!#&'(0'*&2*!$-'2*03'$-41*$-5'6&"$+!,'<br />

7188,.'1-"&*'()&'!-($(*1%('%(!(1(&%9'6*9':,&+;,&-')!"'"*!2(&"'=!%&"'0-'!"#$%&<br />

'())%*')!#&'<br />

!'=*0!"&*'8&*%8&+($#&


#$%&'(')*+!<br />

!<br />

#,-('.!/0!12%3($.4!<br />

5..6(%'*!76(!8'3$&2)!#9::)*!;42$%+!!).4677+!!<br />

!!!!!!@64%!A6B'(!<br />

! "<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5951


UNITED STATES COURT OF APPEALS<br />

FILED<br />

United States Court of Appeals<br />

Tenth Circuit<br />

FOR THE TENTH CIRCUIT<br />

NOV 8 2004<br />

PATRICK FISHER<br />

Clerk<br />

MEDICAL SUPPLY CHAIN, INC.,<br />

Plaintiff-Appellant,<br />

v.<br />

US BANCORP, NA; US BANK<br />

PRIVATE CLIENT GROUP;<br />

CORPORATE TRUST;<br />

INSTITUTIONAL TRUST AND<br />

CUSTODY; MUTUAL FUND<br />

SERVICES, LLC.; PIPER JAFFRAY;<br />

ANDREW CESERE; SUSAN PAINE;<br />

LARS ANDERSON; BRIAN KABBES;<br />

UNKNOWN HEALTHCARE<br />

SUPPLIER,<br />

No. 03-3342<br />

(D.C. No. 02-CV-2539-CM)<br />

(D. Kan.)<br />

Defendants-Appellees.<br />

ORDER AND JUDGMENT *<br />

Before McCONNELL, HOLLOWAY, and PORFILIO, Circuit Judges.<br />

*<br />

This order and judgment is not binding precedent, except under the doctrines of Exb 17<br />

law of the case, res judicata, and collateral estoppel. The court generally disfavors the<br />

citation of orders and judgments; nevertheless, an order and judgment may be cited under<br />

the terms and conditions of 10th Cir. R. 36.3.<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5952


After examining the briefs and appellate record, this panel has determined<br />

unanimously to grant the partiesí request for a decision on the briefs without oral<br />

argument. See Fed. R. App. P. 34(f); 10th Cir. R. 34.1(G). The case is therefore ordered<br />

submitted without oral argument.<br />

<strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. appeals from the dismissal of its complaint asserting<br />

claims under the Sherman Antitrust Act, the Clayton Antitrust Act, the Hobbs Act, and<br />

the USA Patriot Act, and various state law claims. In dismissing the complaint, the<br />

district court determined that plaintiff failed to state a claim for relief under each of the<br />

antitrust acts and that there was no private right of action under the USA Patriot Act.<br />

Because the district court dismissed all of plaintiffís federal law claims, it declined to<br />

retain jurisdiction over appellantís state law claims. Plaintiff argues that the district court<br />

erred by: 1) dismissing plaintiffís antitrust claims by imposing a heightened pleading<br />

standard, 1 and 2) finding no private right of action under the USA Patriot Act. We review<br />

de novo the district courtís grant of a motion to dismiss pursuant to Fed. R. Civ. P.<br />

12(b)(6). Sutton v. Utah State Sch. for the Deaf & Blind, 173 F.3d 1226, 1236 (10th Cir.<br />

1999).<br />

Having reviewed the briefs, the record, and the applicable law pursuant to the<br />

above-mentioned standard, we conclude that the district court correctly decided this case.<br />

We therefore AFFIRM the challenged decision for the same reasons stated by the district<br />

court in its Memorandum and Order of June 16, 2003. Appellantís Motion to Amend<br />

Complaint on Jurisdictional Grounds is DENIED.<br />

Finally, in the district courtís order, the court reminded plaintiffís counsel of his<br />

obligations under Rule 11 and stated ì[p]laintiffís counsel is advised to take greater care<br />

1<br />

Appellantís brief mentions its Clayton Act and Hobbs Act claims, but appellant<br />

fails to include any argument as to how the district court erred in dismissing those claims.<br />

See Aplt. Br. at 7-8, 19. Any issue with respect to those claims is therefore waived.<br />

Ambus v. Granite Bd. of Educ., 975 F.2d 1555 (10th Cir. 1992).<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5953


in ensuring that the claims he brings on his clientsí behalf are supported by the law and<br />

the facts.î Aplt. App. Vol. II at 402. Plaintiff then proceeded to file this appeal that is not<br />

supported by the law or the facts. Accordingly, we ORDER the plaintiff and plaintiffís<br />

counsel to SHOW CAUSE in writing within twenty days of the date of this order why<br />

they, jointly or severally, should not be sanctioned for this frivolous appeal pursuant to<br />

Fed. R. App. P. 38. See Braley v. Campbell, 832 F.2d 1504, 1510-11 (10th Cir. 1987)<br />

(discussing courtís ability to impose sanctions against clients and their attorneys under<br />

Fed. R. App. P. 38).<br />

Entered for the Court<br />

John C. Porfilio<br />

Circuit Judge<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5954


UNITED STATES COURT OF APPEALS<br />

FOR THE TENTH CIRCUIT<br />

MEDICAL SUPPLY CHAIN, INC.,<br />

v.<br />

Plaintiff-Appellant,<br />

US BANCORP, NA; US BANK PRIVATE CLIENT GROUP;<br />

CORPORATE TRUST; INSTITUTIONAL TRUST AND CUSTODY;<br />

MUTUAL FUND SERVICES, LLC.; PIPER JAFFRAY; ANDREW<br />

CESERE; SUSAN PAINE; LARS ANDERSON; BRIAN KABBES;<br />

UNKNOWN HEALTHCARE SUPPLIER,<br />

Defendants-Appellees.<br />

ANSWER TO SHOW CAUSE ON SANCTIONS<br />

At the close of the US Senate Judiciary Committee's Antitrust<br />

Subcommittee's hearing entitled “Hospital Group Purchasing: How to<br />

Maintain Innovation and Cost Savings” on Tuesday, September 14, 2004,<br />

the subcommittee's chair suggested that the 1.8 trillion dollar market's anticompetitive<br />

behavior might be better corrected with private antitrust<br />

litigation than with new legislation. The plaintiff-appellant <strong>Medical</strong> <strong>Supply</strong><br />

<strong>Chain</strong>, Inc. believes the Sherman Act prohibits the admitted conduct of the<br />

defendants in keeping <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. from competing with the<br />

defendants’ openly publicized combination to restrain trade in hospital<br />

1<br />

Exb 18<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5955


supplies which included the threat of malicious USA PATRIOT Act<br />

reporting and the repudiation of the defendants’ contract to provide <strong>Medical</strong><br />

<strong>Supply</strong> <strong>Chain</strong>, Inc. escrow accounts required for capitalizing its market<br />

entry.<br />

Plaintiff and plaintiff’s counsel continue to recognize and assert that<br />

the district court erred by: 1) dismissing plaintiff’s antitrust claims by<br />

imposing a heightened pleading standard, and 2) finding no private right of<br />

action under the USA Patriot Act.<br />

Plaintiff filed this appeal that is supported by the law and the facts.<br />

Plaintiff incorporates by reference plaintiff’s appellate opening and reply<br />

briefs along with the supporting record contained in the appendices for<br />

docket # 03-3342 and docket # 02-3443 including the evidentiary<br />

attachments of both parties in support of their motions for pre-hearing relief.<br />

The defendant U.S. Bank was in contract with <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>,<br />

Inc. to provide escrow accounts. U.S. Bank broke the contract, <strong>Medical</strong><br />

<strong>Supply</strong> <strong>Chain</strong>, Inc.’s complaint (written shortly after to obtain emergency<br />

injunctive relief and avoid the resulting irreparable harm 1 ) alleged the<br />

1<br />

The defendant US Bancorp Piper Jaffray’s adverse admission of<br />

economic research reveals that a web based electronic marketplace for<br />

hospital supplies like <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. would eliminate 83 billion<br />

dollars in inefficiency. Plaintiff’s Amended Complaint 27.<br />

2<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5956


eaking of the contract was a result of exclusive dealing agreements<br />

between the defendants which included Unknown Healthcare Supplier.<br />

“[T]he exclusive dealing arrangement itself satisfies the § 1 requirement of<br />

coordinated action.” Geneva Pharmaceuticals Technology Corp. v. Barr<br />

Laboratories Inc., No. 02-9222 at pg. 45 (Fed. 2nd Cir. 10/18/2004) (Fed.<br />

2nd Cir., 2004).<br />

<strong>Medical</strong> <strong>Supply</strong>’s complaint satisfied the two or more independent<br />

actors requirement for a Sherman 1 prohibited combination. To prove a § 1<br />

violation, a plaintiff must demonstrate: (1) a combination or some form of<br />

concerted action between at least two legally distinct economic entities that<br />

(2) unreasonably restrains trade. See Tops Mkts., 142 F.3d at 95; Capital<br />

Imaging Assocs., P.C. v. Mohawk Valley Med. Assocs., Inc., 996 F.2d 537,<br />

542 (2d Cir. 1993).<br />

The plaintiff’s complaint in the alternative alleged the actions of the<br />

defendant US Bancorp companies as a single firm in breaking the contract<br />

violated Sherman 2:<br />

“The leading case imposing § 2 liability for refusal to deal with<br />

competitors is Aspen Skiing Co. v. Aspen Highlands Skiing Corp., 472<br />

U. S. 585, in which the Court concluded that the defendant's<br />

termination of a voluntary agreement with the plaintiff suggested a<br />

willingness to forsake short-term profits to achieve an anticompetitive<br />

end.” [emphasis added]<br />

3<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5957


Verizon Communications Inc. v. Law Offices of Trinko, 540 U.S. ___<br />

(U.S. 1/13/2004) (2004).<br />

Finally, the plaintiff and plaintiff’s counsel decline to accept Hon.<br />

Judge John C. Porfilio’s revisionist pronouncement about the lack of a<br />

private right of action in the USA PATRIOT Act.<br />

Public Law 107–56 ‘‘Uniting and Strengthening America by<br />

Providing Appropriate Tools Required to Intercept and Obstruct Terrorism<br />

(USA PATRIOT ACT) Act of 2001’’ contains at least two private rights of<br />

action 2 ; SEC. 223. CIVIL LIABILITY FOR CERTAIN UNAUTHORIZED<br />

DISCLOSURES and the plaintiff’s often averred malicious reporting to<br />

which there is a private right in SEC. 355 which states ‘‘(3) MALICIOUS<br />

INTENT.—Notwithstanding any other provision of this subsection,<br />

voluntary disclosure made by an insured depository institution, and any<br />

director, officer, employee, or agent of such institution under this subsection<br />

concerning potentially unlawful activity that is made with malicious intent,<br />

2<br />

Additional private rights of action are communicated in sections that<br />

immunize “good faith” disclosure of information from third parties. The<br />

qualifying of immunity to third parties’ causes of action for civil liability are<br />

expressions of Congressional intent for private rights of action; i.e. § 215 of<br />

USA Patriot amends FISA § 501(e) (as amended): “A person who, in good<br />

faith, produces tangible things under an order pursuant to this section shall<br />

not be liable to any other person for such production.”<br />

4<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5958


shall not be shielded from liability from the person identified in the<br />

disclosure.” [ emphasis added ].<br />

Plaintiff’s counsel calls this court’s attention to the fact that<br />

irreparable harm has been suffered by the plaintiff and the nation’s hospitals,<br />

including loss of human lives while respectful requests for relief have been<br />

met with the trial court’s dismissal, this court’s denial of pre-hearing relief 3<br />

and the present decision.<br />

The plaintiff’s counsel has responded with timely well researched<br />

pleadings based upon a thorough investigation of the facts and applicable<br />

law. <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong>, Inc. will continue to seek a hearing from a court<br />

that will do the same.<br />

Respectfully Submitted<br />

S/Bret D. Landrith<br />

___________________<br />

Bret D. Landrith<br />

Kansas Supreme Court ID # 20380<br />

# G33,<br />

2961 SW Central Park,<br />

Topeka, KS 66611<br />

1-785-267-4<strong>08</strong>4<br />

landrithlaw@cox.net<br />

3<br />

The trial court based its dismissal in part upon this court’s denial of pre<br />

hearing relief in #02-3443, a decision the plaintiff’s memorandums of<br />

6/26/03 and 7/10/03 showed surprisingly contradicted Tenth Circuit<br />

controlling authority.<br />

5<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5959


Certificate of Service<br />

I certify I have served two copies of this pleading upon opposing<br />

counsel listed below via U.S. Mail on November 10 th , 2004.<br />

Mark A. Olthoff<br />

Shughart Thomson & Kilroy, PC--Kansas City<br />

Twelve Wyandotte Plaza<br />

120 West 12th Street<br />

Kansas City, MO 64105<br />

816-421-3355<br />

Fax: 816-374-0509<br />

Email: molthoff@stklaw.com<br />

6<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5960


!<br />

!"#$%&'"(&)*+,'-,..&+'/&/$%,0'+-$%&1+'%+%&!,-23&1+'%+%&+%&-4$&)*+5$&".&-6,+*7&<br />

&<br />

! ! ! ! ! ! ! ! ! ! ! !<br />

! """""""""""""""""""!<br />

&<br />

&<br />

&<br />

&<br />

86$-&97&:+'/6,-4&<br />

#$%&'&()*&+,!<br />

!<br />

;


! "#!$%&!'()&*+,-(&)#!).!%&*&/0!1&*$,20!$%3$!"!13'+&)!3!$*'&!3()!1.**&1$!1.40!<br />

.2!$%&!2.*&-.,(-!$.!/&!)&4.+,$&)!,(!$%&!5676!83,9#!4.+$3-&!4*&43,)#!.(!$%,+!:;$%!<br />

)30!.2!>;!3))*&++&)!$.!<br />

!<br />

@3$*,1A!B6!C1D3'-%9,(!<br />

C3*A!E6!F9$%.22!<br />

E$$.*(&0+!2.*!G&2&()3($+!<br />

7',$&!:H>>!<br />

H>!7.'$%!7,I$%!7$*&&$!<br />

C,((&34.9,+#!C;K:JLM!<br />

N3I!O:;KPJ>K;OJP!<br />

Q&*$,2,&)!/0#!<br />

!<br />

RRRRRRRRRRRRRR!<br />

S*&$!G6!D3()*,$%!<br />

T3(+3+!7'4*&8&!Q.'*$!U!;>PM>!<br />

E$$.*(&0!2.*!@93,($,22!C7Q"!<br />

@6F6!S.I!:VK;:PV!<br />

T3(+3+!Q,$0#!T7!OO::VK>:PV!<br />

:6M:OK;;>KJ:;M!<br />

:6O;>6;P:KVOPO!<br />

N3I!:KVPJKHJLKOJLH!<br />

!<br />

###########################################################<br />

, ! F8(,1&99#!"(16!1.843(0!4*&++!*&9&3+&!)3$&)!E'-'+$!>V#!;>>:!<br />

!<br />

,, ! B'90!;V!W@X>;!<br />

!<br />

= !;!<br />

!<br />

=,, ! !3$4*5(%/0$6'--07$",8-/2(*+$9*%*(:*$;>;!<br />

! !"<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5962


#############################################################################################################################################################################<br />

!<br />

"### ! !!"#$%&'()*"+'$),-".$*/"0%12"34&'"5)2678"19":172".$-,691*-$!%&'()*#+,-!<br />

.)/0$!12!3#456-!78'-!9::9!<br />

!<br />

#; ";79&'7&9"0),,*2":1718&5+545@!AB-!ACCC!<br />

!<br />

; !DE!%71FGHI!17!J5!6#05!,&45K)'5!*5J6!)@0#+/5!@5')@(#*'!L)//#*'!")/856!&L!<br />

"5*<strong>08</strong>@5!L8*(6!#*+/8(#*'!0,&65!&L!DE!%71FGHI!17-!()05(!G+0=!AM-9::9#<br />

;# #15&L&@4)=+&4-!N*+!I@566!H5/5)65$!O)@+,!P:-!9:::!<br />

15&L&@4)=+&4-!N*+=!Q17E>7RS!1TGUV-!T+/#K6W6!F&@K&@)0#&*!Q17E>7RS!TFXIV!<br />

)*(!#@5+0=+&4!I@566!H5/5)65!<br />

O)@+,!9a-!9:::!<br />

#<br />

;#" !0919&"09&,-"),"#'$B&"$("C&-&1'@D"19"#6,&'"E1(('12F!O5#6*5@-!b5LL$!I8'50!E&8*(!<br />

%86#*566!b&8@*)/!G+0!9A-!9::9!<br />

!<br />

;" !NIG4&*#0&@=+&4!()0))65!<br />

!<br />

;"# !>$


#############################################################################################################################################################################<br />

!<br />

"#$$ !%&!'()*+,-!-.-/,!0(11,(2!3456784!1759!:4;!!@@A!<br />

!<br />

"#$$$ #!"#$%&'(#)*"+,&%+,#)-""#,)."/,0)10)2#%/3)')*4$$(0)540%/3)67"4$B!CD>!(56$687


Exb 20<br />

<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5965


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5966


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5967


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5968


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5969


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5970


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5971


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5972


<strong>08</strong>-<strong>3187</strong> <strong>Medical</strong> <strong>Supply</strong> <strong>Chain</strong> vs. Neoforma <strong>Volume</strong> XV 5973

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!